PREDICATE,SUBJECT_NAME,OBJECT_NAME,Factuality_Score,Cancer_Type,Category,text,Predicted_Cancer_Type
AFFECTS,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FGFR2 gene|FGFR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR2 gene|FGFR2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NDUFB3|TNFAIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NDUFB3|TNFAIP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAD51 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Topotecan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Topotecan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ACSL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ACSL4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body mass index,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Body mass index Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metabolites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolites Malignant neoplasm of breast,Female Breast Cancer
CAUSES,anthracene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,anthracene Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"oxoguanine glycosylase 1, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","oxoguanine glycosylase 1, human Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Malignant Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Topoisomerase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Topoisomerase Breast Carcinoma,Female Breast Cancer
CAUSES,Methylcholanthrene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Methylcholanthrene Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,Cadmium Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,C-reactive protein level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-reactive protein level Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Proliferation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Proliferation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinoma of the Large Intestine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma of the Large Intestine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Single Nucleotide Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CD44 gene|CD44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Cycle Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Cycle Progression Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Status Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MTRR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTRR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MTA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Growth Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pregnancy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DYRK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DYRK2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Velcade,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Velcade Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hormone replacement therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone replacement therapy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like-Growth Factor I Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lycopene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lycopene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SMURF1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SMURF1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Metabolic Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Metabolic Diseases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"DNA, Mitochondrial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Mitochondrial Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyphenols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Obesity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Etodolac,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Etodolac Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MST1R gene|MST1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MST1R gene|MST1R Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lactation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lactation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Well in self,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Well in self Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Human Papillomavirus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Human Papillomavirus Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1-Phosphatidylinositol 3-Kinase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgens Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TARBP2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,TARBP2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Tobacco smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tobacco smoke Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Annexin A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAD51 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BCL9 gene|BCL9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL9 gene|BCL9 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GATA3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,GATA3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CHEK2 gene|CHEK2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Carcinoma of Male Breast,Female Breast Cancer
PREDISPOSES,beta-cryptoxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-cryptoxanthin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,response Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physical activity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signal Pathways,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Signal Pathways Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TARBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TARBP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SELENOP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SELENOP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,polyphenols,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,polyphenols Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Weight Gain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Weight Gain Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,pleiotropism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pleiotropism Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Enhancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Enhancer Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GATA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prognostic Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prognostic Factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Monocyte Chemoattractant Protein-1|CCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1|CCL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Complication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Complication Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,kahweol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,kahweol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,INPP5J,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,INPP5J Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,heparanase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,heparanase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fitness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fitness Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Progestins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTGS2 gene|PTGS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Nitrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nitrogen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GLTSCR2 gene|NOP53,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"GLTSCR2 gene|NOP53 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Polymorphism, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Polymorphism, Genetic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Malignant Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethanol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ERBB2 gene|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer invasive NOS,Female Breast Cancer
CAUSES,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endocrine therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Endocrine therapy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Base Excision Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Base Excision Repair Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenesis Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adiponectin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CENPN,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,CENPN Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Reproductive History,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reproductive History Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Menopausal Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menopausal Status Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KISS1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KISS1R Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ABCB1 gene|ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCB1 gene|ABCB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Regular exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Regular exercise Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antisense RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Antisense RNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF410,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF410 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diabetes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diabetes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Total cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Total cholesterol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nuts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nuts Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Therapeutic procedure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Psychosocial problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Psychosocial problem Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Red meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Red meat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lesion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lesion Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Single Nucleotide Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Hypothalamic inhibiting factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Hypothalamic inhibiting factor Breast cancer metastatic,Female Breast Cancer
AUGMENTS,DNM1 gene|DNM1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,DNM1 gene|DNM1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Heterocyclic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heterocyclic Amines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin E Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Primigravida,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Primigravida Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphotransferases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Stromal Cell-Derived Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stromal Cell-Derived Factor 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pharmacotherapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzymes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Behavior Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isoflavones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Taxotere,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Taxotere Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,S100A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Calcium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antioxidants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antioxidants Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,educational intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",educational intervention Malignant neoplasm of breast,Female Breast Cancer
CAUSES,anthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,anthracene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Receptors, Opioid, delta",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Opioid, delta Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Amino Acyl-tRNA Synthetases|TRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Amino Acyl-tRNA Synthetases|TRNA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antibodies Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,AKR1C3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AKR1C3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Radial scar,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Radial scar Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,methyl 4-azidophenylacetimidate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methyl 4-azidophenylacetimidate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methionine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Catechol O-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catechol O-Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TLR3 gene|TLR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TLR3 gene|TLR3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vascular Endothelial Growth Factor Receptor-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,dihydroxyacetone sulfate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,dihydroxyacetone sulfate Breast cancer metastatic,Female Breast Cancer
AFFECTS,Estradiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Estradiol Breast cancer metastatic,Female Breast Cancer
AFFECTS,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Apoptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Apoptosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Taxanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Taxanes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fulvestrant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fulvestrant Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BSG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BSG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thromboembolic event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Thromboembolic event Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CXCR4 gene|CXCR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Alpha-MMC protein, Momordica charantia",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Alpha-MMC protein, Momordica charantia Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Ovarian Serous Adenocarcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Ovarian Serous Adenocarcinoma Breast Carcinoma,Female Breast Cancer
CAUSES,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neoplasm Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor|AHR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HRH4 gene|HRH4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HRH4 gene|HRH4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,6-sulfatoxymelatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6-sulfatoxymelatonin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Methylnitrosourea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methylnitrosourea Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carrier of disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Carrier of disorder Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Fatty Acids, Omega-6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-6 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Not significant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Not significant Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Citrate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Citrate Breast Carcinoma,Female Breast Cancer
DISRUPTS,RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RASAL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Genistein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Estrogens, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Synthetic Malignant neoplasm of breast",Female Breast Cancer
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1A gene|CDKN1A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bilateral salpingectomy with oophorectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bilateral salpingectomy with oophorectomy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Arginine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Drug resistance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Drug resistance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Wine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Wine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Menopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menopause Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcohol consumption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endocrine therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Meat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Smoking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Smoking Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sulfuretin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,sulfuretin Breast cancer metastatic,Female Breast Cancer
AFFECTS,Proto-Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogenes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Expression Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FGF10 gene|FGF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF10 gene|FGF10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSF1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Iodine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iodine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast cancer metastatic,Female Breast Cancer
AFFECTS,Protein Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Expression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Clusterin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Clusterin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cytokine Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cytokine Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PRKACA gene|PRKACA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRKACA gene|PRKACA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Fats Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Eosinophilia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Eosinophilia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin Resistance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin Resistance Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proto-Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogenes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MAD2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAD2L2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Drugs, Investigational",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,"Drugs, Investigational Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Urokinase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Urokinase Breast cancer metastatic,Female Breast Cancer
CAUSES,Neoplasm Metastasis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Breast Carcinoma,Female Breast Cancer
AUGMENTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gamma-tocotrienol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gamma-tocotrienol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TERT gene|TERT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TERT gene|TERT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EGFR gene|EGFR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Breast cancer metastatic,Female Breast Cancer
AFFECTS,Oxidative Stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxidative Stress Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Solvents,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical,Solvents Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,palm oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,palm oil Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tongue feature,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tongue feature Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Blueberries,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Blueberries Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,ITK gene|ITK,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ITK gene|ITK Breast cancer metastatic,Female Breast Cancer
AFFECTS,inhibitors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,inhibitors Breast cancer metastatic,Female Breast Cancer
AFFECTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein tyrosine phosphatase 1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Triclosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Triclosan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Threonine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Threonine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Medical History,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Medical History Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Progestins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CLOCK gene|CLOCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLOCK gene|CLOCK Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CA-15-3 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CA-15-3 Antigen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MicroRNAs,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer metastatic,Female Breast Cancer
AFFECTS,Genomic Stability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Genomic Stability Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methylation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Doxorubicin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,bevacizumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bevacizumab Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prior Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prior Therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Medical Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Medical Imaging Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ATM Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM Gene Mutation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,inner centromere protein|INCENP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",inner centromere protein|INCENP Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN132 gene|MIR132,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,MIRN132 gene|MIR132 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Tumorigenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumorigenesis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Xenograft procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Xenograft procedure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ginkgo biloba extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ginkgo biloba extract Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCNB1 gene|CCNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNB1 gene|CCNB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,chemokine receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chemokine receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Therapeutic procedure Breast cancer metastatic,Female Breast Cancer
AFFECTS,Germ-Line Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vimentin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vimentin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MTR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carotenoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adverse reactions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adverse reactions Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oxidoreductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxidoreductase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Baclofen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Baclofen Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Diphosphonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diphosphonates Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Folate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ORALIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ORALIT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Testosterone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,c-myc Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Genes|MYC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carotenoids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,alpha-carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha-carotene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Breast Carcinoma",Female Breast Cancer
AFFECTS,Treatment Protocols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Treatment Protocols Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DHX9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DHX9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cigarette Smoking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cigarette Smoking Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,stromelysin 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,stromelysin 3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Worried,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Worried Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BARD1 gene|BARD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BARD1 gene|BARD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Raloxifene Hydrochloride,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Raloxifene Hydrochloride Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,ERBB3 gene|ERBB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB3 gene|ERBB3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Somatic mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Somatic mutation Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ANO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ANO1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diet Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Operative Surgical Procedures,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Operative Surgical Procedures Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Klinefelter's Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Klinefelter's Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Translation, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Translation, Genetic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,alpha Tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha Tocopherol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Carrier status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carrier status Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Doxorubicin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Doxorubicin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,distilled alcoholic beverage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,distilled alcoholic beverage Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Flap Endonuclease-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flap Endonuclease-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Contraceptives, Oral Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Whole milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Whole milk Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PARITY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARITY Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lymph Node Involvement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lymph Node Involvement Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body Weight Changes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Body Weight Changes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,osteopontin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,osteopontin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Progestins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cessation of life,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cessation of life Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Ether, Ethyl",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Ether, Ethyl Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,humoral defense mechanism (sensu Vertebrata),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,humoral defense mechanism (sensu Vertebrata) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,gonadotropin inhibitor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,gonadotropin inhibitor Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Adverse effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adverse effects Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Androgens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Androgens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,BRCA2 gene|BRCA2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Familial cancer of breast,Female Breast Cancer
PREDISPOSES,High fat diet NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,High fat diet NOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Polychlorinated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polychlorinated Biphenyls Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,protein kinase C eta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase C eta Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Steroid hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroid hormone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Conflict (Psychology),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Conflict (Psychology) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYR61,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CYR61 Breast cancer metastatic,Female Breast Cancer
AFFECTS,anastrozole,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,anastrozole Breast cancer metastatic,Female Breast Cancer
AFFECTS,Dietary Modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Modification Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Childbirth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Childbirth Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prostate-Specific Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Prostate-Specific Antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Previous pregnancies 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Previous pregnancies 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Infertility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Infertility Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proanthocyanidins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proanthocyanidins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemotherapy-Oncologic Procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chemotherapy-Oncologic Procedure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Systemic Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Systemic Therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Folate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Folate Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Atypical lobular hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atypical lobular hyperplasia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BCHE|SNORA73A|ENOPH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BCHE|SNORA73A|ENOPH1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tumor Angiogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Angiogenesis Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant Neoplasms,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Malignant Neoplasms Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Melatonin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diet Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Markers Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,inhibitors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,inhibitors Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Norplant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Norplant Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Chemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Chemicals Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cholecalciferol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Menopausal symptom,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menopausal symptom Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Matrix Metalloproteinases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Breast Carcinoma,Female Breast Cancer
AFFECTS,inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,inhibitors Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,E-Cadherin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,E-Cadherin Breast cancer invasive NOS,Female Breast Cancer
CAUSES,"Herpesvirus 4, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,"Herpesvirus 4, Human Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Gene-Environment Interaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene-Environment Interaction Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Galectin 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Galectin 3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyperinsulinism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperinsulinism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estradiol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,DNA Adducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Adducts Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Ethylnitrosourea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethylnitrosourea Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beverages Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Axillary Lymph Node Dissection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Axillary Lymph Node Dissection Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA1 Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 Mutation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Meat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Meat intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Free estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Free estradiol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Operative Surgical Procedures,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Operative Surgical Procedures Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Mammary Tumor Virus, Mouse",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,"Mammary Tumor Virus, Mouse Breast Carcinoma",Female Breast Cancer
AFFECTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,Cytomegalovirus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Cytomegalovirus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Linoleic Acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Linoleic Acid Breast cancer metastatic,Female Breast Cancer
CAUSES,DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KAT6A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KAT6A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vegetables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vegetables Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibroblast Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Breast Diseases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Carcinogens, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Genistein Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Methylnitrosourea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Methylnitrosourea Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Smoker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Smoker Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Deficiency of testosterone biosynthesis,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Deficiency of testosterone biosynthesis Carcinoma of Male Breast,Female Breast Cancer
CAUSES,SV40 T Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",SV40 T Proteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Hydroxyestrones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxyestrones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dietary Fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Fiber Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diet Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Breast Carcinoma,Female Breast Cancer
CAUSES,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgens Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pesticides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mastectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mastectomy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,dehydroepiandrosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dehydroepiandrosterone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paclitaxel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oils Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen excess,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogen excess Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Breast Carcinoma",Female Breast Cancer
CAUSES,Dactinomycin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Dactinomycin Breast Carcinoma,Female Breast Cancer
AUGMENTS,Aromatase Inhibitors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Aromatase Inhibitors Breast cancer metastatic,Female Breast Cancer
AFFECTS,Early Diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Early Diagnosis Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin C intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin C intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Combined Oral Contraceptives,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Combined Oral Contraceptives Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proto-Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogenes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TFF1 gene|TFF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TFF1 gene|TFF1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Breast Carcinoma,Female Breast Cancer
AFFECTS,Breast cancer recurrent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer recurrent Malignant neoplasm of breast,Recurrent Breast Cancer
CAUSES,Serum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Serum Malignant neoplasm of breast,Female Breast Cancer
CAUSES,v-Ha-ras Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,v-Ha-ras Oncogenes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Fats Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Genes, Dominant",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Dominant Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Dysplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dysplasia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dehydroepiandrosterone Sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dehydroepiandrosterone Sulfate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tetradecanoylphorbol Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Tetradecanoylphorbol Acetate Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Nuclear Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PREDICTED,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PREDICTED Malignant neoplasm of breast,Female Breast Cancer
CAUSES,methylurea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,methylurea Breast Carcinoma,Female Breast Cancer
AFFECTS,Birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Birth Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Fibrocystic Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Breast Fibrocystic Disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ras Oncogene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ras Oncogene Breast Carcinoma,Female Breast Cancer
DISRUPTS,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fibronectins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fibronectins Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Egg Food Product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Egg Food Product Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Melatonin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tenascin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Tenascin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cholestyramine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cholestyramine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Agent Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Progestins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ovulatory,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ovulatory Malignant neoplasm of breast,Female Breast Cancer
CAUSES,4'-deoxydoxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,4'-deoxydoxorubicin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Imidazole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Imidazole Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,paracrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,paracrine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Fats, Unsaturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Fats, Unsaturated Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatomedins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Early menarche,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Early menarche Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Triceps skin fold thickness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Triceps skin fold thickness Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Neoplasm Breast Carcinoma,Female Breast Cancer
CAUSES,Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Genes Familial cancer of breast,Female Breast Cancer
CAUSES,c-myc Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Genes|MYC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cancer-Predisposing Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pregnancy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Pregnancy Breast Carcinoma,Female Breast Cancer
CAUSES,Thyroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormones Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CATHEPSIN D|CTSD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CATHEPSIN D|CTSD Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fusion procedure,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Fusion procedure Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Contraceptives, Oral Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PNMA3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,PNMA3 Breast Carcinoma,Female Breast Cancer
AFFECTS,Hormone replacement therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone replacement therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,body mass,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,body mass Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytotoxic Chemotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic Chemotherapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Amplification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Amplification Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Histopathology,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histopathology Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fluoroscopy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fluoroscopy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Diseases,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Breast Diseases Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Cystic Fibrosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cystic Fibrosis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Gonadotropin-Releasing Hormone Analog,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Gonadotropin-Releasing Hormone Analog Breast Carcinoma,Female Breast Cancer
CAUSES,"Genes, Suppressor",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Genes, Suppressor Breast Carcinoma",Female Breast Cancer
AFFECTS,Therapeutic procedure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Therapeutic procedure Breast Carcinoma,Female Breast Cancer
CAUSES,Fatty Acids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Fatty Acids Breast Carcinoma,Female Breast Cancer
AFFECTS,Alkaline Phosphatase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Alkaline Phosphatase Breast Carcinoma,Female Breast Cancer
AFFECTS,Cholera Toxin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Cholera Toxin Breast Carcinoma,Female Breast Cancer
CAUSES,Propionate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Propionate Breast Carcinoma,Female Breast Cancer
CAUSES,Contraceptive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Contraceptive Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,alpha-latrotoxin receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,alpha-latrotoxin receptor Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Acute leukemia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Acute leukemia Breast cancer metastatic,Female Breast Cancer
AFFECTS,Methoxamine,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Methoxamine Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,diphenyl,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,diphenyl Breast Carcinoma,Female Breast Cancer
AFFECTS,leukemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leukemia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Relaxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Relaxin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,DNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Fucose,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fucose Breast Carcinoma,Female Breast Cancer
AFFECTS,"Receptors, Progesterone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Glycol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glycol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,soy protein isolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Peptide Nucleic Acids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Peptide Nucleic Acids Breast Carcinoma,Female Breast Cancer
AFFECTS,"Chemotherapy, Adjuvant","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Chemotherapy, Adjuvant Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,adjuvant therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,adjuvant therapy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,estrophilin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estrophilin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA1 gene|BRCA1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Combination Chemotherapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Combination Chemotherapy Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Breast Fibrocystic Change, Proliferative Type",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Breast Fibrocystic Change, Proliferative Type Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,G-Actin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,G-Actin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Theophylline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Theophylline Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cisplatin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Cisplatin Breast cancer metastatic,Female Breast Cancer
AFFECTS,Digitoxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Digitoxin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1|LMOD1|BBS9 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aggressive behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aggressive behavior Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infection Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Cancer-Predisposing Gene,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Familial cancer of breast,Female Breast Cancer
AFFECTS,Screening mammography,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Screening mammography Breast Carcinoma,Female Breast Cancer
AUGMENTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Schistosomiasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Schistosomiasis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Gonadorelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gonadorelin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Chemotherapy, Adjuvant",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Chemotherapy, Adjuvant Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Cell Communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Communication Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Familial cancer of breast,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Familial cancer of breast Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethanol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estradiol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,C-Peptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-Peptide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Polychlorinated Biphenyls,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Polychlorinated Biphenyls Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Dietary fat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary fat intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tamoxifen,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Contralateral breast cancer,Female Breast Cancer
AFFECTS,Retinoblastoma Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Retinoblastoma Genes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Brain hemorrhage,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Brain hemorrhage Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethanol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alleles,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Alleles Breast Carcinoma,Female Breast Cancer
AFFECTS,Mammography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mammography Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II) Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP17A1 gene|CYP17A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Long menstrual cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Long menstrual cycle Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Viral Oncogene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Viral Oncogene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hereditary Malignant Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hereditary Malignant Neoplasm Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Testosterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tobacco,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tobacco Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Receptors, Nuclear",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Nuclear Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,beta catenin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,beta catenin Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Carcinogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,vitamin analog,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Food,vitamin analog Breast Carcinoma,Female Breast Cancer
DISRUPTS,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,celecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,celecoxib Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,COMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,COMT Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Retinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Retinoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Beer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beer Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hereditary Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hereditary Diseases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prostaglandins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Prostaglandins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,stearic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,stearic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,steroid hormone receptor,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,steroid hormone receptor Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,CUL4A gene|CUL4A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CUL4A gene|CUL4A Breast Carcinoma,Female Breast Cancer
CAUSES,Antioxidants,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Antioxidants Breast Carcinoma,Female Breast Cancer
AFFECTS,CAMP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CAMP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Fats Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Polyamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polyamines Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Silicones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Silicones Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Glycosylated hemoglobin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glycosylated hemoglobin A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Agent Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NCOA3 gene|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA3 gene|NCOA3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MYC gene|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC gene|MYC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ovarian Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ovarian Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ATM gene|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM gene|ATM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethylene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TACSTD1 protein, human|EPCAM",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACSTD1 protein, human|EPCAM Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Chlorinated Malignant neoplasm of breast",Female Breast Cancer
CAUSES,"Mammary Tumor Virus, Mouse",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Mammary Tumor Virus, Mouse Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Signal Transduction Pathways,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Pathways Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,maspin|SERPINB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,maspin|SERPINB5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AFP gene|AFP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AFP gene|AFP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Psychological adjustment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Psychological adjustment Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,diagnostic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,diagnostic procedure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FHIT gene|FHIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FHIT gene|FHIT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Merozoite Surface Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Merozoite Surface Protein 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,APC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,APC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Micronutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Micronutrients Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hexachlorobenzene,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Hazardous or Poisonous Substance,Hexachlorobenzene Female Breast Carcinoma,Female Breast Cancer
CAUSES,Growth Factor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Breast Carcinoma,Female Breast Cancer
PREDISPOSES,High weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,High weight Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,17-Ketosteroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,17-Ketosteroids Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"PTPN6 protein, human|PTPN6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTPN6 protein, human|PTPN6 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Contraceptives, Oral Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Microsatellite Instability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Microsatellite Instability Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GSTT1 gene|GSTT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTT1 gene|GSTT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Raloxifene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,impression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",impression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mismatch Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mismatch Repair Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Urokinase Plasminogen Activator Receptor|PLAU|PRAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Urokinase Plasminogen Activator Receptor|PLAU|PRAP1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast,Female Breast Cancer
CAUSES,hydroxytamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,hydroxytamoxifen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogens Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,Venoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Venoms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pre-Eclampsia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pre-Eclampsia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Fatty Acids, Essential",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Essential Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Progestins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Somatotropin-Releasing Hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Somatotropin-Releasing Hormone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oncogenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogenes Breast Carcinoma,Female Breast Cancer
AFFECTS,Curative Surgery,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Curative Surgery Malignant neoplasm of breast,Female Breast Cancer
CAUSES,methylurea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methylurea Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dietary intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oestrogen deficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Oestrogen deficiency Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thromboembolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thromboembolism Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Genistein Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta catenin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dieldrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dieldrin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,leukemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leukemia Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Butyric Acid,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Butyric Acid Breast Carcinoma,Female Breast Cancer
AUGMENTS,fascin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fascin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Retinoblastoma Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Retinoblastoma Genes Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Polychlorinated Biphenyls,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Polychlorinated Biphenyls Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Sausage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sausage Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,cofactor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cofactor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Apoptosis Inhibiting Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Inhibiting Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Li-Fraumeni Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Li-Fraumeni Syndrome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dichlorodiphenyl Dichloroethylene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Phytic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytic Acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Intrinsic factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Intrinsic factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor|AHR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GGCT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GGCT Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,anastrozole,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,anastrozole Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,DNA Sequence,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Conjugated Equine Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Conjugated Equine Estrogens Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast,Female Breast Cancer
CAUSES,EGFR gene|EGFR,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,Amines,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Amines Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Etiology, operative procedure, as cause of",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Etiology, operative procedure, as cause of Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,estrone sulfatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estrone sulfatase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Beer intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beer intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,trilostane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,trilostane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein Kinase C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinase C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Nutrients Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vitamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epithelial Cell Proliferation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial Cell Proliferation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Development of the breasts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Development of the breasts Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Transgenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Transgenes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Feeding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast Feeding Malignant neoplasm of breast,Female Breast Cancer
CAUSES,B-pyridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,B-pyridine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mastodynia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mastodynia Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GSTM1 gene|GSTM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTM1 gene|GSTM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NFKB1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,NFKB1 Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,Vitamin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,AROMATICS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AROMATICS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Symptoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Symptoms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLK14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLK14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tocopherols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tocopherols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Permeability,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Permeability Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ATP7B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ATP7B Breast Carcinoma,Female Breast Cancer
CAUSES,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GGCT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GGCT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TSG101 gene|TSG101,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,TSG101 gene|TSG101 Familial cancer of breast,Female Breast Cancer
CAUSES,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tryptophan|TYRP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tryptophan|TYRP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Mastitis, associated with childbirth",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Mastitis, associated with childbirth Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SLC19A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC19A3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Nutrients Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Primary carcinoma of the liver cells,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Primary carcinoma of the liver cells Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Bone Density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bone Density Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cellular Retinol Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cellular Retinol Binding Protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Down-Regulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Down-Regulation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYR61,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYR61 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Raloxifene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LMO4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LMO4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Peptidyl-Dipeptidase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Peptidyl-Dipeptidase A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Immunologic Adjuvants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunologic Adjuvants Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body Fat Distribution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body Fat Distribution Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SNAI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNAI3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diphosphonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diphosphonates Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP19A1 gene|CYP19A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thyroid Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Thyroid Diseases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mammary Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mammary Neoplasms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Spontaneous abortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Spontaneous abortion Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Mutation, Missense",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Mutation, Missense Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Soybean Oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Soybean Oil Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Abortion, Induced",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Abortion, Induced Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oestrogen increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Oestrogen increased Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NCOA3 gene|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA3 gene|NCOA3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PPIG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPIG Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Contraceptives, Oral Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Polychlorinated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polychlorinated Biphenyls Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Fatty Acids, Omega-3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-3 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatomedins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adhesions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adhesions Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,11q13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,11q13 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Unspecified Abortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Unspecified Abortion Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA Damage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Damage Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Raloxifene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Raloxifene Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Tumor Promoters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Promoters Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatomedins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vegetables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vegetables Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chronic Stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chronic Stress Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIN1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Docosahexaenoic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Docosahexaenoic Acids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzymes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,maspin|SERPINB5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,maspin|SERPINB5 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,protein kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase inhibitor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Nuclear Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Leptin|LEP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leptin|LEP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aneuploidy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aneuploidy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Progestogen hormone therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progestogen hormone therapy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ERBB2|NEU1|NEURL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Breast Carcinoma,Female Breast Cancer
AUGMENTS,Epidermal growth factor receptor inhibitor,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Biologically Active Substance,Epidermal growth factor receptor inhibitor Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Kininogenase|KLK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Kininogenase|KLK4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Oligonucleotides, Antisense",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Oligonucleotides, Antisense Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Infiltrating duct carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Infiltrating duct carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BONE MASS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BONE MASS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BIRTHPLACE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BIRTHPLACE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Skin problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Skin problem Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic breast density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mammographic breast density Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Mutation, Nonsense",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Mutation, Nonsense Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"Metals, Heavy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Single Nucleotide Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Fats Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mammary gland development,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mammary gland development Malignant neoplasm of breast,Female Breast Cancer
CAUSES,19p13.3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,19p13.3 Breast Carcinoma,Female Breast Cancer
AUGMENTS,Leucine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leucine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Magnetic Resonance Imaging Malignant neoplasm of breast,Female Breast Cancer
CAUSES,EMSY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EMSY Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Insulin-Like Growth Factor II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor II Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Folate Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diethylstilbestrol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MCM2 gene|MCM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM2 gene|MCM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ESTROGEN USE,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,ESTROGEN USE Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Normal growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Normal growth Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Environmental Pollutants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Environmental Pollutants Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,genotoxicity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,genotoxicity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,stressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,stressor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,connexin 26,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,connexin 26 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DDT (Insecticide),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Invertebrate,DDT (Insecticide) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stromal Cell-Derived Factor 1|CXCL12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stromal Cell-Derived Factor 1|CXCL12 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,STK6 gene|AURKA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK6 gene|AURKA Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vitamin E,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Food,Vitamin E Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Soy Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Soy Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Somatomedins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Somatomedins Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Urokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Urokinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pollutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pollutant Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcriptional Activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcriptional Activation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thromboembolic event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Thromboembolic event Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Testosterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to Screening for malignant neoplasm of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Encounter due to Screening for malignant neoplasm of breast Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SPRY2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SPRY2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LAG3 gene|LAG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAG3 gene|LAG3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,protective factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,protective factors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signal Transduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Raloxifene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Raloxifene Breast cancer invasive NOS,Female Breast Cancer
CAUSES,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oxidative Stress,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Oxidative Stress Carcinoma of Male Breast,Male Breast Cancer
AUGMENTS,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lipoproteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Transforming Growth Factor beta|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta|TGFB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prenatal Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prenatal Exposure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Diastolic blood pressure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diastolic blood pressure Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neoplasm Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Short menstrual cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Short menstrual cycle Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CA9 gene|CA9,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,CA9 gene|CA9 Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytotoxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Cytotoxin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Osteoporosis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Osteoporosis Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Dietary Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Dietary Carbohydrates Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CXCR4 gene|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Cruciferous Vegetable,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cruciferous Vegetable Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coffee Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to genetic counseling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Encounter due to genetic counseling Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Calcium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fruit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fruit Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Progestational Hormones, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Progestational Hormones, Synthetic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,isoflavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,isoflavonoids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SLC25A18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC25A18 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Juice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Juice Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Focal Adhesion Protein-Tyrosine Kinases,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Focal Adhesion Protein-Tyrosine Kinases Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,"Hemoglobin, Glycosylated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Hemoglobin, Glycosylated Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Granulocyte Colony-Stimulating Factor,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Granulocyte Colony-Stimulating Factor Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Estrogenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Meat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Isoleucine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isoleucine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metabolic Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Metabolic Diseases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carotenoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fat tissue increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fat tissue increased Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Contraceptive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Contraceptive Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,indole-3-carbinol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,indole-3-carbinol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isoflavones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1|LMOD1|BBS9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Abruptio Placentae,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Abruptio Placentae Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Chlorinated Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,SULT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULT gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fruit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fruit Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vegetable intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vegetable intake Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PTGS2 gene|PTGS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Human papillomavirus 16,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,Human papillomavirus 16 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MET gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MET gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cholesterol levels raised,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol levels raised Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Postmenopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Postmenopause Malignant neoplasm of breast,Female Breast Cancer
CAUSES,caveolin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caveolin 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Androgen Receptor|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor|AR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Melatonin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Female Breast Carcinoma,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Female Breast Carcinoma Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Lobular hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lobular hyperplasia Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Prolactin|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin|PRL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dietary restriction NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary restriction NOS Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Polycyclic Hydrocarbons,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Polycyclic Hydrocarbons Breast Carcinoma,Female Breast Cancer
CAUSES,Li-Fraumeni Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Li-Fraumeni Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen receptor positive tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor positive tumor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Iron intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iron intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Hyperparathyroidism, Primary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Hyperparathyroidism, Primary Malignant neoplasm of breast",Female Breast Cancer
CAUSES,migration stimulating factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",migration stimulating factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic field,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Magnetic field Female Breast Carcinoma,Female Breast Cancer
CAUSES,Chemicals,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Chemicals Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Obesity,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Obesity Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,sulforafan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sulforafan Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERCC2 gene|ERCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC2 gene|ERCC2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Monoclonal Antibody Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Monoclonal Antibody Therapy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Arachidonic Acid,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Arachidonic Acid Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Hyposensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyposensitivity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,decaffeinated coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,decaffeinated coffee Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,mammaglobin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,mammaglobin Breast cancer metastatic,Female Breast Cancer
AUGMENTS,ADAM12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADAM12 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Integrin beta3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrin beta3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,apolipoprotein D|APOD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein D|APOD Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Motility,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Motility Breast cancer metastatic,Female Breast Cancer
DISRUPTS,CDV3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDV3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"progesterone, micronized",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"progesterone, micronized Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,SR-2508,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SR-2508 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quercetin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PBRM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PBRM1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CISH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CISH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,rho GTP-Binding Proteins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",rho GTP-Binding Proteins Breast cancer invasive NOS,Female Breast Cancer
CAUSES,NCOA3 gene|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA3 gene|NCOA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adiponectin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RETN gene|RETN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RETN gene|RETN Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Adverse effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adverse effects Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,caspase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caspase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Soy Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Soy Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cancer Promoting Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer Promoting Genes Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HIC1 gene|HIC1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"HIC1 gene|HIC1 Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,hemagglutinin I,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,hemagglutinin I Breast Carcinoma,Female Breast Cancer
AFFECTS,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Menopause, Premature",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Menopause, Premature Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Oestrogen therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Oestrogen therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Receptor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Receptor Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fusion Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fusion Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Molecular Fingerprint of Tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Molecular Fingerprint of Tumor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Impaired cognition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Impaired cognition Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,APOA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,APOA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Disease,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Disease Breast cancer metastatic,Female Breast Cancer
AFFECTS,Combined Modality Therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Combined Modality Therapy Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,ATM gene|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM gene|ATM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcription Repressor/Corepressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Repressor/Corepressor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,beta-adrenergic receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-adrenergic receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nicotinamide adenine dinucleotide (NAD),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinamide adenine dinucleotide (NAD) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC45A2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ERBB2|NEU1|NEURL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Breast Carcinoma,Female Breast Cancer
AFFECTS,ETS1 gene|ETS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ETS1 gene|ETS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Exercise Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,S-Phase Fraction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S-Phase Fraction Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HSF1 gene|HSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSF1 gene|HSF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biguanides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biguanides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLLN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MLLT11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,MLLT11 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Drink,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Drink Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Indigotindisulfonate Sodium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Indigotindisulfonate Sodium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Catechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catechin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Garlic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Garlic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Acids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Acids Breast Carcinoma,Female Breast Cancer
AFFECTS,WISP3 gene|WISP3,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,WISP3 gene|WISP3 Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplasm Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Xeroderma pigmentosum, group C",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Xeroderma pigmentosum, group C Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LAMR1 gene|RPSA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAMR1 gene|RPSA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,osteosarcoma,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,osteosarcoma Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,TWIST1 gene|TWIST1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Ultrasonography,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Ultrasonography Breast cancer metastatic,Female Breast Cancer
AFFECTS,Androgen therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,erlotinib,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,erlotinib Breast cancer metastatic,Female Breast Cancer
AFFECTS,Sentinel Lymph Node Mapping,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sentinel Lymph Node Mapping Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAD50,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAD50 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sedentary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sedentary Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BLCAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BLCAP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CpG Islands Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,14q31,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,14q31 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"RNA, Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"RBL2 protein, human|RBL2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","RBL2 protein, human|RBL2 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2|NEU1|NEURL1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"2,5-dichloro-4-bromophenol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"2,5-dichloro-4-bromophenol Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,SHFM1 gene|SEM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHFM1 gene|SEM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DUSP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DUSP4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,participation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",participation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA Repair Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNA Repair Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Processed meat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Processed meat intake Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Receptors, Progesterone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Interleukin-6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Interleukin-6 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Breast tenderness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast tenderness Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,stress-activated protein kinase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",stress-activated protein kinase 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MTHFR gene|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTHFR gene|MTHFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cardiovascular Diseases,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Disease or Syndrome,Cardiovascular Diseases Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,gemcitabine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gemcitabine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Screening mammography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Screening mammography Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isoflavones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pumpkin seeds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pumpkin seeds Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Phytochemical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemical Malignant neoplasm of breast,Female Breast Cancer
CAUSES,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fruit intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fruit intake Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Angiogenesis Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Decreased translucency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Decreased translucency Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,atorvastatin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,atorvastatin Breast Carcinoma,Female Breast Cancer
CAUSES,Phosphoglycerate dehydrogenase|PHGDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoglycerate dehydrogenase|PHGDH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Collagen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Collagen Breast Carcinoma,Female Breast Cancer
AFFECTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1-Phosphatidylinositol 3-Kinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Topoisomerase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Topoisomerase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nitrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nitrate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Angiopoietin-2|ANG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Angiopoietin-2|ANG Breast Carcinoma,Female Breast Cancer
AFFECTS,Neoplasm progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm progression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,receptor Breast cancer metastatic,Female Breast Cancer
CAUSES,Mucins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mucins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Folate intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Folate intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphotransferases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Contraceptive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Contraceptive Agents Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Flavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavonoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Animal Feed,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Animal Feed Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BRD7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body mass index,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Body mass index Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Atypical hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atypical hyperplasia Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quercetin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Virus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Obesity Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BRIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BRIP1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Point Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Point Mutation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lesion,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Lesion Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Hypoxia,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Hypoxia Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,ERBB2|NEU1|NEURL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Breast Carcinoma,Female Breast Cancer
AFFECTS,MicroRNAs,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Vitamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXP3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Serine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Serine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,lycopene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lycopene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pathogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Pathogenesis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SRSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SRSF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Nuclear Receptor Subfamily 4, Group A, Member 1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Nuclear Receptor Subfamily 4, Group A, Member 1 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leptin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Antibodies, Anti-Idiotypic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,paclitaxel liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,paclitaxel liposome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin D intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D intake Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alleles Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AXL gene|AXL,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,AXL gene|AXL Breast cancer metastatic,Female Breast Cancer
AFFECTS,JTB gene|JTB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JTB gene|JTB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Interferon Alpha, Human|IFNA1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Interferon Alpha, Human|IFNA1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Vitamin intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,toxicant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,toxicant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Insulin, Long-Acting",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Insulin, Long-Acting Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Prolactin|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin|PRL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Radiotherapy, Adjuvant",Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,"Radiotherapy, Adjuvant Contralateral breast cancer",Female Breast Cancer
DISRUPTS,Taxol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Taxol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SPDEF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SPDEF Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,equol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,equol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VEGFA,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,VEGFA Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,BRIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BRIP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Soy Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Soy Foods Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BEX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BEX2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HIF1A gene|HIF1A,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"HIF1A gene|HIF1A Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Metabolic syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Metabolic syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Transcription, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Transcription, Genetic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Atypical antipsychotic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atypical antipsychotic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Visual Accommodation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Visual Accommodation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cancer prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cancer prevention Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hormone Receptor,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Hormone,Hormone Receptor Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,CISH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CISH Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Placental Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Placental Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,METHYLATE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,METHYLATE Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GPER1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,congener,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,congener Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Xanthine Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xanthine Dehydrogenase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,progesterone analog,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone analog Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Single Nucleotide Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epidermal Growth Factor Receptor|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CASP8 gene|CASP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASP8 gene|CASP8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NCOA3|ANIB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NCOA3|ANIB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Xenograft Model,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Xenograft Model Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Progestins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Progestins Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glutathione S-Transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutathione S-Transferase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BHMT gene|BHMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BHMT gene|BHMT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXCL12 gene|CXCL12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL12 gene|CXCL12 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Therapeutic procedure Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,response,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,response Breast cancer metastatic,Female Breast Cancer
AFFECTS,Phytochemical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemical Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA Adducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Adducts Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RASSF1A,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,RASSF1A Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Thyrotropin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thyrotropin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PTEN gene|PTEN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Candidate Disease Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HDAC9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,HDAC9 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ESTROGEN USE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,ESTROGEN USE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Familial cancer of breast,Female Breast Cancer
AFFECTS,Gelatinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclooxygenase 2 Inhibitors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Breast Carcinoma,Female Breast Cancer
AFFECTS,Tumorigenicity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumorigenicity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ITGA11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ITGA11 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Small Nucleolar RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Small Nucleolar RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TOX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TOX3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physically active,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physically active Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Niacinamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Niacinamide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein p53|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Protein p53|TP53 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA Repair Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNA Repair Gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,epigallocatechin gallate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,epigallocatechin gallate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Paravertebral anesthesia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Paravertebral anesthesia Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Matrix Metalloproteinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gene polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,gene polymorphism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Psychotherapy, Multiple",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Psychotherapy, Multiple Malignant neoplasm of breast",Female Breast Cancer
CAUSES,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TP53 gene|TP53,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"TP53 gene|TP53 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Body Weight decreased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Body Weight decreased Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypertensive disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hypertensive disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Collagen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant Bone Neoplasm,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Bone Neoplasm Breast cancer metastatic,Female Breast Cancer
CAUSES,Endocrine Disruptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Disruptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cardiovascular Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Cardiovascular Diseases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN34A gene|MIR34A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN34A gene|MIR34A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fisetin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,fisetin Breast cancer metastatic,Female Breast Cancer
AFFECTS,systemic administration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",systemic administration Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GM2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GM2A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,progesterone receptor positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone receptor positive Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR655,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR655 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcohol consumption,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Contralateral breast cancer,Female Breast Cancer
AFFECTS,peoniflorin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,peoniflorin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phosphatidylethanolamine N-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphatidylethanolamine N-Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cholesterol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Lipid,Cholesterol Breast cancer metastatic,Female Breast Cancer
DISRUPTS,SPRY1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SPRY1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epidermal growth factor receptor inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal growth factor receptor inhibitor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Choline Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Depressed mood,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Depressed mood Breast cancer metastatic,Female Breast Cancer
AFFECTS,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Receptor Activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Receptor Activation Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Epidermal growth factor receptor inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal growth factor receptor inhibitor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fibronectins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibronectins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Lipopolysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lipopolysaccharides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary malignant neoplasm of lymph node,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lymph node Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,F3 gene|F3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,F3 gene|F3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RSU1 gene|RSU1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RSU1 gene|RSU1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,3' Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",3' Untranslated Regions Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Induction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Induction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Paget's Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Paget's Disease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,curdione,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",curdione Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Pharmacotherapy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,14q24.1,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,14q24.1 Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclophosphamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclophosphamide Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SOAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOAT1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Response Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Response Elements Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HIF1A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LOH11CR2A gene|VWA5A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,LOH11CR2A gene|VWA5A Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary fiber intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary fiber intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PALB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prevention Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTPN12 gene|PTPN12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN12 gene|PTPN12 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Extracellular Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Extracellular Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Atypical hyperplasia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Atypical hyperplasia Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Functional RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|ESR2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXC1 gene|FOXC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXC1 gene|FOXC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ARNTL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ARNTL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Infiltration,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Breast cancer metastatic,Female Breast Cancer
CAUSES,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplasm Metastasis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Breast cancer metastatic,Female Breast Cancer
DISRUPTS,PORPHOBILINOGEN SYNTHASE|ALAD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PORPHOBILINOGEN SYNTHASE|ALAD Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyperandrogenemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Hyperandrogenemia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Histone Deacetylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histone Deacetylase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RAB8A gene|RAB8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAB8A gene|RAB8A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical activity,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Physical activity Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Tubulin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Tubulin Breast cancer metastatic,Female Breast Cancer
AUGMENTS,ZYX gene|ZYX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZYX gene|ZYX Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MBTPS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MBTPS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NCOR2 gene|NCOR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOR2 gene|NCOR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ethacrynic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ethacrynic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF423,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF423 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,6q25.1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6q25.1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Exertion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Exertion Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transcript Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TRIM25,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,TRIM25 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,MIR520C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR520C Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tetradecanoylphorbol Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tetradecanoylphorbol Acetate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,C6orf106,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,C6orf106 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"MAPK14 protein, human|MAPK14",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MAPK14 protein, human|MAPK14 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Functional RNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Disease Breast Carcinoma,Female Breast Cancer
DISRUPTS,Fibroblast Growth Factor Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptors Breast cancer metastatic,Female Breast Cancer
DISRUPTS,UBE3A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,UBE3A Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Dehydration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dehydration Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Cell Invasion,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Tumor Cell Invasion Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pesticides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transforming Growth Factor beta Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Receptors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estradiol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Receptors, Interleukin-1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Interleukin-1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Forkhead Transcription Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Forkhead Transcription Factors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,G0S2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,G0S2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Phosphoric Monoester Hydrolases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Phosphoric Monoester Hydrolases Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Death (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Death (finding) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,zoledronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,zoledronic acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,F Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,F Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diabetes Mellitus, Non-Insulin-Dependent Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,TFF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TFF3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Advance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Advance Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa|RPS6KB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Ribosomal Protein S6 Kinases, 70-kDa|RPS6KB1 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Metalloproteases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,vasodilator-stimulated phosphoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",vasodilator-stimulated phosphoprotein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Curcumin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Curcumin Breast cancer metastatic,Female Breast Cancer
AFFECTS,Neoadjuvant Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neoadjuvant Therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,anastrozole,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,anastrozole Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,PLAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PLAC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,docetaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,docetaxel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transforming Growth Factor beta|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta|TGFB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Overweight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Overweight Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Neoantigen,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Immunologic Factor,Neoantigen Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TNFRSF6B gene|TNFRSF6B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF6B gene|TNFRSF6B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,XRCC3 gene|XRCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NF-kappa B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,prevention through information dissemination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",prevention through information dissemination Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Zinc Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metaplastic Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metaplastic Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Lymph,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lymph Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SETD7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SETD7 Breast cancer metastatic,Female Breast Cancer
AFFECTS,PIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytotoxic Chemotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic Chemotherapy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"Fatty Acids, Omega-3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-3 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,CYP27A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP27A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CA-15-3 Antigen,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Immunologic Factor,CA-15-3 Antigen Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,tumor growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tumor growth Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,P2RY6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,P2RY6 Breast cancer metastatic,Female Breast Cancer
CAUSES,MAGI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAGI3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,diallyl disulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,diallyl disulfide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Performance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Performance Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dietary Component,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Component Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcript,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Transcript Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Metabolites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolites Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,stanniocalcin 2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,stanniocalcin 2 Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,Paclitaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Paclitaxel Breast cancer metastatic,Female Breast Cancer
AFFECTS,Genes,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Genes Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,synaptotagmin I|RELA|SYT1|GORASP1|WNK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,synaptotagmin I|RELA|SYT1|GORASP1|WNK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EPHB2|MAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EPHB2|MAPK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Soluble ErbB-1|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Soluble ErbB-1|EGFR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic,Female Breast Cancer
AUGMENTS,CYR61,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYR61 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Primary Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Primary Neoplasm Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signal Transduction Pathways,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Pathways Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,CAMK2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CAMK2B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HOXD10,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,HOXD10 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Honey,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Honey Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Polymerase|ERVK-9|ERVK-19|ERVK-11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polymerase|ERVK-9|ERVK-19|ERVK-11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Synaptophysin|SYP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Synaptophysin|SYP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ADIPOR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADIPOR1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ISL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ISL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RUNX1 gene|RUNX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX1 gene|RUNX1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estradiol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,hepatocellular carcinoma protein 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",hepatocellular carcinoma protein 1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Regulatory Element,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Regulatory Element Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Granulocyte-Macrophage Colony-Stimulating Factor|CSF2|LAMC2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Granulocyte-Macrophage Colony-Stimulating Factor|CSF2|LAMC2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIR gene|MLXIP|MYLIP|MARCH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR gene|MLXIP|MYLIP|MARCH8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cytotoxic T-Lymphocyte-Associated Protein 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic T-Lymphocyte-Associated Protein 4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Tocopherols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tocopherols Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Anthocyanins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anthocyanins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DMXL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DMXL2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Curcumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Curcumin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,POU5F1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,POU5F1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stromal Cell-Derived Factor 1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Stromal Cell-Derived Factor 1 Breast Carcinoma,Female Breast Cancer
AFFECTS,OBSCN gene|OBSCN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OBSCN gene|OBSCN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,STAT5A gene|STAT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT5A gene|STAT5A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WBP2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,myricetin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,myricetin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Ethanol,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Ethanol Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Ultrasonography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ultrasonography Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PITX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PITX2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SUMO1P3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SUMO1P3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Autophagy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Autophagy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SOHLH2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SOHLH2 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Clomiphene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Clomiphene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AKT2 gene|AKT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKT2 gene|AKT2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GPR1 gene|GPR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPR1 gene|GPR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNAJB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNAJB4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,discoidin domain receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,discoidin domain receptor 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PLAUR gene|PLAUR,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,PLAUR gene|PLAUR Breast cancer recurrent,Female Breast Cancer
PREDISPOSES,SHH gene|SHH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHH gene|SHH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NEK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NEK6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,O-GlcNAc transferase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,O-GlcNAc transferase Breast cancer metastatic,Female Breast Cancer
AFFECTS,Tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tea Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phosphoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphoproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ACKR3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ACKR3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,MicroRNAs,"cellular diagnosis, breast cancer",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","MicroRNAs cellular diagnosis, breast cancer",Female Breast Cancer
AFFECTS,Cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cisplatin Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,"Lung Diseases, Interstitial",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Disease or Syndrome,"Lung Diseases, Interstitial Breast cancer recurrent",Recurrent Breast Cancer
AFFECTS,Cisplatin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cisplatin Breast Carcinoma,Female Breast Cancer
AFFECTS,Dinoprostone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dinoprostone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transcriptase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transcriptase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunity Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA2 gene|BRCA2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Reading,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reading Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,depolarization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",depolarization Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tea Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HRG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HRG Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GATA3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MERTK gene|MERTK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MERTK gene|MERTK Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin B 12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B 12 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Peptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cyclic AMP-Responsive DNA-Binding Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclic AMP-Responsive DNA-Binding Protein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Thrombosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thrombosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Variation (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Variation (Genetics) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Genes, X-Linked",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, X-Linked Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,FOXA1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,FOXA1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GAS5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GGN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GGN Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SLC4A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC4A7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"PDGFA protein, human|PDGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PDGFA protein, human|PDGFA Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Crisis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Crisis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Calcitriol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Calcitriol Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,RICTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RICTOR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GACAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GACAT3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,preference,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,preference Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,"Biological function, NOS",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Biological function, NOS Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Twin birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Twin birth Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP3A4 gene|CYP3A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP3A4 gene|CYP3A4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CXCL13 gene|CXCL13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL13 gene|CXCL13 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PSMB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PSMB4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Carcinoma, Non-Small-Cell Lung",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Carcinoma, Non-Small-Cell Lung Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,PRMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRMT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Small cell carcinoma of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Small cell carcinoma of lung Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gefitinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gefitinib Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAD51 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cruciferous Vegetable,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cruciferous Vegetable Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PTHLH gene|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FBXL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FBXL14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 gene|BRCA1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Familial cancer of breast,Female Breast Cancer
AFFECTS,Topoisomerase Inhibitors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Topoisomerase Inhibitors Breast Carcinoma,Female Breast Cancer
AFFECTS,ERBB2 gene|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,BDE-99,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BDE-99 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radionuclide Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radionuclide Imaging Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Risedronate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Risedronate Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Antibodies, Anti-Idiotypic Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,recessive allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,recessive allele Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cyclooxygenase 2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,DNAJC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNAJC2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HORMAD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HORMAD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Habits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Habits Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EREG|ESR1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,EREG|ESR1 Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,N-Cadherins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,N-Cadherins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,16q12.1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,16q12.1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,C3|ERVK-2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,C3|ERVK-2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Hypothyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypothyroidism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1A gene|CDKN1A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,S100A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prognosis bad,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prognosis bad Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cell Cycle Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,resveratrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,resveratrol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADAM17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADAM17 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,sunflower seed oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sunflower seed oil Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sun Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sun Exposure Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Raloxifene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oils Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TYMS gene|TYMS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TYMS gene|TYMS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cytokeratin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytokeratin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,KDM1A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,KDM1A Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Transcript,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Transcript Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,"sal protein, Drosophila",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","sal protein, Drosophila Breast cancer invasive NOS",Female Breast Cancer
CAUSES,Coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coffee Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RAP1A|RABGEF1|TERF2IP,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,RAP1A|RABGEF1|TERF2IP Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Mutate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mutate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,piperine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,piperine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SPC24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SPC24 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Endocrine substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine substance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EGFL6 gene|EGFL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFL6 gene|EGFL6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tubulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tubulin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Focal Adhesion Protein-Tyrosine Kinases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NOTCH1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOTCH1 gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LSINCT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LSINCT5 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,decaffeinated coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,decaffeinated coffee Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,high-dose chemotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,high-dose chemotherapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibrosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Fibrosis Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Steryl-sulfatase|STS Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oils Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,blood lipid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,blood lipid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphotransferases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00310,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00310 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Black tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Black tea Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Premarin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Premarin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ESR2 gene|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR2 gene|ESR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EPHB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EPHB4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,EIF4G1,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,EIF4G1 Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Inflammation Mediators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Mediators Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,baicalein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,baicalein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,erbB-2 Receptor|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,racial differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,racial differences Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Histologic type,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histologic type Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Raloxifene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Raloxifene Breast Carcinoma,Female Breast Cancer
AFFECTS,"UBD protein, human|UBD",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","UBD protein, human|UBD Breast cancer metastatic",Female Breast Cancer
PREDISPOSES,CDC16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDC16 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammary Tumorigenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Mammary Tumorigenesis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases|DNMT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,ARHGAP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ARHGAP9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogenic effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic effect Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metformin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Membrane Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cell invasion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cell invasion Malignant neoplasm of breast,Female Breast Cancer
CAUSES,lysophosphatidic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,lysophosphatidic acid Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MMP9 gene|MMP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP9 gene|MMP9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Postmenopausal syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Postmenopausal syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hyperthyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperthyroidism Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Compete,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Compete Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Head circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Head circumference Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Succinate Dehydrogenase|SARDH|SDHB|SDS,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Succinate Dehydrogenase|SARDH|SDHB|SDS Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,cell motility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cell motility Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen hormone therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen hormone therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Pleural Effusion, Malignant",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Pleural Effusion, Malignant Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Immunologic Adjuvants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunologic Adjuvants Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SULF2 gene|SULF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULF2 gene|SULF2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ARF6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ARF6 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Alcoholic Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alcoholic Beverages Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Progestins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Progestins Breast Carcinoma,Female Breast Cancer
AFFECTS,NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BAX gene|BAX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BAX gene|BAX Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormone replacement therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Hormone replacement therapy Breast Carcinoma,Female Breast Cancer
AFFECTS,Uterine Cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Uterine Cancer Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,health-related beliefs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,health-related beliefs Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypoxia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Hypoxia Breast Carcinoma,Female Breast Cancer
AFFECTS,ZD 6126,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ZD 6126 Breast Carcinoma,Female Breast Cancer
AFFECTS,"VEGF protein, human|VEGFA",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Breast Carcinoma",Female Breast Cancer
CAUSES,Mucins,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Mucins Ductal Breast Carcinoma,Female Breast Cancer
AUGMENTS,Tyrphostins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tyrphostins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lactation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Lactation Breast Carcinoma,Female Breast Cancer
CAUSES,Organochlorine pesticide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Organochlorine pesticide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lean body mass,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Lean body mass Breast Carcinoma,Female Breast Cancer
DISRUPTS,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatomedins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,genetic aspects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic aspects Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Beta Carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beta Carotene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Osteoporosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Osteoporosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Daily drinker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Daily drinker Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thinness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thinness Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pain relief,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pain relief Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,alpha-carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha-carotene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Amitriptyline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Amitriptyline Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Polyamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polyamines Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Sulfuric Acid Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfuric Acid Esters Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Somatomedins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Somatomedins Breast Carcinoma,Female Breast Cancer
AUGMENTS,BNIP3,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,BNIP3 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Steroid hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroid hormone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Reexcision,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Reexcision Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,"Endometriosis, site unspecified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Endometriosis, site unspecified Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,GSTT1 gene|GSTT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTT1 gene|GSTT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,GSTP1 gene|GSTP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTP1 gene|GSTP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Insulin Resistance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin Resistance Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,celecoxib,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,celecoxib Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PRSS3P2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRSS3P2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACSTD2 protein, human|TACSTD2 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,VEGF gene|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical activity,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Physical activity Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,leptin receptor|LEPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,leptin receptor|LEPR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dichlorodiphenyl Dichloroethylene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,sulfotransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sulfotransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Progesterone Receptor Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Receptor Status Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ibandronate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ibandronate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RGS17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RGS17 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Behavior showing increased motor activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Behavior showing increased motor activity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fever,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fever Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anthracyclines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anthracyclines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Almond Nut,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Almond Nut Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Up-Regulation (Physiology),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Up-Regulation (Physiology) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERCC5 gene|ERCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC5 gene|ERCC5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary malignant neoplasm of liver,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of liver Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FOXL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXL2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RHOA gene|RHOA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOA gene|RHOA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LGMN gene|LGMN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LGMN gene|LGMN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Enkephalins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Enkephalins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antihypertensive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antihypertensive Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PRKD1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,PRKD1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Atypia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atypia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD55|TCN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD55|TCN2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Waist circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Waist circumference Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Antigens, CD5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"Antigens, CD5 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,tibolone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,tibolone Breast Carcinoma,Female Breast Cancer
AFFECTS,Diagnostic Neoplasm Staging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diagnostic Neoplasm Staging Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pancreatectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Pancreatectomy Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,MicroRNAs,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Carcinoma of Male Breast,Male Breast Cancer
AUGMENTS,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,personal experience,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,personal experience Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Choline Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,syndecan 2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,syndecan 2 Breast Carcinoma,Female Breast Cancer
CAUSES,Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Selenium Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tumor Antigens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Tumor Antigens Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Recreation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recreation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Angiogenesis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Tumor Angiogenesis Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Minipill,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Minipill Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiotensin-Converting Enzyme Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Angiotensin-Converting Enzyme Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Ablation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ablation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Detection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Detection Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Energy Metabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Energy Metabolism Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Diseases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Breast Diseases Breast Carcinoma,Female Breast Cancer
AFFECTS,Sentinel Lymph Node Biopsy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Sentinel Lymph Node Biopsy Ductal Breast Carcinoma,Female Breast Cancer
AUGMENTS,8q24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,8q24 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Angiotensin-Converting Enzyme Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Angiotensin-Converting Enzyme Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hydroxyestrones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxyestrones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Iron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iron Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogen Antagonists,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogen Antagonists Breast Carcinoma,Female Breast Cancer
PREDISPOSES,IGFBP3 gene|IGFBP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGFBP3 gene|IGFBP3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RHOC gene|RHOC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Promoter Regions (Genetics),Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Promoter Regions (Genetics) Breast Carcinoma,Female Breast Cancer
PREDISPOSES,DDT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DDT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Berries,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Berries Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Disease Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Peptidyl-Dipeptidase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Peptidyl-Dipeptidase A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Malignant Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,binge drinking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,binge drinking Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,17q12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,17q12 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antidepressive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antidepressive Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fiber Malignant neoplasm of breast,Female Breast Cancer
CAUSES,mammary tumor virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mammary tumor virus Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"KLK15 protein, human|KLK15",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","KLK15 protein, human|KLK15 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,response,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,response Breast Carcinoma,Female Breast Cancer
PREDISPOSES,IL6 gene|IL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL6 gene|IL6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Positron-Emission Tomography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positron-Emission Tomography Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PRLR gene|PRLR|PTP4A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LOC118430 gene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,LOC118430 gene Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,FCER1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FCER1A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Endometrial Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Endometrial Carcinoma Breast Carcinoma,Female Breast Cancer
AFFECTS,Exploration procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Exploration procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SHC1 gene|SHC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHC1 gene|SHC1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Free Radicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Free Radicals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ELF3 gene|ELF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELF3 gene|ELF3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Fatty Acids, Saturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Saturated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pesticides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stearoyl-CoA Desaturase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stearoyl-CoA Desaturase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antidepressive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antidepressive Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Doxorubicin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Recombinant Erythropoietin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Recombinant Erythropoietin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Prolactin Receptor|PRLR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Receptor|PRLR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,capecitabine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,capecitabine Breast cancer metastatic,Female Breast Cancer
AFFECTS,Tocotrienols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tocotrienols Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BMP7 gene|BMP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMP7 gene|BMP7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Complication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Complication Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Low Dose Radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low Dose Radiation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,hemiplegia; ascending,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hemiplegia; ascending Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HPR gene|HPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HPR gene|HPR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MUTYH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MUTYH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,soy protein isolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endocrine Disruptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Disruptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Beta-carotene intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beta-carotene intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pulse vegetables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pulse vegetables Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,claudin 6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,claudin 6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,soy protein isolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tretinoin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tretinoin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epirubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Epirubicin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,UQCRFS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UQCRFS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,pterostilbene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pterostilbene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Folic Acid Deficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Deficiency Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Duffy blood group phenotype,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Duffy blood group phenotype Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Asthma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Asthma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"NUP214 protein, human|NUP214",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NUP214 protein, human|NUP214 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,CCNE1 gene|CCNE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNE1 gene|CCNE1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sleep disturbances,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sleep disturbances Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,argatroban,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,argatroban Breast cancer metastatic,Female Breast Cancer
AFFECTS,Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Genes Familial cancer of breast,Female Breast Cancer
PREDISPOSES,taxane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,taxane Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,retinoic acid receptor beta 2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Chemical,"retinoic acid receptor beta 2 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Osteoporosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Osteoporosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CLOCK gene|CLOCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLOCK gene|CLOCK Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proto-Oncogene Proteins c-akt|AKT1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,HERC4,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"HERC4 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,responsibility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,responsibility Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,pulmonary complications,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pulmonary complications Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,[X]Unspecified osteoporosis with pathological fracture,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,[X]Unspecified osteoporosis with pathological fracture Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mRNA Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mRNA Expression Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RHOA gene|RHOA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOA gene|RHOA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lectin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,OSU 03012,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OSU 03012 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fine needle aspiration biopsy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Fine needle aspiration biopsy Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Methylenetetrahydrofolate reductase (NADPH)|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methylenetetrahydrofolate reductase (NADPH)|MTHFR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2|NEU1|NEURL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Low glycemic index food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Low glycemic index food Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to In vitro fertilization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Encounter due to In vitro fertilization Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ovarian cancer prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ovarian cancer prevention Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Abdominal obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Abdominal obesity Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Collagen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endocrine therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Endocrine therapy Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dimethyl Sulfoxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dimethyl Sulfoxide Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HGS gene|HGS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HGS gene|HGS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,research outcome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,research outcome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,hypercholesterolemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,hypercholesterolemia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tomatoes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tomatoes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gross' disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Gross' disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mucin 1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mucin 1 protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metastatic malignant neoplasm to brain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ductal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ductal Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,abnormal glucose tolerance test,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,abnormal glucose tolerance test Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Functional RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ID1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ID1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Interstitial Collagenase|MMP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interstitial Collagenase|MMP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,Cadmium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paclitaxel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APOBEC3A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,APOBEC3A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PPARG gene|PPARG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPARG gene|PPARG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LOX gene|LOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LOX gene|LOX Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Human papilloma virus infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Human papilloma virus infection Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,3' Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",3' Untranslated Regions Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SULT1A1|SULT1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SULT1A1|SULT1A2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast size Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FTO Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cyclooxygenase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,C-reactive protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-reactive protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TNF gene|TNF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNF gene|TNF Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinoembryonic Antigen|CEACAM5|CEACAM3|PSG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen|CEACAM5|CEACAM3|PSG2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast size,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Breast size Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Underweight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Underweight Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA2 Mutation,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 Mutation Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adiponectin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RNF8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RNF8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STN gene|EEF1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STN gene|EEF1A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Depressive disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Depressive disorder Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ascorbic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ascorbic Acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Botanicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Botanicals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOX2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLF4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Weight fluctuates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Weight fluctuates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carboplatin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Carboplatin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Equine laminitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Equine laminitis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Thyroid dysfunction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thyroid dysfunction Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NMU gene|NMU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NMU gene|NMU Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GAL3ST1|SLC35A1|CASZ1|CST12P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GAL3ST1|SLC35A1|CASZ1|CST12P Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diethylhexyl Phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diethylhexyl Phthalate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypoxia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypoxia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lymphedema,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Lymphedema Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Motion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Motion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTGS2 gene|PTGS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,breast cancer diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,breast cancer diagnosis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,tibolone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,tibolone Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Pharmacotherapy,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Pharmacotherapy Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,"RNA, circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, circular Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Seizures,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Seizures Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Bendroflumethiazide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bendroflumethiazide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FLII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FLII Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,aurora kinase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,aurora kinase Breast cancer metastatic,Female Breast Cancer
CAUSES,Insulin|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin|INS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KIF4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KIF4A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ultrasonography,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Ultrasonography Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELK3 gene|ELK3|KCNH8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Peanut butter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Peanut butter Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Strenuous Exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Strenuous Exercise Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diffuse Scleroderma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diffuse Scleroderma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Symptoms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Symptoms Breast Carcinoma,Female Breast Cancer
AFFECTS,Diet,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Diet Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,Metastasis Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Metastasis Suppressor Genes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Gastrin|GAST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gastrin|GAST Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TLR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TLR1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oral contraception,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oral contraception Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypersensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypersensitivity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Organochlorine pesticide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Organochlorine pesticide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Reduction mammaplasty,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Reduction mammaplasty Contralateral breast cancer,Female Breast Cancer
AFFECTS,Nephroblastoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nephroblastoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Excision,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Excision Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELK3 gene|ELK3|KCNH8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pork,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pork Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary Fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Fiber Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCND1 gene|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Zn-alpha-2-glycoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Zn-alpha-2-glycoprotein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epithelial hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Epithelial hyperplasia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nuclear Hormone Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Nuclear Hormone Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,resistin|RETN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,resistin|RETN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Curcumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Curcumin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vegetables,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Vegetables Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Reflexology,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reflexology Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,vinorelbine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,vinorelbine Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Willing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Willing Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S100A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KISS1 gene|KISS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KISS1 gene|KISS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stress Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Protein Subunits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Subunits Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MAP Kinase Kinase Kinase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAP Kinase Kinase Kinase 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CHD5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CHD5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,zoledronic acid,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical,zoledronic acid Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aspirin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Caffeine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Caffeine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Tomography, Emission-Computed",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Tomography, Emission-Computed Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,TWIST2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TWIST2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cyclophosphamide/fluorouracil/methotrexate protocol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclophosphamide/fluorouracil/methotrexate protocol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Metals, Heavy",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Breast cancer invasive NOS",Female Breast Cancer
CAUSES,XRCC6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,XRCC6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Mammography Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Migraine Disorders,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Migraine Disorders Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metformin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Histopathology,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histopathology Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PRLR gene|PRLR|PTP4A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Androgen Receptor|AR,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Androgen Receptor|AR Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,"Diet, Mediterranean",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diet, Mediterranean Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,HIF1A gene|HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fish intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fish intake Malignant neoplasm of breast,Female Breast Cancer
CAUSES,feral,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,feral Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,5-Alpha reductase inhibitor,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,5-Alpha reductase inhibitor Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Follistatin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Follistatin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Inflammatory Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inflammatory Response Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TGFB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TGFB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Engine Exhaust,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Engine Exhaust Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dioxygenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dioxygenases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Receptor, Angiotensin, Type 1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptor, Angiotensin, Type 1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,cyclooxygenase 2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","cyclooxygenase 2 Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Mass Screening,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mass Screening Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microsatellite Repeats,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Microsatellite Repeats Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Sentinel Lymph Node Biopsy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Sentinel Lymph Node Biopsy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,"Antidepressive Agents, Tricyclic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Antidepressive Agents, Tricyclic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Chinese cabbage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chinese cabbage Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oncogene Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,anastrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,anastrozole Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Screening mammography,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Screening mammography Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Vitamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Environmental Tobacco Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Environmental Tobacco Smoke Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,mullerian-inhibiting hormone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,XRCC1 gene|XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Defense Mechanisms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Defense Mechanisms Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Expressed Sequence Tags,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Expressed Sequence Tags Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Dissection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dissection Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Red meat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Red meat intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Skin necrosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Skin necrosis Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,SOX10,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,SOX10 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,XRCC2 gene|XRCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC2 gene|XRCC2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Autoantibodies,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Autoantibodies Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Dinoprostone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dinoprostone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Estrogens Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,DNA Repair Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNA Repair Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Non-Invasive Lesion,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Non-Invasive Lesion Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,PREDICTED,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,PREDICTED Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vitality Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KMT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KMT5A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Blood hormone levels,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Blood hormone levels Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,bicalutamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bicalutamide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,oleuropein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,oleuropein Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ALKBH3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ALKBH3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metformin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chemopreventive Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemopreventive Agent Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant Neoplasms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cytochrome P-450 CYP1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP1A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Progesterone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Progesterone Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Lesion,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Lesion Breast Carcinoma,Female Breast Cancer
AFFECTS,"Polymorphism, Genetic",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Polymorphism, Genetic Breast Carcinoma",Female Breast Cancer
PREDISPOSES,GH1 gene|GH1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,GH1 gene|GH1 Breast Carcinoma,Female Breast Cancer
CAUSES,Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Untranslated Regions Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Virus Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Virus Diseases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epidermal Growth Factor Receptor|EGFR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Angiogenesis Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast Carcinoma,Female Breast Cancer
PREDISPOSES,SLC45A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SLC45A2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,25-hydroxyvitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,25-hydroxyvitamin D Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sulfotransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sulfotransferase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA topoisomerase II alpha|TOP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA topoisomerase II alpha|TOP2A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RHBDD1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,RHBDD1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Gelatinase B|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase B|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN150 gene|MIR150,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN150 gene|MIR150 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,tibolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tibolone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adenosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adenosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Discrepancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Discrepancy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Needle biopsy procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Needle biopsy procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclin-Dependent Kinase 10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin-Dependent Kinase 10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary malignant neoplasm of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lung Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Medroxyprogesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,exemestane,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,exemestane Breast cancer metastatic,Female Breast Cancer
AFFECTS,Invasive Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hot flushes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hot flushes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP2D6 gene|CYP2D6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2D6 gene|CYP2D6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GGT1|GGTLC5P|GGTLC3|GGT2|GGTLC4P,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,GGT1|GGTLC5P|GGTLC3|GGT2|GGTLC4P Breast Carcinoma,Female Breast Cancer
CAUSES,Polychlorinated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polychlorinated Biphenyls Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,cyclin D3|CCND3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclin D3|CCND3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Lipids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Serotonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Serotonin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SMAD3 gene|SMAD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD3 gene|SMAD3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,USP11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,USP11 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Ethanol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Ethanol Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aspirin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IRF4 gene|IRF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRF4 gene|IRF4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Composition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Composition Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic Resonance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Magnetic Resonance Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MAP2K3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAP2K3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP2D6 gene|CYP2D6,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,CYP2D6 gene|CYP2D6 Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,CXCR4 gene|CXCR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA Repair,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Repair Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,P-Cadherin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,P-Cadherin Breast Carcinoma,Female Breast Cancer
AFFECTS,Doxorubicin Hydrochloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Doxorubicin Hydrochloride Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,QUINTILE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,QUINTILE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mass of body structure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mass of body structure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnostic radiologic examination,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic radiologic examination Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,Calcium Channel Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Channel Blockers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Strenuous Exercise,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Strenuous Exercise Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Environmental Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Environmental Estrogen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,receptor activator of NF-kappaB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,receptor activator of NF-kappaB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Exposure to,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Exposure to Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,collapsin response mediator protein-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",collapsin response mediator protein-2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin D Deficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Deficiency Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,equol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,equol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"2,3-bis(3'-hydroxybenzyl)butyrolactone Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,GSTT1 gene|GSTT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,GSTT1 gene|GSTT1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Cyclophosphamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclophosphamide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin A intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin A intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Hydroxymethylglutaryl-CoA Reductase Inhibitors Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Sentinel Lymph Node Biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sentinel Lymph Node Biopsy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Red breast,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Red breast Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,endogenous steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,endogenous steroids Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Iron, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Iron, Dietary Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Hetastarch,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Hetastarch Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,White bread,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,White bread Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Endometrial Hyperplasia,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Endometrial Hyperplasia Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,"1,4-dioxin",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"1,4-dioxin Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Lasofoxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lasofoxifene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"1,4-dioxin",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"1,4-dioxin Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,DNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast cancer metastatic,Female Breast Cancer
CAUSES,Noninfiltrating Intraductal Carcinoma,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Noninfiltrating Intraductal Carcinoma Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,XRCC3 gene|XRCC3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,MTA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Human Development,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Human Development Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,G-T mismatch-binding protein|MSH6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-T mismatch-binding protein|MSH6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCL1 gene|CCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL1 gene|CCL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STAT3 gene|STAT3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,retinoic acid receptor beta 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,retinoic acid receptor beta 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ID2 gene|ID2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ID2 gene|ID2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cullin 1|CUL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Cullin 1|CUL1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Breast cancer metastatic,Female Breast Cancer
CAUSES,IARS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IARS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proteasome inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proteasome inhibitor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Functional RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genetic Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Markers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chronic inflammatory disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic inflammatory disorder Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interleukins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DSCAM-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ORALIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ORALIT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S100A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PIK3CA gene|PIK3CA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Trans Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Trans Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Protein phosphatase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein phosphatase Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Trans Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Trans Fats Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Corticosterone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Corticosterone Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Tryptophan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tryptophan Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,K-ras Oncogene|KRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alanine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-8,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Interleukin-8 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,DNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GTP-Binding Protein alpha Subunits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GTP-Binding Protein alpha Subunits Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TBX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TBX3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HOXC6 gene|HOXC6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXC6 gene|HOXC6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Body mass index procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Body mass index procedure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Peptide Nucleic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Peptide Nucleic Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Disease or Syndrome,Disease Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,anastrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,anastrozole Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DANCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DANCR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Growth Hormone Receptor|GHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Growth Hormone Receptor|GHR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Urokinase|PLAU|PRAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Urokinase|PLAU|PRAP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proto-Oncogene Proteins c-myc|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-myc|MYC Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP1B1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,survivin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,survivin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Primary idiopathic dilated cardiomyopathy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Primary idiopathic dilated cardiomyopathy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Polysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polysaccharides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SNORA7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNORA7B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NanoGel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NanoGel Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Positive Lymph Node,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Positive Lymph Node Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Small Inducible Cytokine A18|CCL18,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,Small Inducible Cytokine A18|CCL18 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,BRCA2 Mutation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA2 Mutation Breast cancer metastatic,Female Breast Cancer
AFFECTS,Serum Proteins,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Amino Acid, Peptide, or Protein",Serum Proteins Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Physiological stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physiological stress Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anisotropy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Anisotropy Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,STAR gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAR gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Exons,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Exons Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Genes, ras",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, ras Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,RPE65|UVRAG|TP63|CKAP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RPE65|UVRAG|TP63|CKAP4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MAFG gene|MAFG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MAFG gene|MAFG Breast Carcinoma,Female Breast Cancer
AFFECTS,TWIST1 gene|TWIST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Self-Examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Self-Examination Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PARVA gene|PARVA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARVA gene|PARVA Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CBFB gene|CBFB|NFYA|NFYB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBFB gene|CBFB|NFYA|NFYB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP1B1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Arachidonic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Arachidonic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Plant Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Plant Preparations Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Parabens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parabens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC00968,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00968 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,leukemia,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,leukemia Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Gastric Inhibitory Polypeptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Gastric Inhibitory Polypeptide Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNHG7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNHG7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tic disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Tic disorder Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biopsy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Biopsy Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,"RNA, Untranslated",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Breast cancer invasive NOS",Female Breast Cancer
PREDISPOSES,CYP1B1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,CYP1B1 Carcinoma of Male Breast,Male Breast Cancer
AUGMENTS,PLK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PLK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GALNT16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GALNT16 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease susceptibility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease susceptibility Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"CHEK2 protein, human|CHEK2",Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CHEK2 protein, human|CHEK2 Familial cancer of breast",Female Breast Cancer
AFFECTS,taxane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,taxane Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Red meat,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Red meat Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Digital mammography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Digital mammography Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,LINC00460,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00460 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CUL4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CUL4B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,honokiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,honokiol Breast cancer metastatic,Female Breast Cancer
AFFECTS,DNA Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Repair Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epstein-Barr Virus Infections,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Epstein-Barr Virus Infections Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TUFT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,TUFT1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Insulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glucocorticoid Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucocorticoid Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Cell Invasion,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Cell Invasion Breast cancer metastatic,Female Breast Cancer
CAUSES,Malignant neoplasm of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of lung Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCAT1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SCUBE2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SCUBE2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Anthracycline Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Anthracycline Antibiotics Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"N',N''-diacetylspermine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"N',N''-diacetylspermine Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Aromatase|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase|CYP19A1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Receptors, Steroid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,"Receptors, Steroid Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor II Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Leptin|LEP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leptin|LEP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gelatinase A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Gelatinase A Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Medication use,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Medication use Carcinoma in situ of breast,Female Breast Cancer
AFFECTS,Vascular Endothelial Growth Factor Receptor-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Electromagnetic Energy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Electromagnetic Energy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coffee Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NCAPD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NCAPD2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Radiotherapy, Adjuvant",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Radiotherapy, Adjuvant Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,ginsenoside M1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ginsenoside M1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Metformin hydrochloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metformin hydrochloride Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Spermine Synthase|SMS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Spermine Synthase|SMS Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hip circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hip circumference Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PCB 180,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 180 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIRN34A gene|MIR34A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN34A gene|MIR34A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,silybin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,silybin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KDM5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM5B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Ascorbic Acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Ascorbic Acid Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Flavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavonoids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,activated RNA polymerase II transcription cofactor 4|IFRD1|KRT6B|SUB1|PCSK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",activated RNA polymerase II transcription cofactor 4|IFRD1|KRT6B|SUB1|PCSK4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methyl-CpG-Binding Protein 2|MECP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Methyl-CpG-Binding Protein 2|MECP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Androgen Receptor|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor|AR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prognosis good,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Prognosis good contralateral breast cancer,Female Breast Cancer
AFFECTS,Combined Modality Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Combined Modality Therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sulforafan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sulforafan Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Secondary Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Secondary Neoplasm Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PRNCR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRNCR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Syndrome Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RHOA gene|RHOA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RHOA gene|RHOA Breast cancer metastatic,Female Breast Cancer
DISRUPTS,everolimus,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,everolimus Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Functional assessment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional assessment Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR99A gene|MIR99A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR99A gene|MIR99A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stable weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stable weight Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,27-hydroxycholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,27-hydroxycholesterol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ATP8A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ATP8A2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,YAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,YAP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CELF6 gene|CELF6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CELF6 gene|CELF6 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Menstruation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menstruation Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Mitogen-Activated Protein Kinase 3|MAPK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinase 3|MAPK3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CGRRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CGRRF1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZMYND10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZMYND10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Procedure findings:Finding:Point in time:^Patient:Narrative Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DNMT3B gene|DNMT3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNMT3B gene|DNMT3B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MicroRNAs,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast Carcinoma,Female Breast Cancer
AFFECTS,RNA metabolic process,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA metabolic process Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Chemotherapy Regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chemotherapy Regimen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dense breasts NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dense breasts NOS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vascular Endothelial Growth Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Low absolute lymphocyte count,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Low absolute lymphocyte count Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Bilateral Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Bilateral Disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Paralogous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Paralogous Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PAK6 gene|PAK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAK6 gene|PAK6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00173 gene|LINC00173,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00173 gene|LINC00173 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Angiogenic Process,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Phenomenon or Process,Angiogenic Process Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Positron Emission Tomography and Magnetic Resonance Imaging,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Positron Emission Tomography and Magnetic Resonance Imaging HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,clinical aspects,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,clinical aspects Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,claudin 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,claudin 4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast Density Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypertriglyceridemic Waist,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Hypertriglyceridemic Waist Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PDZRN4 gene|PDZRN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDZRN4 gene|PDZRN4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MK 2206,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,MK 2206 HER2-positive carcinoma of breast,Female Breast Cancer
CAUSES,BRD7 gene|BRD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRD7 gene|BRD7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KDM1A gene|KDM1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM1A gene|KDM1A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR451A gene|MIR451A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR451A gene|MIR451A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,Genes Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
DISRUPTS,LINC00993 gene|LINC00993,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00993 gene|LINC00993 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,JAG1 gene|JAG1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,JAG1 gene|JAG1 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,"Leukemia Virus, Bovine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Leukemia Virus, Bovine Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TP53 gene|TP53,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 contralateral breast cancer,Female Breast Cancer
AFFECTS,Breast-Conserving Surgery,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast-Conserving Surgery Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Secondary Neoplasm Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Menopause Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menopause Status Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SFRP2 gene|SFRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFRP2 gene|SFRP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Exogenous Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Exogenous Factors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neoplasms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Reproductive History,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Reproductive History Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Histamine H1 Antagonists,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Histamine H1 Antagonists contralateral breast cancer,Female Breast Cancer
AFFECTS,FNDC5 gene|FNDC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FNDC5 gene|FNDC5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Family history,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Family history Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CNN1 gene|CNN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CNN1 gene|CNN1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,beta catenin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,beta catenin Breast Carcinoma,Female Breast Cancer
AFFECTS,citronellol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,citronellol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,osteopontin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,osteopontin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FOXK1 gene|FOXK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXK1 gene|FOXK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Variation (Genetics),Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,Variation (Genetics) Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,RNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,RNA Sequence Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"ITK protein, human|ITK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ITK protein, human|ITK Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"ATP Binding Cassette Transporter, Sub-Family G, Member 2|ABCG2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"ATP Binding Cassette Transporter, Sub-Family G, Member 2|ABCG2 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast Carcinoma,Female Breast Cancer
AFFECTS,GSTM1 gene|GSTM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTM1 gene|GSTM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor size Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,sulforafan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sulforafan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA Motifs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Motifs Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CHEK2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Mirn124a microRNA, human",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Mirn124a microRNA, human Breast Carcinoma",Female Breast Cancer
CAUSES,SDHC gene|SDHC,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SDHC gene|SDHC Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Vaccines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vaccines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypersensitivity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Hypersensitivity Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Gene Mutant,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Gene Mutant Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,TFCP2 gene|TFCP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TFCP2 gene|TFCP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diagnosis Malignant neoplasm of breast,Female Breast Cancer
CAUSES,RWDD4 gene|RWDD4,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,RWDD4 gene|RWDD4 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Discordance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Discordance Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Calcium-Sensing Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium-Sensing Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormone Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hormone,Hormone Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,tissue-factor-pathway inhibitor 2|TFPI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tissue-factor-pathway inhibitor 2|TFPI2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,neoplasm-associated factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,neoplasm-associated factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Escape,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Escape Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High Level,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,High Level Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Signs and Symptoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Signs and Symptoms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Subjective:Finding:Point in time:^Patient:Narrative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Subjective:Finding:Point in time:^Patient:Narrative Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOX10 gene|SOX10,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SOX10 gene|SOX10 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Aggressive behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aggressive behavior Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Muscle Strength,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Other,Muscle Strength Malignant neoplasm of female breast,Female Breast Cancer
AUGMENTS,"MET protein, human",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MET protein, human Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CDYL2 gene|CDYL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDYL2 gene|CDYL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Quintile,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quintile Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FGFR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FGFR3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carotenoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Matrix Metalloproteinase 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stiffness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stiffness Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CBLB gene|CBLB|MMAB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBLB gene|CBLB|MMAB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic Breast Density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mammographic Breast Density Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ribonucleotide reductase M2|RRM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ribonucleotide reductase M2|RRM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TRDMT1 gene|TRDMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRDMT1 gene|TRDMT1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical Inactivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physical Inactivity Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,brown adipose tissue uncoupling protein,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Amino Acid, Peptide, or Protein",brown adipose tissue uncoupling protein Basal-Like Breast Carcinoma,Female Breast Cancer
DISRUPTS,daunorubicin liposomal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,daunorubicin liposomal Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Suppressor Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,bisphenol A,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,bisphenol A estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Pharmacotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Pharmacotherapy Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TMPO-AS1 gene|TMPO-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TMPO-AS1 gene|TMPO-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,huaier,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,huaier Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Flavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavonoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prune Belly Syndrome,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Disease or Syndrome,Prune Belly Syndrome contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Human Class I Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Human Class I Antigens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Increased risk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Increased risk Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NUDT21 gene|NUDT21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUDT21 gene|NUDT21 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,concise,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,concise Breast Carcinoma,Female Breast Cancer
PREDISPOSES,NEK10 gene|NEK10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEK10 gene|NEK10 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GPER1 gene|GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPER1 gene|GPER1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,letrozole,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,letrozole HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,YES1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,YES1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CCL8 gene|CCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL8 gene|CCL8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,polygene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,polygene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RUNX1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,RUNX1 estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Carbohydrate intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrate intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplastic Cell Transformation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Neoplastic Cell Transformation Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MCM3AP-AS1 gene|MCM3AP-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM3AP-AS1 gene|MCM3AP-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,interleukin-10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pathologic Response,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Pathologic Response Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,antiporter,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,antiporter HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,ELAVL2 gene|ELAVL2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Genes Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Neuropilin-1|NRP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neuropilin-1|NRP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Finding of body mass index,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Finding of body mass index Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fumigant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fumigant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclin B1|CCNB1,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,Cyclin B1|CCNB1 Luminal B Breast Carcinoma,Female Breast Cancer
AUGMENTS,RNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,RNA Sequence Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,calycopterin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,calycopterin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,arctigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arctigenin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibrin fragment D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrin fragment D Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,pristimerin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pristimerin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Sedentary lifestyle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sedentary lifestyle Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,kusunokinin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,kusunokinin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DAPK1 gene|DAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DAPK1 gene|DAPK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Late Relapse,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Late Relapse Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,risk factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,risk factors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FGFBP1 gene|FGFBP1,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,FGFBP1 gene|FGFBP1 estrogen receptor-negative breast cancer,Female Breast Cancer
AFFECTS,ZEB1 gene|ZEB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TNF wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TNF wt Allele Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Puberty,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Puberty Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RIOK1 gene|RIOK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RIOK1 gene|RIOK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,magnesium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,magnesium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Neoplasms Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,IMPACT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IMPACT gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Disease or Syndrome,Disease Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,ergocalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ergocalciferol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Markers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,naringenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,naringenin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Flavanones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavanones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metastatic malignant neoplasm to brain,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"RNA, Messenger",Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Recurrent Breast Carcinoma",Recurrent Breast Cancer
CAUSES,wogonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,wogonin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BCL11A gene|BCL11A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BCL11A gene|BCL11A Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transcript Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,podofilox,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,podofilox Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ERR1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ERR1 protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LIMK2 gene|LIMK2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LIMK2 gene|LIMK2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Antimalarials,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antimalarials Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MLF2 gene|MLF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLF2 gene|MLF2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MALAT1 gene|MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MALAT1 gene|MALAT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor size,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Tumor size estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,sunitinib,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,sunitinib Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Hyperthyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperthyroidism Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AMH gene|AMH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AMH gene|AMH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ACVR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ACVR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CKLF gene|CKLF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CKLF gene|CKLF Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Screening procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Screening procedure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PRKN gene|PRKN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRKN gene|PRKN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,baicalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,baicalin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,simvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,simvastatin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Anti-Mullerian Hormone Receptor Type II, Human|AMHR2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Anti-Mullerian Hormone Receptor Type II, Human|AMHR2 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Excessive dietary caloric intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Excessive dietary caloric intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genetic Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Polymorphism Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNAI1 gene|SNAI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNAI1 gene|SNAI1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ADIPOR1 gene|ADIPOR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADIPOR1 gene|ADIPOR1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Fibroblast Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APOBEC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,APOBEC3B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Protein, Organized by Structure",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Protein, Organized by Structure Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Angiogenic Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Angiogenic Process Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,tamoxifen,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,tamoxifen estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Organophosphate pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Organophosphate pesticides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HER-2 protein|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER-2 protein|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormone Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,water Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Response Modifiers Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,dna genetics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,dna genetics Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"DNM1L protein, human|DNM1L",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DNM1L protein, human|DNM1L Malignant neoplasm of breast",Female Breast Cancer
CAUSES,GSTP1P1 gene|GSTP1P1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTP1P1 gene|GSTP1P1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FANCM gene|FANCM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FANCM gene|FANCM Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SNAI2 gene|SNAI2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,SNAI2 gene|SNAI2 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Trichorhinophalangeal dysplasia type I Breast Carcinoma,Female Breast Cancer
AFFECTS,Sodium-Glucose Transporter 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sodium-Glucose Transporter 2 Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ZFPM2-AS1 gene|ZFPM2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZFPM2-AS1 gene|ZFPM2-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BBOX1 gene|BBOX1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BBOX1 gene|BBOX1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Uptake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Uptake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Procedure findings:Finding:Point in time:^Patient:Narrative Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,Conventional Treatment,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Conventional Treatment Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"Chemotherapy, Adjuvant",Carcinoma breast stage I,0.0,Female Breast Cancer,Other,"Chemotherapy, Adjuvant Carcinoma breast stage I",Female Breast Cancer
CAUSES,Injection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Injection Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oils,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Oils Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,TP53 gene|TP53,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,SERPINE1 gene|SERPINE1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SERPINE1 gene|SERPINE1 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,RASAL2 gene|RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RASAL2 gene|RASAL2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC00922 gene|LINC00922,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00922 gene|LINC00922 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,acetate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,c-Mer Tyrosine Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,c-Mer Tyrosine Kinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Moderate risk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Moderate risk Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Processed meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Processed meat Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,estrogens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hormone,estrogens Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,HMGB1 gene|HMGB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGB1 gene|HMGB1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"PDIA3 protein, human|PDIA3",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PDIA3 protein, human|PDIA3 Invasive carcinoma of breast",Female Breast Cancer
DISRUPTS,MIR30E gene|MIR30E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR30E gene|MIR30E Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,MTOR gene|MTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTOR gene|MTOR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",American College of Cardiology/American Heart Association Lesion Complexity Score C Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RSPO3 Gene|RSPO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RSPO3 Gene|RSPO3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Present,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Present Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1A1 gene|CYP1A1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,A2M-AS1 gene|A2M-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,A2M-AS1 gene|A2M-AS1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Progranulins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Progranulins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Thymidylate Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thymidylate Synthase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SALL4 gene|SALL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SALL4 gene|SALL4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Anthracyclines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anthracyclines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KCNQ1OT1 gene|KCNQ1OT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KCNQ1OT1 gene|KCNQ1OT1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,METTL14 gene|METTL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL14 gene|METTL14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypoxia-Inducible Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypoxia-Inducible Factor 1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cryptotanshinone,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,cryptotanshinone estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,TUG1 gene|TUG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TUG1 gene|TUG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Neural Networks,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Biological Neural Networks Breast Carcinoma,Female Breast Cancer
PREDISPOSES,mortalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mortalin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Zearalenone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Zearalenone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alternative Splicing,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,resistin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,resistin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,bisphenol A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bisphenol A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCAT7 gene|PCAT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT7 gene|PCAT7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lamin B2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,lamin B2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,High Level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,High Level Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC01271 gene|LINC01271,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01271 gene|LINC01271 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Elasticity Imaging Techniques,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Elasticity Imaging Techniques Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"RNA, Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Magnetic Resonance Imaging,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Magnetic Resonance Imaging Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,hereditary factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hereditary factors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTEN gene|PTEN,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,UBE3C gene|UBE3C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE3C gene|UBE3C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"IL2RB protein, human|IL2RB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL2RB protein, human|IL2RB Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,ZNF670-ZNF695 gene|ZNF670-ZNF695,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF670-ZNF695 gene|ZNF670-ZNF695 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ATM gene|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM gene|ATM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Risk Scores,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Risk Scores Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,OXER1 gene|OXER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OXER1 gene|OXER1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FBXO22 gene|FBXO22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO22 gene|FBXO22 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,selenium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Uncertainty,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Uncertainty Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aspirin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,mullerian-inhibiting hormone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TINCR gene|TINCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TINCR gene|TINCR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00665 gene|LINC00665,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00665 gene|LINC00665 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bilateral mastectomy,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Bilateral mastectomy contralateral breast cancer,Female Breast Cancer
AFFECTS,Pharmacotherapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Pharmacotherapy Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,iron,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,iron Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Tumor Promotion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Promotion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UCHL1 gene|UCHL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UCHL1 gene|UCHL1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lactates,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Lactates estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,CHEK2 gene|CHEK2,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
PREDISPOSES,AGAP2-AS1 gene|AGAP2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AGAP2-AS1 gene|AGAP2-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Psychosocial Intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Psychosocial Intervention Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoadjuvant Chemotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Neoadjuvant Chemotherapy HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Immune Checkpoint Blockade,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Immune Checkpoint Blockade Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SDHC gene|SDHC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SDHC gene|SDHC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MBD2 gene|MBD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MBD2 gene|MBD2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adiponectin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Obesity, Abdominal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Obesity, Abdominal Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Leisure physical activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leisure physical activity Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC01271 gene|LINC01271,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Gene or Genome,LINC01271 gene|LINC01271 malignant neoplasm of breast staging,Female Breast Cancer
PREDISPOSES,calcium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,calcium Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,leptin receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,leptin receptor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Nutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Nutrients Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Calcium intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypoxia,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Hypoxia Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Metric (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Metric (substance) Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FZD2 gene|FZD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FZD2 gene|FZD2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,gambogic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,gambogic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,"Breast Cancer, Familial",0.0,Female Breast Cancer,Neoplastic Process,"Malignant neoplasm of breast Breast Cancer, Familial",Female Breast Cancer
AFFECTS,hydroxyl group,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hydroxyl group Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Secondary Neoplasm,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Secondary Neoplasm Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CPT1A gene|CPT1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CPT1A gene|CPT1A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,calmodulin-dependent protein kinase III,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",calmodulin-dependent protein kinase III Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SENP3 gene|SENP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SENP3 gene|SENP3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,elaidic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,elaidic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"CDKN1A protein, human|CDKN1A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDKN1A protein, human|CDKN1A Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,ATM gene|ATM,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ATM gene|ATM Breast Carcinoma,Female Breast Cancer
AFFECTS,Heterogeneous-Nuclear Ribonucleoprotein K,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Heterogeneous-Nuclear Ribonucleoprotein K Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,O(6)-Methylguanine-DNA Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",O(6)-Methylguanine-DNA Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ovarian failure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ovarian failure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYTOR gene|CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYTOR gene|CYTOR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunologic Surveillance,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Immunologic Surveillance estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,COVID-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,COVID-19 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Inhibitor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Inhibitor Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Tumor Microenvironment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LRRC3B gene|LRRC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LRRC3B gene|LRRC3B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,recreational activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",recreational activity Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hypoxia-Inducible Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypoxia-Inducible Factor 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Zinostatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Zinostatin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Systemic Inflammatory Response Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Systemic Inflammatory Response Syndrome Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ropivacaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ropivacaine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NF-kappa B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Body mass index procedure,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,Body mass index procedure malignant neoplasm of breast staging,Female Breast Cancer
AFFECTS,"PLK1 protein, human|PLK1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PLK1 protein, human|PLK1 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,Prognostic Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prognostic Factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FBXO32 gene|FBXO32,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO32 gene|FBXO32 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ELF5 gene|ELF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELF5 gene|ELF5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ENTPD1 wt Allele|ENTPD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ENTPD1 wt Allele|ENTPD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDK15 gene|CDK15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK15 gene|CDK15 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcription Coactivator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Coactivator Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Neoantigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Neoantigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adrenergic beta-Antagonists Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ropivacaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ropivacaine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FADS1 gene|FADS1,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,FADS1 gene|FADS1 Recurrent Breast Carcinoma,Female Breast Cancer
DISRUPTS,hyaluronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hyaluronic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fetal valproate syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Fetal valproate syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DPP6 gene|DPP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP6 gene|DPP6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TWIST1 gene|TWIST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Intronic Mutation,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Element, Ion, or Isotope","Intronic Mutation Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,PADI1 gene|PADI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PADI1 gene|PADI1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR599 gene|MIR599,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR599 gene|MIR599 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dynamic Contrast-Enhanced Magnetic Resonance Imaging Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FANCA gene|FANCA,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"FANCA gene|FANCA Breast Cancer, Familial",Female Breast Cancer
DISRUPTS,LOC100505851,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LOC100505851 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR638 gene|MIR638,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR638 gene|MIR638 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LOC105371267,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LOC105371267 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinoembryonic Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,receptor operated channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,receptor operated channel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Graphene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Graphene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hydroxymethylglutaryl-CoA reductase,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA reductase HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Thrombophilia,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Thrombophilia Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,vitamin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,vitamin A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ARHGAP1 gene|ARHGAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP1 gene|ARHGAP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WNT9B gene|WNT9B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT9B gene|WNT9B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VGLL1 gene|VGLL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VGLL1 gene|VGLL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Collagen Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Collagen Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR21 gene|MIR21 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HAGLR gene|HAGLR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HAGLR gene|HAGLR Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,cytotoxicity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,cytotoxicity Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,KIF23 gene|KIF23,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KIF23 gene|KIF23 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Consideration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Consideration Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"herstatin protein, human",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Xenograft procedure,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Xenograft procedure Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,CDKN2B-AS1 gene|CDKN2B-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2B-AS1 gene|CDKN2B-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,medication risk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,medication risk Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Full Term Birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Full Term Birth Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,VCAN-AS1 gene|VCAN-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VCAN-AS1 gene|VCAN-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,LINC01094 gene|LINC01094,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01094 gene|LINC01094 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cerebrovascular accident,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Cerebrovascular accident estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,epithelial to mesenchymal transition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL27 gene|MYDGF|IL27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL27 gene|MYDGF|IL27 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Metals, Heavy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Hepatocyte Nuclear Factor 3-alpha|FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hepatocyte Nuclear Factor 3-alpha|FOXA1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GLUT-1 protein,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GLUT-1 protein Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC01315 gene|LINC01315,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01315 gene|LINC01315 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adhesions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adhesions Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coronary Arteriosclerosis,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Coronary Arteriosclerosis estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,"Drug Resistance, Neoplasm",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,"Drug Resistance, Neoplasm Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,NEIL2 gene|NEIL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEIL2 gene|NEIL2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ursolic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,ursolic acid Breast cancer metastatic,Female Breast Cancer
AFFECTS,bone morphogenetic protein 4|BMP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 4|BMP4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ZBTB7A|AKIRIN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZBTB7A|AKIRIN2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Diagnosis Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,fluorouracil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fluorouracil Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,LINC00922 gene|LINC00922,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00922 gene|LINC00922 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,baicalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,baicalin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrates Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stress,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Stress Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HOXC10 gene|HOXC10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXC10 gene|HOXC10 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,New medications,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,New medications Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Progression Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Transcript,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Transcript Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",American College of Cardiology/American Heart Association Lesion Complexity Score C Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"EIF4EL3 protein, human|EIF4E2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EIF4EL3 protein, human|EIF4E2 Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,"herstatin protein, human",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human HER2-positive carcinoma of breast",Female Breast Cancer
DISRUPTS,"RNA, Small Interfering",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Small Interfering Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,Mucin-1 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Mucin-1 Antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Problem Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MICAL2 gene|MICAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MICAL2 gene|MICAL2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TLR1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,TLR1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Endoplasmic Reticulum Stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endoplasmic Reticulum Stress Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,COVID-19,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,COVID-19 Breast Carcinoma,Female Breast Cancer
AFFECTS,EHD1 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EHD1 wt Allele Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CD69 protein, human|CD69",malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 malignant neoplasm of breast staging",Female Breast Cancer
PREDISPOSES,Fiber intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fiber intake Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HSPA9 gene|HSPA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPA9 gene|HSPA9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,New Diagnosis Procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,New Diagnosis Procedure Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ergocalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ergocalciferol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,high weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,high weight Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,2-(4-morpholinoanilino)-6-cyclohexylaminopurine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2-(4-morpholinoanilino)-6-cyclohexylaminopurine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,High residue diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,High residue diet Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RBM38 gene|RBM38,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBM38 gene|RBM38 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"herstatin protein, human",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human HER2-positive carcinoma of breast",Female Breast Cancer
PREDISPOSES,Lactation established in non-human animal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lactation established in non-human animal Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDC20 gene|CDC20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC20 gene|CDC20 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,granzyme B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,granzyme B Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Prieto X-linked mental retardation syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prieto X-linked mental retardation syndrome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NFIL3 gene|NFIL3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NFIL3 gene|NFIL3 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,KRT19P3 gene|KRT19P3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,KRT19P3 gene|KRT19P3 Breast Carcinoma,Female Breast Cancer
AUGMENTS,PTEN gene|PTEN,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Pathologic Complete Response,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Pathologic Complete Response Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,"LATS1 protein, human|LATS1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","LATS1 protein, human|LATS1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,CARD.RISK,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,CARD.RISK HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,"Genes, cdc",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, cdc Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,omega-3 fatty acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,omega-3 fatty acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,liquiritigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,liquiritigenin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Autophagy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Autophagy Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Vital activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vital activity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,oxaliplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,oxaliplatin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ADRB2 gene|ADRB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADRB2 gene|ADRB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,doxorubicin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"EZH2 protein, human|EZH2",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Secondary malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Antibody Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Antibody Therapy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Agonist,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Agonist Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,hydrogen peroxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",hydrogen peroxide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Obesity, Visceral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Obesity, Visceral Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Chemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Chemicals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ultrasound scan finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ultrasound scan finding Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SRP9 gene|SRP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRP9 gene|SRP9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tramadol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tramadol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HTR1A gene|HTR1A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HTR1A gene|HTR1A Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,LINC00466 gene|LINC00466,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00466 gene|LINC00466 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,OPRM1 gene|OPRM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OPRM1 gene|OPRM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLK3 gene|KLK3,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"KLK3 gene|KLK3 Breast Cancer, Familial",Female Breast Cancer
AUGMENTS,DDT (Insecticide),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Invertebrate,DDT (Insecticide) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Life Expectancy Less than Five Years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Life Expectancy Less than Five Years Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ARHGAP17 gene|ARHGAP17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP17 gene|ARHGAP17 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Duration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Duration Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,tegaserod maleate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tegaserod maleate Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NEAT1 gene|NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEAT1 gene|NEAT1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Nutrients,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Food,Nutrients Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Sports,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sports Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypoxia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypoxia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Screening mammography,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Screening mammography Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Migraine Disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Migraine Disorders Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,physiological aspects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,physiological aspects Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NEDD4L gene|NEDD4L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEDD4L gene|NEDD4L Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoadjuvant Chemotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neoadjuvant Chemotherapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR210HG gene|MIR210HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR210HG gene|MIR210HG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD31 Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD31 Antigens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mRNA Expression,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",mRNA Expression Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,G-Protein-Coupled Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TRIP13 gene|TRIP13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIP13 gene|TRIP13 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Keratin-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Keratin-19 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cisplatin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,cisplatin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,RAB8A gene|RAB8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAB8A gene|RAB8A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PSAT1 gene|PSAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSAT1 gene|PSAT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCR2 gene|CCR2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,CCR2 gene|CCR2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,RAB8A gene|RAB8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAB8A gene|RAB8A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epithelial ovarian cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epithelial ovarian cancer Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SREBF1 gene|SREBF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SREBF1 gene|SREBF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Score,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Score Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metabolism,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Metabolism Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Has difficulty doing (qualifier value),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Has difficulty doing (qualifier value) Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"tropomyosin-related kinase-B, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"tropomyosin-related kinase-B, human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,iron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,iron Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pediatric Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pediatric Obesity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NCAPD2 gene|NCAPD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCAPD2 gene|NCAPD2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hyperactive behavior,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Hyperactive behavior Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,Players,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Players Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endoplasmic Reticulum Stress,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Endoplasmic Reticulum Stress Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,purinoceptor P2X4|P2RX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,purinoceptor P2X4|P2RX4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Manipulation procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Manipulation procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,GTSE1 gene|GTSE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GTSE1 gene|GTSE1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic Field Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Magnetic Field Therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypersensitivity,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Hypersensitivity HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Biological Response Modifiers Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"Human B-Lymphocyte Antigen CD20, human|MS4A1|KRT20",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"Human B-Lymphocyte Antigen CD20, human|MS4A1|KRT20 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,anhydroicaritin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,anhydroicaritin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical function,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Physical function Locally advanced breast cancer,Female Breast Cancer
AFFECTS,Breast Self-Examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast Self-Examination Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC01287 gene|LINC01287,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01287 gene|LINC01287 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Adipokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adipokines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Frailty,Locally advanced breast cancer,0.0,Female Breast Cancer,Other,Frailty Locally advanced breast cancer,Female Breast Cancer
PREDISPOSES,Dietary Habits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Habits Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Receptor, PAR-1",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,"Receptor, PAR-1 Invasive carcinoma of breast",Female Breast Cancer
PREDISPOSES,dietary fiber intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dietary fiber intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diabetes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diabetes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ATAD2B gene|ATAD2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATAD2B gene|ATAD2B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoadjuvant Chemotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Neoadjuvant Chemotherapy Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,FOXD3-AS1 gene|FOXD3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXD3-AS1 gene|FOXD3-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Triglycerides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Triglycerides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Post-mastectomy radiotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Post-mastectomy radiotherapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DDX21 gene|DDX21,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DDX21 gene|DDX21 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nicotinamide Phosphoribosyltransferase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"protein TDP-43, human",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","protein TDP-43, human Triple Negative Breast Neoplasms",Female Breast Cancer
CAUSES,si-wu-tang,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,si-wu-tang Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Comorbidity,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Comorbidity Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,folic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,folic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,benzene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,benzene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydrogen Sulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydrogen Sulfide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,2-mercaptoethanesulfonic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,2-mercaptoethanesulfonic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gamma-Secretase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gamma-Secretase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PSME2 gene|PSME2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSME2 gene|PSME2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ergocalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ergocalciferol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Helicobacter pylori,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Helicobacter pylori Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,SCG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SCG2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Carcinogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZNHIT1 gene|ZNHIT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNHIT1 gene|ZNHIT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Biological Markers Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,GUSBP11 gene|GUSBP11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GUSBP11 gene|GUSBP11 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,CUEDC2 gene|CUEDC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CUEDC2 gene|CUEDC2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNA Recognition Motif,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RNA Recognition Motif Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TP53,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TP53 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Florid red complexion (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Florid red complexion (finding) Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Orthologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Orthologous Gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GTF2H1 gene|GTF2H1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CD47,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,CD47 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Aurora Kinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aurora Kinase A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,intrinsic factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,intrinsic factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Claudins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Claudins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PON1 gene|PON1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PON1 gene|PON1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Eosinum, eosin, Homeopathic preparation",malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Eosinum, eosin, Homeopathic preparation malignant neoplasm of breast staging",Female Breast Cancer
PREDISPOSES,Androgen Binding Protein|SHBG|CCHCR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Androgen Binding Protein|SHBG|CCHCR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Sleep,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sleep Malignant neoplasm of breast,Female Breast Cancer
CAUSES,catalpol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,catalpol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic Breast Density,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Mammographic Breast Density Invasive carcinoma of breast,Female Breast Cancer
CAUSES,Peptides,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Lymphatic Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymphatic Metastasis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Saturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Saturated fat Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00520 gene|LINC00520,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00520 gene|LINC00520 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"RNA, Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,High grade serous carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,High grade serous carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PIK3CA Gene Mutation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,PIK3CA Gene Mutation HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,TRANSCRIPTION FACTOR,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Rich food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Rich food Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"RNA, Long Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Triple Negative Breast Neoplasms",Female Breast Cancer
CAUSES,Colorectal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Colorectal Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antibody-Drug Conjugates,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,Antibody-Drug Conjugates HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinogens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,BVES gene|BVES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BVES gene|BVES Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Diet, Paleolithic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diet, Paleolithic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DNMT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cardiac event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,cardiac event Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Inhibitor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Inhibitor Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLC1A5 gene|SLC1A5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC1A5 gene|SLC1A5 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Parabens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parabens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,adenosine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Pharmaceutical Preparations,Carcinoma breast stage IV,0.0,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,BRCA2 gene|BRCA2,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,SPATA25 gene|SPATA25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPATA25 gene|SPATA25 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metric (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Metric (substance) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,pigment epithelium-derived factor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,pigment epithelium-derived factor Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Intercellular adhesion molecule 1|ICAM1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Intercellular adhesion molecule 1|ICAM1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,IGHG1 gene|IGHG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGHG1 gene|IGHG1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,agonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,agonists Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Screening procedure,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Screening procedure Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DDX11-AS1 gene|DDX11-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DDX11-AS1 gene|DDX11-AS1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cerulenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cerulenin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Life Expectancy Less than Five Years,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Life Expectancy Less than Five Years Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,FTO gene|FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FTO gene|FTO Malignant neoplasm of breast,Female Breast Cancer
CAUSES,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoprotein Cholesterol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Receptors, Progesterone",Advanced breast cancer diagnosis,0.0,Female Breast Cancer,Hormone,"Receptors, Progesterone Advanced breast cancer diagnosis",Female Breast Cancer
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Poly(ADP-ribose) Polymerase Inhibitors estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,arsenic trioxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arsenic trioxide Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Liposomes,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Liposomes Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Diagnosis Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,"RAF Proto-Oncogene Serine/Threonine-Protein Kinase, human|RAF1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"RAF Proto-Oncogene Serine/Threonine-Protein Kinase, human|RAF1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Provisional,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Provisional Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,metformin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,metformin Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,tiliroside,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,tiliroside Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Programmed cell death ligand 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Programmed cell death ligand 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transection (procedure),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transection (procedure) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Drugs, Non-Prescription",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,"Drugs, Non-Prescription Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Hypoxia Inducible Factor Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypoxia Inducible Factor Family Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SMURF1 gene|SMURF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMURF1 gene|SMURF1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,genistein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,genistein Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,insulin-like growth factor 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,insulin-like growth factor 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,choline Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Catechols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catechols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Microcalcification Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",methionine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GNAO1 gene|GNAO1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,GNAO1 gene|GNAO1 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCND1 gene|CCND1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Breast Carcinoma,Female Breast Cancer
AFFECTS,AXL,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,AXL Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,FOXO1 gene|FOXO1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,FOXO1 gene|FOXO1 Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,CCN1 gene|CCNA2|CYR61|PPP3CA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCN1 gene|CCNA2|CYR61|PPP3CA Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Metabolic marker,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Metabolic marker estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Transcription Factor AP-2 Beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Factor AP-2 Beta Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SIRT1 gene|SIRT1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SIRT1 gene|SIRT1 Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,DANCR gene|DANCR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DANCR gene|DANCR Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,malignant disease,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,malignant disease Invasive carcinoma of breast,Female Breast Cancer
CAUSES,IGF2BP1 gene|IGF2BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF2BP1 gene|IGF2BP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"High Mobility Group Protein HMG-I, Human|HMGA1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","High Mobility Group Protein HMG-I, Human|HMGA1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,beta-arrestin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-arrestin 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AKTIP gene|AKTIP,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,AKTIP gene|AKTIP estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Prolactin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,green tea extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,green tea extract Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Drug resistance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,Drug resistance Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,eriocalyxin B,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,eriocalyxin B Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HULC gene|HULC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HULC gene|HULC Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,USP13 gene|USP13,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,USP13 gene|USP13 Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NLRP3 gene|NLRP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NLRP3 gene|NLRP3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Factors Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PHB2 gene|PHB2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PHB2 gene|PHB2 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,dietary fat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dietary fat intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Senility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Senility Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,toosendanin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,toosendanin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,VDR gene|VDR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VDR gene|VDR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Amino Sugars,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Amino Sugars Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Meal (occasion for eating),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Meal (occasion for eating) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lactates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lactates Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,clinical aspects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,clinical aspects Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,eltrombopag,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,eltrombopag Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TTC17 gene|TTC17,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TTC17 gene|TTC17 Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA2 gene|BRCA2,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"BRCA2 gene|BRCA2 Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,Atrial Fibrillation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Atrial Fibrillation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Exogenous hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Exogenous hormones Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Amino Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amino Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,factor VII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,factor VII Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PKMYT1 gene|PKMYT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PKMYT1 gene|PKMYT1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Specific antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Specific antibody Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"DICER1 protein, human|DICER1",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Secondary malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,NUMB gene|NUMB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUMB gene|NUMB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,collagen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Obesity,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Obesity Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,COG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,COG2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ultrasonography,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Ultrasonography Breast Carcinoma,Female Breast Cancer
AFFECTS,Salpingo-oophorectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Salpingo-oophorectomy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Microenvironment,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Sleep duration:Time:Pt:^Patient:Qn,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sleep duration:Time:Pt:^Patient:Qn Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ursolic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ursolic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hydroxy Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Hydroxy Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"SDHD protein, human|SDHD",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SDHD protein, human|SDHD Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,cholesterol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immune checkpoint inhibitor therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immune checkpoint inhibitor therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lactates,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Lactates Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,"CTSH protein, human|CTSH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CTSH protein, human|CTSH Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Nicotinamide Phosphoribosyltransferase Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Immune Checkpoint Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Immune Checkpoint Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TYMS|PYCARD,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,TYMS|PYCARD Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,CDK1 gene|CDK1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDK1 gene|CDK1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNRPC gene|SNRPC Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Epithelial proliferation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial proliferation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibronectins,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Fibronectins Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,COPS6 gene|COPS6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COPS6 gene|COPS6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Life Expectancy Less than Ten Years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Life Expectancy Less than Ten Years Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KIF2C gene|KIF2C,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KIF2C gene|KIF2C Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Severe (severity modifier),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Severe (severity modifier) Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neoplasms Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIR326 gene|MIR326,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR326 gene|MIR326 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"HMGA2 protein, human|HMGA2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HMGA2 protein, human|HMGA2 Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,RNA-Binding Protein Musashi Homolog 1,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 1 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Non-Small Cell Lung Carcinoma,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Non-Small Cell Lung Carcinoma HER2-positive carcinoma of breast,Female Breast Cancer
CAUSES,arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arsenic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IPO7 gene|IPO7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IPO7 gene|IPO7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ROR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ROR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Peripheral Nerve Sheath Neoplasm,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Peripheral Nerve Sheath Neoplasm Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"TNF protein, human|TNF",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"2,3-bis(3'-hydroxybenzyl)butyrolactone Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,RNA-Binding Protein Musashi Homolog 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Peptides,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Biological Markers,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Biological Markers Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PPP1R14B-AS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPP1R14B-AS1 gene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,doxorubicin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,doxorubicin Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RNA-Binding Protein Musashi Homolog 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FOXP3 gene|FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXP3 gene|FOXP3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,palbociclib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,palbociclib Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inhibitor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA2 Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 Gene Mutation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Inflammasomes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inflammasomes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,leptin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,zinc Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HIPK3 gene|HIPK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIPK3 gene|HIPK3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pre-miRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",pre-miRNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Metabolite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolite Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,alpha Catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha Catenin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,YOD1 gene|YOD1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YOD1 gene|YOD1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Obesity,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Obesity estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,SMYD2 gene|SMYD2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SMYD2 gene|SMYD2 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cell Growth Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TUSC2 gene|TUSC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TUSC2 gene|TUSC2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GPX4 gene|GPX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPX4 gene|GPX4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Circulating Tumor DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Circulating Tumor DNA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,interleukin-6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,interleukin-6 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,AURKA gene|AURKA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AURKA gene|AURKA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"CREB1 protein, human|CREB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CREB1 protein, human|CREB1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Cervical Cancer Screening,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cervical Cancer Screening Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Protons,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Protons Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ascorbic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ascorbic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Performance,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Performance Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,zoledronate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,zoledronate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Caspase-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Caspase-1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,astragaloside IV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,astragaloside IV Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,mammaglobin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,mammaglobin Breast Carcinoma,Female Breast Cancer
AFFECTS,TMED2 gene|TMED2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMED2 gene|TMED2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary Neoplasm,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Secondary Neoplasm Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,HASPIN gene|HASPIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HASPIN gene|HASPIN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Ferritin Light Chain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ferritin Light Chain Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNHG14 gene|SNHG14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG14 gene|SNHG14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lymphatic Invasion,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Lymphatic Invasion Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Allele-Specific Oligonucleotide,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Allele-Specific Oligonucleotide Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,beta catenin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,beta catenin Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NR1D1 gene|NR1D1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR1D1 gene|NR1D1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mitosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,risk factors,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,risk factors Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,metformin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,estrogens,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,estrogens estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,euphorbia factor L1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,euphorbia factor L1 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ketamine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,ketamine Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXO3 gene|FOXO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXO3 gene|FOXO3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1-Phosphatidylinositol 3-Kinase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,andrographolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,andrographolide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NEK2 gene|NEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEK2 gene|NEK2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Flavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavonoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pharmacologic Substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmacologic Substance Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,signaling cascade,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,signaling cascade Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Phosphates,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Phosphates Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,PAXX gene|PAXX,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PAXX gene|PAXX Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Obesity,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Obesity estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,Sesquiterpenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sesquiterpenes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Colorectal Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Colorectal Carcinoma Breast Carcinoma,Female Breast Cancer
AUGMENTS,PIN1 gene|PIN1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,PIN1 gene|PIN1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Trace Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trace Elements Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FMO4 gene|FMO4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FMO4 gene|FMO4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibroblast Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vacuum assisted biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vacuum assisted biopsy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR223 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR223 wt Allele Malignant neoplasm of breast,Female Breast Cancer
CAUSES,taxane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,taxane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inhibitor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Inhibitor Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,hydroxypropylbetadex (0.58-0.68 MS),Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,hydroxypropylbetadex (0.58-0.68 MS) Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"POSTN protein, human|POSTN",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","POSTN protein, human|POSTN Triple Negative Breast Neoplasms",Female Breast Cancer
CAUSES,TWIST1 gene|TWIST1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,chelidonine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chelidonine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Homologous Recombination Repair Gene,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Homologous Recombination Repair Gene Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,YBX1 gene|YBX1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YBX1 gene|YBX1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Plasma Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Plasma Proteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,raloxifene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FBXO3 gene|FBXO3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FBXO3 gene|FBXO3 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Precision Medicine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Precision Medicine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",American College of Cardiology/American Heart Association Lesion Complexity Score A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chlordan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chlordan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Shift worker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Shift worker Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Stress, Psychological",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Stress, Psychological Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,MTDH gene|MTDH,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,MTDH gene|MTDH Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,calcifediol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,calcifediol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Low Level,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Low Level Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,c-src Genes|SRC,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,c-src Genes|SRC Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HSP90 Inhibitor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,HSP90 Inhibitor Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Psychotic Disorders,Carcinoma breast stage IV,0.0,Female Breast Cancer,Disease or Syndrome,Psychotic Disorders Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Ubiquitin-Conjugating Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Ubiquitin-Conjugating Enzymes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Equilibrium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Equilibrium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TIPARP gene|TIPARP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIPARP gene|TIPARP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proliferative vitreoretinopathy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Proliferative vitreoretinopathy Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Complementary therapies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Complementary therapies Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RAD51 gene|RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51 gene|RAD51 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Duration,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Duration Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,GALNT7 gene|GALNT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GALNT7 gene|GALNT7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nicotinamide Phosphoribosyltransferase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MELK gene|MELK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MELK gene|MELK Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Leukotriene B4 Receptors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Eicosanoid,Leukotriene B4 Receptors Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,GRB2 gene|GRB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GRB2 gene|GRB2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LIAS gene|LIAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIAS gene|LIAS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HER2/Neu Positive,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2/Neu Positive Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNORD16 gene|SNORD16,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,SNORD16 gene|SNORD16 Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,clinical aspects,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,clinical aspects HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,FBXO8 gene|FBXO8,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FBXO8 gene|FBXO8 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fertility Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Fertility Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,icariin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,icariin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Receptor Protein-Tyrosine Kinases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,cadmium chloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,cadmium chloride Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oxidoreductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxidoreductase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ECM1 gene|ECM1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ECM1 gene|ECM1 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNHG1 gene|SNHG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG1 gene|SNHG1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Personal status - Adopted,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Personal status - Adopted Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"ORF74 protein, Human herpesvirus 8",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ORF74 protein, Human herpesvirus 8 Triple Negative Breast Neoplasms",Female Breast Cancer
DISRUPTS,Tea Extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tea Extract Malignant neoplasm of breast,Female Breast Cancer
CAUSES,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases|DNMT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ubiquitin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ubiquitin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNORD49B gene|SNORD49B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNORD49B gene|SNORD49B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Healthy Lifestyle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Healthy Lifestyle Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,YAP1 gene|YAP1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YAP1 gene|YAP1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"herstatin protein, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Clinical Significance,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Clinical Significance Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,HOTAIR gene|HOTAIR,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR malignant neoplasm of breast staging,Female Breast Cancer
AFFECTS,Secondary Neoplasm,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Secondary Neoplasm Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"ATP8A2 protein, human|ATP8A2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ATP8A2 protein, human|ATP8A2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Menarche,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menarche Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABCB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alzheimer's Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Alzheimer's Disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pathogenic Variant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Pathogenic Variant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alzheimer's Disease,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Disease or Syndrome,Alzheimer's Disease estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Performance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Performance Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Obesity,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Obesity Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,UGT2B7 gene|UGT2B7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UGT2B7 gene|UGT2B7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HIF1A gene|HIF1A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,O(6)-Methylguanine-DNA Methyltransferase|MGMT,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",O(6)-Methylguanine-DNA Methyltransferase|MGMT Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,baicalein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,baicalein Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Biological Processes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Phenomenon or Process,Biological Processes Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,GCKR gene|GCKR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GCKR gene|GCKR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PDP1 gene|PDP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDP1 gene|PDP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Family Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FSCN1 gene|FSCN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FSCN1 gene|FSCN1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,thiostrepton,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,thiostrepton Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diabetes Mellitus, Non-Insulin-Dependent Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,"CDK7 protein, human|CDK7",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDK7 protein, human|CDK7 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,NODAL gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,NODAL gene Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,"Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6, human|CEACAM6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6, human|CEACAM6 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Progranulins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Progranulins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Uridine Diphosphate Glucose Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Uridine Diphosphate Glucose Dehydrogenase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Personal Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Personal Behavior Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Oligoribonucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligoribonucleotides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nitric Oxide Synthase Type II,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Nitric Oxide Synthase Type II Breast cancer metastatic,Female Breast Cancer
DISRUPTS,FAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TCF7L2 gene|TCF7L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TCF7L2 gene|TCF7L2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NCOA1 gene|NCOA1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NCOA1 gene|NCOA1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP19A1 gene|CYP19A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MLH1 gene|MLH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLH1 gene|MLH1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Motility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Motility Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"GMNN protein, human|GMNN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GMNN protein, human|GMNN Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,PAK1|PKN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PAK1|PKN1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methotrexate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Methotrexate Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Adenosine A1 Receptor|ADORA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adenosine A1 Receptor|ADORA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammary Neoplasms,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Other,Mammary Neoplasms Carcinoma in situ of breast,Female Breast Cancer
PREDISPOSES,DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DNMT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estrone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,LSP1 gene|LSP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LSP1 gene|LSP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,indole-3-carbinol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,indole-3-carbinol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TNFSF6 gene|FASLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF6 gene|FASLG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prevention,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Prevention Familial cancer of breast,Female Breast Cancer
DISRUPTS,bortezomib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bortezomib Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methionine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NME1 gene|NME1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Amyloid beta-Protein Precursor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amyloid beta-Protein Precursor Breast Carcinoma,Female Breast Cancer
AFFECTS,survivin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,survivin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Connexins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Connexins Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Compound V,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Compound V Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmaceutical Preparations,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast Carcinoma,Female Breast Cancer
DISRUPTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Bacterial Endocarditis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Bacterium,Bacterial Endocarditis Breast cancer metastatic,Female Breast Cancer
AUGMENTS,activating transcription factor 3|ATF3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",activating transcription factor 3|ATF3 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Immune Cell Activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immune Cell Activation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD47 gene|CD47,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD47 gene|CD47 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer metastatic,Female Breast Cancer
AFFECTS,Interleukin-17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-17 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MMP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MMP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,bone morphogenetic protein 6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AR gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AR gene|AR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NTRK2 gene|NTRK2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,NTRK2 gene|NTRK2 Breast cancer recurrent,Female Breast Cancer
AUGMENTS,PITPNM1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PITPNM1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,IGKC gene|IGKC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGKC gene|IGKC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CIP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CIP2A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,mammaglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mammaglobin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,Cadmium Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BST2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BST2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor beta|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to genetic counseling,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Encounter due to genetic counseling Familial cancer of breast,Female Breast Cancer
PREDISPOSES,ethnic differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ethnic differences Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BMP2 gene|BMP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMP2 gene|BMP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Free Radicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Free Radicals Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Estrogen receptor positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor positive Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoprotein Cholesterol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,mullerian-inhibiting hormone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Catenins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catenins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MYC gene|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC gene|MYC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Genes, cdc",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, cdc Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,nitidine chloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,nitidine chloride Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"DNA, Mitochondrial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Mitochondrial Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,BIRC4 gene|XIAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC4 gene|XIAP Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Contraceptive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Contraceptive Agents Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MC4R gene|MC4R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MC4R gene|MC4R Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KIFC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KIFC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Syndrome,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Disease or Syndrome,Syndrome Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,PSMB6|YY1|DLL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PSMB6|YY1|DLL1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNA-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cilostazol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,cilostazol Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,FOXM1 gene|FOXM1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,PAWR gene|PAWR,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,PAWR gene|PAWR Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,UBE2N,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,UBE2N Breast cancer metastatic,Female Breast Cancer
AFFECTS,STMN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,STMN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IQGAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IQGAP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,profilin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,profilin 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KISS1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KISS1R Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neuromedin U|NMU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neuromedin U|NMU Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pain Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mullerian-inhibiting substance receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Mullerian-inhibiting substance receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR98,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,MIR98 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CENPA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CENPA Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,isoliquiritigenin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,isoliquiritigenin Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Centchroman,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Centchroman Breast cancer metastatic,Female Breast Cancer
AUGMENTS,MIRN21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN21 gene|MIR21 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RASAL2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estradiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Estradiol Breast cancer metastatic,Female Breast Cancer
AFFECTS,ERBB2IP gene|ERBIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2IP gene|ERBIN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RARRES3 gene|RARRES3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RARRES3 gene|RARRES3 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Adenocarcinoma of large intestine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenocarcinoma of large intestine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,dihydroxyacetone sulfate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,dihydroxyacetone sulfate Breast cancer metastatic,Female Breast Cancer
CAUSES,PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PALB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Leisure Time,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leisure Time Malignant neoplasm of breast,Female Breast Cancer
CAUSES,EPSTI1 gene|EPSTI1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,EPSTI1 gene|EPSTI1 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Prodrugs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Prodrugs Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NRIP1 gene|NRIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRIP1 gene|NRIP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,platelet-derived growth factor C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,platelet-derived growth factor C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"TIMP1 protein, human|TIMP1",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TIMP1 protein, human|TIMP1 Breast cancer metastatic",Female Breast Cancer
PREDISPOSES,Estriol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estriol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclophosphamide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cyclophosphamide Breast Carcinoma,Female Breast Cancer
AUGMENTS,Diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diethylstilbestrol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to genetic counseling,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,Encounter due to genetic counseling Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Thymidylate Synthase,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Thymidylate Synthase Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,APC gene|APC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APC gene|APC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclin D1|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1|CCND1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Urokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Urokinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,Genes Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast cancer invasive NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Orosomucoid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Orosomucoid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CTCF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTCF Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TLR4 gene|TLR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TLR4 gene|TLR4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sialoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Sialoproteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Trace Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trace Elements Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHEK1 gene|CHEK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK1 gene|CHEK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Organic Chemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Organic Chemicals Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Leptin|LEP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leptin|LEP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,XRCC4 gene|XRCC4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC4 gene|XRCC4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Phosphotransferases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Phosphotransferases Breast cancer metastatic,Female Breast Cancer
AUGMENTS,estrone sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estrone sulfate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glutamate Carboxypeptidase II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glutamate Carboxypeptidase II Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDH1 gene|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH1 gene|CDH1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KISS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KISS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"HGF protein, human|HGF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HGF protein, human|HGF Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,STAT5B gene|STAT5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT5B gene|STAT5B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,transcription cofactor activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",transcription cofactor activity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLF5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Supraventricular arrhythmia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Supraventricular arrhythmia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Wiskott-Aldrich Syndrome Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Wiskott-Aldrich Syndrome Protein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Proto-Oncogene Proteins c-sis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-sis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CA-125 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CA-125 Antigen Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PFN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PFN1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sodium Selenite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sodium Selenite Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GRHL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GRHL3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epigenetic Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Epigenetic Process Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Glutamic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Glutamic Acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,1-Phosphatidylinositol 4-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1-Phosphatidylinositol 4-Kinase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Receptors, Tumor Necrosis Factor, Type II",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Receptors, Tumor Necrosis Factor, Type II Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,PELP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PELP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOX11,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,SOX11 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,Interleukin 4 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin 4 Receptor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CMA1|SLC16A1|MCAT|MCTS1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,CMA1|SLC16A1|MCAT|MCTS1 Breast Carcinoma,Female Breast Cancer
AFFECTS,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isoflavones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Polysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polysaccharides Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,gamma-secretase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gamma-secretase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carboxypeptidase U,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carboxypeptidase U Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Atrial Fibrillation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Atrial Fibrillation Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Cancer of Rectum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer of Rectum Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TNFSF10 gene|TNFSF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF10 gene|TNFSF10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epstein-Barr virus antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Epstein-Barr virus antibody Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TSG101 gene|TSG101,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,TSG101 gene|TSG101 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Neoplasm,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Neoplasm Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Epinephrine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Epinephrine Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Reserpine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reserpine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Castration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Castration Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIRN17 gene|MIR17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN17 gene|MIR17 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"SHC1 protein, human|SHC1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SHC1 protein, human|SHC1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,In complete remission,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",In complete remission Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aspartic Endopeptidases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Aspartic Endopeptidases Breast cancer metastatic,Female Breast Cancer
AFFECTS,Reproduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reproduction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Up-Regulation (Physiology),Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Up-Regulation (Physiology) Breast cancer metastatic,Female Breast Cancer
CAUSES,chromosome 17q,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chromosome 17q Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Milk intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Milk intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chronic inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chronic inflammation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibrosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrosis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Caseins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Caseins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Menstrual cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menstrual cycle Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Androgens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Androgens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Reserpine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Reserpine Breast Carcinoma,Female Breast Cancer
AUGMENTS,SRC gene|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRC gene|SRC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,OLFM4 gene|OLFM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OLFM4 gene|OLFM4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Circadian Rhythms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Circadian Rhythms Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Virus,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Virus,Virus Female Breast Carcinoma,Female Breast Cancer
CAUSES,retinol acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,retinol acetate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Selenium intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Selenium intake Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Vinyl Chloride,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Vinyl Chloride Breast Carcinoma,Female Breast Cancer
PREDISPOSES,N-acetyltransferase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,N-acetyltransferase 1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,retinyl methyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,retinyl methyl ether Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA2 gene|BRCA2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Interleukin-13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,inhibitors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,inhibitors Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Exogenous hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Exogenous hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,calcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",calcification Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GPER1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"RARB protein, human|RARB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","RARB protein, human|RARB Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,LEPR gene|LEPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LEPR gene|LEPR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Xeroradiography,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Xeroradiography Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Bread,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bread Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,leptin receptor|LEP,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,leptin receptor|LEP Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Exogenous hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Exogenous hormones Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cyclin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin E Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast cancer metastatic,Female Breast Cancer
DISRUPTS,"CST6 protein, human|CST6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CST6 protein, human|CST6 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Metabolites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolites Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Fatty Acids, Essential",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Essential Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"Puberty, Female",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Puberty, Female Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Vitamin D3 Receptor|VDR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Food,Vitamin D3 Receptor|VDR Breast Carcinoma,Female Breast Cancer
PREDISPOSES,pyrrolidino-4-iodotamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,pyrrolidino-4-iodotamoxifen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcriptional Activation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Transcriptional Activation Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,valyl-valyl-valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,valyl-valyl-valine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Infusion procedures,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Infusion procedures Breast cancer metastatic,Female Breast Cancer
AUGMENTS,20q13.2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,20q13.2 Breast Carcinoma,Female Breast Cancer
DISRUPTS,Proto-Oncogene Proteins c-akt|AKT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,LOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LOX Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Somatotropin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatotropin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Progesterone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Progesterone Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Fibroblast Growth Factor 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BONE MASS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BONE MASS Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Urokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Urokinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,No past history,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,No past history Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Candidate Disease Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Molecular Abnormality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Molecular Abnormality Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Indoles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Indoles Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estradiol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Estradiol Breast Carcinoma,Female Breast Cancer
AFFECTS,Immunotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Immunotherapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Involution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Involution Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cadherins,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Cadherins Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biopsy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Melatonin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Retroviridae,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Retroviridae Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Enzymes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Enzymes Breast Carcinoma,Female Breast Cancer
PREDISPOSES,EYA2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,EYA2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Pill,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pill Malignant neoplasm of breast,Female Breast Cancer
CAUSES,neu Differentiation Factor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",neu Differentiation Factor Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Reproductive History,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Reproductive History Breast cancer invasive NOS,Female Breast Cancer
CAUSES,parathyroid hormone-related protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hyaluronan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyaluronan Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aromatic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aromatic Amines Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Fats Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Neoplasm Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,CA1|S100A10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CA1|S100A10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Binding Sites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Binding Sites Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Proto-Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogenes Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Urea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Urea Breast Carcinoma,Female Breast Cancer
AFFECTS,Melatonin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Melatonin Breast Carcinoma,Female Breast Cancer
DISRUPTS,Fenretinide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fenretinide Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Oncogene, HST|FGF4|HSF1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Oncogene, HST|FGF4|HSF1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Estrogen Replacement Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Replacement Therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Arginine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sterility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sterility Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Benzanthracenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Benzanthracenes Breast Carcinoma,Female Breast Cancer
AFFECTS,Absolute Alcohol,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Absolute Alcohol Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Cytotoxic agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic agent Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Polyunsaturated fat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polyunsaturated fat intake Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Polyamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polyamines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,3-hydroxytamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,3-hydroxytamoxifen Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PHENYL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,PHENYL Breast Carcinoma,Female Breast Cancer
AFFECTS,Termination of pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Termination of pregnancy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,adjuvant therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,adjuvant therapy Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,Secondary malignant neoplasm of bone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Breast Carcinoma,Female Breast Cancer
AUGMENTS,Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Estrone Breast Carcinoma,Female Breast Cancer
PREDISPOSES,hormonal changes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hormonal changes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fluorouracil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fluorouracil Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TAG 12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TAG 12 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Term pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Term pregnancy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alkaline Phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alkaline Phosphatase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alkaline Phosphatase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Alkaline Phosphatase Breast Carcinoma,Female Breast Cancer
CAUSES,Advance,Breast cancer stage II,0.0,Female Breast Cancer,Other,Advance Breast cancer stage II,Female Breast Cancer
PREDISPOSES,Athletics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Athletics Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EGF gene|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGF gene|EGF Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Height / growth measure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Height / growth measure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ARGINASE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ARGINASE Breast Carcinoma,Female Breast Cancer
AFFECTS,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Breast Diseases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Seizures,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Seizures Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Induction,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Induction Breast Carcinoma,Female Breast Cancer
CAUSES,Malignant transformation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant transformation Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Thyroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tissue Polypeptide Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tissue Polypeptide Antigen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Glycoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glycoproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Pharmacotherapy Breast Carcinoma,Female Breast Cancer
CAUSES,Malignant neoplasm of stomach,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of stomach Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Testicular Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Testicular Neoplasms Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammography,Breast Mucinous Carcinoma,0.0,Female Breast Cancer,Other,Mammography Breast Mucinous Carcinoma,Female Breast Cancer
AFFECTS,Haloperidol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Haloperidol Breast Carcinoma,Female Breast Cancer
AFFECTS,Hysterectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hysterectomy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Medroxyprogesterone 17-Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Breast Carcinoma,Female Breast Cancer
AFFECTS,Ovariectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ovariectomy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,v-H-ras Oncogenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,v-H-ras Oncogenes Breast Carcinoma,Female Breast Cancer
AUGMENTS,Prolactin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Prolactin Breast Carcinoma,Female Breast Cancer
AFFECTS,Hair Dyes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Hair Dyes Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neuromedin U|NMU,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Neuromedin U|NMU Breast Carcinoma,Female Breast Cancer
COMPLICATES,"Liver Failure, Acute",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"Liver Failure, Acute Breast Carcinoma",Female Breast Cancer
AFFECTS,Ovariectomy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Ovariectomy Breast Carcinoma,Female Breast Cancer
DISRUPTS,Monoterpenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Monoterpenes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Hydrocortisone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Hydrocortisone Breast Carcinoma,Female Breast Cancer
AFFECTS,melanoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,melanoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Antagonists,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogen Antagonists Breast Carcinoma,Female Breast Cancer
AFFECTS,Neurotropism,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Neurotropism Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cystic Lesion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cystic Lesion Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Contraction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Contraction Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Prostaglandins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Eicosanoid,Prostaglandins Breast Carcinoma,Female Breast Cancer
PREDISPOSES,2-hydroxyestrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2-hydroxyestrone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Hamartoma Syndrome, Multiple",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,"Hamartoma Syndrome, Multiple Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Aminoglutethimide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aminoglutethimide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antipyrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antipyrine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Levamisole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Levamisole Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,transglutaminase 1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,transglutaminase 1 Breast Carcinoma,Female Breast Cancer
AFFECTS,Hydrocortisone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydrocortisone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Goserelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Goserelin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Visual impairment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Visual impairment Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Antigens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Scanning,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Scanning Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogenic,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogenic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Introns,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Introns Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Flutamide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Flutamide Breast Carcinoma,Female Breast Cancer
AUGMENTS,CATHEPSIN D|CTSD,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,CATHEPSIN D|CTSD Breast Carcinoma,Female Breast Cancer
AUGMENTS,TP53 gene|TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Dichlorodiphenyl Dichloroethylene,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Dichlorodiphenyl Dichloroethylene Female Breast Carcinoma,Female Breast Cancer
CAUSES,Acetyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetyltransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carrier of disorder,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Disease or Syndrome,Carrier of disorder Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II) Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Mixture,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mixture Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Human Chorionic Gonadotropin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Human Chorionic Gonadotropin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Date of birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Date of birth Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Short stature,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Short stature Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin D1|CCND1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Cyclin D1|CCND1 Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,Complex carbohydrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Complex carbohydrate Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SERPINB2 gene|SERPINB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SERPINB2 gene|SERPINB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic Resonance Spectroscopy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Magnetic Resonance Spectroscopy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PTK2B gene|PTK2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTK2B gene|PTK2B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phenothiazines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phenothiazines Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Focal Adhesion Protein-Tyrosine Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,retinoic acid receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,retinoic acid receptor alpha Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cyclic AMP Receptor Protein,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclic AMP Receptor Protein Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Maternal history,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Maternal history Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Vegetable Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vegetable Oils Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,6-pyruvoyltetrahydropterin synthase|SLC25A3|REG1A|PTPRU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6-pyruvoyltetrahydropterin synthase|SLC25A3|REG1A|PTPRU Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Beans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beans Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Insulin-Like Growth-Factor-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth-Factor-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Integrins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Integrins Breast Carcinoma,Female Breast Cancer
COMPLICATES,Pathological fracture,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pathological fracture Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzymes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nulliparous,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nulliparous Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mean blood pressure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mean blood pressure Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,glypican 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,glypican 3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Herpesvirus 4, Human",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,"Herpesvirus 4, Human Breast Carcinoma",Female Breast Cancer
AUGMENTS,DNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast Carcinoma,Female Breast Cancer
CAUSES,"Smoking, Passive",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Smoking, Passive Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Lhermitte-Duclos disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Lhermitte-Duclos disease Breast Carcinoma,Female Breast Cancer
PREDISPOSES,BRCA2 gene|BRCA2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Chlorinated Malignant neoplasm of breast",Female Breast Cancer
CAUSES,CDKN2A gene|CDKN2A,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,NAT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NAT2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Overnutrition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Overnutrition Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcription Factor AP-2 Alpha|FABP4|GTF3A|TFAP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Factor AP-2 Alpha|FABP4|GTF3A|TFAP2A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SPO11 gene|SPO11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPO11 gene|SPO11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ultraviolet Rays,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ultraviolet Rays Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GRB7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GRB7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Premature Birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Premature Birth Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Expression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Gene Expression Breast Carcinoma,Female Breast Cancer
AUGMENTS,Mitogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Amplification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Gene Amplification Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,ras Oncogene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ras Oncogene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Invasive Carcinoma,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Fibroadenoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibroadenoma Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Receptors, Nuclear",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Nuclear Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Cytochrome P450 3A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P450 3A4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,estriol 3-sulfate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,estriol 3-sulfate Breast Carcinoma,Female Breast Cancer
AFFECTS,CHGA gene|CHGA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHGA gene|CHGA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MDM2 gene|MDM2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Vascular Endothelial Growth Factor Receptor-1|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-1|VEGFA Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Disintegrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Disintegrins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NMU gene|NMU,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NMU gene|NMU Breast Carcinoma,Female Breast Cancer
AFFECTS,Pre-Eclampsia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pre-Eclampsia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ovarian function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ovarian function Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast Carcinoma,Female Breast Cancer
CAUSES,Gross' disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Gross' disease Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Polycyclic Hydrocarbons, Aromatic",Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Sporadic Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Vitamin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin E Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dichlorodiphenyl Dichloroethylene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Endostatins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endostatins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,glutathione S-transferase M1|CHRM1|MRLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase M1|CHRM1|MRLN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,bone sialoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bone sialoprotein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Adrenal carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adrenal carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Encounter due to prophylactic surgery, unspecified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Encounter due to prophylactic surgery, unspecified Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Scanning,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Scanning Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,psychological stressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,psychological stressor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Opioid Peptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Opioid Peptide Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BRCA1 Protein|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 Protein|BRCA1 Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,Depo-Provera,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Depo-Provera Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Stress, acute",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Stress, acute Malignant neoplasm of breast",Female Breast Cancer
CAUSES,3MC,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,3MC Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer metastatic,Female Breast Cancer
CAUSES,Chemopreventive Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemopreventive Agent Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epoxy Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Epoxy Compounds Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methylcholanthrene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Methylcholanthrene Breast Carcinoma,Female Breast Cancer
AFFECTS,Ibuprofen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ibuprofen Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Beta Carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beta Carotene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine Malignant neoplasm of breast",Female Breast Cancer
CAUSES,ESRRA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ESRRA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB2 gene|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,specific immunity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,specific immunity Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Repressor Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Repressor Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radioimmunotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Radioimmunotherapy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,TIE gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIE gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thyroid Hormone Receptor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Thyroid Hormone Receptor Gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HDAC1 gene|HDAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HDAC1 gene|HDAC1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Androgen Receptor|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor|AR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ATM gene|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM gene|ATM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gelatinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,XRCC2 gene|XRCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC2 gene|XRCC2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Therapeutic procedure Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Kininogenase|KLK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Kininogenase|KLK4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,EGFR gene|EGFR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Breast Carcinoma,Female Breast Cancer
CAUSES,Substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Substance Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ZHX2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ZHX2 Breast Carcinoma,Female Breast Cancer
CAUSES,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,PIK3CA|PIK3CB|PIK3CD|PIK3CG Breast Carcinoma,Female Breast Cancer
AFFECTS,Sporadic Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sporadic Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oleic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Oleic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GTPase-Activating Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GTPase-Activating Proteins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Telomerase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Telomerase Breast Carcinoma,Female Breast Cancer
AFFECTS,COMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,COMT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth-Factor-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth-Factor-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cysteine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Estrogens, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Synthetic Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Guanosine Triphosphate Phosphohydrolases,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Guanosine Triphosphate Phosphohydrolases Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,TP53 gene|TP53,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Apple,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Apple Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Chlorinated Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,parathyroid hormone-related protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Female genital tract problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Female genital tract problem Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fatty food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Fatty food Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Embolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Embolism Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CHEK2 gene|CHEK2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Carcinoma of Male Breast,Female Breast Cancer
CAUSES,Carcinoma of Male Breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma of Male Breast Malignant neoplasm of breast,Male Breast Cancer
DISRUPTS,"SKIL protein, human|SKIL",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SKIL protein, human|SKIL Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,ADAM23,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADAM23 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"retinoic acid binding protein II, cellular",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","retinoic acid binding protein II, cellular Breast Carcinoma",Female Breast Cancer
PREDISPOSES,CANADIAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CANADIAN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mass in breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mass in breast Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Carcinoma, Lobular","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Carcinoma, Lobular Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,Medroxyprogesterone 17-Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lignans Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA1 Mutation,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 Mutation Familial cancer of breast,Female Breast Cancer
DISRUPTS,Prolactin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Prolactin Breast Carcinoma,Female Breast Cancer
AFFECTS,Mammary Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mammary Neoplasms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BIRC5 gene|BIRC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC5 gene|BIRC5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Creatinine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Creatinine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mammary Tumorigenesis,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Mammary Tumorigenesis Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Hepatocyte Growth Factor|HGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Hepatocyte Growth Factor|HGF Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"JARID1B protein, human|KDM5B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","JARID1B protein, human|KDM5B Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Receptiveness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Receptiveness Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pregnancy hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,pregnancy hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Recreation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Recreation Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,peptide I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",peptide I Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IGKV2D-40,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IGKV2D-40 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of prostate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hexachlorobenzene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Hexachlorobenzene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HFE gene|HFE,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,HFE gene|HFE Carcinoma of Male Breast,Female Breast Cancer
CAUSES,Methylcholanthrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methylcholanthrene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Single-Stranded Conformational Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Single-Stranded Conformational Polymorphism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Emotional support,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Emotional support Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,WNT7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WNT7B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Therapeutic procedure Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Synucleins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Synucleins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Conjugated Equine Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Conjugated Equine Estrogens Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,beta-ionone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-ionone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Androgen therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Androgen therapy Breast Carcinoma,Female Breast Cancer
AFFECTS,death receptor-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,death receptor-4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Iodides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iodides Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Tumor Protein p53 Binding Protein 2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tumor Protein p53 Binding Protein 2 Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Paroxysmal atrial tachycardia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paroxysmal atrial tachycardia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Endocrine Disruptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Disruptors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogenic,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Hormone,Estrogenic Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Hyperglycemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperglycemia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Carcinogens, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Thrombospondin 1|THBS1|CRISP2|PRSS55,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Thrombospondin 1|THBS1|CRISP2|PRSS55 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Increase in blood pressure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Increase in blood pressure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Convenience food,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Food,Convenience food Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,AKR1C1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AKR1C1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|ESR2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EVL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EVL Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Estrogens Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,"Contraceptives, Oral",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"Contraceptives, Oral Breast Carcinoma",Female Breast Cancer
AUGMENTS,Fibrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CHEST PATHOLOGY,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,CHEST PATHOLOGY Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,CYP1A2 gene|CYP1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1A2 gene|CYP1A2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transcription Initiation Site,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Initiation Site Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aggressive cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aggressive cancer Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,connective tissue growth factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,connective tissue growth factor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Dopamine Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Dopamine Antagonists Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WNT7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WNT7B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cyclic Peptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclic Peptides Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Spray,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Spray Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,N-Cadherins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,N-Cadherins Breast Carcinoma,Female Breast Cancer
AFFECTS,Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Antibiotics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HSP90 Heat-Shock Proteins|HSP90AA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HSP90 Heat-Shock Proteins|HSP90AA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dairy Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dairy Products Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLC25A18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC25A18 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transcript Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Climacteric discomfort,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Climacteric discomfort Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Valine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microdochectomy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Microdochectomy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Molecular Chaperones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Molecular Chaperones Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Trans Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Trans Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Integrins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Integrins Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"Diabetes, Gestational",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes, Gestational Malignant neoplasm of breast",Female Breast Cancer
CAUSES,intestinal bacteria,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Bacterium,intestinal bacteria Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Prolactin level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin level Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Suppressor Genes,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,ADRA1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADRA1D Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IRS1 gene|IRS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,IRS1 gene|IRS1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Pregnanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pregnanes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Valine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PRL increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRL increased Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Molecular Target,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Molecular Target Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PTH gene|PTH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTH gene|PTH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tocotrienols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tocotrienols Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biopsy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Biopsy Breast Carcinoma,Female Breast Cancer
PREDISPOSES,IGF1 gene|IGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1 gene|IGF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,E-Cadherin,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,E-Cadherin Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,allyl sulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,allyl sulfide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP1B1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Antibiotics Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tetanus Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tetanus Vaccine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Biological Models,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Models Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mouse Pancreatic Intraepithelial Neoplasia-1B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Mouse Pancreatic Intraepithelial Neoplasia-1B Breast Carcinoma,Female Breast Cancer
DISRUPTS,"Estrogens, Catechol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Catechol Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Lymph Node Involvement,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Lymph Node Involvement Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Anti-Inflammatory Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Inflammatory Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Betaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Betaine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Platelet-Derived Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Platelet-Derived Growth Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,gamma-Glutamyl Hydrolase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gamma-Glutamyl Hydrolase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Integrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Endocrine Disruptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Disruptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD44 gene|CD44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Matrix Metalloproteinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin B Complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B Complex Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,BRMS1 gene|BRMS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRMS1 gene|BRMS1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Disclosure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Disclosure Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,phospholipid-hydroperoxide glutathione peroxidase,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","phospholipid-hydroperoxide glutathione peroxidase Carcinoma, Ductal, Breast",Female Breast Cancer
DISRUPTS,alpha-Fetoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha-Fetoproteins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SIRT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SIRT7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tea intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tea intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TP53 gene|TP53,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,CATHEPSIN D|CTSD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CATHEPSIN D|CTSD Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TP53 gene|TP53,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Familial cancer of breast,Female Breast Cancer
AUGMENTS,Metalloproteases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Diethylstilbestrol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Diethylstilbestrol Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Coronary heart disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Coronary heart disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Serotonin Uptake Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Serotonin Uptake Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pesticides Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Detectors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Detectors Breast Carcinoma,Female Breast Cancer
PREDISPOSES,XRCC1 gene|XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Serine Protease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Serine Protease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,prolylarginine|ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prolylarginine|ABL2|RERE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHEK2 gene|CHEK2,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Contralateral breast cancer,Female Breast Cancer
AFFECTS,Insulin|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin|INS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cortisol level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cortisol level Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 Protein|BRCA1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 Protein|BRCA1 Familial cancer of breast,Female Breast Cancer
AFFECTS,NEK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NEK3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,EGFR gene|EGFR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Breast Carcinoma,Female Breast Cancer
AFFECTS,Thrombospondin 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Thrombospondin 1 Breast cancer metastatic,Female Breast Cancer
CAUSES,Aldosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aldosterone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anthracycline Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Anthracycline Antibiotics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCNA2 gene|CCNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNA2 gene|CCNA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast cancer invasive NOS",Female Breast Cancer
AFFECTS,Estrogen Receptor beta|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Cell Invasion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Cell Invasion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,saturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,saturated fat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TRANSCRIPTION FACTOR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Breast Carcinoma,Female Breast Cancer
PREDISPOSES,NPY1R gene|NPY1R,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NPY1R gene|NPY1R Breast cancer metastatic,Female Breast Cancer
AFFECTS,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoprotein Cholesterol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HGS gene|HGS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HGS gene|HGS Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Ascorbic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ascorbic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FANCA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FANCA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Actin bundling protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Actin bundling protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypermethylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypermethylation Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Oligonucleotides,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotides Breast cancer metastatic,Female Breast Cancer
AFFECTS,Metabolic syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Metabolic syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PGR gene|PGR,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PGR gene|PGR Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Cyproterone Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cyproterone Acetate Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast cancer metastatic,Female Breast Cancer
AUGMENTS,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Development of the breasts,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Development of the breasts Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,PIN1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,PIN1 Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,Alpha tocopheryl succinate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Alpha tocopheryl succinate Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Obesity,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Obesity Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,steroid hormone receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,steroid hormone receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Guanosine Triphosphate Phosphohydrolases,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Guanosine Triphosphate Phosphohydrolases Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Alar,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alar Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANXA1 gene|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANXA1 gene|ANXA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,estradiol-17 beta-glucuronide,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,estradiol-17 beta-glucuronide Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,NF1 gene|NF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NF1 gene|NF1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Receptors, Notch",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Notch Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Organic Anion Transport Polypeptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Organic Anion Transport Polypeptides Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Nucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nucleotides Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Polyomavirus Middle T Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Polyomavirus Middle T Antigens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thymidine Phosphorylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thymidine Phosphorylase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Study models,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Study models Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hyperthyroidism,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Hyperthyroidism Breast Carcinoma,Female Breast Cancer
PREDISPOSES,SLC25A4|CD5|IL1RL1|TRAPPC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC25A4|CD5|IL1RL1|TRAPPC9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CENPH gene|CENPH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CENPH gene|CENPH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,erlotinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erlotinib Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aging Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,lapatinib,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,lapatinib Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Carcinogens, Environmental",Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Sporadic Breast Carcinoma",Female Breast Cancer
AUGMENTS,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Telomerase,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Telomerase Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,JAG2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,JAG2 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,PARP1|COL11A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARP1|COL11A2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD27,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,CD27 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Estrogens, Catechol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Catechol Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Vanadium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vanadium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cancer Treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Treatment Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SPN|DEAF1|PPP1R9B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,SPN|DEAF1|PPP1R9B Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CLDN2 gene|CLDN2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CLDN2 gene|CLDN2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Sex Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sex Behavior Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Antagonists,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Estrogen Antagonists Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TWSG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TWSG1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Enzyme variant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzyme variant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Development of the breasts,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Development of the breasts Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,PIK3R1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,PIK3R1 Breast Carcinoma,Female Breast Cancer
AFFECTS,CD24,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,CD24 Breast Carcinoma,Female Breast Cancer
AFFECTS,dehydroepiandrosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dehydroepiandrosterone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Levonorgestrel,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Levonorgestrel Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,Epicatechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Epicatechin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Vascular Endothelial Growth Factor C|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C|VEGFA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SH3KBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SH3KBP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Double Strand Break Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Double Strand Break Repair Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,SLC9A3R1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC9A3R1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,LEPR gene|LEPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LEPR gene|LEPR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Mutagens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Mutagens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Homeostasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Homeostasis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ESR1 gene|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Migraine Disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Migraine Disorders Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mastication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mastication Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,2q35,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2q35 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell physiology,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cell physiology Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sphingosine-1-Phosphate Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sphingosine-1-Phosphate Receptors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nicotinic Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nicotinic Receptors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenesis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Angiogenesis Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Insulin|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin|INS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,8q24,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,8q24 Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,src-Family Kinases|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,src-Family Kinases|SRC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Microsatellite Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Microsatellite Repeats Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Increased estrogen level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Increased estrogen level Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oxidation-Reduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oxidation-Reduction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MicroRNAs,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,B3GNT2|B3GNTL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,B3GNT2|B3GNTL1 Breast cancer metastatic,Female Breast Cancer
CAUSES,FRAGMENTS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FRAGMENTS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD44 gene|CD44,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"CD44 gene|CD44 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Elevated insulin-like growth factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Elevated insulin-like growth factor I Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,WWP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Calcium, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Calcium, Dietary Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,High Mobility Group Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Mobility Group Proteins Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Calgranulin B|S100A9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calgranulin B|S100A9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRAZILIAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BRAZILIAN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydroxide Ion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxide Ion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Angiotensin-Converting Enzyme Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Enzyme,Angiotensin-Converting Enzyme Inhibitors Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adenosine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAD51C gene|RAD51C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51C gene|RAD51C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,6q22.33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6q22.33 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NF-kappa B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,brightness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,brightness Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SPN|DEAF1|PPP1R9B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,SPN|DEAF1|PPP1R9B Breast Carcinoma,Female Breast Cancer
AFFECTS,FHL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FHL1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leptin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sodium Valproate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sodium Valproate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TOPBP1 Gene|TOPBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOPBP1 Gene|TOPBP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proteins,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,RPE65|UVRAG|TP63|CKAP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RPE65|UVRAG|TP63|CKAP4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatomedins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,epithelial to mesenchymal transition,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Enhancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Enhancer Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Phosphatidylethanolamine Binding Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphatidylethanolamine Binding Protein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,PTPN11 gene|PTPN11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN11 gene|PTPN11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cadherin 5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,cadherin 5 Breast cancer metastatic,Female Breast Cancer
AFFECTS,METHYLATE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,METHYLATE Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1-Phosphatidylinositol 3-Kinase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Disease Breast Carcinoma,Female Breast Cancer
AUGMENTS,soy protein isolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SNAI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNAI2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,patient family history,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,patient family history Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Tamoxifen,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Sirolimus (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Sirolimus (substance) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MicroRNAs,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,Malignant neoplasm of cervix uteri,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of cervix uteri Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"Receptors, Cytoplasmic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Cytoplasmic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Mutation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,MS4A1|BBS9|IGKV7-3|SPANXB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MS4A1|BBS9|IGKV7-3|SPANXB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Very high,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Very high Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Paraffin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paraffin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAB1B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,RAB1B Breast cancer metastatic,Female Breast Cancer
AUGMENTS,PYRUVATE CARBOXYLASE|PC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PYRUVATE CARBOXYLASE|PC Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Annexin A1|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A1|ANXA1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL18 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Integral Membrane Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Integral Membrane Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Arthralgia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Arthralgia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PIAS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PIAS1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Chemotaxis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Chemotaxis Breast Carcinoma,Female Breast Cancer
AFFECTS,Lead compound,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Lead compound Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,treatment method,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,treatment method Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,betaine-homocysteine methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,betaine-homocysteine methyltransferase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYP4Z1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP4Z1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STAT3 gene|STAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PRICKLE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRICKLE1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transfer RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Transfer RNA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PROTEIN KINASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Choline dehydrogenase|CHDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Choline dehydrogenase|CHDH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,N-ras Genes|NRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,N-ras Genes|NRAS Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,saturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,saturated fat Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Extravasation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Extravasation Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,IGF2BP2|IMMP2L|SPPL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IGF2BP2|IMMP2L|SPPL3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABCG2 gene|ABCG2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ABCG2 gene|ABCG2 Breast Carcinoma,Female Breast Cancer
AFFECTS,furanodiene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,furanodiene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Androgen Receptor|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor|AR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTEN gene|PTEN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Malignant neoplasm of breast,Female Breast Cancer
CAUSES,2q33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2q33 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Tumor Necrosis Factor Receptor Superfamily, Member 10B",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,"Tumor Necrosis Factor Receptor Superfamily, Member 10B Breast cancer metastatic",Female Breast Cancer
CAUSES,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IL33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL33 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vascular Cell Adhesion Molecule-1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Vascular Cell Adhesion Molecule-1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,OTUD1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,OTUD1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Neurofibromin 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neurofibromin 2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA1 gene|BRCA1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Annexin A3|ANXA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A3|ANXA3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,galangin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,galangin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Environmental Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Environmental Estrogen Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Processed meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Processed meat Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PALB2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,tubeimoside I,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,tubeimoside I Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Sulindac,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sulindac Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PAQR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PAQR3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,G-Protein-Coupled Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,RECQL gene|RECQL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RECQL gene|RECQL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Trans-Activation (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Trans-Activation (Genetics) Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Response Modifiers Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pyrimidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pyrimidine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SOX17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOX17 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Disease or Syndrome,Disease Carcinoma in situ of breast,Female Breast Cancer
DISRUPTS,"DICER1 protein, human|DICER1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,myristoylated alanine-rich C kinase substrate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,myristoylated alanine-rich C kinase substrate Breast Carcinoma,Female Breast Cancer
AFFECTS,Ovarian ablation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovarian ablation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IKBKB,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,IKBKB Breast cancer metastatic,Female Breast Cancer
CAUSES,Secondary malignant neoplasm of lymph node,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lymph node Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Osteopenia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Osteopenia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Extracellular Matrix Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Extracellular Matrix Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RHOBTB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RHOBTB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SYF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SYF2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Enhancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Enhancer Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CTSO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTSO Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary cholesterol intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Dietary cholesterol intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PK 11195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PK 11195 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TAF7L gene|TAF7L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAF7L gene|TAF7L Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL8RB gene|CXCR2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,IL8RB gene|CXCR2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,NEUROD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NEUROD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Maternal history,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Maternal history Contralateral breast cancer,Female Breast Cancer
DISRUPTS,Diphosphonates,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Diphosphonates Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Solid tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Solid tumor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KDM6A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM6A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Matrix Metalloproteinase Inhibitor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase Inhibitor Breast cancer metastatic,Female Breast Cancer
AFFECTS,butylbenzyl phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,butylbenzyl phthalate Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Prolactin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Prolactin Breast Carcinoma,Female Breast Cancer
DISRUPTS,Recombinant Interferon-gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Recombinant Interferon-gamma Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BRD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BRD7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Myosin Light Chain Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Myosin Light Chain Kinase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pain relief,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Pain relief Breast cancer metastatic,Female Breast Cancer
AFFECTS,Magnetic field,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Magnetic field Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Curcumin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Curcumin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,STXBP4 gene|STXBP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STXBP4 gene|STXBP4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Treatment Protocols,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Treatment Protocols Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Extracellular Matrix Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Extracellular Matrix Proteins Breast Carcinoma,Female Breast Cancer
AFFECTS,EGF gene|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGF gene|EGF Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cyclopamine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,cyclopamine Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GABPA|NFE2L2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,sphingosine 1-phosphate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sphingosine 1-phosphate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PRDM1 gene|PRDM1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PRDM1 gene|PRDM1 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Iodine-131,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iodine-131 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,XRCC1 gene|XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epigenetic Process,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Epigenetic Process Breast cancer metastatic,Female Breast Cancer
AFFECTS,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Morphine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Morphine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Triazoles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Triazoles Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast Carcinoma,Female Breast Cancer
AFFECTS,recombinational repair,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",recombinational repair Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,BMP4 gene|BMP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMP4 gene|BMP4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ADAMTS18,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ADAMTS18 Breast cancer metastatic,Female Breast Cancer
AFFECTS,MAS1 gene|MAS1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"MAS1 gene|MAS1 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Housekeeping Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Housekeeping Gene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Genes, Developmental",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Genes, Developmental Breast Carcinoma",Female Breast Cancer
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Birth length,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Birth length Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,beta catenin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,beta catenin Breast cancer metastatic,Female Breast Cancer
AFFECTS,Genes,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,Genes Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,WNT10B gene|WNT10B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,WNT10B gene|WNT10B Breast cancer metastatic,Female Breast Cancer
CAUSES,Helminths,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Helminths Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN200A gene|MIR200A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN200A gene|MIR200A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PVT1 gene|PVT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PVT1 gene|PVT1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BRF1 gene|ZFP36L1|BRF1|MST1L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRF1 gene|ZFP36L1|BRF1|MST1L Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RECQL4 gene|RECQL4,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,RECQL4 gene|RECQL4 Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,RAB11FIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAB11FIP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,molecular chaperone GRP78,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,molecular chaperone GRP78 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of stomach,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of stomach Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Sirolimus (substance),Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Substance,Sirolimus (substance) Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,TCP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TCP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibroblast Growth Factor Receptor 2|FGFR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 2|FGFR2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Vascular Endothelial Growth Factor C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EHMT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EHMT2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MST1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZEB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ZEB2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,FGFR1 gene|FGFR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR1 gene|FGFR1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NF-kappa B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pertuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pertuzumab Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nelfinavir,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nelfinavir Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDK6-associated protein p18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CDK6-associated protein p18 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Metastasis Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Metastasis Suppressor Genes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cucurbitacin B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,cucurbitacin B Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,imbalance,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,imbalance Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Hypogonadism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypogonadism Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WBP2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Atenolol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atenolol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic breast density,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Mammographic breast density Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,STX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,STX3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Methylene blue,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methylene blue Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EIF4G2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EIF4G2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,epigallocatechin gallate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,epigallocatechin gallate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammary Neoplasms,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Mammary Neoplasms Breast cancer metastatic,Female Breast Cancer
AUGMENTS,SKP2 gene|SKP2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SKP2 gene|SKP2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HIF1A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,HIF1A Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,exemestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,exemestane Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BCYRN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BCYRN1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,chrysophanic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,chrysophanic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SRPK1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SRPK1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,capecitabine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,capecitabine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body Weight decreased,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Body Weight decreased Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,SRD5A2 gene|SRD5A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRD5A2 gene|SRD5A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Calcitriol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcitriol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,proto-oncogene protein Spi-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,proto-oncogene protein Spi-1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Factors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Biological Factors Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Neprilysin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Neprilysin Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,EIF4G1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EIF4G1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cardiovascular event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Cardiovascular event Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,resistin|RETN,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,resistin|RETN Breast cancer metastatic,Female Breast Cancer
AFFECTS,Monoclonal Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Monoclonal Antibodies Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EZH2 gene|EZH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cereals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cereals Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NF-kappa B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Suppressor Genes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Estradiol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Estradiol Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,TCF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TCF4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UGT2B4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UGT2B4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LATS1 gene|LATS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LATS1 gene|LATS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"RNA, Small Interfering",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Small Interfering Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,IQUB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IQUB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SYVN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SYVN1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Sponges, Gauze",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"Sponges, Gauze Breast Carcinoma",Female Breast Cancer
AFFECTS,KLF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLF5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LIMK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LIMK2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Luciferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Luciferases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PCDH17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCDH17 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CD8B1 gene|CD8B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD8B1 gene|CD8B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,endogenous steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,endogenous steroids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,POMC gene|POMC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,POMC gene|POMC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DLG5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DLG5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Quercetin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Quercetin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CDK14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDK14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Does stand,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Does stand Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,genetic locus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic locus Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PMS2 gene|PMS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PMS2 gene|PMS2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TSLP gene|TSLP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSLP gene|TSLP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TP53BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53BP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ITGB2 gene|ITGB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ITGB2 gene|ITGB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BIBR 1532,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BIBR 1532 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tumorigenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumorigenesis Malignant neoplasm of breast,Female Breast Cancer
CAUSES,extracellular signal-regulated kinase 3|MAPK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,extracellular signal-regulated kinase 3|MAPK6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Extracellular Matrix Proteins,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Extracellular Matrix Proteins Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,MFN2 gene|MFN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MFN2 gene|MFN2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,brca gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,brca gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,REST gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,REST gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PKM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PKM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth-Factor Binding Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth-Factor Binding Protein 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP17A1 gene|CYP17A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RNF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RNF5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Membrane Transport Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Transport Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SPRY4-IT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SPRY4-IT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"PER2 protein, mammalian",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian Malignant neoplasm of breast",Female Breast Cancer
CAUSES,cytokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer metastatic,Female Breast Cancer
AFFECTS,Alkaloids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alkaloids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Eicosanoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Eicosanoids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vision Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADAM12,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ADAM12 Breast cancer metastatic,Female Breast Cancer
AFFECTS,LINC01116,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC01116 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,OIP5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OIP5-AS1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,polyphenols,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,polyphenols Breast cancer metastatic,Female Breast Cancer
AFFECTS,Blue light,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Blue light Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIR195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR195 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,phenyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phenyl ether Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Heparitin Sulfate,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Heparitin Sulfate Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,Study models,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Study models Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FAS gene|FAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAS gene|FAS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hesperidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hesperidin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mutagens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Mutagens Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PDK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PDK4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Garlic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Garlic Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Multiple Myeloma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Multiple Myeloma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anesthesia procedures,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Anesthesia procedures Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Soybeans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Soybeans Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclical mastalgia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclical mastalgia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NAT2 gene|NAT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAT2 gene|NAT2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PIK3CA|PIK3CB|PIK3CD|PIK3CG Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Yogurt,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Yogurt Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UGT8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UGT8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nuclear Factor 45 Protein|ILF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Factor 45 Protein|ILF2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"DNA, Mitochondrial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Mitochondrial Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,PSMD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PSMD2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,antibody conjugate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",antibody conjugate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GSTM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GSTM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sterol Regulatory Element Binding Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Sterol Regulatory Element Binding Protein 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,chemokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chemokine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,src-Family Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,src-Family Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MYC gene|MYC,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,MYC gene|MYC Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Chicken Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chicken Meat Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A7,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,S100A7 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,CD24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD24 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYTH3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYTH3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interleukin-2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Interleukin-2 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,UGT1A1 gene|UGT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UGT1A1 gene|UGT1A1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,2-chloroethyl ethyl sulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2-chloroethyl ethyl sulfide Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB2 gene|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Signal Transduction,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Breast cancer metastatic,Female Breast Cancer
AFFECTS,Flavonols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavonols Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Alcoholic Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alcoholic Beverages Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Depressed mood,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Depressed mood Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ZFHX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZFHX3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Functional disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional disorder Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Intellectual functioning disability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intellectual functioning disability Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD247,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD247 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Epidermal Growth Factor Receptor|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transfer RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Transfer RNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gene therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,gene therapy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,lysophosphatidic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,lysophosphatidic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Measles-Mumps-Rubella Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Measles-Mumps-Rubella Vaccine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,agonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,agonists Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,THBS1 gene|THBS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,THBS1 gene|THBS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Loss of Heterozygosity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Loss of Heterozygosity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Smoke Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,WWOX,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,WWOX Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Deoxycholic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Deoxycholic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,polymorphic microsatellite markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polymorphic microsatellite markers Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of endometrium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of endometrium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Menstrual cycle,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Menstrual cycle Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,dietary intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",dietary intervention Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Reliance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reliance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PSYCHIATRIC HISTORY,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,PSYCHIATRIC HISTORY Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Neoplastic Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplastic Processes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibroblast Growth Factor Receptor 2|FGF7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 2|FGF7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"RNA, Messenger",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Breast cancer metastatic",Female Breast Cancer
AFFECTS,"DNA, Complementary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Complementary Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Histamine H2 Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histamine H2 Antagonists Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antipsychotic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hormones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Hormones Breast Carcinoma,Female Breast Cancer
AFFECTS,ESR1 gene|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,interleukin-23,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-23 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CXCL1 gene|CXCL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL1 gene|CXCL1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Acetaminophen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetaminophen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diphosphonates,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Diphosphonates Breast cancer metastatic,Female Breast Cancer
CAUSES,Malignant neoplasm of breast,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Female Breast Carcinoma,Female Breast Cancer
CAUSES,benzanthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,benzanthracene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GSTM1 gene|GSTM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTM1 gene|GSTM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,adjuvant therapy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,adjuvant therapy Contralateral breast cancer,Female Breast Cancer
AFFECTS,Disease Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Disease Progression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation therapy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Strenuous Exercise,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Other,Strenuous Exercise Carcinoma in situ of breast,Female Breast Cancer
PREDISPOSES,EGR1 gene|EGR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGR1 gene|EGR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Familial cancer of breast,Female Breast Cancer
PREDISPOSES,"Insulin, Glargine, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Insulin, Glargine, Human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Zinc Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,IL13Ralpha2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,IL13Ralpha2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Ataxia Telangiectasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ataxia Telangiectasia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Analgesics,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Analgesics Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Insulin Receptor|INSR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin Receptor|INSR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immune response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Immune response Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Calcium Channel Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Channel Blockers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,alcohol effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alcohol effect Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 gene|BRCA1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast Carcinoma,Female Breast Cancer
CAUSES,Ovarian Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ovarian Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Female Homosexuality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Female Homosexuality Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Protein pp60 (c-src)|SRC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,delta-hexachlorocyclohexane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,delta-hexachlorocyclohexane Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Manganese Superoxide Dismutase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Manganese Superoxide Dismutase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Receptor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Receptor Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DPF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DPF3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP1A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Personality Traits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Personality Traits Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Paraoxonase 1|PON1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paraoxonase 1|PON1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydroxyestrones,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Hydroxyestrones Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,checkpoint kinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,checkpoint kinase 2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HMGB1 gene|HMGB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGB1 gene|HMGB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSD11B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSD11B1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Growth Factor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Breast Carcinoma,Female Breast Cancer
AFFECTS,DNA Methylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Methylation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF217 gene|ZNF217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF217 gene|ZNF217 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tenascin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tenascin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IRS1 gene|IRS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRS1 gene|IRS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXC Chemokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CXC Chemokines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Organic solvent product,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Chemical,Organic solvent product Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Simvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Simvastatin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,bevacizumab,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,bevacizumab Breast cancer metastatic,Female Breast Cancer
CAUSES,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethanol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inflammation Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Process Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Moderate Exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Moderate Exercise Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Uniparental Disomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Uniparental Disomy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Rubidium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rubidium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,19p13.1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,19p13.1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Injection procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Injection procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Plasminogen Activator Inhibitor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Plasminogen Activator Inhibitor 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sitting height,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sitting height Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,JNK Mitogen-Activated Protein Kinases|JUN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",JNK Mitogen-Activated Protein Kinases|JUN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,E2F3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,E2F3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyphenols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 gene|BRCA1,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,6/4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6/4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,capecitabine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,capecitabine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Heme Oxygenase-1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Heme Oxygenase-1 Breast Carcinoma,Female Breast Cancer
AFFECTS,Pregnancy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Pregnancy Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Metric,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metric Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Insulin|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin|INS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CpG Islands Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RABGEF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RABGEF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,participation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",participation Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,FLOT2 gene|FLOT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FLOT2 gene|FLOT2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Behavior,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Behavior Familial cancer of breast,Female Breast Cancer
AFFECTS,Thromboembolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thromboembolism Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,response,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,response Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,NBN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NBN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chronic lymphocytic inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chronic lymphocytic inflammation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Organic Food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Organic Food Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HFE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HFE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"APEX1 protein, human|APEX1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","APEX1 protein, human|APEX1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,RRM2 gene|RRM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RRM2 gene|RRM2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemotherapy-Oncologic Procedure,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Chemotherapy-Oncologic Procedure Breast cancer metastatic,Female Breast Cancer
AFFECTS,Enrich,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Enrich Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Nipple discharge NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nipple discharge NOS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Symptoms,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Symptoms Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Hair Dyes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Hair Dyes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Histopathology,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Histopathology Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Renin-angiotensin system inhibition,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Renin-angiotensin system inhibition Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,MAP Kinase Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAP Kinase Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Autoantibody NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Autoantibody NOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neutropenia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neutropenia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Decalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Decalcification Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Asthenia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Asthenia Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Nicotine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nicotine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sulfonylurea Compounds,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical,Sulfonylurea Compounds Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Protein-Serine-Threonine Kinases,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Protein-Serine-Threonine Kinases Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,Cyclin D1|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1|CCND1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Pharmacotherapy Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Vitamin D-Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Vitamin D-Binding Protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ursolic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ursolic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical activity,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Physical activity Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,NANOG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NANOG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breastfeeding performance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breastfeeding performance Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TRAN gene|TRA-TGC7-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRAN gene|TRA-TGC7-1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Overweight,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Overweight Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Estrogens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Depressive Symptoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Depressive Symptoms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,receptor for advanced glycation endproducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",receptor for advanced glycation endproducts Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anorexia Nervosa,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anorexia Nervosa Malignant neoplasm of breast,Female Breast Cancer
CAUSES,crocetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,crocetin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AKT1 gene|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKT1 gene|AKT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,delphinidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,delphinidin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Common wart,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Common wart Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,apolipoprotein D|APOD,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein D|APOD Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Inflammation,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Inflammation Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,LAPTM4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LAPTM4B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,COPS5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,COPS5 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Breast Feeding, Exclusive",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Breast Feeding, Exclusive Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,everolimus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,everolimus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Xenograft Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Xenograft Model Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Radiation-Induced Change,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation-Induced Change Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stress,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Stress Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Self-Examination,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Self-Examination Breast Carcinoma,Female Breast Cancer
AFFECTS,Breast neoplasm screening,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast neoplasm screening Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 gene|BRCA1,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Multiple alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Multiple alleles Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Deficient knowledge,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Deficient knowledge Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CLCN3 gene|CLCN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLCN3 gene|CLCN3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ethylmalonic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ethylmalonic acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HTATIP gene|KAT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HTATIP gene|KAT5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Taurine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Taurine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,Genes Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Menopausal Status,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Menopausal Status Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Angiotensin-Converting Enzyme Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Enzyme,Angiotensin-Converting Enzyme Inhibitors Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Benzodiazepines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benzodiazepines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Untranslated Regions,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Untranslated Regions Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,LINC01585,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC01585 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MGMT gene|MGMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MGMT gene|MGMT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Natural Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Natural Products Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical activity,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Physical activity Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Ibuprofen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ibuprofen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Serine Protease,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Enzyme,Serine Protease Breast cancer metastatic,Female Breast Cancer
AFFECTS,Emergency contraception,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Emergency contraception Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carbon ion,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Carbon ion Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Prognostic Factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Prognostic Factor Breast cancer metastatic,Female Breast Cancer
CAUSES,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Chemical Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Chemical Exposure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,vitamin supplement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,vitamin supplement Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,coenzyme Q10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,coenzyme Q10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Verbal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Verbal Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Genes,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Genes Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,PGR gene|PGR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PGR gene|PGR Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CCDC6 gene|CCDC6,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CCDC6 gene|CCDC6 Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Personal Satisfaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Personal Satisfaction Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oligonucleotide Arrays,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotide Arrays Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hot water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hot water Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methotrexate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methotrexate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Consanguinity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Consanguinity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Verbal,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Verbal Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Ions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ions Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BLM gene|BLM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BLM gene|BLM Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Tamoxifen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,DMBT1 gene|DMBT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DMBT1 gene|DMBT1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TBX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TBX3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Multiple Sclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Multiple Sclerosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Positron-Emission Tomography,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Positron-Emission Tomography Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Noninfiltrating Intraductal Carcinoma,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Human Chorionic Gonadotropin|CGA|HTC2|CGB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Human Chorionic Gonadotropin|CGA|HTC2|CGB5 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Steroidal Aromatase Inhibitor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Steroid,Steroidal Aromatase Inhibitor Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"Obesity, Morbid",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,"Obesity, Morbid Breast cancer recurrent",Recurrent Breast Cancer
PREDISPOSES,perfluorooctanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorooctanoic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,F2RL1|NR1I2|SLC52A1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,F2RL1|NR1I2|SLC52A1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Arginine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Rheumatoid Arthritis,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Rheumatoid Arthritis Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,NFKB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NFKB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,letrozole,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,letrozole Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,GHRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GHRL Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MATP gene|SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MATP gene|SLC45A2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BRCA1 gene|BRCA1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Animal fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Animal fat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP19A1 gene|CYP19A1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Dietary Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Dietary Carbohydrates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,peroxiredoxin I|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,peroxiredoxin I|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GHSR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GHSR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NBS1 gene|NBN|NLRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NBS1 gene|NBN|NLRP2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrone sulfotransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estrone sulfotransferase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Recombinant Interferon-gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Recombinant Interferon-gamma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,[V]Follow-up examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",[V]Follow-up examination Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Diphosphonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diphosphonates Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breasts asymmetrical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breasts asymmetrical Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Long chain fatty acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Long chain fatty acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Interleukin-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HSD17B6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,HSD17B6 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Positive Lymph Node,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Positive Lymph Node Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,XRCC5 gene|XRCC5,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,XRCC5 gene|XRCC5 Breast cancer recurrent,Female Breast Cancer
DISRUPTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Steryl-sulfatase|STS Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Triglycerides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Triglycerides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Membrane Glycoproteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Glycoproteins Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Systemic Scleroderma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Systemic Scleroderma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast composition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast composition Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LHX1 gene|LHX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LHX1 gene|LHX1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,density Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infection Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Life Style,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Life Style Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PGRMC1 gene|PGRMC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGRMC1 gene|PGRMC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIWIL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIWIL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ANLN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ethnic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ethnic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gynecomastia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gynecomastia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NAT2 gene|NAT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAT2 gene|NAT2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,WWC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adverse effects,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Adverse effects Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,pertuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pertuzumab Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Behcet Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Behcet Syndrome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carrier of disorder,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Disease or Syndrome,Carrier of disorder Contralateral breast cancer,Female Breast Cancer
AUGMENTS,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Egg Food Product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Egg Food Product Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Whole-Brain Radiotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Whole-Brain Radiotherapy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Perceived comfort level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Perceived comfort level Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glutamate Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutamate Dehydrogenase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anovulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Anovulation Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,phenylpyruvate tautomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phenylpyruvate tautomerase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ovarian Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Ovarian Diseases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FANCM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FANCM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Invasive Malignant Neoplasm,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Invasive Malignant Neoplasm Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,tibolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tibolone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,chemokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chemokine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Obesity,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Obesity Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,CCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCAT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Levonorgestrel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Levonorgestrel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Free testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Free testosterone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mimicry,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mimicry Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Operative Surgical Procedures,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Operative Surgical Procedures Carcinoma, Ductal, Breast",Female Breast Cancer
DISRUPTS,1-Phosphatidylinositol 3-Kinase|PI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1-Phosphatidylinositol 3-Kinase|PI3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vaccines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vaccines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sclerosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Sclerosis Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,flavan-3-ol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,flavan-3-ol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast cancer invasive NOS,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,MME gene|MME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MME gene|MME Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MicroRNAs,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lignans Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Galectin 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Galectin 3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Mutation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PARK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARK7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,alpha Tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha Tocopherol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Excision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Excision Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endocrine therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Endocrine therapy Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Protein Overexpression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Overexpression Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen receptor negative,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor negative Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,BRCA2 Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 Mutation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gall Bladder Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Gall Bladder Diseases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STAT5A gene|STAT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT5A gene|STAT5A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTEN gene|PTEN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Calcium Channel Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Channel Blockers Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ionizing radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ionizing radiation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor I|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I|INS Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Carcinoma Breast Carcinoma,Female Breast Cancer
AFFECTS,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lignans Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Bleomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bleomycin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Testosterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MSH6 gene|MSH6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MSH6 gene|MSH6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Suspensions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Suspensions Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Coronary Arteriosclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coronary Arteriosclerosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcoholic Beverages,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Alcoholic Beverages Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Maternal Mortality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Maternal Mortality Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Reaction emotional,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reaction emotional Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sulfonylurea Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfonylurea Compounds Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplasm,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Neoplasm Breast Carcinoma,Female Breast Cancer
AFFECTS,KDM4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM4A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"7,3'-dihydroxy-4'-methoxyisoflavone Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Cerebrovascular accident,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cerebrovascular accident Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Undifferentiated carcinoma of ovary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Undifferentiated carcinoma of ovary Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,glutathione S-transferase M1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase M1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,brca gene,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,brca gene Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MDM4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,MDM4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KPNA2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,KPNA2 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,cytotoxicity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,cytotoxicity Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Positive Finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Positive Finding Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MFG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MFG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diethylstilbestrol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,desires,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,desires Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,bufadienolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bufadienolide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tamoxifen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,PGK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PGK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinoembryonic Antigen|CEACAM5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen|CEACAM5 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,ZNHIT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNHIT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SEMA3C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SEMA3C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta catenin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Amino Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amino Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Little's Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Little's Disease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ginsenoside Rk1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ginsenoside Rk1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Physiological Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Physiological Processes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Pimozide,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Pimozide Breast cancer metastatic,Female Breast Cancer
AFFECTS,ZNF423,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF423 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNA Sequence,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Nucleotide Sequence,RNA Sequence Breast cancer metastatic,Female Breast Cancer
AFFECTS,Antidiabetics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antidiabetics Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HIF1alpha protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HIF1alpha protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adriamycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adriamycin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,caveolin 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,caveolin 1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,ZNHIT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNHIT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNHG7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNHG7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MALAT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SOX8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOX8 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MIRN106A gene|MIR106A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN106A gene|MIR106A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CXCR4 gene|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Myocardial Ischemia,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Myocardial Ischemia Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,phthalates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phthalates Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphoric Monoester Hydrolases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Leucine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leucine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDC2 gene|CDK1|POLD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC2 gene|CDK1|POLD1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cancer-Predisposing Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERBB2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,shikonin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,shikonin Breast cancer metastatic,Female Breast Cancer
DISRUPTS,NFE2L3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NFE2L3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,lysyllysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lysyllysine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,G3BP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,G3BP2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CBX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CBX2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Interleukin-4,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Interleukin-4 Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,Monomeric GTP-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monomeric GTP-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PPM1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPM1D Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mitomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitomycin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Luteolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Luteolin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Endocrine System Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine System Diseases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cell motility,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,cell motility Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,ataxia telangiectasia mutated protein|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ataxia telangiectasia mutated protein|ATM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,glutathione S-transferase M1|GSTM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase M1|GSTM1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Xenobiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Xenobiotics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,9-deoxy-delta-9-prostaglandin D2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,9-deoxy-delta-9-prostaglandin D2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Liposomes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Liposomes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,activated RNA polymerase II transcription cofactor 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",activated RNA polymerase II transcription cofactor 4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HGS gene|HGS,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,HGS gene|HGS Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,Cadmium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Formaldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Formaldehyde Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Natural Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Natural Products Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phenols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,preference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,preference Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PIK3R1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIK3R1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC00339,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00339 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VIRMA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VIRMA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VIRMA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VIRMA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Compete,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Compete Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Platelet-Derived Growth Factor beta Receptor|PDGFRB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Platelet-Derived Growth Factor beta Receptor|PDGFRB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"3,4-Methylenedioxyamphetamine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"3,4-Methylenedioxyamphetamine Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Single Nucleotide Polymorphism,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Bariatric Surgery,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Bariatric Surgery Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Integrin alphaVbeta3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrin alphaVbeta3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IDO1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,IDO1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIK3CA|PIK3CB|PIK3CD|PIK3CG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,kaempferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,kaempferol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nephroblastoma,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Nephroblastoma Breast cancer metastatic,Female Breast Cancer
AFFECTS,Diphenylamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diphenylamine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Homologous Gene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Homologous Gene Breast cancer metastatic,Female Breast Cancer
AFFECTS,SERPINI2 gene|SERPINI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SERPINI2 gene|SERPINI2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,centromere protein F,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",centromere protein F Breast cancer metastatic,Female Breast Cancer
AFFECTS,Aging-Related Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Aging-Related Process Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,anillin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,anillin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"PTTG1 protein, human|PTTG1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTTG1 protein, human|PTTG1 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphoric Monoester Hydrolases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Poly(ADP-ribose) Polymerases|WDTC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Poly(ADP-ribose) Polymerases|WDTC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FBXL19-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FBXL19-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Treatment Protocols,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Treatment Protocols Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Polychlorinated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polychlorinated Biphenyls Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TAGLN2 gene|TAGLN2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TAGLN2 gene|TAGLN2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,gadoterate meglumine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gadoterate meglumine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCB 138,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 138 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antipsychotic Agents,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Carcinoma in situ of breast,Female Breast Cancer
PREDISPOSES,SLC4A11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC4A11 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antioestrogen therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Antioestrogen therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UDP-Glucuronosyltransferase 1A1|SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UDP-Glucuronosyltransferase 1A1|SLC45A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pigment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pigment Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mitochondrial Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitochondrial Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Formance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Formance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHD4 gene|CHD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHD4 gene|CHD4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gambogic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,gambogic acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RPS27 gene|RPS27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPS27 gene|RPS27 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,hippo signaling,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,hippo signaling Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,BARD1 gene|BARD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BARD1 gene|BARD1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cholecalciferol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,food product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,food product Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Functional RNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast cancer metastatic,Female Breast Cancer
AFFECTS,Albendazole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Albendazole Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Activator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Activator Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Interleukin-17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-17 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydrogel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Hydrogel Breast cancer metastatic,Female Breast Cancer
AFFECTS,Glioblastoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glioblastoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Untranslated Regions Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TTN-AS1 gene|TTN-AS1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,TTN-AS1 gene|TTN-AS1 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,"MMP14 protein, human|MMP14",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MMP14 protein, human|MMP14 Breast cancer metastatic",Female Breast Cancer
AUGMENTS,RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RASAL2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,small molecule,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,small molecule Breast cancer metastatic,Female Breast Cancer
AFFECTS,Profilins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Profilins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HAND2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HAND2-AS1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Lipid Peroxides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Lipid Peroxides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pre-op diagnosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Pre-op diagnosis Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,HSPA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSPA5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SOX2 Transcription Factor|SOX2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Transcription Factor|SOX2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Letter:Finding:Point in time:{Setting}:Document:{Provider},Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Letter:Finding:Point in time:{Setting}:Document:{Provider} Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP27A1 gene|CYP27A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP27A1 gene|CYP27A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ENO1 gene|ENO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ENO1 gene|ENO1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA2 Gene Mutation,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,BRCA2 Gene Mutation Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,rosemary extract,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,rosemary extract Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hormone use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone use Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RESF1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RESF1 gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Integrin alpha3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrin alpha3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PPEF1 gene|PPEF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPEF1 gene|PPEF1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HDAC5 gene|HDAC5,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Gene or Genome,HDAC5 gene|HDAC5 Malignant neoplasm of female breast,Female Breast Cancer
AFFECTS,Colorectal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Colorectal Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP7B1 gene|CYP7B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP7B1 gene|CYP7B1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PAK2 gene|PAK2|PKN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAK2 gene|PAK2|PKN2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,socioeconomic differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,socioeconomic differences Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,epigallocatechin gallate,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,epigallocatechin gallate Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,FTSJ3 gene|FTSJ3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FTSJ3 gene|FTSJ3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"SFRP1 protein, human|SFRP1",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SFRP1 protein, human|SFRP1 Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AFFECTS,Alternative Splicing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CD69 protein, human|CD69",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 HER2-positive carcinoma of breast",Female Breast Cancer
PREDISPOSES,GACAT3 gene|GACAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GACAT3 gene|GACAT3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Adriamycin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Adriamycin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SPRY4-IT1 gene|SPRY4-IT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPRY4-IT1 gene|SPRY4-IT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KLK12 gene|KLK12,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KLK12 gene|KLK12 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"GOLPH3 protein, human|GOLPH3",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GOLPH3 protein, human|GOLPH3 Invasive carcinoma of breast",Female Breast Cancer
PREDISPOSES,Underlying,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Underlying Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microsatellite Instability,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Microsatellite Instability Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prolactin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,USP43 gene|USP43,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USP43 gene|USP43 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"CEACAM5 protein, human|CEACAM5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CEACAM5 protein, human|CEACAM5 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,TRIP6 gene|TRIP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIP6 gene|TRIP6 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,mica,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,mica Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Detection,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Detection Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,paclitaxel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERR1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ERR1 protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immune response,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Immunologic Factor,Immune response HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,FOXN4 gene|FOXN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXN4 gene|FOXN4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Soluble fiber (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Soluble fiber (substance) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High expression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",High expression Breast Carcinoma,Female Breast Cancer
AFFECTS,leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,leptin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CD69 protein, human|CD69",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Breast Carcinoma",Female Breast Cancer
PREDISPOSES,MYCN gene|MYCN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYCN gene|MYCN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transforming Growth Factor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor alpha Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Chemotherapy, Adjuvant",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"Chemotherapy, Adjuvant Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,inhibitors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,inhibitors Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Genome,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Genome Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,ATM,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,ATM contralateral breast cancer,Female Breast Cancer
AUGMENTS,glypican 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,glypican 4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTTG1 gene|PTTG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTTG1 gene|PTTG1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adipokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adipokines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lectin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CTCb regimen,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,CTCb regimen Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,lumican,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lumican Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,doxorubicin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOAT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tissue-factor-pathway inhibitor 2|TFPI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tissue-factor-pathway inhibitor 2|TFPI2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NEAT1 gene|NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEAT1 gene|NEAT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXM1 gene|FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Marital Status,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Marital Status Female Breast Carcinoma,Female Breast Cancer
AUGMENTS,MYC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,MYC Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SLCO6A1|GSTK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLCO6A1|GSTK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gestational Diabetes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Gestational Diabetes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CERNA2 gene|CERNA2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CERNA2 gene|CERNA2 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,"TP53BP1 protein, human|TP53BP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"TP53BP1 protein, human|TP53BP1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,interleukin-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBR3-AS1 gene|CBR3-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ALKBH5 gene|ALKBH5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALKBH5 gene|ALKBH5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BET Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BET Inhibitor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptor alpha,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Diagnostic Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diagnostic Factor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Integrin alpha5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Integrin alpha5 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,IMPACT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IMPACT gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ECE1 gene|ECE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ECE1 gene|ECE1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,lovastatin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,lovastatin Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,receptor Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Invasive Carcinoma,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,XRCC3 gene|XRCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenic Process,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Phenomenon or Process,Angiogenic Process Invasive carcinoma of breast,Female Breast Cancer
DISRUPTS,GKLF protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GKLF protein Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,PRR14 gene|PRR14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRR14 gene|PRR14 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GKLF protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GKLF protein Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Equol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Equol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,hexane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hexane Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNA-Binding Protein Musashi Homolog 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Account number:Identifier:Point in time:^Patient:Nominal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Account number:Identifier:Point in time:^Patient:Nominal Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KIF15 gene|KIF15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF15 gene|KIF15 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,bisphenol A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bisphenol A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,D Vitamin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Food,D Vitamin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,FZR1 wt Allele|CDH1,"Breast Cancer, Familial",0.0,Female Breast Cancer,Other,"FZR1 wt Allele|CDH1 Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,LINC00707 gene|LINC00707,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00707 gene|LINC00707 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FGFR1 wt Allele|FGFR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FGFR1 wt Allele|FGFR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Abnormal metabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Abnormal metabolism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,aquaporin 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aquaporin 7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,COTL1 gene|COTL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COTL1 gene|COTL1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GPX3 gene|GPX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPX3 gene|GPX3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Herbicides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Herbicides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,caspase-3|CASP3,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,caspase-3|CASP3 Luminal B Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"SLC16A3 protein, human|SLC16A3",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SLC16A3 protein, human|SLC16A3 Invasive carcinoma of breast",Female Breast Cancer
PREDISPOSES,Pivot,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pivot Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NME1 gene|NME1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,erastin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erastin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Metastatic malignant neoplasm to brain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Anti-Inflammatory Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Inflammatory Agents Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tumor Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Progression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TNIP2 gene|TNIP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNIP2 gene|TNIP2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,acetylglucosamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,acetylglucosamine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alternative Splicing,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Breast Carcinoma,Female Breast Cancer
DISRUPTS,purpurin 18,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,purpurin 18 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,hesperetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hesperetin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Geldanamycin Analogue,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Geldanamycin Analogue Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,XIST gene|XIST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XIST gene|XIST Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Flavonols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavonols Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ado-trastuzumab emtansine|DMPK|IGHD1-7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,ado-trastuzumab emtansine|DMPK|IGHD1-7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dysbiosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dysbiosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Therapeutic Effect,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,Therapeutic Effect malignant neoplasm of breast staging,Female Breast Cancer
PREDISPOSES,Matrix Metalloproteinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mucin-1 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Mucin-1 Antigen Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aspirin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,OIP5-AS1 gene|OIP5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OIP5-AS1 gene|OIP5-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hyperlipidemia,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Lipid,Hyperlipidemia estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Sexual function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sexual function Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnostic radiologic examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic radiologic examination Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CERNA2 gene|CERNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CERNA2 gene|CERNA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diphosphonates,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Diphosphonates Early-Stage Breast Carcinoma,Female Breast Cancer
CAUSES,Viral Tumor Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Viral Tumor Antigens Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Disease Progression,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Disease Progression Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,CMTM5 gene|CMTM5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CMTM5 gene|CMTM5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ethanol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR22 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR22 wt Allele Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Serum Proteins,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serum Proteins HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,arbutin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arbutin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diet high in saturated fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diet high in saturated fats Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MSH2 gene|MSH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MSH2 gene|MSH2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCNAP1 gene|PCNAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCNAP1 gene|PCNAP1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aspirin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOSL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOSL1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC00346 gene|LINC00346,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00346 gene|LINC00346 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signaling Protein,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Signaling Protein HER2-positive carcinoma of breast,Female Breast Cancer
CAUSES,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF1 gene|YTHDF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANGPTL4 gene|ANGPTL4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ANGPTL4 gene|ANGPTL4 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Negative Regulation of Apoptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Negative Regulation of Apoptosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD8A wt Allele|CD8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD8A wt Allele|CD8A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,sunitinib,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,sunitinib Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,brazilin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,brazilin Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,cyclooxygenase 2|PTGS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2|PTGS2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAD21 gene|RAD21,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,RAD21 gene|RAD21 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,DYRK2 gene|DYRK2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DYRK2 gene|DYRK2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal Malignant neoplasm of breast,Female Breast Cancer
CAUSES,prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prolactin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,leptin,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,leptin Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TT genotype,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TT genotype Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Water consumption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Water consumption Malignant neoplasm of breast,Female Breast Cancer
CAUSES,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Vitronectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vitronectin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Product containing glucagon-like peptide 1 receptor agonist (product),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Product containing glucagon-like peptide 1 receptor agonist (product) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYP27B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP27B1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR100HG gene|MIR100HG,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR100HG gene|MIR100HG Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,diethylstilbestrol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Response Modifiers Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sphingomyelins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sphingomyelins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Infiltration,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,Thyroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,melatonin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Acetylserotonin N-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Acetylserotonin N-Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Sleeve,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sleeve Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Rheumatoid Arthritis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rheumatoid Arthritis Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MicroRNA 205-5p,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 205-5p estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Cyclin-Dependent Kinase Inhibitor p16|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin-Dependent Kinase Inhibitor p16|CDKN2A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,periodate-oxidized adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,periodate-oxidized adenosine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nicotinamide Phosphoribosyltransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Acidosis,Carcinoma breast stage IV,0.0,Female Breast Cancer,Chemical,Acidosis Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Intercellular adhesion molecule 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intercellular adhesion molecule 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KIF15 gene|KIF15,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KIF15 gene|KIF15 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Erythropoietin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Erythropoietin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,K-ras Oncogene|KRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Imaging Reporting and Data System,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast Imaging Reporting and Data System Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DNMT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnosis,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Diagnosis Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Circulating Tumor DNA,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Circulating Tumor DNA Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,ciclesonide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ciclesonide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cisplatin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,paclitaxel Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NRG1 gene|NRG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRG1 gene|NRG1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ryanodine Receptor 3|RYR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ryanodine Receptor 3|RYR3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PPP2R2B gene|PPP2R2B,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PPP2R2B gene|PPP2R2B Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,FN1 gene|FN1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FN1 gene|FN1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,patient characteristics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,patient characteristics Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Weight decreased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Weight decreased Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,amygdalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,amygdalin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GPM6B gene|GPM6B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,GPM6B gene|GPM6B Breast Carcinoma,Female Breast Cancer
DISRUPTS,HHEX gene|HHEX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HHEX gene|HHEX Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Copy Number Polymorphism,"Breast Cancer, Familial",0.0,Female Breast Cancer,Other,"Copy Number Polymorphism Breast Cancer, Familial",Female Breast Cancer
DISRUPTS,SOY ISOFLAVONES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOY ISOFLAVONES Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,verteporfin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,verteporfin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High expression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Apoptosis Inducing Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Inducing Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BTF3 gene|BTF3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BTF3 gene|BTF3 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Metastatic malignant neoplasm to brain,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Carcinoma breast stage IV,Female Breast Cancer
CAUSES,butein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,butein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ST8SIA6-AS1 gene|ST8SIA6-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ST8SIA6-AS1 gene|ST8SIA6-AS1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,si-wu-tang,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,si-wu-tang Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"ITK protein, human|ITK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ITK protein, human|ITK Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,A2M-AS1 gene|A2M-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,A2M-AS1 gene|A2M-AS1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Matrix Metalloproteinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MIR22HG gene|MIR22HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR22HG gene|MIR22HG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bilateral mastectomy,Unilateral Breast Carcinoma,0.0,Female Breast Cancer,Other,Bilateral mastectomy Unilateral Breast Carcinoma,Female Breast Cancer
AFFECTS,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBR3-AS1 gene|CBR3-AS1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,27-hydroxycholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,27-hydroxycholesterol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,paclitaxel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,paclitaxel Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Detection,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Detection Breast Carcinoma,Female Breast Cancer
AUGMENTS,DSCAM-AS1 gene|DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DSCAM-AS1 gene|DSCAM-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PGK1 gene|PGK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGK1 gene|PGK1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neuropeptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Neuropeptides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor size,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Tumor size Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,EZH2 gene|EZH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Diphosphonates,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Diphosphonates Invasive carcinoma of breast,Female Breast Cancer
CAUSES,interleukin-10,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,interleukin-10 Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"WFDC2 protein, human|WFDC2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WFDC2 protein, human|WFDC2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Proliferation (morphologic abnormality),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Proliferation (morphologic abnormality) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,testosterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SMAD2 gene|SMAD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD2 gene|SMAD2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IL6ST gene|IL6ST,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IL6ST gene|IL6ST Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,COVID-19,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,COVID-19 Early-Stage Breast Carcinoma,Female Breast Cancer
DISRUPTS,TRIM6 gene|TRIM6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM6 gene|TRIM6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"UBASH3A protein, human|UBASH3A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","UBASH3A protein, human|UBASH3A Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,PALB2 gene|PALB2,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,PALB2 gene|PALB2 Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
PREDISPOSES,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,YY1 gene|YY1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YY1 gene|YY1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LAGE3 gene|LAGE3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAGE3 gene|LAGE3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00885 gene|LINC00885,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,LINC00885 gene|LINC00885 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,CCL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCL5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Element, Ion, or Isotope","Mutation Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,ZNF385B gene|ZNF385B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF385B gene|ZNF385B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pain relief,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Pain relief Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Procedure findings:Finding:Point in time:^Patient:Narrative Breast Carcinoma,Female Breast Cancer
CAUSES,Connexin 43|GJA1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Connexin 43|GJA1 Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,CHFR gene|CHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHFR gene|CHFR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,pristane,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,pristane Breast Carcinoma,Female Breast Cancer
DISRUPTS,ruthenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ruthenium Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,tripterine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tripterine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Trans Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Trans Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL20RA gene|IL20RA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL20RA gene|IL20RA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Health behavior,"Breast Cancer, Familial",0.0,Female Breast Cancer,Other,"Health behavior Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,paclitaxel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Functional Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional Status Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phosphatidylinositide 3-Kinase Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphatidylinositide 3-Kinase Inhibitor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AQP5 gene|AQP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AQP5 gene|AQP5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC00511 gene|LINC00511,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00511 gene|LINC00511 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MDM2 gene|MDM2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,OLFML2A gene|OLFML2A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,OLFML2A gene|OLFML2A Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Basis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Basis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gene Mutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Mutant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High Level,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,High Level Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Volatile Organic Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Volatile Organic Compounds Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,USP6NL gene|USP6NL,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,USP6NL gene|USP6NL Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"Transcription, Genetic",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,"Transcription, Genetic HER2-positive carcinoma of breast",Female Breast Cancer
AFFECTS,Tumor Microenvironment,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,HOXB5 gene|HOXB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXB5 gene|HOXB5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gamma-glutamyl transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gamma-glutamyl transferase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormone Therapy,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,Hormone Therapy estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,MTUS1 gene|MTUS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTUS1 gene|MTUS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SF3B3 gene|SF3B3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SF3B3 gene|SF3B3 Breast Carcinoma,Female Breast Cancer
AUGMENTS,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,IMPACT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IMPACT gene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"LCN2 protein, human|LCN2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","LCN2 protein, human|LCN2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,ATP5F1B gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP5F1B gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Cancer Prognostic Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cancer Prognostic Factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Discoidin Domain Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Discoidin Domain Receptor 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyphenols Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Photochemotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Photochemotherapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoantigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Neoantigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diuretics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diuretics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Transcript,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Transcript Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arsenic Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Matrix Metalloproteinases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Pills,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pills Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Autoimmune Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Autoimmune Diseases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,antagonists Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,paracrine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,paracrine Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Radiation,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GA-Binding Protein Transcription Factor|GABPA|NFE2L2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ferroptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ferroptosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Candidate Disease Gene,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,Candidate Disease Gene Recurrent Breast Carcinoma,Recurrent Breast Cancer
AFFECTS,Central Serous Chorioretinopathy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Central Serous Chorioretinopathy Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,triclosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,triclosan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin E Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAD51 gene|RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51 gene|RAD51 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"HIF1A protein, human|HIF1A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HIF1A protein, human|HIF1A Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,high density lipoprotein binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",high density lipoprotein binding protein Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HOXB7 gene|HOXB7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXB7 gene|HOXB7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pathologic Complete Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pathologic Complete Response Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,paclitaxel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,paclitaxel Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Tobacco smoking behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tobacco smoking behavior Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Infiltration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PIR gene|PIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIR gene|PIR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDC25C gene|CDC25C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC25C gene|CDC25C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CLEC2D gene|CLEC2D,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CLEC2D gene|CLEC2D Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,sirolimus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sirolimus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"MEN1 protein, human|MEN1",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MEN1 protein, human|MEN1 estrogen receptor-positive breast cancer",Female Breast Cancer
PREDISPOSES,Brominated Diphenyl Ethers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Brominated Diphenyl Ethers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ACSL4 gene|ACSL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ACSL4 gene|ACSL4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Flap Endonuclease-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flap Endonuclease-1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IDO1 gene|IDO1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IDO1 gene|IDO1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Immune response,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Immune response Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,>40 years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,>40 years Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclin-Dependent Kinases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Cyclin-Dependent Kinases Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,DPP3 gene|DPP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP3 gene|DPP3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,niclosamide,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,niclosamide HER2-positive carcinoma of breast,Female Breast Cancer
CAUSES,PQBP1 gene|PQBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PQBP1 gene|PQBP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antihypertensive Agents,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemical Viewed Functionally,Antihypertensive Agents HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Responsive Disease,Locally advanced breast cancer,0.0,Female Breast Cancer,Disease or Syndrome,Responsive Disease Locally advanced breast cancer,Female Breast Cancer
PREDISPOSES,CEP295 gene|CEP295,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CEP295 gene|CEP295 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,tissue polypeptide specific antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tissue polypeptide specific antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,beta catenin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,beta catenin Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,PBXIP1 gene|PBXIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PBXIP1 gene|PBXIP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pyroptosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Pyroptosis Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Duration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Duration Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Axillary node METASTASIS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Axillary node METASTASIS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR655 gene|MIR655,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR655 gene|MIR655 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LOC105371267,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LOC105371267 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ITGA2B wt Allele|ITGA2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ITGA2B wt Allele|ITGA2B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Pathogenic Variant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Pathogenic Variant Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"E2F1 protein, human|E2F1|UBE2L3",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","E2F1 protein, human|E2F1|UBE2L3 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,phthalates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phthalates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Neoplasm Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CATHEPSIN D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CATHEPSIN D Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Possible,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Possible Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,IL27 gene|MYDGF|IL27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL27 gene|MYDGF|IL27 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AZD4547,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AZD4547 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Gene Mutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Mutant Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GANT 61,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GANT 61 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MARCHF5 gene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MARCHF5 gene Breast Carcinoma,Female Breast Cancer
AFFECTS,GLI1 gene|GLI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLI1 gene|GLI1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LGALS8-AS1 gene|LGALS8-AS1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,LGALS8-AS1 gene|LGALS8-AS1 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Body mass index procedure,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Body mass index procedure Invasive carcinoma of breast,Female Breast Cancer
DISRUPTS,Liposomes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Liposomes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Drug resistance,Carcinoma breast stage IV,0.0,Female Breast Cancer,Pharmacologic Substance,Drug resistance Carcinoma breast stage IV,Female Breast Cancer
CAUSES,HOXD9 gene|HOXD9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXD9 gene|HOXD9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Immunologic Adjuvants,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Immunologic Adjuvants Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Genome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,POTEH-AS1 gene|POTEH-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,POTEH-AS1 gene|POTEH-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STAT3 gene|STAT3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FAM111B gene|FAM111B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAM111B gene|FAM111B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Growth Differentiation Factor 15|PAEP,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Growth Differentiation Factor 15|PAEP Early-Stage Breast Carcinoma,Female Breast Cancer
DISRUPTS,AR gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AR gene|AR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Decreased translucency,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Decreased translucency Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Performance,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Performance Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TSPAN1 gene|TSPAN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSPAN1 gene|TSPAN1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,astaxanthin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,astaxanthin Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Hypoxia-Inducible Factor 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Hypoxia-Inducible Factor 1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Elevated Expression,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Elevated Expression Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,KLF5 gene|KLF5,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,KLF5 gene|KLF5 Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,SETDB1 gene|SETDB1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SETDB1 gene|SETDB1 Breast Carcinoma,Female Breast Cancer
AFFECTS,"RNA, Circular",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,"TNFSF10 protein, human|TNFSF10",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNFSF10 protein, human|TNFSF10 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,"WNK1 protein, human|WNK1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WNK1 protein, human|WNK1 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,ENPP1 gene|ENPP1,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,ENPP1 gene|ENPP1 Recurrent Breast Carcinoma,Female Breast Cancer
AFFECTS,METTL14 gene|METTL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL14 gene|METTL14 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NDUFV1 gene|NDUFV1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NDUFV1 gene|NDUFV1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hydrogel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydrogel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NOLC1 gene|NOLC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOLC1 gene|NOLC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Resistance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Resistance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AMACR wt Allele,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,AMACR wt Allele Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,ADRB2 gene|ADRB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADRB2 gene|ADRB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"SEP15 protein, human|SELENOF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SEP15 protein, human|SELENOF Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,HOXC-AS3 gene|HOXC-AS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXC-AS3 gene|HOXC-AS3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mutant Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mutant Proteins Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,AA genotype,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AA genotype Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Architectural Distortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Architectural Distortion Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,EPB41L4A-AS1 gene|EPB41L4A-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EPB41L4A-AS1 gene|EPB41L4A-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genomic Instability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Genomic Instability Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Consideration,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Element, Ion, or Isotope","Consideration Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,Circulating Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Circulating Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Elevated Expression,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Elevated Expression Female Breast Carcinoma,Female Breast Cancer
CAUSES,KCNQ1OT1 gene|KCNQ1OT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KCNQ1OT1 gene|KCNQ1OT1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GA-Binding Protein Transcription Factor|GABPA|NFE2L2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,endosulfine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,endosulfine Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Hormone Receptor,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Hormone,Hormone Receptor Recurrent Breast Carcinoma,Recurrent Breast Cancer
PREDISPOSES,fusion transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",fusion transcript Malignant neoplasm of breast,Female Breast Cancer
CAUSES,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF1 gene|YTHDF1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Protein Subunits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Subunits Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,COVID-19,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,COVID-19 malignant neoplasm of breast staging,Female Breast Cancer
PREDISPOSES,PPP1R14C gene|PPP1R14C,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PPP1R14C gene|PPP1R14C Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Ovarian hyperstimulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovarian hyperstimulation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,brazilian,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,brazilian Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inhibitor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Cancer Therapeutic Procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cancer Therapeutic Procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Healthy Lifestyle,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Healthy Lifestyle Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,choline Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NFIB gene|NFIB,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NFIB gene|NFIB Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Procedure findings:Finding:Point in time:^Patient:Narrative Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Pathogenic Variant,"Breast Cancer, Familial",0.0,Female Breast Cancer,Virus,"Pathogenic Variant Breast Cancer, Familial",Female Breast Cancer
AUGMENTS,fluvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fluvastatin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RAC2 gene|RAC2,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,RAC2 gene|RAC2 estrogen receptor-negative breast cancer,Female Breast Cancer
PREDISPOSES,interleukin-6,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,interleukin-6 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GSDMB gene|GSDMB,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,GSDMB gene|GSDMB HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Immune,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immune Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypercholesterolemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Hypercholesterolemia Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LINC00092 gene|LINC00092,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,LINC00092 gene|LINC00092 Invasive Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Sleep Apnea, Obstructive",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Sleep Apnea, Obstructive Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,HMMR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HMMR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Agent,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical Viewed Functionally,Agent Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Organic solvent product,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Chemical,Organic solvent product Female Breast Carcinoma,Female Breast Cancer
AFFECTS,DDX5 gene|DDX5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DDX5 gene|DDX5 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Pharmacologic Substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmacologic Substance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,1 time,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1 time Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,secretory protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",secretory protein Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcohol consumption,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,"IL17A protein, human|IL17A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL17A protein, human|IL17A Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,LINC00472 gene|LINC00472,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00472 gene|LINC00472 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diffusion Kurtosis Imaging,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Diffusion Kurtosis Imaging Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CCNB2 gene|CCNB2,Stage 0 Breast Cancer AJCC v6 and v7,0.0,Female Breast Cancer,Gene or Genome,CCNB2 gene|CCNB2 Stage 0 Breast Cancer AJCC v6 and v7,Female Breast Cancer
CAUSES,Adenocarcinoma in Situ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenocarcinoma in Situ Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Carcinoma, Lobular","Breast Cancer, Familial",0.0,Female Breast Cancer,Neoplastic Process,"Carcinoma, Lobular Breast Cancer, Familial",Female Breast Cancer
AFFECTS,anastrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,anastrozole Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"CD69 protein, human|CD69","Breast Cancer, Familial",0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Breast Cancer, Familial",Female Breast Cancer
AUGMENTS,RBMS1 gene|RBMS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBMS1 gene|RBMS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tea without milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tea without milk Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,genetic risk factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic risk factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Infantile Neuroaxonal Dystrophy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Infantile Neuroaxonal Dystrophy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,doxorubicin liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,doxorubicin liposome Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,sigma-2 receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sigma-2 receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SNHG3 gene|SNHG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG3 gene|SNHG3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HMGB1 gene|HMGB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGB1 gene|HMGB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Processes,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Phenomenon or Process,Biological Processes Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Silencing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Silencing Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,False Positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,False Positive Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Multifactorial,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Multifactorial Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MEDAG gene|MEDAG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEDAG gene|MEDAG Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GTF2H1 gene|GTF2H1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Post-mastectomy radiotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Post-mastectomy radiotherapy Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,PIK3CA gene|PIK3CA,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,"Antibodies, Bispecific",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"Antibodies, Bispecific Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,FBXW7 gene|FBXW7,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,FBXW7 gene|FBXW7 Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,CCL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCL3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mitochondrial mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mitochondrial mutation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Basis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Basis Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MIR191 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR191 wt Allele Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GLI4 gene|GLI4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLI4 gene|GLI4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Convenience food intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Convenience food intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cancer Therapeutic Procedure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cancer Therapeutic Procedure Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PEDS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PEDS1 gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Monoclonal Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Monoclonal Antibodies Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,fluoxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fluoxetine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,canagliflozin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,canagliflozin Breast Carcinoma,Female Breast Cancer
AFFECTS,PAFAH1B1 gene|PAFAH1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAFAH1B1 gene|PAFAH1B1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proto-Oncogene Protein c-kit,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Proto-Oncogene Protein c-kit Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CCDC102B gene|CCDC102B,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,CCDC102B gene|CCDC102B Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RACK1 gene|RACK1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,RACK1 gene|RACK1 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Imbrication (procedure),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Imbrication (procedure) Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,catalpol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,catalpol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"RNA, Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Score,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Score Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Transsexual (finding),Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Transsexual (finding) Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Responsive Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Responsive Disease Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"IL17A protein, human|IL17A",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL17A protein, human|IL17A Inflammatory Breast Carcinoma",Female Breast Cancer
PREDISPOSES,ZNF276 gene|ZNF276,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ZNF276 gene|ZNF276 Breast Carcinoma,Female Breast Cancer
AFFECTS,Antioxidants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antioxidants Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anabolism,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Anabolism Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,TIMM8A gene|TIMM8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIMM8A gene|TIMM8A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrus,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Estrus estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,METTL3 gene|METTL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL3 gene|METTL3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FER1L4 gene|FER1L4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FER1L4 gene|FER1L4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vitamin D Deficiency,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Food,Vitamin D Deficiency Malignant neoplasm of female breast,Female Breast Cancer
AUGMENTS,UBE2C gene|UBE2C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2C gene|UBE2C Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,diltiazem,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,diltiazem Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,resveratrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,resveratrol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FRG1 gene|FRG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FRG1 gene|FRG1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NF2 gene|NF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NF2 gene|NF2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Observation parameter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Observation parameter Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Emodin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Emodin Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Clinical Significance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Clinical Significance Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"PIK3CB protein, human|PIK3CB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,METTL14 gene|METTL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL14 gene|METTL14 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,N-acetyltransferase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,N-acetyltransferase 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Selective Estrogen Receptor Down Regulator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Down Regulator Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,water channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,water channel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diffusion weighted imaging,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Diffusion weighted imaging Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,ARL11 gene|ARL11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARL11 gene|ARL11 Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,MIR217 gene|MIR217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR217 gene|MIR217 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2 Overexpression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2 Overexpression Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXN3 gene|FOXN3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FOXN3 gene|FOXN3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,ellagic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ellagic acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Retinol-Binding Proteins, Cellular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Retinol-Binding Proteins, Cellular Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Cancer-Related Death,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Cancer-Related Death Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cell-Free DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cell-Free DNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Duration,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Duration Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Risk Scores,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Risk Scores contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Present,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Present Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,1-Phosphatidylinositol 3-Kinase,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,1-Phosphatidylinositol 3-Kinase HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,"neoisoliquiritin, (E)-isomer",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"neoisoliquiritin, (E)-isomer Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Phosphotransferases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Phosphotransferases Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Matrix Metalloproteinase 9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 9 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HDAC7 gene|HDAC7,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HDAC7 gene|HDAC7 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,IGF2BP2 gene|IGF2BP2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IGF2BP2 gene|IGF2BP2 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,BCL2A1 gene|BCL2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL2A1 gene|BCL2A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Cycle Arrest,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cell Cycle Arrest Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GNAS gene|GNAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GNAS gene|GNAS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,arginylproline|ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arginylproline|ABL2|RERE Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,hexanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hexanoic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antipsychotic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tripe,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tripe Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RMI2 gene|RMI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RMI2 gene|RMI2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Candidiasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Candidiasis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SCAMP3 gene|SCAMP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SCAMP3 gene|SCAMP3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SPC25 gene|SPC25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPC25 gene|SPC25 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,KDM4A gene|KDM4A,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,KDM4A gene|KDM4A Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Treatment Protocols,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Treatment Protocols HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Neuregulin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neuregulin 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmaceutical Preparations,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,LBH589,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LBH589 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CBX7 gene|CBX7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBX7 gene|CBX7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PRAF2 gene|PRAF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRAF2 gene|PRAF2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Histone H3 Lysine 27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histone H3 Lysine 27 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Low Level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Low Level Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,paclitaxel,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,paclitaxel Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WWTR1 protein, human|WWTR1 Malignant neoplasm of breast",Female Breast Cancer
COMPLICATES,Malignant neoplasm of breast,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genetic Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Loci Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANTXR1 wt Allele|ATR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ANTXR1 wt Allele|ATR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Genes Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,FKBP12-rapamycin associated protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",FKBP12-rapamycin associated protein Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ROS1 wt Allele|ROS1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,ROS1 wt Allele|ROS1 estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Mitophagy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Mitophagy Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,"FABP1 protein, human|FABP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FABP1 protein, human|FABP1 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,gamma-aminobutyric acid,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Chemical,gamma-aminobutyric acid Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mouse mammary tumor virus infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mouse mammary tumor virus infection Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,chaperone-mediated autophagy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chaperone-mediated autophagy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dairy Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dairy Products Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen receptor positive,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor positive estrogen receptor-negative breast cancer,Female Breast Cancer
AFFECTS,Neoadjuvant Therapy,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Neoadjuvant Therapy Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,KAT7 gene|KAT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KAT7 gene|KAT7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anxiety,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anxiety Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,stanniocalcin 2|STC2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,stanniocalcin 2|STC2 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,RNF43 gene|RNF43,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RNF43 gene|RNF43 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Secondary Neoplasm,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Secondary Neoplasm Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC2A1 gene|SLC2A1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,F-Actin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,F-Actin Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CPVL gene|CPVL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CPVL gene|CPVL Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vegetarian diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vegetarian diet Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TMEM105 gene|TMEM105,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TMEM105 gene|TMEM105 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SIRT7 gene|SIRT7,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SIRT7 gene|SIRT7 Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNRPC gene|SNRPC Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Response Modifiers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estradiol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RHD gene|RHD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHD gene|RHD Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MYC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,MYC Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,STAT1 gene|STAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT1 gene|STAT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Axillary node METASTASIS,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Axillary node METASTASIS Breast Carcinoma,Female Breast Cancer
PREDISPOSES,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNRPC gene|SNRPC Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,HHEX gene|HHEX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HHEX gene|HHEX Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyphenols Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Kanglaite Injection,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Kanglaite Injection Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SIRT7 gene|SIRT7,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,SIRT7 gene|SIRT7 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,SDC1 gene|SDC1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"RNA, Long Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Marital Status,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Marital Status Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CARD.RISK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CARD.RISK Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Agent,Carcinoma breast stage IV,0.0,Female Breast Cancer,Chemical Viewed Functionally,Agent Carcinoma breast stage IV,Female Breast Cancer
CAUSES,human papillomavirus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,human papillomavirus Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,kaempferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,kaempferol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,dydrogesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dydrogesterone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Ribonucleoprotein, U1 Small Nuclear",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Ribonucleoprotein, U1 Small Nuclear Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,USP29 gene|USP29,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,USP29 gene|USP29 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"Galanin peptides, human (123 aa, ~13 kDa)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Galanin peptides, human (123 aa, ~13 kDa) Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,NDC80 gene|NDC80,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NDC80 gene|NDC80 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inflammatory Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inflammatory Response Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLF2 gene|KLF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF2 gene|KLF2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Luteolin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Luteolin Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"PDCD1 protein, human|PDCD1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PDCD1 protein, human|PDCD1 Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Magnetic Resonance Imaging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Magnetic Resonance Imaging Breast Carcinoma,Female Breast Cancer
CAUSES,copper,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,copper Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VEGFA gene|VEGFA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VEGFA gene|VEGFA Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Negative Surgical Margin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Negative Surgical Margin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Agonist,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Agonist Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NUCB2 gene|NUCB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUCB2 gene|NUCB2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mouse mammary tumor virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mouse mammary tumor virus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Oligonucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotides Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Betaretrovirus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Betaretrovirus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,stanniocalcin 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,stanniocalcin 2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Methylnitrosourea,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Methylnitrosourea estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,epithelial to mesenchymal transition,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CDH12 gene|CDH12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH12 gene|CDH12 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,HER2-negative breast cancer,0.0,Female Breast Cancer,Other,Pharmacotherapy HER2-negative breast cancer,Female Breast Cancer
CAUSES,Invasive Ductal Breast Carcinoma,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Invasive Ductal Breast Carcinoma Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,RNA-Binding Protein Musashi Homolog 2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 2 Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,16 alpha-hydroxyestrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,16 alpha-hydroxyestrone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,hydrocortisone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hydrocortisone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ectonucleotide pyrophosphatase phosphodiesterase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ectonucleotide pyrophosphatase phosphodiesterase 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,oxybenzone,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,oxybenzone Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Menstrual period late,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menstrual period late Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pediatric Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pediatric Obesity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lysine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NR2F1-AS1 gene|NR2F1-AS1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,NR2F1-AS1 gene|NR2F1-AS1 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MCM6 gene|MCM6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM6 gene|MCM6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Psoriasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Psoriasis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MAP7D3 gene|MAP7D3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MAP7D3 gene|MAP7D3 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,DEGS1 wt Allele|DEGS1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,DEGS1 wt Allele|DEGS1 Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Pharmacotherapy,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Pharmacotherapy Female Breast Carcinoma,Female Breast Cancer
AFFECTS,polyphyllin D,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,polyphyllin D Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tocopherol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SPDEF gene|SPDEF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPDEF gene|SPDEF Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FAM171A1 gene|FAM171A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAM171A1 gene|FAM171A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,olive oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,olive oil Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Poly(ADP-ribose) Polymerase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Poly(ADP-ribose) Polymerase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HNRNPA2B1 gene|HNRNPA2B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HNRNPA2B1 gene|HNRNPA2B1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EYA4 gene|EYA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EYA4 gene|EYA4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Parafibromin|CDC73,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parafibromin|CDC73 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RHOV gene|RHOV,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RHOV gene|RHOV Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,LINC01140 gene|LINC01140,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01140 gene|LINC01140 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Progression,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Tumor Progression Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,"TNFSF10 protein, human|TNFSF10",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNFSF10 protein, human|TNFSF10 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Neoadjuvant Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Neoadjuvant Therapy HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,TYMSOS gene|TYMSOS,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TYMSOS gene|TYMSOS Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Basal-Like Breast Carcinoma,Female Breast Cancer
DISRUPTS,Glycoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glycoproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ligands,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Ligands Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,CD69,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD69 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Life Expectancy Less than Five Years,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Life Expectancy Less than Five Years Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Decreased Expression,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Decreased Expression Early-Stage Breast Carcinoma,Female Breast Cancer
DISRUPTS,Phenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phenols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,medroxyprogesterone acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,medroxyprogesterone acetate Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SEMA3B-AS1 gene|SEMA3B-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SEMA3B-AS1 gene|SEMA3B-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Anti-HER2 Monoclonal Antibody|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Anti-HER2 Monoclonal Antibody|ERBB2 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,C-reactive protein,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-reactive protein Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,MIR122 gene|MIR122,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR122 gene|MIR122 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MAF1 gene|MAF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAF1 gene|MAF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Toll-Like Receptor 1, human|TLR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Toll-Like Receptor 1, human|TLR1 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,perfluorooctanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorooctanoic acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oncogenes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Oncogenes Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,CD82 gene|CD82,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CD82 gene|CD82 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Biological Markers,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,Other,Biological Markers Stage 0 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Matrix Metalloproteinases,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ketogenic Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ketogenic Diet Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MicroRNA Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MicroRNA Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PSMD14 gene|PSMD14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSMD14 gene|PSMD14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00702 gene|LINC00702,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00702 gene|LINC00702 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phytochemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemicals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNPH1 gene|DNPH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNPH1 gene|DNPH1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IMPA2 gene|IMPA2,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,IMPA2 gene|IMPA2 Basal-Like Breast Carcinoma,Female Breast Cancer
DISRUPTS,FBXO3 gene|FBXO3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FBXO3 gene|FBXO3 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Survival,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cell Survival Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,OLT1177,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,OLT1177 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Neuroleptic Malignant Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neuroleptic Malignant Syndrome Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,beta catenin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,beta catenin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Crohn Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Crohn Disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HMGB3 gene|HMGB3,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,HMGB3 gene|HMGB3 Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Tumor Markers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Tumor Markers Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"COPEB protein, human|KLF6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","COPEB protein, human|KLF6 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,quercetin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary Neoplasm,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Secondary Neoplasm Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Cardiorespiratory Fitness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cardiorespiratory Fitness Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"PIK3CB protein, human|PIK3CB",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Secondary malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Radiation-Sensitizing Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation-Sensitizing Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STMN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,STMN1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Waist Circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Waist Circumference Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,olaparib,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,olaparib Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Mammographic Breast Density,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Mammographic Breast Density Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PALMD gene|PALMD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PALMD gene|PALMD Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,1+,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1+ Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NOTCH3 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOTCH3 gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ferroptosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Ferroptosis Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,CELSR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CELSR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WASF3 gene|WASF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WASF3 gene|WASF3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Rhythm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rhythm Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thrombospondin 1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Thrombospondin 1 HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Dormancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dormancy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR203A gene|MIR203A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR203A gene|MIR203A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lutein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lutein Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Secondary malignant neoplasm of liver,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of liver HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Macrophage Activation Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Macrophage Activation Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnosis,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Diagnosis Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Mouse Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mouse Model Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,post surgery radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",post surgery radiation therapy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Pathogenic Variant,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Virus,Pathogenic Variant Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
AFFECTS,Cell Death,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cell Death Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Plasma Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Plasma Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ARHGAP6 gene|ARHGAP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP6 gene|ARHGAP6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ELAVL1 gene|ELAVL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELAVL1 gene|ELAVL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FRY gene|FRY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FRY gene|FRY Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IDO1 gene|IDO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IDO1 gene|IDO1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CLEC11A protein, human|CLEC11A",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CLEC11A protein, human|CLEC11A Secondary malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Polynucleotide Adenylyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Polynucleotide Adenylyltransferase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,idebenone,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,idebenone Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"Tenascin, human|TNC|TNNC1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Tenascin, human|TNC|TNNC1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Breast Fibrocystic Disease,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Disease or Syndrome,Breast Fibrocystic Disease Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,OGG1 gene|OGG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OGG1 gene|OGG1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PDZK1 gene|PDZK1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PDZK1 gene|PDZK1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Poly(ADP-ribose) Polymerase Inhibitors Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,MTCH2 gene|MTCH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTCH2 gene|MTCH2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Infiltration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KLRK1 gene|KLRK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLRK1 gene|KLRK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC01572 gene|LINC01572,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC01572 gene|LINC01572 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Dickkopf-Related Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Dickkopf-Related Protein 1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RAMP2-AS1 gene|RAMP2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAMP2-AS1 gene|RAMP2-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TLR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TLR2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA1 gene|BRCA1,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"BRCA1 gene|BRCA1 Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,SLCO1B1 gene|SLCO1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLCO1B1 gene|SLCO1B1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ezetimibe,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,ezetimibe Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NR2F2 gene|NR2F2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR2F2 gene|NR2F2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Nanotubes, Carbon",Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Nanotubes, Carbon Carcinoma breast stage IV",Female Breast Cancer
AUGMENTS,Follistatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Follistatin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,AGRN gene|AGRN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AGRN gene|AGRN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NKAIN1 gene|NKAIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NKAIN1 gene|NKAIN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,mitochondrial calcium uniporter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mitochondrial calcium uniporter Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ononin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,ononin Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,tanshinone II A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tanshinone II A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,S14 gene|PSMD8|RPS14|THRSP|LOC107228383,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S14 gene|PSMD8|RPS14|THRSP|LOC107228383 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TCF7L2 gene|TCF7L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TCF7L2 gene|TCF7L2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,oncostatin M receptor|OSMR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,oncostatin M receptor|OSMR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anthocyanins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anthocyanins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prostaglandins,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Eicosanoid,Prostaglandins Ductal Breast Carcinoma,Female Breast Cancer
DISRUPTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin used,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin used Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TAL1 gene|TAL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TAL1 gene|TAL1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Tumor Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Markers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNMT3B gene|DNMT3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNMT3B gene|DNMT3B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,resveratrol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,resveratrol Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,RHOC gene|RHOC,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Human plasma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Human plasma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,glycosylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glycosylation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Antagonists,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Estrogen Antagonists Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,CA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Steroid 17-alpha-monooxygenase|CYP17A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Steroid 17-alpha-monooxygenase|CYP17A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adenosine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EZH2 gene|EZH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cardiovascular morbidity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cardiovascular morbidity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IKZF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IKZF2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Interleukin-24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-24 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Necrosis Factor Ligand Superfamily Member 6|FASLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Necrosis Factor Ligand Superfamily Member 6|FASLG Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TAZ gene|TAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAZ gene|TAZ Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-tyrosine kinase inhibitor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Benzoic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Benzoic Acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Estrogen Receptor alpha,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Breast cancer metastatic,Female Breast Cancer
CAUSES,SMARCA4 gene|SMARCA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMARCA4 gene|SMARCA4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radioisotope scan of lymphatic system,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radioisotope scan of lymphatic system Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Neoplasm Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,RHOA gene|RHOA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RHOA gene|RHOA Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Folic acid supplementation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic acid supplementation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Acrylamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acrylamide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ESTROGEN USE,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,ESTROGEN USE Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,recombinational repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",recombinational repair Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,KDM5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM5B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Menopause, Premature",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Menopause, Premature Malignant neoplasm of breast",Female Breast Cancer
CAUSES,APC2 gene|APC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APC2 gene|APC2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CETN1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,CETN1 Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Aging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Aging Breast Carcinoma,Female Breast Cancer
AFFECTS,Metaplastic carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metaplastic carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Suicide Gene Therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Suicide Gene Therapy Breast cancer metastatic,Female Breast Cancer
AFFECTS,Combined Modality Therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Combined Modality Therapy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GATA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDX2 gene|CDX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDX2 gene|CDX2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DUSP4 gene|DUSP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DUSP4 gene|DUSP4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Selenium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FLT1 gene|FLT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FLT1 gene|FLT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Menstrual migraine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menstrual migraine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant transformation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Eclampsia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Eclampsia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nucleic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nucleic Acids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,APOBEC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,APOBEC3B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Immunologic Adjuvants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunologic Adjuvants Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Whole Cell Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Whole Cell Vaccine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,XBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,XBP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cancer Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Model Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Calcium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cytochrome P-450 CYP1A1|CYP2B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP1A1|CYP2B6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,High fiber food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,High fiber food Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast Carcinoma,Female Breast Cancer
AUGMENTS,MAP3K3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAP3K3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,UDP-Glucuronosyltransferase 1A1|SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UDP-Glucuronosyltransferase 1A1|SLC45A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NANOG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NANOG Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CADMIUM EXPOSURE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,CADMIUM EXPOSURE Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TISSUE TRANSGLUTAMINASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TISSUE TRANSGLUTAMINASE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glycoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glycoproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TLR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TLR3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Quinones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quinones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Progestins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Progestins Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VEGF gene|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,[D]Nausea and vomiting NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,[D]Nausea and vomiting NOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,JAG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,JAG1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Fatty Acids, Saturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Saturated Malignant neoplasm of breast",Female Breast Cancer
CAUSES,8q22,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,8q22 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,transcription factor PEA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",transcription factor PEA3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TLR4 gene|TLR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TLR4 gene|TLR4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Genes, Homeobox",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Homeobox Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Deferoxamine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Deferoxamine Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrogens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogens Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,PCAF gene|KAT2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAF gene|KAT2B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Specimen from breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Specimen from breast Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR27B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,MIR27B Breast cancer metastatic,Female Breast Cancer
AFFECTS,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,BIRC5 gene|BIRC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC5 gene|BIRC5 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,RUNX1|MECOM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RUNX1|MECOM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ANKRD12|ANKRD11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ANKRD12|ANKRD11 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Interleukin-8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RNASE3L gene|DROSHA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNASE3L gene|DROSHA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,RHOBTB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RHOBTB2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paclitaxel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TP53 gene|TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Estrogen excess,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogen excess Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,ID1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ID1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Leptin|LEP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leptin|LEP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transferase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Quantitative Trait Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quantitative Trait Loci Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MRPS30,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MRPS30 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Genes, Homeobox",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Genes, Homeobox Breast Carcinoma",Female Breast Cancer
PREDISPOSES,BIRC7 gene|BIRC7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC7 gene|BIRC7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Annexin A2|ANXA2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Annexin A2|ANXA2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ATR gene|ATR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATR gene|ATR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TSLP gene|TSLP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TSLP gene|TSLP Breast cancer metastatic,Female Breast Cancer
CAUSES,Endostatins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endostatins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SH3KBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SH3KBP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,S100A9 gene|S100A9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A9 gene|S100A9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nitrite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nitrite Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Cancer Treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cancer Treatment Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-tyrosine kinase inhibitor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ARF6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ARF6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Extracellular Signal Regulated Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Extracellular Signal Regulated Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunoglobulin G,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunoglobulin G Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1B gene|CDKN1B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CTNNB1 gene|CTNNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTNNB1 gene|CTNNB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antiperspirants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antiperspirants Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leptin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signaling Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Signaling Protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,asparaginylendopeptidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,asparaginylendopeptidase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Soy Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Soy Foods Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,20q,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,20q Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,STAT3 gene|STAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CXCR3 gene|CXCR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR3 gene|CXCR3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTPN11 gene|PTPN11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN11 gene|PTPN11 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant neoplasm of endometrium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of endometrium Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Interleukin 7 Receptor|IL7R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin 7 Receptor|IL7R Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Livebirth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Livebirth Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease Outcome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease Outcome Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BMPR1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BMPR1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sulfuric Acid Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfuric Acid Esters Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BMPR2 gene|BMPR2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,BMPR2 gene|BMPR2 Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Laminin Receptor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Laminin Receptor Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Protein-Serine-Threonine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-Serine-Threonine Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic Resonance Imaging,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Magnetic Resonance Imaging Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Environmental Effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Environmental Effect of Humans,Environmental Effects Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ACR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ACR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metabolic Rates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolic Rates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CATHEPSIN D|CTSD,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CATHEPSIN D|CTSD Breast cancer metastatic,Female Breast Cancer
AFFECTS,"Antibodies, Anti-Idiotypic",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,"Antibodies, Anti-Idiotypic Breast cancer metastatic",Female Breast Cancer
AFFECTS,Carotenoids,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Carotenoids Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Fibroadenoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fibroadenoma Breast Carcinoma,Female Breast Cancer
CAUSES,Insulin-Like Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cDNA Library,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cDNA Library Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrous Cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estrous Cycle Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Toxic effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Toxic effect Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Irregular menstrual cycle NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Irregular menstrual cycle NOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Pregnancy, Multiple",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Pregnancy, Multiple Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,TACSTD2 gene|TACSTD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TACSTD2 gene|TACSTD2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cystic Breast Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Cystic Breast Disease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA1 gene|BRCA1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Familial cancer of breast,Female Breast Cancer
AFFECTS,LAMR1 gene|RPSA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAMR1 gene|RPSA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fulvestrant,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,fulvestrant Breast cancer metastatic,Female Breast Cancer
AFFECTS,BCAS1 gene|BCAS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAS1 gene|BCAS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSD17B4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSD17B4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nifedipine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nifedipine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mechanics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mechanics Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body mass index,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Other,Body mass index Carcinoma in situ of breast,Female Breast Cancer
AUGMENTS,LRRC32,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LRRC32 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cysteine Proteinase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cysteine Proteinase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signal Pathways,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Signal Pathways Breast cancer metastatic,Female Breast Cancer
DISRUPTS,salinomycin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,salinomycin Breast Carcinoma,Female Breast Cancer
AUGMENTS,mutant gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,mutant gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Reconstructive Surgical Procedures,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reconstructive Surgical Procedures Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Prostaglandin-Endoperoxide Synthase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Eicosanoid,Prostaglandin-Endoperoxide Synthase Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,GALNT14,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,GALNT14 Breast cancer metastatic,Female Breast Cancer
CAUSES,mammary tumor virus,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,mammary tumor virus Breast Carcinoma,Female Breast Cancer
CAUSES,Cadherins,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Cadherins Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Manganese Superoxide Dismutase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Manganese Superoxide Dismutase Breast Carcinoma,Female Breast Cancer
DISRUPTS,Genes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Genes Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Tretinoin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Tretinoin Breast Carcinoma,Female Breast Cancer
CAUSES,Medroxyprogesterone,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hormone,Medroxyprogesterone Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Para 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Para 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dessert,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dessert Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Trihalomethanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Trihalomethanes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ZNF121,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF121 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Paraffin,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Paraffin Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Retroviridae,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Retroviridae Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cytologic finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytologic finding Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GATA3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,GATA3 Breast cancer metastatic,Female Breast Cancer
CAUSES,hybrid gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,hybrid gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CCND1 gene|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Etoposide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Etoposide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Collagen,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Collagen Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,activity level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,activity level Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Factors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Trans-Activators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Trans-Activators Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SHBG gene|SHBG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHBG gene|SHBG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Athletic Training,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Athletic Training Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Aromatic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aromatic Amines Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Androgens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Androgens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Anovulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Anovulation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,alpha-Lactalbumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha-Lactalbumin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FGF3 gene|FGF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF3 gene|FGF3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Prolactin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Operative Surgical Procedures,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Operative Surgical Procedures Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Serum Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serum Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Photosensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Photosensitivity Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Tamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast Carcinoma,Female Breast Cancer
CAUSES,Female Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Female Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Electromagnetic Fields,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Electromagnetic Fields Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phosphotransferases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Phosphotransferases Breast Carcinoma,Female Breast Cancer
AFFECTS,DNA biosynthesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA biosynthesis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TFF1 protein, human|TFF1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF1 protein, human|TFF1 Malignant neoplasm of breast",Female Breast Cancer
COMPLICATES,Hypercalcemia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Hypercalcemia Breast cancer metastatic,Female Breast Cancer
AUGMENTS,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"serine repeat antigen, Plasmodium",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"serine repeat antigen, Plasmodium Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Estrogenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pharmaceutical Preparations,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Animal protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Animal protein Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proto-Oncogene Proteins p21(ras)|HRAS,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins p21(ras)|HRAS Breast Carcinoma,Female Breast Cancer
DISRUPTS,Estrogen Antagonists,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogen Antagonists Breast Carcinoma,Female Breast Cancer
CAUSES,FGF3 gene|FGF3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FGF3 gene|FGF3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,international differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",international differences Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Genes, Suppressor",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Suppressor Malignant neoplasm of breast",Female Breast Cancer
CAUSES,"Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Aromatic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,onapristone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,onapristone Breast Carcinoma,Female Breast Cancer
AFFECTS,Paraffin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Paraffin Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Monoclonal Antibodies,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Monoclonal Antibodies Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Debrisoquin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Debrisoquin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gonadorelin|GNRH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gonadorelin|GNRH1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Urea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Urea Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Burden,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Burden Breast cancer metastatic,Female Breast Cancer
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Breast cancer recurrent",Recurrent Breast Cancer
CAUSES,Dimethyl Sulfoxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dimethyl Sulfoxide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BCL-2 Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",BCL-2 Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,beta-hexachlorocyclohexane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-hexachlorocyclohexane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gamma-glutamyl transferase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Gamma-glutamyl transferase Breast Carcinoma,Female Breast Cancer
DISRUPTS,Interferons,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Interferons Breast Carcinoma,Female Breast Cancer
AFFECTS,Bromocriptine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bromocriptine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,IGF2 gene|IGF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF2 gene|IGF2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,methylurea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methylurea Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Secondary malignant neoplasm of bone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Breast cancer metastatic,Female Breast Cancer
AFFECTS,Pathogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Pathogenesis Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Prognostic Factor,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Prognostic Factor Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,Advanced cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Advanced cancer Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ascorbic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ascorbic Acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Antigens, Viral",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,"Antigens, Viral Breast Carcinoma",Female Breast Cancer
DISRUPTS,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,AFP gene|AFP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AFP gene|AFP Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Antipsychotic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HRAS gene|HRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HRAS gene|HRAS Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Breast cancer invasive NOS,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,PIP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PIP Breast cancer metastatic,Female Breast Cancer
AFFECTS,Wound Healing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Wound Healing Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast cancer metastatic,Female Breast Cancer
AFFECTS,Lymph node excision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lymph node excision Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Genes, Regulator",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Regulator Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,High income,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,High income Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lutein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lutein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radionuclide Imaging,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Radionuclide Imaging Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,X-Pro dipeptidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,X-Pro dipeptidase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,New finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,New finding Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Antibiotics Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Obesity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Obesity Breast Carcinoma,Female Breast Cancer
AFFECTS,CATHEPSIN D|CTSD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CATHEPSIN D|CTSD Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,tissue-factor-pathway inhibitor 2|PPP5C|TFPI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tissue-factor-pathway inhibitor 2|PPP5C|TFPI2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fever,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Fever Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,alpha-Linolenic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,alpha-Linolenic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MLH1 gene|MLH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLH1 gene|MLH1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,regular physical activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,regular physical activity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELK3 gene|ELK3|KCNH8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transfection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transfection Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NBEAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NBEAL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Linoleic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Linoleic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinoma in Situ,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Lobular carcinoma in situ of breast,Female Breast Cancer
PREDISPOSES,C2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,C2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BUB1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BUB1B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Glucagon|GCG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Glucagon|GCG Breast Carcinoma,Female Breast Cancer
AFFECTS,"Fatty Acids, Unsaturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Unsaturated Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,MFT 279,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,MFT 279 Breast Carcinoma,Female Breast Cancer
DISRUPTS,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,receptor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estradiol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Estradiol Breast Carcinoma,Female Breast Cancer
PREDISPOSES,GATA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GATA5 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ETS Variant Gene 6 Protein|ETV6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ETS Variant Gene 6 Protein|ETV6 Breast Carcinoma,Female Breast Cancer
DISRUPTS,folligen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,folligen Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cyclin D1|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1|CCND1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Genes, Regulator",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,"Genes, Regulator Breast cancer invasive NOS",Female Breast Cancer
PREDISPOSES,sodium-iodide symporter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sodium-iodide symporter Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prolactin|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin|PRL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Indomethacin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Indomethacin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Increased body mass index,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Increased body mass index Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Integrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Insulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Decapeptyl,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Decapeptyl Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Radium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Radium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interstitial Collagenase,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Interstitial Collagenase Breast cancer invasive NOS,Female Breast Cancer
CAUSES,MYC gene|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC gene|MYC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HIV Infections,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HIV Infections Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Allelic Imbalance,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Allelic Imbalance Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,response to hormone stimulus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,response to hormone stimulus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,glycosylation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",glycosylation Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Polyamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polyamines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Communication,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cell Communication Breast cancer metastatic,Female Breast Cancer
CAUSES,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Genistein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Electromagnetic Energy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Electromagnetic Energy Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Chronic Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic Disease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein Overexpression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Overexpression Breast Carcinoma,Female Breast Cancer
AFFECTS,CDC25A gene|CDC25A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC25A gene|CDC25A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,checkpoint kinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,checkpoint kinase 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Passive smoker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Passive smoker Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypokinesia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypokinesia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Isotopes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Isotopes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Sterol Regulatory Element Binding Protein 1c,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Sterol Regulatory Element Binding Protein 1c Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aspirin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Psychometrics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Psychometrics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,I Kappa B-Alpha,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,I Kappa B-Alpha Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,Antioxidants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antioxidants Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Triethylenemelamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Triethylenemelamine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fluorodeoxyglucose positron emission tomography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",fluorodeoxyglucose positron emission tomography Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lymphoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lymphoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NFKBIA gene|NFKBIA,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,NFKBIA gene|NFKBIA Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Fibroblast Growth Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chromosome abnormality,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Chromosome abnormality Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Kininogenase|KLK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Kininogenase|KLK4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CLARITY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CLARITY Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ral Guanine Nucleotide Exchange Factor|RALGDS,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ral Guanine Nucleotide Exchange Factor|RALGDS Breast Carcinoma,Female Breast Cancer
AUGMENTS,letrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,letrozole Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Transcription Coactivator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Coactivator Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Retroviral Vector,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Retroviral Vector Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Serine Protease,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Enzyme,Serine Protease Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Saturated fat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Saturated fat intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"N,N-dimethyl-4-anisidine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"N,N-dimethyl-4-anisidine Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,BRCA1 gene|BRCA1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,skills,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,skills Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EMSY,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,EMSY Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Family history of breast cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Family history of breast cancer Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Amino Acid Substitution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amino Acid Substitution Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Reproductive Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reproductive Behavior Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERCC4 gene|ERCC4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC4 gene|ERCC4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Venous Thrombosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Venous Thrombosis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,VEGF gene|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Quantitative Trait Loci,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Quantitative Trait Loci Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Prempro,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prempro Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,maspin|SERPINB5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,maspin|SERPINB5 Breast cancer metastatic,Female Breast Cancer
CAUSES,Dehydroepiandrosterone Sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dehydroepiandrosterone Sulfate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphotransferases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Micronutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Micronutrients Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Retinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Retinoids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ID-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ID-1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Polypeptides,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Polypeptides Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,MPO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MPO Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Soy bean product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Soy bean product Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cancer-Predisposing Gene,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Familial cancer of breast,Female Breast Cancer
CAUSES,Angiogenic Switch,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Angiogenic Switch Breast Carcinoma,Female Breast Cancer
PREDISPOSES,ID1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ID1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cryptococcus,Cancer en cuirasse,0.0,Female Breast Cancer,Other,Cryptococcus Cancer en cuirasse,Female Breast Cancer
AFFECTS,Infertility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Infertility Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,EEF1B2P2|BHLHE22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EEF1B2P2|BHLHE22 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Decreased density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Decreased density Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CD82 gene|CD82,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD82 gene|CD82 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein Kinase C Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinase C Inhibitor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NQO1 gene|NQO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NQO1 gene|NQO1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,apomucin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,apomucin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NELFB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NELFB Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplasm Metastasis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,repair enzyme,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Enzyme,repair enzyme Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Orthologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Orthologous Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast,Female Breast Cancer
CAUSES,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CASP1 gene|CASP1,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Gene or Genome,CASP1 gene|CASP1 Lobular carcinoma in situ of breast,Female Breast Cancer
PREDISPOSES,TNFRSF1B gene|TNFRSF1B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,TNFRSF1B gene|TNFRSF1B Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Granulocyte Colony-Stimulating Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Granulocyte Colony-Stimulating Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tamoxifen,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Carcinoma in situ of breast,Female Breast Cancer
AFFECTS,cyclooxygenase 2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,IL8 gene|CXCL8,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,IL8 gene|CXCL8 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Steroidal Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroidal Estrogen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Fibroblast Growth Factor 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MFG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MFG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Catechol O-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catechol O-Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyperprolactinemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperprolactinemia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aromatase Inhibitors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Aromatase Inhibitors Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,CAV1 gene|CAV1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAV1 gene|CAV1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Tamoxifen,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Contralateral breast cancer,Female Breast Cancer
AFFECTS,Estradiol,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Estradiol Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lignans Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,lariciresinol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lariciresinol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Single Nucleotide Polymorphism,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Raloxifene,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Other,Raloxifene Carcinoma in situ of breast,Female Breast Cancer
PREDISPOSES,Anovulatory,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anovulatory Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sore to touch,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sore to touch Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gegenhalten,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gegenhalten Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CLCA2 gene|CLCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLCA2 gene|CLCA2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Xanthine Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xanthine Dehydrogenase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,pleiotrophin|PTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pleiotrophin|PTN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,epigallocatechin gallate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,epigallocatechin gallate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,beta catenin,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"beta catenin Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,WISP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WISP2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Glutathione S-Transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutathione S-Transferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Endopeptidases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endopeptidases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,anti-apoptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,anti-apoptosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Environmental stimuli,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Environmental stimuli Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Asparagine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Asparagine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HPSE gene|HPSE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HPSE gene|HPSE Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Steryl-sulfatase|STS Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cytochrome P450 3A4|CYP3A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P450 3A4|CYP3A4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Signaling Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Signaling Protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,polyphenols,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,polyphenols Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Estrogen Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer metastatic,Female Breast Cancer
CAUSES,Breast Cyst,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast Cyst Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Retinoblastoma Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Retinoblastoma Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mannose Binding Lectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mannose Binding Lectin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Stanolone,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Stanolone Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,YBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,YBX1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ghrelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ghrelin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ovarian Cysts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ovarian Cysts Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adaptor Signaling Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Adaptor Signaling Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor alpha|EREG|ESR1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha|EREG|ESR1 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Fertility Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Fertility Agents Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Thrombospondins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Thrombospondins Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Catecholamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catecholamines Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oxytocinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxytocinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Apolipoprotein E|APOE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein E|APOE Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isoflavones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to puberty,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Encounter due to puberty Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CXCL12 gene|CXCL12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL12 gene|CXCL12 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PLAT gene|PLAT,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PLAT gene|PLAT Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TSPYL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TSPYL5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SIPA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SIPA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PPAR gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPAR gamma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Operative Surgical Procedures,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Operative Surgical Procedures Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CXCR4 gene|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Vitamin E,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Food,Vitamin E Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Walking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Walking Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABCC11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABCC11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXCL12 gene|CXCL12,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL12 gene|CXCL12 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Primary Prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Primary Prevention Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Antibodies, Anti-Idiotypic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,SHFM1 gene|SEM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHFM1 gene|SEM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thrombolytic Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thrombolytic Therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,14q24.1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,14q24.1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NRP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MTNR1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTNR1A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"PSMD10 protein, human|PSMD10",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PSMD10 protein, human|PSMD10 Breast cancer metastatic",Female Breast Cancer
PREDISPOSES,MTNR1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTNR1B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Receptors, Progesterone|PGR",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Breast cancer invasive NOS",Female Breast Cancer
PREDISPOSES,Titanium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Titanium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gastric Adenocarcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gastric Adenocarcinoma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,mTOR Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mTOR Inhibitor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Clonal Expansion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Clonal Expansion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Acetyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetyltransferase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metformin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADH1B gene|ADH1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADH1B gene|ADH1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SULT1A1|SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SULT1A1|SULT1A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Potato,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Potato Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast tenderness,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Breast tenderness Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,TNFSF11 gene|TNFSF11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TNFSF11 gene|TNFSF11 Breast cancer metastatic,Female Breast Cancer
CAUSES,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transfection,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Transfection Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Autoimmune thyroiditis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Autoimmune thyroiditis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,OPN1LW|CRCP|RAB11FIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OPN1LW|CRCP|RAB11FIP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,K-ras Oncogene|KRAS,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Ductal Breast Carcinoma,Female Breast Cancer
CAUSES,Carcinogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gene polymorphism,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,gene polymorphism Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PREDICTED,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,PREDICTED Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Interleukin-15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-15 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NEK8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NEK8 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cigarette smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cigarette smoke Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Sulfatases|ARSH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sulfatases|ARSH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,estrogen receptor gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",estrogen receptor gamma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PALB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Single Nucleotide Polymorphism,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Breast cancer invasive NOS,Female Breast Cancer
CAUSES,TRANCE protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KL gene|KL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KL gene|KL Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCDC88A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCDC88A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Retinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Retinoids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogen Receptors|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Agent,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Agent Breast cancer metastatic,Female Breast Cancer
DISRUPTS,"Fatty Acids, Omega-6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-6 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,SP1 gene|SP1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SP1 gene|SP1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,G-Protein-Coupled Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Diabetes Mellitus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diabetes Mellitus Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1A1 gene|CYP1A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Somatomedins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Somatomedins Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Hypermethylation,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Hypermethylation Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Phototherapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Phototherapy Breast Carcinoma,Female Breast Cancer
AUGMENTS,Granulocyte Colony-Stimulating Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Granulocyte Colony-Stimulating Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Breast Carcinoma",Female Breast Cancer
AUGMENTS,IL8 gene|CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL8 gene|CXCL8 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,UTS2R|SLC14A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UTS2R|SLC14A2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANP32B gene|ANP32B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANP32B gene|ANP32B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Compete,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Compete Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Magnesium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Magnesium Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Calgranulin A|S100A8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calgranulin A|S100A8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytochrome P450,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P450 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERR1 protein|ESRRA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ERR1 protein|ESRRA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ETV4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ETV4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Bone Morphogenetic Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Bone Morphogenetic Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"PTH protein, human|PTH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTH protein, human|PTH Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Minisatellite Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Minisatellite Repeats Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Anabolic steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Anabolic steroids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PPAR gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPAR gamma Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NOTCH4 gene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NOTCH4 gene Breast Carcinoma,Female Breast Cancer
AUGMENTS,S100A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Growth retardation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Growth retardation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1A1 gene|CYP1A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Niacin intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Niacin intake Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SIX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SIX1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Arrestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Arrestins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BACH1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,BACH1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,chromosome decondensation factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",chromosome decondensation factors Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PHB2|SIL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PHB2|SIL1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Advance,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Advance Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VEGFA Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MAPK14 gene|MAPK14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK14 gene|MAPK14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Protein Isoforms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Isoforms Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DNA Adducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Adducts Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLX4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tetradecanoylphorbol Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Tetradecanoylphorbol Acetate Breast Carcinoma,Female Breast Cancer
PREDISPOSES,amsonic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,amsonic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcoholic Liver Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Alcoholic Liver Diseases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AKT1 gene|AKT1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,AKT1 gene|AKT1 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Catechol O-Methyltransferase|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catechol O-Methyltransferase|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MRE11,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,MRE11 Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,protein-tyrosine kinase c-src|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein-tyrosine kinase c-src|SRC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,vasodilator-stimulated phosphoprotein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",vasodilator-stimulated phosphoprotein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,hesperetin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,hesperetin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,BRIP1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,BRIP1 Carcinoma of Male Breast,Male Breast Cancer
AUGMENTS,ING5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ING5 Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Angioendotheliomatosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angioendotheliomatosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phosphatidylethanolamine Binding Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphatidylethanolamine Binding Protein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Aromatase Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Aromatase Inhibitors Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Pharmaceutical Preparations,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"2,3-bis(3'-hydroxybenzyl)butyrolactone Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BCL6 gene|BCL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6 gene|BCL6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Paclitaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Paclitaxel Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,RPRD1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RPRD1B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,XPO5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,XPO5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Therapeutic procedure,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Therapeutic procedure Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,Natural menopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Natural menopause Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MYC gene|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC gene|MYC Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,sphingosine kinase-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sphingosine kinase-1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,KLF9 gene|KLF9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KLF9 gene|KLF9 Breast cancer metastatic,Female Breast Cancer
AFFECTS,NKD1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"NKD1 Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Hyperbaric Oxygenation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hyperbaric Oxygenation Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,USP21 gene|USP21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USP21 gene|USP21 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hexachlorobenzene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Hexachlorobenzene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CRHBP gene|CRHBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CRHBP gene|CRHBP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Myeloid Leukemia, Chronic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Myeloid Leukemia, Chronic Malignant neoplasm of breast",Female Breast Cancer
CAUSES,ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERBB2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,benzyl isothiocyanate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,benzyl isothiocyanate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Oxides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ABCB10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABCB10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SMAD3 gene|SMAD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD3 gene|SMAD3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACSTD2 protein, human|TACSTD2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,"20-hydroxy-5,8,11,14-eicosatetraenoic acid",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,"20-hydroxy-5,8,11,14-eicosatetraenoic acid Breast cancer metastatic",Female Breast Cancer
AFFECTS,shikonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,shikonin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KLF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLF4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,fucoidan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fucoidan Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PROTEIN KINASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,letrozole,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacologic Substance,letrozole Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Cyclin E,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Cyclin E Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,"Lupus Erythematosus, Systemic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Lupus Erythematosus, Systemic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA1 gene|BRCA1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Lipogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Lipogenesis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant meningitis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant meningitis Breast Carcinoma,Female Breast Cancer
AFFECTS,Folic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NBAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NBAT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Promoter Regions (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Promoter Regions (Genetics) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SULF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SULF2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Acids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,arctigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arctigenin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,xanthohumol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,xanthohumol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interstitial Collagenase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Interstitial Collagenase Breast cancer metastatic,Female Breast Cancer
DISRUPTS,BVES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BVES Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,POU5F1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,POU5F1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MSI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MSI2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANXA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ANXA3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,curcumol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,curcumol Breast cancer metastatic,Female Breast Cancer
AFFECTS,iron ion homeostasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",iron ion homeostasis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oxygen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oxygen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transferrin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Transferrin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Phosphotransferases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Phosphotransferases Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,pomegranate juice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pomegranate juice Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LRRC3B gene|LRRC3B,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,LRRC3B gene|LRRC3B Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,MET gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MET gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,YAP1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,YAP1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ITGB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ITGB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,discoidin domain receptor 2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,discoidin domain receptor 2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,protein tyrosine phosphatase 1B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein tyrosine phosphatase 1B Breast cancer metastatic,Female Breast Cancer
AFFECTS,Heat Shock Protein 27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat Shock Protein 27 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Complement 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Complement 3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,HVCN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HVCN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IGKV6D-21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IGKV6D-21 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fertility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fertility Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cell invasion,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","cell invasion Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Tenascin|TNC,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Tenascin|TNC Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Heightened perception,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Heightened perception Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,C1GALT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,C1GALT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bone remodeling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bone remodeling Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,caveolin 1|CA5A|CAV2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caveolin 1|CA5A|CAV2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Functional RNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant tumor of colon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant tumor of colon Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PGR gene|PGR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PGR gene|PGR Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Serotonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Serotonin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANG gene|ANG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ANG gene|ANG Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CALCA gene|CALCA,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,CALCA gene|CALCA Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Lactate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Lactate Breast cancer metastatic,Female Breast Cancer
AFFECTS,Agent,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Agent Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Diabetes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Diabetes Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,bakuchiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,bakuchiol Breast cancer metastatic,Female Breast Cancer
AFFECTS,Dyslipidemias,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Dyslipidemias Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TFF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TFF3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,pregnane X receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pregnane X receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm Metastasis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,OGG1 gene|OGG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OGG1 gene|OGG1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MT2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MT2A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endocrine therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Endocrine therapy Breast cancer metastatic,Female Breast Cancer
AFFECTS,isoalantolactone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,isoalantolactone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LEF1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,LEF1 Breast cancer metastatic,Female Breast Cancer
CAUSES,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Raloxifene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HIST2H2AC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HIST2H2AC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epithelial antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Epithelial antibody Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"BCAR1 protein, human|BCAR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BCAR1 protein, human|BCAR1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Fluoxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fluoxetine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,sinomenine hydrochloride,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,sinomenine hydrochloride Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Interleukin-17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-17 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TARDBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TARDBP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin B6 intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B6 intake Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fibroblast Growth Factor Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptors Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|ESR2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,exemestane,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,exemestane Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Adenocarcinoma of esophagus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenocarcinoma of esophagus Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADAM33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADAM33 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Pharmacotherapy Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Homologous Recombination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Homologous Recombination Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Breast cancer metastatic,Female Breast Cancer
CAUSES,TP53 gene|TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,hepatocellular carcinoma protein 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",hepatocellular carcinoma protein 1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HOTAIR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VTCN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VTCN1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RELN gene|RELN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RELN gene|RELN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Urine protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Urine protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FCRL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FCRL3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast cancer metastatic,Female Breast Cancer
AUGMENTS,PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Interleukin-1 beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-1 beta Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Antibodies, Anti-Idiotypic",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,"Antibodies, Anti-Idiotypic Breast cancer metastatic",Female Breast Cancer
AUGMENTS,Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzymes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,intervention program,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",intervention program Familial cancer of breast,Female Breast Cancer
DISRUPTS,PTEN gene|PTEN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SHARPIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SHARPIN Malignant neoplasm of breast,Female Breast Cancer
CAUSES,methyl 4-azidophenylacetimidate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methyl 4-azidophenylacetimidate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Total estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Total estrogens Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PGR gene|PGR,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,PGR gene|PGR Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Polycomb,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Polycomb Breast Carcinoma,Female Breast Cancer
DISRUPTS,S1PR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S1PR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SP7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SP7 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,CD44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD44 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCL20 gene|CCL20,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCL20 gene|CCL20 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ITK gene|ITK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ITK gene|ITK Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RNU4-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RNU4-2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,meleagrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,meleagrin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Brown rice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Brown rice Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AR gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AR gene|AR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphoric Monoester Hydrolases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD29 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD29 Antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Forkhead Transcription Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Forkhead Transcription Factors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Transcriptase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transcriptase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Receptors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast Carcinoma,Female Breast Cancer
AFFECTS,salinomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,salinomycin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANKLE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ANKLE1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,skills,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,skills Familial cancer of breast,Female Breast Cancer
AUGMENTS,sigma-1 receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sigma-1 receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MAPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAPT Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Orthologous Gene,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,Orthologous Gene Female Breast Carcinoma,Female Breast Cancer
CAUSES,Polysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polysaccharides Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TGFBR1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,TGFBR1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,NBS1 gene|NBN|NLRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NBS1 gene|NBN|NLRP2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Apoptosis Inhibiting Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Inhibiting Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,sphingosine kinase-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sphingosine kinase-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ischemia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Ischemia Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,S100A4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,S100A4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Cervix carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cervix carcinoma Breast Carcinoma,Female Breast Cancer
AFFECTS,Stem cell transplant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stem cell transplant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,progesterone receptor negative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone receptor negative Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Soybean preparation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Soybean preparation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BRD7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Therapeutic procedure Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,CDC42 gene|CDC42,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC42 gene|CDC42 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Multiple malignancy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Multiple malignancy Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,SENP2 gene|SENP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SENP2 gene|SENP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SUCLA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SUCLA2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplasm,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Neoplasm Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,CDCA7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDCA7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,diallyl disulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,diallyl disulfide Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Relaxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Relaxin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GEN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GEN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,4-chlorophenyl methyl sulfide,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,4-chlorophenyl methyl sulfide Contralateral breast cancer,Female Breast Cancer
CAUSES,H2AFX gene|H2AFX,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,H2AFX gene|H2AFX Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,CDH1 gene|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH1 gene|CDH1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Difficulty sleeping,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Difficulty sleeping Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PRI-2191,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PRI-2191 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Collagen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Collagen Breast Carcinoma,Female Breast Cancer
AUGMENTS,CXCR4 gene|CXCR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Toremifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Toremifene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MSH6 gene|MSH6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MSH6 gene|MSH6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCND2 gene|CCND2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND2 gene|CCND2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GLS gene|GLS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLS gene|GLS Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Dietary Component,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Component Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-1 beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-1 beta Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Isoprostanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isoprostanes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TXNIP gene|TXNIP,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,TXNIP gene|TXNIP Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,WWC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWC1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,phenidone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,phenidone Breast Carcinoma,Female Breast Cancer
DISRUPTS,MALAT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,MALAT1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,fibulin-3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,fibulin-3 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Chitosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chitosan Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MAPK8 gene|MAPK8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK8 gene|MAPK8 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ZEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZEB1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"PER2 protein, mammalian",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Breast Carcinoma",Female Breast Cancer
CAUSES,"RNA, Satellite",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Satellite Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,LGALSL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LGALSL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,aloperine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aloperine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CD80 gene|CD80,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD80 gene|CD80 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein Precursors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Precursors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydrogels,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydrogels Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB2 gene|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Adverse effects,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Adverse effects Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Estradiol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Estradiol Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Test Result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Test Result Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TAZ gene|TAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAZ gene|TAZ Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cancer cachexia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer cachexia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibrosis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Fibrosis Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Membrane receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Membrane receptor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Glycine Hydroxymethyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glycine Hydroxymethyltransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta catenin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Luteolin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Luteolin Breast cancer metastatic,Female Breast Cancer
AUGMENTS,TLN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TLN2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Gelatinase B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Gelatinase B Breast cancer metastatic,Female Breast Cancer
AFFECTS,disease stage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,disease stage Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,midkine|MDK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,midkine|MDK Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pregnane X receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pregnane X receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cigarette Smoking,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Cigarette Smoking Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,BITTER MELON,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BITTER MELON Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BCAR3 gene|BCAR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAR3 gene|BCAR3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,crystalloid,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,crystalloid Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,genetic locus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic locus Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHI3L2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,CHI3L2 Breast cancer invasive NOS,Female Breast Cancer
CAUSES,3MC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,3MC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AR gene|AR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,AR gene|AR Breast cancer metastatic,Female Breast Cancer
AUGMENTS,FGFR2 gene|FGFR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR2 gene|FGFR2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TMEM25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TMEM25 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLK10 gene|KLK10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLK10 gene|KLK10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD247,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD247 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,YAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,YAP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oncogene Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MLL gene|KMT2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLL gene|KMT2A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDH1 gene|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH1 gene|CDH1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antineoplastic Agents,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Breast Carcinoma,Female Breast Cancer
AFFECTS,TP53 gene|TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast Carcinoma,Female Breast Cancer
AFFECTS,Cyclin D1|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1|CCND1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Axillary Lymph Node Involvement,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Axillary Lymph Node Involvement Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,"TNF protein, human|TNF",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Breast Carcinoma",Female Breast Cancer
AFFECTS,Mutation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Breast Carcinoma,Female Breast Cancer
AFFECTS,CATHEPSIN D|CTSD,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,CATHEPSIN D|CTSD Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Skim milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Skim milk Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Lipids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Epidermal Growth Factor Receptor|EGFR,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,Dissection,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Dissection Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Symptoms,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Symptoms Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Atypical lobular hyperplasia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Atypical lobular hyperplasia Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Hexachlorobenzene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Hexachlorobenzene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,personal responsibility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,personal responsibility Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,beta-hexachlorocyclohexane,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,beta-hexachlorocyclohexane Breast Carcinoma,Female Breast Cancer
AFFECTS,Growth,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Growth Breast Carcinoma,Female Breast Cancer
AFFECTS,receptor expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",receptor expression Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Generalized obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Generalized obesity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RHCE|FIP1L1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,RHCE|FIP1L1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Ischemic stroke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ischemic stroke Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Malignant disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant disease Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Tamoxifen,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,CD27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD27 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SALL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SALL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cathepsin K|CTSK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cathepsin K|CTSK Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,paxillin|PXN,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,paxillin|PXN Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Metformin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Metformin Breast Carcinoma,Female Breast Cancer
AFFECTS,CTHRC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTHRC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CTHRC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CTHRC1 Breast cancer metastatic,Female Breast Cancer
CAUSES,Hydroxyl Radical,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Hydroxyl Radical Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,DDT (Insecticide),Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Invertebrate,DDT (Insecticide) Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Medication use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Medication use Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Depo-Provera,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Depo-Provera Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Composition,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Composition Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Ductal Breast Hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ductal Breast Hyperplasia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,prednisolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prednisolone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,5-hydroxymethyl-2'-deoxyuridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,5-hydroxymethyl-2'-deoxyuridine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diabetic Retinopathy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diabetic Retinopathy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,APC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Depressive disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Depressive disorder Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SYK gene|SYK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYK gene|SYK Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DHFR gene|DHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DHFR gene|DHFR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERBB2|NEU1|NEURL1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,IGF1 gene|IGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1 gene|IGF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Aspirin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Aspirin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Dairy Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dairy Products Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Maternal status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Maternal status Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PAX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PAX2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vascular Endothelial Growth Factor Receptor-1|FLT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-1|FLT1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Paclitaxel,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Paclitaxel Breast Carcinoma,Female Breast Cancer
PREDISPOSES,OR10J3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OR10J3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IRS2 gene|IRS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRS2 gene|IRS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fine needle aspiration biopsy,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Fine needle aspiration biopsy Carcinoma of Male Breast,Female Breast Cancer
PREDISPOSES,ERBB2 gene|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Therapeutic regimen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Therapeutic regimen Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP1B1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Allelic Imbalance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Allelic Imbalance Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Soy Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Soy Foods Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,2-hydroxyestrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2-hydroxyestrone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MTHFR gene|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTHFR gene|MTHFR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Early Diagnosis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Early Diagnosis Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Lobular Neoplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lobular Neoplasia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ultrasonography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Ultrasonography Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,small molecule,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,small molecule Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Noscapine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Noscapine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S100A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VEGFA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,response,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,response Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,SLCO1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLCO1B1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD40 gene|CD40,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CD40 gene|CD40 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Acquired Immunodeficiency Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Acquired Immunodeficiency Syndrome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Systemic Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Systemic Therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KISS1 gene|KISS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KISS1 gene|KISS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,osteopontin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,osteopontin Breast cancer metastatic,Female Breast Cancer
CAUSES,Zeranol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Zeranol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF365,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF365 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Leg length,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leg length Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Worried,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Worried Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Calgranulin B|S100A9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Calgranulin B|S100A9 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,CCNE1 gene|CCNE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNE1 gene|CCNE1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Suppressor Genes,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,Tumor Suppressor Genes Carcinoma of Male Breast,Male Breast Cancer
CAUSES,Progesterone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Progesterone Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MIRN27A gene|MIR27A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN27A gene|MIR27A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,B3GNT2|B3GNTL1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,B3GNT2|B3GNTL1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,coping resources,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,coping resources Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DDX5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DDX5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aberrant DNA Methylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aberrant DNA Methylation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,aldehyde dehydrogenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"ribosomal protein S6 kinase, 70kD, polypeptide 2|RPS6KB2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ribosomal protein S6 kinase, 70kD, polypeptide 2|RPS6KB2 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,S100A9 gene|S100A9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A9 gene|S100A9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ORAI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ORAI1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,XRCC3 gene|XRCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Creatinine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Creatinine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Speech reception threshold,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Speech reception threshold Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interleukin-17,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Interleukin-17 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,osteopontin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,osteopontin Breast cancer metastatic,Female Breast Cancer
AFFECTS,Therapeutic procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Therapeutic procedure Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,SOD2 gene|SOD2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,SOD2 gene|SOD2 Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Metaplastic Breast Carcinoma,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Metaplastic Breast Carcinoma Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Testosterone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Testosterone Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Free Radicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Free Radicals Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Berberine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Berberine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Squamous cell carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Squamous cell carcinoma Breast Carcinoma,Female Breast Cancer
DISRUPTS,AG 14361,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AG 14361 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Functional disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional disorder Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Amenorrhea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Amenorrhea Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Biological function, NOS",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Biological function, NOS Breast cancer metastatic",Female Breast Cancer
PREDISPOSES,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Fluoxetine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Fluoxetine Breast cancer metastatic,Female Breast Cancer
AFFECTS,SMARCE1 gene|SMARCE1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMARCE1 gene|SMARCE1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,PTEN gene|PTEN,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"PTEN gene|PTEN Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,GSTT1 protein|SLC25A4|CD5|IL1RL1|TRAPPC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GSTT1 protein|SLC25A4|CD5|IL1RL1|TRAPPC9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GSTT1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GSTT1 protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oral form estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oral form estradiol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microinvasive carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Microinvasive carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,"Diabetes Mellitus, Non-Insulin-Dependent Female Breast Carcinoma",Female Breast Cancer
CAUSES,beta Sitosterol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,beta Sitosterol Breast Carcinoma,Female Breast Cancer
DISRUPTS,Pharmaceutical Preparations,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Estradiol acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estradiol acetate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell fusion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell fusion Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KDM3A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM3A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,May-Hegglin anomaly,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,May-Hegglin anomaly Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Invasive Malignant Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Invasive Malignant Neoplasm Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MMP9 gene|MMP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP9 gene|MMP9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,trastuzumab,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Pharmacologic Substance,trastuzumab Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,crocin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,crocin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PGR gene|PGR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PGR gene|PGR Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Rare Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Rare Diseases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PGRMC1 gene|PGRMC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGRMC1 gene|PGRMC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,meningioma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,meningioma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Deferoxamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Deferoxamine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Bread,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bread Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Rifabutin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rifabutin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Supplementation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Supplementation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Diabetes Mellitus, Insulin-Dependent",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diabetes Mellitus, Insulin-Dependent Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Alcohol consumption,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,XIST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,XIST Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glucocorticoids,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Glucocorticoids Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,RNASEL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNASEL Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Arsenic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,oncostatin M|OSM,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,oncostatin M|OSM Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Not significant,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Not significant Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,"Metals, Heavy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Carcinogens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Breast cancer metastatic,Female Breast Cancer
AFFECTS,MIRN223 gene|MIR223,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN223 gene|MIR223 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERBB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TERT gene|TERT,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TERT gene|TERT Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Prophylactic immunotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Prophylactic immunotherapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TP53 gene|TP53,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,RNA I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA I Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fertility problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fertility problem Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HTATIP2 gene|HTATIP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HTATIP2 gene|HTATIP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL10 gene|IL10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL10 gene|IL10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cyclooxygenase 2|XK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2|XK Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,S-Adenosylmethionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S-Adenosylmethionine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyperparathyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperparathyroidism Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,household cleaner,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,household cleaner Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Behavior,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Behavior Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,LUM gene|LUM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LUM gene|LUM Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Extravasation of lymph,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extravasation of lymph Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CAV1 gene|CAV1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAV1 gene|CAV1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast surgery,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast surgery Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PRKDC gene|PRKDC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRKDC gene|PRKDC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ethanol Metabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethanol Metabolism Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABCB1 gene|ABCB1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ABCB1 gene|ABCB1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,BAX gene|BAX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BAX gene|BAX Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,acadesine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,acadesine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIRN21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN21 gene|MIR21 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclooxygenase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NR4A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NR4A2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcohol interaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol interaction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Insulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Angiography, Digital Subtraction",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope","Angiography, Digital Subtraction Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
PREDISPOSES,Malaise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Malaise Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDK2AP1 gene|CDK2AP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK2AP1 gene|CDK2AP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD28 gene|CD28,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CD28 gene|CD28 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Disease Outcome,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Disease or Syndrome,"Disease Outcome Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Primary tumor size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Primary tumor size Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Genes,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"Genes Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,S100A9 gene|S100A9,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,S100A9 gene|S100A9 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,breast cancer prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,breast cancer prevention Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SPSB1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,SPSB1 Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,TNFRSF1B gene|TNFRSF1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF1B gene|TNFRSF1B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inflammatory Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Inflammatory Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC2A1 gene|SLC2A1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cytochrome P450,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P450 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fertilization in Vitro,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fertilization in Vitro Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ligands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ligands Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cookie and/or cracker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cookie and/or cracker Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Heregulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heregulin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Kininogenase|KLK4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Kininogenase|KLK4 Breast Carcinoma,Female Breast Cancer
AFFECTS,"TERT protein, human|TERT",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TERT protein, human|TERT Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Conjugated Equine Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Conjugated Equine Estrogens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Uterine hemorrhage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Uterine hemorrhage Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,steroid sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,steroid sulfate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Clinical Protocols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Clinical Protocols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Beef,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beef Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RNA Interference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Interference Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Saponins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Saponins Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,glutathione S-transferase M1|CHRM1|MRLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase M1|CHRM1|MRLN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Saponins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Saponins Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Maximum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Maximum Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,versican|VCAN,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,versican|VCAN Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Regional Disease,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Regional Disease Breast cancer metastatic,Female Breast Cancer
AFFECTS,Glucocorticoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucocorticoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Unreported,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Unreported Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Total cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Total cholesterol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Chlorogenic Acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Chlorogenic Acid Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,SGCB|APOBEC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SGCB|APOBEC3B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AANAT gene|AANAT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AANAT gene|AANAT Malignant neoplasm of breast,Female Breast Cancer
CAUSES,4-hydroxy-2-nonenal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,4-hydroxy-2-nonenal Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Contraceptives, Oral Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,CD2 gene|CD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD2 gene|CD2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PROCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PROCR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SELPLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SELPLG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic breast density,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Mammographic breast density Contralateral breast cancer,Female Breast Cancer
AUGMENTS,TIAM1 gene|TIAM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIAM1 gene|TIAM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Examination of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Examination of breast Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Detection,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Detection Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,CDKN1C gene|CDKN1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1C gene|CDKN1C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,8-oxo-7-hydrodeoxyguanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,8-oxo-7-hydrodeoxyguanosine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carboplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carboplatin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chemoprevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chemoprevention Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DAND5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,DAND5 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Cosmic Radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cosmic Radiation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,loss; bone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,loss; bone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,lobaplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lobaplatin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Peptide Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptide Hydrolases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,zoledronic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,zoledronic acid Breast cancer metastatic,Female Breast Cancer
DISRUPTS,DMBT1 gene|DMBT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DMBT1 gene|DMBT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,arginylarginine|ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arginylarginine|ABL2|RERE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Female Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Female Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ABCG2 gene|ABCG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCG2 gene|ABCG2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adaptation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adaptation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Toll-like receptor 9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Toll-like receptor 9 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1R gene|IGF1R Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adenocarcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenocarcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Neoplasm Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,Atypical lobular hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atypical lobular hyperplasia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,kinase inhibitor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AR gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AR gene|AR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Not significant,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Not significant Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Hemoglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hemoglobin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Propranolol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Propranolol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cosmetic surgery,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Cosmetic surgery Familial cancer of breast,Female Breast Cancer
AFFECTS,Paget's Disease,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Disease or Syndrome,"Paget's Disease Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,NF-kappa B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,NF-kappa B Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,MIRN107 gene|MIR107,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN107 gene|MIR107 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Thioctic Acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Thioctic Acid Breast cancer metastatic,Female Breast Cancer
AFFECTS,Mammaplasty,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mammaplasty Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fat graft,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Fat graft Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Regulatory Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Regulatory Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"ESR1 protein, human|ESR1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR1 protein, human|ESR1 Breast Carcinoma",Female Breast Cancer
DISRUPTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Initiative - finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Initiative - finding Malignant neoplasm of breast,Female Breast Cancer
CAUSES,tumor growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tumor growth Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Iron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iron Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Calcium Channel Blockers,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Calcium Channel Blockers Breast Carcinoma,Female Breast Cancer
AFFECTS,Adverse effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adverse effects Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,autoimmune thyroid disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,autoimmune thyroid disease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Injectables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Injectables Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proto-Oncogenes|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Proto-Oncogenes|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor necrosis factor receptor 11b Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Local Anesthetics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Local Anesthetics Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thymine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Thymine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Puberty,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Puberty Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Tumor Markers,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Markers Breast cancer metastatic,Female Breast Cancer
AFFECTS,"Absorptiometry, Photon",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Absorptiometry, Photon Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Osteocalcin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Osteocalcin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Alendronate,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Alendronate Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,KDM4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM4A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phthalate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TINCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TINCR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KRT19 gene|KRT19,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,KRT19 gene|KRT19 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,DDT EXPOSURE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DDT EXPOSURE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Benzanthracenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benzanthracenes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vimentin|VIM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vimentin|VIM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PIK3CA|PIK3CB|PIK3CD|PIK3CG Breast cancer metastatic,Female Breast Cancer
CAUSES,Latent Virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Latent Virus Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant neoplasm of breast,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast Carcinoma,Female Breast Cancer
AUGMENTS,phospholipase C beta2|NEUROD1|TUBB4B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,phospholipase C beta2|NEUROD1|TUBB4B Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Folic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Steroid hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroid hormone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EVI1 gene|RUNX1|MECOM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EVI1 gene|RUNX1|MECOM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATG9A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ATG9A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MUTYH,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,MUTYH Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Periodontal Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Periodontal Diseases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,K-ras Oncogene|KRAS,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"K-ras Oncogene|KRAS Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Morphine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Morphine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00339,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00339 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MKNK1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,MKNK1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,nicotinamide phosphoribosyltransferase|NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,nicotinamide phosphoribosyltransferase|NAMPT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Induction,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Induction Breast cancer metastatic,Female Breast Cancer
DISRUPTS,VEGFA,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,VEGFA Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Little's Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Little's Disease Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HOXA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fluphenazine Hydrochloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fluphenazine Hydrochloride Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen receptor negative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor negative Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Naloxone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Naloxone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Glucosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucosides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FOXP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXP4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antibodies Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FOXP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXP4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNORA7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNORA7B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnesium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Magnesium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CASC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CASC9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fatty acid glycerol esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty acid glycerol esters Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Infiltration,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Small Inducible Cytokine A18|CCL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Small Inducible Cytokine A18|CCL18 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,beta catenin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,beta catenin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,LINC01857,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC01857 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tissue Model,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Tissue Model Breast cancer metastatic,Female Breast Cancer
AFFECTS,Schizophrenia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Schizophrenia Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antisense RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Antisense RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CASC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CASC9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,glycogen synthase kinase 3 beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,glycogen synthase kinase 3 beta Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NR0B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NR0B1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,schisandrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,schisandrin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Antigens, Fos-Related|FOS",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"Antigens, Fos-Related|FOS Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Treatment Protocols,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Treatment Protocols Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,RFP2 gene|TRIM13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RFP2 gene|TRIM13 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Green Fluorescent Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Green Fluorescent Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FSIP1 gene|FSIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FSIP1 gene|FSIP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SIRT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SIRT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,racial differences,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,racial differences Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,COPB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,COPB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Binding Sites,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Binding Sites Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,tropomyosin-4|TPM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tropomyosin-4|TPM4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KDM1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM1A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Steroid 17-alpha-monooxygenase|CYP17A1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Steroid 17-alpha-monooxygenase|CYP17A1 Carcinoma of Male Breast,Female Breast Cancer
PREDISPOSES,Estrogen receptor positive,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor positive Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,saikosaponin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,saikosaponin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of lung Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RHPN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RHPN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chronic inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chronic inflammation Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00460,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00460 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,UBE2D2 gene|UBE2D2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2D2 gene|UBE2D2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RASSF1A|RASSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RASSF1A|RASSF1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TGFB1 gene|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TGFB1 gene|TGFB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP24A1 gene|CYP24A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP24A1 gene|CYP24A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SATB1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SATB1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ENOLASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ENOLASE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ACSF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ACSF3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Red Meat Consumption,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Red Meat Consumption Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,E2F1 gene|E2F1|UBE2L3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"Estrogens, Conjugated (USP)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Conjugated (USP) Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,NCK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NCK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Matrix Metalloproteinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ENO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ENO1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CUL5 gene|CUL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CUL5 gene|CUL5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BODY HEIGHT:LENGTH:POINT IN TIME:^PATIENT:QUANTITATIVE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BODY HEIGHT:LENGTH:POINT IN TIME:^PATIENT:QUANTITATIVE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Apocrine adenocarcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Apocrine adenocarcinoma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FOSL1 gene|FOSL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOSL1 gene|FOSL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,mastitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mastitis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ribosomal RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Ribosomal RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCB 153,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 153 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STIM2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,STIM2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,NBEAL1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,NBEAL1 Familial cancer of breast,Female Breast Cancer
AUGMENTS,PCB 153,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 153 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,acetylacetone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,acetylacetone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,betulinic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,betulinic acid Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CYP24A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP24A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADCY4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADCY4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AZIN2|GADL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AZIN2|GADL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCB 118,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 118 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,11-beta-Hydroxysteroid Dehydrogenase Type 2|HSD11B2|RNU1-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",11-beta-Hydroxysteroid Dehydrogenase Type 2|HSD11B2|RNU1-4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Implantation procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Implantation procedure Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,caspase-8|CASP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caspase-8|CASP8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Electromagnetic Energy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Electromagnetic Energy Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,PALB2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,PALB2 Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Polycystic Ovary Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Polycystic Ovary Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neuropathy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neuropathy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GTPase-Activating Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GTPase-Activating Proteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,C11orf74|C17orf49,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,C11orf74|C17orf49 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Biological Markers estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,ATP8A2 gene|ATP8A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ATP8A2 gene|ATP8A2 Breast cancer metastatic,Female Breast Cancer
CAUSES,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,regulatory loop,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,regulatory loop Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Enrich (product),Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Enrich (product) Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,CGRRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CGRRF1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,estrogens,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,estrogens estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,GTPase-Activating Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GTPase-Activating Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor-Associated Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor-Associated Process Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PPAR gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPAR gamma Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NAMPT Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PRDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRDM2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,Thrombospondin 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Thrombospondin 1 Breast cancer metastatic,Female Breast Cancer
CAUSES,MIR223 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR223 wt Allele Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Hepatolenticular Degeneration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Hepatolenticular Degeneration Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nuclear Receptor Coactivator 3|NCOA3|ANIB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nuclear Receptor Coactivator 3|NCOA3|ANIB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MAP2K4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAP2K4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LHX1 gene|LHX1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,LHX1 gene|LHX1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,blood test result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,blood test result Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MIR195 gene|MIR195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR195 gene|MIR195 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,quinoline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,quinoline Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Deoxyuridine,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Deoxyuridine HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,High Confidence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,High Confidence Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UGT2B7 gene|UGT2B7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UGT2B7 gene|UGT2B7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Biological Markers Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,LINC02657 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC02657 gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ZEB1-AS1 gene|ZEB1-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZEB1-AS1 gene|ZEB1-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,thrombin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,thrombin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,prasterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prasterone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Substance with phenol structure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Substance with phenol structure Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,thymoquinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thymoquinone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cyclin D1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cyclin D1 Breast Carcinoma,Female Breast Cancer
AUGMENTS,"TFF1 protein, human|TFF1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF1 protein, human|TFF1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,SETD3 gene|SETD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SETD3 gene|SETD3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Biological Markers Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,melatonin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnostic Imaging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Diagnostic Imaging Breast Carcinoma,Female Breast Cancer
CAUSES,GADD45A gene|GADD45A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GADD45A gene|GADD45A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LSR gene|LSR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LSR gene|LSR Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,27-hydroxycholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,27-hydroxycholesterol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Accumulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Accumulation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Radiopharmaceuticals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Radiopharmaceuticals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prognosis bad,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Prognosis bad Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,DNA Minor Groove Binding Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Minor Groove Binding Agent Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Sex Hormone-Binding Globulin,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,GSTT1 gene|GSTT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTT1 gene|GSTT1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,mullerian-inhibiting hormone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NOP2 gene|NOP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOP2 gene|NOP2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,E2F3 gene|E2F3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F3 gene|E2F3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gamma-linolenic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,gamma-linolenic acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Adriamycin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Adriamycin HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,PLSCR1 gene|PLSCR1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,PLSCR1 gene|PLSCR1 Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,glutathione S-transferase pi|GSTP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase pi|GSTP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Primigravida,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Primigravida Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,MIR454 gene|MIR454,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR454 gene|MIR454 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Binge Drinking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Binge Drinking Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Basaloid squamous cell carcinoma,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Neoplastic Process,Basaloid squamous cell carcinoma Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,apolipoprotein D|APOD,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein D|APOD Breast Carcinoma,Female Breast Cancer
PREDISPOSES,IGFBP7|SFPQ,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,IGFBP7|SFPQ estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,Small Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Small Molecule Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TXNIP gene|TXNIP,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TXNIP gene|TXNIP Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,platinum,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,platinum Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"EIF2C2 protein, human|AGO2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EIF2C2 protein, human|AGO2 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,pioglitazone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pioglitazone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,gonadorelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gonadorelin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A14 gene|S100A14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A14 gene|S100A14 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,LINC00261 gene|LINC00261,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00261 gene|LINC00261 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Methyl-CpG-Binding Protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Methyl-CpG-Binding Protein 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CTHRC1 gene|CTHRC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTHRC1 gene|CTHRC1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,rhein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,rhein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"POU5F1 protein, human|POU5F1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","POU5F1 protein, human|POU5F1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,MIR622 gene|MIR622,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIR622 gene|MIR622 Breast Carcinoma,Female Breast Cancer
AFFECTS,TFEB gene|TFEB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TFEB gene|TFEB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Profilin 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Profilin 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Aromatase,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Enzyme,Aromatase estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Hypersensitivity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Hypersensitivity Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,RB1CC1 gene|RB1CC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RB1CC1 gene|RB1CC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mitotic Activity,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Mitotic Activity Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,LMNB1,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,LMNB1 Luminal B Breast Carcinoma,Female Breast Cancer
CAUSES,ESM1 wt Allele,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ESM1 wt Allele Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cereal intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cereal intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,aggressive cancer,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,aggressive cancer Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,LOXL4 gene|LOXL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LOXL4 gene|LOXL4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Extensive Necrosis,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Other,Extensive Necrosis Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,quercetin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TMPO wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TMPO wt Allele Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"RNA, Messenger",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Inflammatory Breast Carcinoma",Female Breast Cancer
PREDISPOSES,MIR145 gene|MIR145,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR145 gene|MIR145 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HOPX gene|HOPX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOPX gene|HOPX Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,risk factors,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,risk factors Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,CD163,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD163 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neurosurgical Procedures,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Neurosurgical Procedures Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,LMNB1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,LMNB1 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,3-methylquercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,3-methylquercetin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TMED3 gene|TMED3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMED3 gene|TMED3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GPC1 gene|GPC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPC1 gene|GPC1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Transcript,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Transcript estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Industrial fungicide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Industrial fungicide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Factors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Biological Factors Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Negative,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Negative HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast malignant neoplasm of breast staging,Female Breast Cancer
AFFECTS,NEAT1 gene|NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEAT1 gene|NEAT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TAC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TAC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alleles,"Breast Cancer, Familial",0.0,Female Breast Cancer,Other,"Alleles Breast Cancer, Familial",Female Breast Cancer
AFFECTS,Negative Regulation of S Phase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Negative Regulation of S Phase Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SALL4 gene|SALL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SALL4 gene|SALL4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunoregulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immunoregulation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,IL31 gene|IL31,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,IL31 gene|IL31 Breast Carcinoma,Female Breast Cancer
AUGMENTS,fos-related antigen 1|FOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,fos-related antigen 1|FOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cyclophosphamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclophosphamide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SAMD4A gene|SAMD4A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SAMD4A gene|SAMD4A Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,WWOX wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWOX wt Allele Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Treatment modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Treatment modification Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SMAD7 gene|SMAD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD7 gene|SMAD7 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Residual Tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Residual Tumor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Low Density Lipoprotein Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Low Density Lipoprotein Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Illness (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Illness (finding) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,UGT1A1 gene|UGT1A1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,UGT1A1 gene|UGT1A1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SKA3 gene|SKA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SKA3 gene|SKA3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glucocorticoid Receptor,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Other,Glucocorticoid Receptor Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,Nucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nucleotides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HOMER1 gene|HOMER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOMER1 gene|HOMER1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Blood Proteins,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Blood Proteins malignant neoplasm of breast staging,Female Breast Cancer
PREDISPOSES,Hyperphagia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperphagia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypomethylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypomethylation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cytokine,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Biologically Active Substance,cytokine Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Synthetic glucocorticoid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Synthetic glucocorticoid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,fructose,Carcinoma breast stage IV,0.0,Female Breast Cancer,Carbohydrate,fructose Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,CYFIP1 gene|CYFIP1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CYFIP1 gene|CYFIP1 Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,HER2-negative breast cancer,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2-negative breast cancer Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,"GPER protein, human|GPER1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GPER protein, human|GPER1 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,Family history,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Family history Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Deubiquitinating Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Deubiquitinating Enzymes Malignant neoplasm of breast,Female Breast Cancer
CAUSES,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,doxorubicin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Family history,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Family history Breast Carcinoma,Female Breast Cancer
DISRUPTS,"CRYAB protein, human|CRYAB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CRYAB protein, human|CRYAB Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,"YAP1 protein, human|YAP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","YAP1 protein, human|YAP1 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,DSCC1 gene|DSCC1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,DSCC1 gene|DSCC1 Breast Carcinoma,Female Breast Cancer
DISRUPTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Benzo(a)pyrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benzo(a)pyrene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin-Dependent Kinase Inhibitor Proteins,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclin-Dependent Kinase Inhibitor Proteins HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,ATXN8OS gene|ATXN8OS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATXN8OS gene|ATXN8OS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,"Diabetes Mellitus, Non-Insulin-Dependent estrogen receptor-positive breast cancer",Female Breast Cancer
PREDISPOSES,CHPF gene|CHPF,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CHPF gene|CHPF Breast Carcinoma,Female Breast Cancer
AFFECTS,palbociclib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,palbociclib Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,epithelial to mesenchymal transition,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Breast Carcinoma,Female Breast Cancer
DISRUPTS,Aurora Kinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aurora Kinase A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC12A8 gene|SLC12A8,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC12A8 gene|SLC12A8 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Transferrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transferrin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Deodorants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Deodorants Malignant neoplasm of breast,Female Breast Cancer
CAUSES,beta catenin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,beta catenin Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alleles Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,thioguanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",thioguanine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Copy Number Polymorphism,"Breast Cancer, Familial",0.0,Female Breast Cancer,Other,"Copy Number Polymorphism Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,"Receptor, Transforming Growth Factor-beta Type I|TGFBR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"Receptor, Transforming Growth Factor-beta Type I|TGFBR1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,cadmium Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GOLPH3L gene|GOLPH3L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GOLPH3L gene|GOLPH3L Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cystathionine beta-Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cystathionine beta-Synthase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Color doppler ultrasound,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Color doppler ultrasound Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,KIF15 gene|KIF15,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KIF15 gene|KIF15 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,osthol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,osthol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KIF3B gene|KIF3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF3B gene|KIF3B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DNA Methyltransferase Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Methyltransferase Inhibitor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,letrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,letrozole Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Agent,Carcinoma breast stage IV,0.0,Female Breast Cancer,Chemical Viewed Functionally,Agent Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,mitogen-activated protein kinase kinase kinase 11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mitogen-activated protein kinase kinase kinase 11 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,KIF3B gene|KIF3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF3B gene|KIF3B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cathepsin L,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Cathepsin L Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,Squalene monooxygenase,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Squalene monooxygenase Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,osthol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,osthol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Hormone Receptor Positive Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Positive Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"ABCG2 protein, human|ABCG2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ABCG2 protein, human|ABCG2 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Genes,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,Genes HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,PARP inhibitor therapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,PARP inhibitor therapy Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inhibitor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ITM2A gene|ITM2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ITM2A gene|ITM2A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,thymoquinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thymoquinone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TOX3 gene|TOX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOX3 gene|TOX3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR22 gene|MIR22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR22 gene|MIR22 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Insulin Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Insulin Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,estradiol,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,estradiol HER2-positive carcinoma of breast,Female Breast Cancer
CAUSES,saffron extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,saffron extract Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcohol consumption,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Recurrent Breast Carcinoma,Recurrent Breast Cancer
PREDISPOSES,beta-2 Microglobulin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,beta-2 Microglobulin Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,small size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,small size Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SHISA3 gene|SHISA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHISA3 gene|SHISA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GSEC gene|GSEC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GSEC gene|GSEC Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Smoking,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Smoking contralateral breast cancer,Female Breast Cancer
DISRUPTS,ST7-AS1 gene|ST7-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ST7-AS1 gene|ST7-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alleles,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Alleles Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,KIAA1109 gene|KIAA1109,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,KIAA1109 gene|KIAA1109 Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Aquaporin 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Aquaporin 1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,ACTL8 gene|ACTL8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ACTL8 gene|ACTL8 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Stimulation procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stimulation procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,2 times,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2 times Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,interleukin-10,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,interleukin-10 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Botanical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Botanical Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"RNA, Small Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Small Untranslated Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,LGMN gene|LGMN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LGMN gene|LGMN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,research results,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,research results Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SLAMF7 gene|SLAMF7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLAMF7 gene|SLAMF7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Childbirth,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Childbirth HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,calcium ion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",calcium ion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,bisphenol A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bisphenol A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fatty-acid synthase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,Fatty-acid synthase Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,UGT1A7 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UGT1A7 wt Allele Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Modest-Temperature Hyperthermia,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Modest-Temperature Hyperthermia Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,SRSF1 gene|SRSF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SRSF1 gene|SRSF1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,PVR gene|PVR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PVR gene|PVR Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,E-Box Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",E-Box Elements Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,FBXO5 gene|FBXO5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FBXO5 gene|FBXO5 Breast Carcinoma,Female Breast Cancer
AFFECTS,SRSF1 gene|SRSF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SRSF1 gene|SRSF1 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,CEP55 gene|CEP55,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CEP55 gene|CEP55 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Artificially Sweetened Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Artificially Sweetened Beverages Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mood:-:Point in time:^Patient:-,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mood:-:Point in time:^Patient:- Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Crotoxin,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Chemical,Crotoxin estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,jolkinolide B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,jolkinolide B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antigen Processing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigen Processing Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DPP4 gene|DPP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP4 gene|DPP4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary Intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Intake Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Portal Hypertension,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Portal Hypertension Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR526B gene|MIR526B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR526B gene|MIR526B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Biological Processes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Heparin Binding Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Heparin Binding Growth Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EN1 gene|EN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EN1 gene|EN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Smoke Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Smoke Exposure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Microcalcification Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IFI30 gene|IFI30,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IFI30 gene|IFI30 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EGR1 gene|EGR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGR1 gene|EGR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DPP10 gene|DPP10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP10 gene|DPP10 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Glycosphingolipids,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Lipid,Glycosphingolipids Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,pyridine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,pyridine Breast Carcinoma,Female Breast Cancer
AFFECTS,cyclin B2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,cyclin B2 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Xenograft procedure,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,Xenograft procedure Luminal B Breast Carcinoma,Female Breast Cancer
AUGMENTS,ANLN gene|ANLN,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ANLN gene|ANLN Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,LINC01089 gene|LINC01089,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01089 gene|LINC01089 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Copy Number Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Copy Number Polymorphism Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SMUG1 gene|SMUG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMUG1 gene|SMUG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RNA modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RNA modification Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ataxia telangiectasia mutated protein|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ataxia telangiectasia mutated protein|ATM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Stilbenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stilbenes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Biological Markers Invasive carcinoma of breast,Female Breast Cancer
DISRUPTS,NOL10 gene|NOL10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOL10 gene|NOL10 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TMEM238L gene|TMEM238L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMEM238L gene|TMEM238L Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Drug Combinations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Drug Combinations Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IMPACT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IMPACT gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR155 gene|MIR155,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR155 gene|MIR155 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Monocyte Chemoattractant Protein-1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Intravenous therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Intravenous therapy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TCOF1 gene|TCOF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TCOF1 gene|TCOF1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,TBX15 gene|TBX15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TBX15 gene|TBX15 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,disorder control (procedure),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,disorder control (procedure) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,H1-5 gene|HIST1H1B,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,H1-5 gene|HIST1H1B Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,caveolin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caveolin 1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Oils,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Oils Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Breast Density,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Breast Density Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Coronary Arteriosclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coronary Arteriosclerosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tRNA modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tRNA modification Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA1 Mutation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 Mutation Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Normal weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Normal weight Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR4521 gene|MIR4521,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR4521 gene|MIR4521 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Periodontitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Periodontitis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lead,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Inorganic Chemical,lead Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Polyunsaturated fatty acid intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated fatty acid intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Response to treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Response to treatment Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Parity,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Parity estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,hyaluronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hyaluronic acid Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LIG1 gene|LIG1|LRIG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIG1 gene|LIG1|LRIG1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ARHGAP9 gene|ARHGAP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP9 gene|ARHGAP9 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,mortalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mortalin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RPS6KA3 gene|RPS6KA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPS6KA3 gene|RPS6KA3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Matrix Metalloproteinase 11,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 11 HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Hypersensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypersensitivity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tanshinol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tanshinol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,glucose Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RTL8C gene|RTL8C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RTL8C gene|RTL8C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,Genes Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,JAM2 gene|JAM2|JAM3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JAM2 gene|JAM2|JAM3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,progesterone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,progesterone Breast Carcinoma,Female Breast Cancer
DISRUPTS,SYVN1 gene|SYVN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYVN1 gene|SYVN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Constitutive skin pigmentation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Constitutive skin pigmentation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genetic Profile,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Profile Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MALAT1 gene|MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MALAT1 gene|MALAT1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FAM189A2 gene|FAM189A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAM189A2 gene|FAM189A2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,sinomenine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sinomenine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Lipoxygenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lipoxygenase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VIRMA gene|VIRMA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TSHZ1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TSHZ1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MRPS30-DT gene|MRPS30-DT,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MRPS30-DT gene|MRPS30-DT Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Transcription Factor|SOX2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Taxol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Taxol Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,HOXC-AS3 gene|HOXC-AS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXC-AS3 gene|HOXC-AS3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LPAR6 gene|LPAR6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LPAR6 gene|LPAR6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estradiol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Very Important,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Very Important Female Breast Carcinoma,Female Breast Cancer
CAUSES,Anti-Bacterial Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Bacterial Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Injections, Intraperitoneal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Injections, Intraperitoneal Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,"Receptors, KIR2DL4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, KIR2DL4 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,EIF6 gene|EIF6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EIF6 gene|EIF6 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Rhythm,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Rhythm Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,ANKDD1A gene|ANKDD1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANKDD1A gene|ANKDD1A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MEOX2 gene|MEOX2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MEOX2 gene|MEOX2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MIR660 gene|MIR660,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR660 gene|MIR660 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Luminal B Breast Carcinoma,Female Breast Cancer
AUGMENTS,UHRF1 gene|UHRF1,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,UHRF1 gene|UHRF1 Invasive Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,mRNA Precursor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",mRNA Precursor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDC42,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,CDC42 estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,PDE5A wt Allele|PDE5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PDE5A wt Allele|PDE5A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pregnancy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Pregnancy Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"IL22 protein, human|IL22",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL22 protein, human|IL22 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Homologous Recombination Deficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Homologous Recombination Deficiency Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,inermin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,inermin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,STAMBPL1 gene|STAMBPL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAMBPL1 gene|STAMBPL1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LINC00472 gene|LINC00472,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00472 gene|LINC00472 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Therapeutic procedure Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GZMK gene|GZMK,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,GZMK gene|GZMK estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,CDK16 gene|CDK16,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDK16 gene|CDK16 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Sulfatases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sulfatases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"RNA, Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Triple Negative Breast Neoplasms",Female Breast Cancer
CAUSES,Indicators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Protein p53|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Protein p53|TP53 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Genes Carcinoma breast stage IV,Female Breast Cancer
CAUSES,diallyl trisulfide,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,diallyl trisulfide Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Malignant Neoplasms,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,ATP6AP2 gene|ATP6AP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP6AP2 gene|ATP6AP2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LMNB1 gene|LMNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LMNB1 gene|LMNB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alleles Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Secondary malignant neoplasm of bone,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Recurrent Breast Carcinoma,Female Breast Cancer
AUGMENTS,MARK2 gene|MARK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MARK2 gene|MARK2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RBIS gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBIS gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,corynoline,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,corynoline Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Ovarian Stimulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovarian Stimulation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,urokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,urokinase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mouse mammary tumor virus,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Mouse mammary tumor virus Breast Carcinoma,Female Breast Cancer
PREDISPOSES,History of previous events,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,History of previous events Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Micelles,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Micelles Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cytochrome b561,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cytochrome b561 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,File Being Validated,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,File Being Validated Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,C17orf49 gene|C17orf49,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,C17orf49 gene|C17orf49 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,docetaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,docetaxel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,eribulin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,eribulin Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,MYC gene|MYC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYC gene|MYC Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,RUNX2 gene|RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX2 gene|RUNX2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNHG14 gene|SNHG14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG14 gene|SNHG14 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,intracellular protein transport,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",intracellular protein transport Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WNT2 gene|WNT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT2 gene|WNT2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,fulvestrant,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,fulvestrant estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,"Food, Preserved",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,"Food, Preserved Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Malignant Neoplasms,"Breast Cancer, Familial",0.0,Female Breast Cancer,Neoplastic Process,"Malignant Neoplasms Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,Elevated Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elevated Expression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KIF11 gene|KIF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF11 gene|KIF11 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Lactic acid dehydrogenase isoenzyme 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Lactic acid dehydrogenase isoenzyme 5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ANLN gene|ANLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANLN gene|ANLN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,COL11A1 gene|COL11A1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,COL11A1 gene|COL11A1 estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Melanocyte stimulating hormone,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Hormone,Melanocyte stimulating hormone Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ACTA2-AS1 gene|ACTA2-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ACTA2-AS1 gene|ACTA2-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,"IRS1 protein, human|IRS1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IRS1 protein, human|IRS1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Necrosis Factor Signaling Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Necrosis Factor Signaling Process Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IMPA1 gene|IMPA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IMPA1 gene|IMPA1 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,LINC01194 gene|LINC01194,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC01194 gene|LINC01194 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,4 times,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,4 times Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,perfluorooctane sulfonic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorooctane sulfonic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sulfonic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfonic Acids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Refractory Breast Carcinoma,0.0,Other,Disease or Syndrome,Disease Refractory Breast Carcinoma,Female Breast Cancer
AFFECTS,EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EGF Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,New medications,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,New medications Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MRPS7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MRPS7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ascorbic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ascorbic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sirolimus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sirolimus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Matrix Metalloproteinase 9|MMP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 9|MMP9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Generalized obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Generalized obesity Malignant neoplasm of breast,Female Breast Cancer
CAUSES,IMPA1 gene|IMPA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IMPA1 gene|IMPA1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider},Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider} Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Membrane Transport Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Transport Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,E2F6 gene|E2F6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,E2F6 gene|E2F6 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,homocysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,homocysteine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TP53 gene|TP53,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ACBD3 gene|ACBD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ACBD3 gene|ACBD3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GAS6-AS1 gene|GAS6-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS6-AS1 gene|GAS6-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SERPINA12 gene|SERPINA12,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SERPINA12 gene|SERPINA12 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,SEMA3B-AS1 gene|SEMA3B-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEMA3B-AS1 gene|SEMA3B-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Calcinosis universalis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcinosis universalis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLC3A2 gene|SLC3A2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC3A2 gene|SLC3A2 Breast Carcinoma,Female Breast Cancer
AFFECTS,GLI1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,GLI1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,carbidopa,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,carbidopa estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,RYK gene|RYK,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,RYK gene|RYK Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,heparanase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,heparanase Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Matrix Metalloproteinase 2|MMP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 2|MMP2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FRY gene|FRY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FRY gene|FRY Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"ITK protein, human|ITK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ITK protein, human|ITK Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,MUC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MUC1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"ERCC5 protein, human|ERCC5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ERCC5 protein, human|ERCC5 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,MYCL gene|MYCL,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYCL gene|MYCL Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,CXCL14 gene|CXCL14,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CXCL14 gene|CXCL14 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,AURKB gene|AURKB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AURKB gene|AURKB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lipopolysaccharides,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Lipopolysaccharides estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,lidocaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lidocaine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSPB2 gene|HSPB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPB2 gene|HSPB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Early Diagnosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Early Diagnosis Breast Carcinoma,Female Breast Cancer
AUGMENTS,RECQL4 gene|RECQL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RECQL4 gene|RECQL4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EXO1 gene|EXO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EXO1 gene|EXO1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF217 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Ligands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ligands Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mevalonate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mevalonate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunogenic Cell Death,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunogenic Cell Death Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Pathogenic Variant,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Virus,Pathogenic Variant Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Metabolite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolite Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,glutathione S-transferase pi|GSTP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase pi|GSTP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00473 gene|LINC00473,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00473 gene|LINC00473 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Inhibitor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Inhibitor Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,FOXA1 gene|FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXA1 gene|FOXA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,glutathione,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BARRIER,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,BARRIER Breast Carcinoma,Female Breast Cancer
AFFECTS,Antiplatelet Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antiplatelet Agents Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Basis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Basis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,USP37 gene|USP37,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,USP37 gene|USP37 estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,PPARA gene|PPARA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPARA gene|PPARA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,boswellic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,boswellic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Biological Markers Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,dihydrotanshinone I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dihydrotanshinone I Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aspirin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SOX8 gene|SOX8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SOX8 gene|SOX8 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Low-Dose Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Low-Dose Aspirin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,health knowledge,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,health knowledge Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00536 gene|LINC00536,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00536 gene|LINC00536 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,panobinostat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,panobinostat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CBX3 gene|CBX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBX3 gene|CBX3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arsenic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Anti-Inflammatory Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Inflammatory Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interventional procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interventional procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOAT2 gene|SOAT2,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,SOAT2 gene|SOAT2 Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,FRMD3 gene|FRMD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FRMD3 gene|FRMD3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ENOLASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ENOLASE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,HER2-negative breast cancer,0.0,Female Breast Cancer,Other,Biological Markers HER2-negative breast cancer,Female Breast Cancer
PREDISPOSES,perfluorooctanoate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,perfluorooctanoate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,thiamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thiamine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IMPACT gene,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,IMPACT gene contralateral breast cancer,Female Breast Cancer
CAUSES,SDC1 gene|SDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Circulating MicroRNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Circulating MicroRNA Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TINCR gene|TINCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TINCR gene|TINCR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,birth control pill use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,birth control pill use Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MIR497HG gene|MIR497HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR497HG gene|MIR497HG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Differential Diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Differential Diagnosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Responsive Disease,Carcinoma breast stage IV,0.0,Female Breast Cancer,Disease or Syndrome,Responsive Disease Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,LAPTM5 gene|LAPTM5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAPTM5 gene|LAPTM5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CLDN6 gene|CLDN6,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,CLDN6 gene|CLDN6 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TAF15 gene|TAF15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAF15 gene|TAF15 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RHOV gene|RHOV,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RHOV gene|RHOV Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sauchinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sauchinone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Targeted Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Targeted Therapy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GABRD gene|GABRD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GABRD gene|GABRD Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MVP wt Allele|RPSA|LRP1|PTPRA|MVP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MVP wt Allele|RPSA|LRP1|PTPRA|MVP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CBFB|NFYA|NFYB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CBFB|NFYA|NFYB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SIRT7 gene|SIRT7,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,SIRT7 gene|SIRT7 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,MicroRNAs,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Early-Stage Breast Carcinoma,Female Breast Cancer
AUGMENTS,caspase-3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,caspase-3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Disease/diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease/diagnosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Energy Balance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Energy Balance Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MYBL2 gene|MYBL2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYBL2 gene|MYBL2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Improved,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Improved Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NOTCH1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOTCH1 gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,COMMD3 gene|COMMD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COMMD3 gene|COMMD3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Leisure behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leisure behavior Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NPY1R gene|NPY1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NPY1R gene|NPY1R Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cyclic guanosine monophosphate-adenosine monophosphate,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,cyclic guanosine monophosphate-adenosine monophosphate Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Biological Markers,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Other,Biological Markers estrogen receptor-negative breast cancer,Female Breast Cancer
PREDISPOSES,Sugar-Sweetened Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sugar-Sweetened Beverages Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cobalt dichloride,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Cobalt dichloride Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Hexokinase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hexokinase 1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"herstatin protein, human",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human Breast Carcinoma",Female Breast Cancer
AUGMENTS,"Adaptor Proteins, Signal Transducing",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Adaptor Proteins, Signal Transducing Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,PLPP4 gene|PLPP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PLPP4 gene|PLPP4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TIPARP gene|TIPARP,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,TIPARP gene|TIPARP Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Metabolic Profile,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolic Profile Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Hexokinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hexokinase 2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GJA1 gene|GJA1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,GJA1 gene|GJA1 estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Pathogenic Variant,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Virus,Pathogenic Variant contralateral breast cancer,Female Breast Cancer
CAUSES,Phytochemicals,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,Phytochemicals Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Pyrenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pyrenes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,C1QL4 gene|C1QL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,C1QL4 gene|C1QL4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Food Habits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food Habits Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Noninfiltrating Intraductal Carcinoma,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,fruit extracts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fruit extracts Malignant neoplasm of breast,Female Breast Cancer
CAUSES,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Heat Shock Protein 27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat Shock Protein 27 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sulfhydryl Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfhydryl Compounds Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IDO2 gene|IDO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IDO2 gene|IDO2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Players,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Players Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,NDC80 gene|NDC80,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NDC80 gene|NDC80 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,reproductive hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,reproductive hormone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ADAR gene|ADAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAR gene|ADAR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Liposomes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Liposomes Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,GPT2 gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GPT2 gene Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Long Interspersed Nucleotide Element-1,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Long Interspersed Nucleotide Element-1 Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,PTCSC3 gene|PTCSC3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTCSC3 gene|PTCSC3 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,histone deacetylase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,histone deacetylase 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SCRIB gene|SCRIB,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SCRIB gene|SCRIB Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Triple Negative Breast Neoplasms",Female Breast Cancer
DISRUPTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Infiltration,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,cholesterol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Microenvironment of Metastasis Density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment of Metastasis Density Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Immune,HER2-negative breast cancer,0.0,Female Breast Cancer,Other,Immune HER2-negative breast cancer,Female Breast Cancer
PREDISPOSES,IRF7 gene|IRF7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRF7 gene|IRF7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HDAC1 gene|HDAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HDAC1 gene|HDAC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ferritin Light Chain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ferritin Light Chain Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypothalamic inhibiting factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypothalamic inhibiting factor Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,MED1 gene|MED1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MED1 gene|MED1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Triple Negative Breast Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Triple Negative Breast Neoplasms Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MAPK1 gene|MAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK1 gene|MAPK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinogenesis,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,xiaoyaosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,xiaoyaosan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gravidity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gravidity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cytochrome b561,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cytochrome b561 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Obesity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Obesity Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Suppressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Suppressor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Multiple tumors,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Multiple tumors Invasive carcinoma of breast,Female Breast Cancer
CAUSES,agonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,agonists Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Thrombotic Microangiopathies,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Thrombotic Microangiopathies Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Dynamic Contrast-Enhanced Magnetic Resonance Imaging Breast Carcinoma,Female Breast Cancer
AFFECTS,Alkaloids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Alkaloids Breast Carcinoma,Female Breast Cancer
DISRUPTS,ZNF831 gene|ZNF831,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF831 gene|ZNF831 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MC1R gene|MC1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MC1R gene|MC1R Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,estrogens,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,estrogens estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,pristane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pristane Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Non-alcoholic Fatty Liver Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Non-alcoholic Fatty Liver Disease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ginsenosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ginsenosides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ethanol,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,ethanol HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,40-49,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,40-49 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,interleukin-6|IL6,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Other,interleukin-6|IL6 Invasive Ductal Breast Carcinoma,Female Breast Cancer
AUGMENTS,"estrogens, conjugated (USP)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"estrogens, conjugated (USP) Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,MIR429 gene|MIR429,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR429 gene|MIR429 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"Interleukin-16, human",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,"Interleukin-16, human HER2-positive carcinoma of breast",Female Breast Cancer
DISRUPTS,polyphyllin II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyphyllin II Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"ATF2 protein, human|ATF2",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ATF2 protein, human|ATF2 estrogen receptor-positive breast cancer",Female Breast Cancer
AUGMENTS,FTO gene|FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FTO gene|FTO Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mahanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mahanine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,trastuzumab deruxtecan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab deruxtecan Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,doxorubicin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,doxorubicin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,KLF5 gene|KLF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF5 gene|KLF5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Perimenopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Perimenopause Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FZR1 wt Allele|CDH1,"Breast Cancer, Familial",0.0,Female Breast Cancer,Other,"FZR1 wt Allele|CDH1 Breast Cancer, Familial",Female Breast Cancer
AFFECTS,Screening for malignant neoplasm of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Screening for malignant neoplasm of breast Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FAM83D gene|FAM83D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAM83D gene|FAM83D Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RACK1 gene|RACK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RACK1 gene|RACK1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-6 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CXCL8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,CXCL8 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,A1BG-AS1 gene|A1BG-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,A1BG-AS1 gene|A1BG-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ANO6 gene|ANO6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANO6 gene|ANO6 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJB4 gene|DNAJB4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AFF4 gene|AFF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AFF4 gene|AFF4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PROS1 gene|PROS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PROS1 gene|PROS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,testosterone,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,testosterone Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Hemoglobin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Hemoglobin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,chemokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chemokine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,butylbenzyl phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,butylbenzyl phthalate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lesch-Nyhan Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Lesch-Nyhan Syndrome Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CAVIN1 gene|CAVIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAVIN1 gene|CAVIN1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Receptors, Opioid, kappa",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,"Receptors, Opioid, kappa estrogen receptor-positive breast cancer",Female Breast Cancer
AFFECTS,AMACR wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AMACR wt Allele Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TDRKH-AS1 gene|TDRKH-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TDRKH-AS1 gene|TDRKH-AS1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"IMP3 protein, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IMP3 protein, human Malignant neoplasm of breast",Female Breast Cancer
CAUSES,"MFGE8 protein, human|MFGE8",Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MFGE8 protein, human|MFGE8 Invasive Ductal Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Organic solvent product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Organic solvent product Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endometriosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endometriosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TTPAL gene|TTPAL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TTPAL gene|TTPAL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FOXK1 gene|FOXK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXK1 gene|FOXK1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR205 gene|MIR205,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR205 gene|MIR205 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Non-alcoholic Fatty Liver Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Non-alcoholic Fatty Liver Disease Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Implants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biomedical or Dental Material,Implants Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ESR1,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,ESR1 malignant neoplasm of breast staging,Female Breast Cancer
AFFECTS,FTO gene|FTO,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FTO gene|FTO Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,GNAO1 gene|GNAO1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,GNAO1 gene|GNAO1 Carcinoma breast stage IV,Female Breast Cancer
CAUSES,Tobacco,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tobacco Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXQ1 gene|FOXQ1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXQ1 gene|FOXQ1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tea,Breast cancer stage II,0.0,Female Breast Cancer,Other,Tea Breast cancer stage II,Female Breast Cancer
AUGMENTS,PARK7 gene|PARK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARK7 gene|PARK7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PPARGC1B gene|PPARGC1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPARGC1B gene|PPARGC1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TPM2 gene|TPM2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TPM2 gene|TPM2 Breast Carcinoma,Female Breast Cancer
AFFECTS,Pivot,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Pivot Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RSRC2 gene|RSRC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RSRC2 gene|RSRC2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|ERBB2,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Invasive carcinoma of breast,Female Breast Cancer
COMPLICATES,Sarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sarcoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"CD69 protein, human|CD69",Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Female Breast Carcinoma",Female Breast Cancer
AUGMENTS,Estrogen Receptor alpha,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Score,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Other,Score Recurrent Breast Carcinoma,Recurrent Breast Cancer
PREDISPOSES,SIK2 gene|SIK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIK2 gene|SIK2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carney Complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carney Complex Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"interleukin-1, beta",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"interleukin-1, beta Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,magnesium cation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",magnesium cation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplastic Cell Transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplastic Cell Transformation Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,pimozide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pimozide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Movement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Movement Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR205 gene|MIR205,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,MIR205 gene|MIR205 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Androgen Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Androgen Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SLC7A11 gene|SLC7A11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SLC7A11 gene|SLC7A11 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Gene Expression,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Gene Expression Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,MT-RNR1 gene|RNR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MT-RNR1 gene|RNR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAB5A gene|RAB5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAB5A gene|RAB5A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CAT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAT gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Patient Derived Xenograft,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Patient Derived Xenograft Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CCDC150 gene|CCDC150,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CCDC150 gene|CCDC150 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Male-to-female transsexual (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Male-to-female transsexual (finding) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Autoantibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Autoantibodies Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MXRA5 gene|MXRA5,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,MXRA5 gene|MXRA5 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,claudin 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,claudin 3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,doxorubicin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NF2 gene|NF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NF2 gene|NF2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inhibitor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,humanin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,humanin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,translation factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",translation factor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,WWOX gene|WWOX,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,WWOX gene|WWOX Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,metformin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EP300 gene|EP300,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EP300 gene|EP300 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Leucine-Rich Repeat Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Leucine-Rich Repeat Proteins Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,scopolamine,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,scopolamine Secondary malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,EYA2 gene|EYA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EYA2 gene|EYA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PKMYT1 gene|PKMYT1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PKMYT1 gene|PKMYT1 Breast Carcinoma,Female Breast Cancer
AUGMENTS,ME1 gene|ME1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ME1 gene|ME1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CACNG4 gene|CACNG4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CACNG4 gene|CACNG4 Breast Carcinoma,Female Breast Cancer
AFFECTS,Upstaging,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Upstaging Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,obeticholic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,obeticholic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoadjuvant Therapy,bilateral breast cancer,0.0,Female Breast Cancer,Other,Neoadjuvant Therapy bilateral breast cancer,Female Breast Cancer
AUGMENTS,CCL20 gene|CCL20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL20 gene|CCL20 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MBD2 gene|MBD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MBD2 gene|MBD2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"IL1A protein, human|IL1A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL1A protein, human|IL1A Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,IL22 gene|IL22,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IL22 gene|IL22 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Neoadjuvant Therapy,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,Neoadjuvant Therapy Luminal B Breast Carcinoma,Female Breast Cancer
DISRUPTS,taurine,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,taurine Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Multiple Sclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Multiple Sclerosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Targeted Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Targeted Therapy HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Trichorhinophalangeal dysplasia type I Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Bee Venoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bee Venoms Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ESR1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Human Class I Antigens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Human Class I Antigens Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,DNA Replication,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",DNA Replication Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,CCNB1 gene|CCNB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CCNB1 gene|CCNB1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Urolithin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Urolithin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Protective Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Protective Factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pyruvate dehydrogenase kinase 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pyruvate dehydrogenase kinase 4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tissue texture abnormality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tissue texture abnormality Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Basal Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Basal Diet Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC38A5 gene|SLC38A5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SLC38A5 gene|SLC38A5 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,FGF11 gene|FGF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF11 gene|FGF11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,phosphatidylinositols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phosphatidylinositols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,4-aminohippuric acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,4-aminohippuric acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZBTB10 gene|ZBTB10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZBTB10 gene|ZBTB10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Combination Chemotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Combination Chemotherapy Breast cancer metastatic,Female Breast Cancer
AFFECTS,Folliculin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Folliculin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nitric Oxide Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nitric Oxide Synthase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,20q13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,20q13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GRB7 gene|GRB7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GRB7 gene|GRB7 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CCL18 gene|CCL18,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCL18 gene|CCL18 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,TBX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TBX2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAS Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TIMM50,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TIMM50 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Stromelysin 1|MMP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stromelysin 1|MMP3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EPHA10 gene|EPHA10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EPHA10 gene|EPHA10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cancer-Predisposing Gene,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,MAP3K1 gene|MAP3K1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAP3K1 gene|MAP3K1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Estrogens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast cancer metastatic,Female Breast Cancer
AFFECTS,Integrin alpha4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrin alpha4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,intraoperative radiotherapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,intraoperative radiotherapy Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Menopause,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Menopause Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,BRMS1L,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,BRMS1L Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CYP1A1 gene|CYP1A1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,CYP1A1 gene|CYP1A1 Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,"WBSCR22 protein, human|BUD23",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WBSCR22 protein, human|BUD23 Breast cancer invasive NOS",Female Breast Cancer
PREDISPOSES,11q13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,11q13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Environmental Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Environmental Estrogen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1|LMOD1|BBS9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Renal Cell Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Renal Cell Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cyclin A1|CCNA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclin A1|CCNA1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Oxygen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oxygen Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Pollutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pollutant Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tangeretin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tangeretin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Enhancer Elements (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Enhancer Elements (Genetics) Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Glutamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glutamine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Heregulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heregulin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN143 gene|MIR143,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN143 gene|MIR143 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RAD51C gene|RAD51C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51C gene|RAD51C Malignant neoplasm of breast,Female Breast Cancer
CAUSES,AATF gene|AATF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AATF gene|AATF Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,beta catenin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,beta catenin Breast cancer metastatic,Female Breast Cancer
AFFECTS,STF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,STF Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Selective serotonin re-uptake inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Selective serotonin re-uptake inhibitor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC39A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC39A6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTGS2 gene|PTGS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,8-Oxoguanine DNA Glycosylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",8-Oxoguanine DNA Glycosylase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Annexin A1|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A1|ANXA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Organized pneumonia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Organized pneumonia Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Methotrexate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methotrexate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IFNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IFNB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Suppressor Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast Carcinoma,Female Breast Cancer
DISRUPTS,VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VEGFA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-18 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Receptors, Opioid, delta",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Opioid, delta Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,IL18 gene|IL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL18 gene|IL18 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Androgen Receptor|AR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Androgen Receptor|AR Breast Carcinoma,Female Breast Cancer
CAUSES,Pads,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Pads Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Hypoxia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Hypoxia Breast cancer metastatic,Female Breast Cancer
AFFECTS,Autophagy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Autophagy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Genuineness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Genuineness Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BAG3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,BAG3 Breast Carcinoma,Female Breast Cancer
AFFECTS,"Carcinoma, Ductal, Breast",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Carcinoma, Ductal, Breast Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,SNAI1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SNAI1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cytotoxicity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,cytotoxicity Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NOP14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NOP14 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Rectal hemorrhage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rectal hemorrhage Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NRIP1 gene|NRIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRIP1 gene|NRIP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Activins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Activins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Microtubule-Associated Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Microtubule-Associated Proteins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phosphoglycerate dehydrogenase|PHGDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoglycerate dehydrogenase|PHGDH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WRAP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WRAP53 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Epidermal Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,STC1 gene|STC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STC1 gene|STC1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Environmental Pollutants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Environmental Pollutants Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SNAI1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SNAI1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,TRIM62,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TRIM62 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Wound Healing,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Wound Healing Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERBB2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,osteoblast cadherin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,osteoblast cadherin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Congestive heart failure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Congestive heart failure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,octylphenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,octylphenol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ir Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Ir Genes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ADGRF5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ADGRF5 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Salts,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Salts Breast Carcinoma,Female Breast Cancer
PREDISPOSES,FH: Father NOS,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,FH: Father NOS Familial cancer of breast,Female Breast Cancer
AFFECTS,carnosol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,carnosol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Insulin-Like Growth Factor Receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor Receptor Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ADRA2A gene|ADRA2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADRA2A gene|ADRA2A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"1,4-dioxin",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"1,4-dioxin Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,icariin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,icariin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Expression Regulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Expression Regulation Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR200A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR200A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"ST13 protein, human|ST13",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ST13 protein, human|ST13 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,PIK3R1|PIK3R2|ARHGEF7|CBFA2T2|PPP1R13B|PPP1R12C,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PIK3R1|PIK3R2|ARHGEF7|CBFA2T2|PPP1R13B|PPP1R12C Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Physical activity decreased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physical activity decreased Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,anthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,anthracene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FABP5 gene|FABP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FABP5 gene|FABP5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Follicle Stimulating Hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Follicle Stimulating Hormone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetate Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PRLR gene|PRLR|PTP4A3,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,GSTA1 gene|GSTA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTA1 gene|GSTA1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,retinyl methyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,retinyl methyl ether Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIK3CA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estrone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cytokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,High Vegetable Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,High Vegetable Diet Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Levodopa,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Levodopa Breast Carcinoma,Female Breast Cancer
AFFECTS,receptor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,receptor Breast Carcinoma,Female Breast Cancer
AFFECTS,Gin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Oncogenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogenes Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor I,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Clomiphene,bilateral breast cancer,0.0,Female Breast Cancer,Other,Clomiphene bilateral breast cancer,Female Breast Cancer
CAUSES,Viral Tumor Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Viral Tumor Antigens Breast Carcinoma,Female Breast Cancer
AUGMENTS,mammaglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mammaglobin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Diphosphonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diphosphonates Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,glycosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,glycosyltransferase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Brachytherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Brachytherapy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Proliferating Cell Nuclear Antigen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nifedipine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nifedipine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cytokine,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Central Nervous System Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Central Nervous System Agents Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dichlorodiphenyl Dichloroethylene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ukrain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ukrain Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin D1|LMOD1|BBS9,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cyclin D1|LMOD1|BBS9 Breast Carcinoma,Female Breast Cancer
CAUSES,Human papillomavirus 16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Human papillomavirus 16 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant mixed salivary gland tumor,Cancer en cuirasse,0.0,Female Breast Cancer,Neoplastic Process,Malignant mixed salivary gland tumor Cancer en cuirasse,Female Breast Cancer
DISRUPTS,"Receptors, Progesterone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Human Platelet Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Human Platelet Antigens Malignant neoplasm of breast,Female Breast Cancer
CAUSES,reproductive hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,reproductive hormone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TARBP2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,TARBP2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Alcohol consumption,bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption bilateral breast cancer,Female Breast Cancer
CAUSES,Agent,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Agent Breast Carcinoma,Female Breast Cancer
AFFECTS,MAPKAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAPKAP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CTTN gene|CTTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTTN gene|CTTN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Atypical proliferation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Atypical proliferation Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Tumor Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Antigens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Edema,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Edema Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Voluntary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Voluntary Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Sulfones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Sulfones Breast Carcinoma,Female Breast Cancer
AFFECTS,Polyunsaturated Fatty Acids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Breast Carcinoma,Female Breast Cancer
AUGMENTS,CD44 gene|CD44,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Breast Carcinoma,Female Breast Cancer
CAUSES,Herpesviridae,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Herpesviridae Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Microsatellite Repeats,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Microsatellite Repeats Breast Carcinoma,Female Breast Cancer
DISRUPTS,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Z-alpha-chlorochalcone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Z-alpha-chlorochalcone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PRLR gene|PRLR|PTP4A3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,LALBA gene|LALBA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LALBA gene|LALBA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,R-38486,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,R-38486 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant neoplasm of breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Cyclophosphamide,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Cyclophosphamide Breast cancer metastatic,Female Breast Cancer
AUGMENTS,"TFF1 protein, human|TFF1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF1 protein, human|TFF1 Breast Carcinoma",Female Breast Cancer
AUGMENTS,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carotenoids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MENSTRUAL STATUS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MENSTRUAL STATUS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Common Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Common Neoplasm Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Menopausal Status,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Menopausal Status Contralateral breast cancer,Female Breast Cancer
AUGMENTS,Mechlorethamine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Mechlorethamine Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Goiter,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Goiter Breast Carcinoma,Female Breast Cancer
AFFECTS,Epidermal Growth Factor Receptor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGF Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,OK-432,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OK-432 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tall stature,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tall stature Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,dehydroepiandrosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dehydroepiandrosterone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Caloric Restriction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Caloric Restriction Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Esters,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Esters Breast Carcinoma,Female Breast Cancer
CAUSES,Hodgkin Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Hodgkin Disease Breast Carcinoma,Female Breast Cancer
CAUSES,"Carcinogens, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Atrophic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atrophic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Excessive self-esteem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Excessive self-esteem Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Confident,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Confident Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Dinoprost,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Dinoprost Breast Carcinoma,Female Breast Cancer
CAUSES,cDNA Library,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cDNA Library Breast Carcinoma,Female Breast Cancer
AUGMENTS,FGF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FGF4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibrosing adenosis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Fibrosing adenosis Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Epoprostenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Epoprostenol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RBBP1L1 Protein|ARID4B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RBBP1L1 Protein|ARID4B Breast Carcinoma,Female Breast Cancer
AFFECTS,FGF4 gene|FGF4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FGF4 gene|FGF4 Breast Carcinoma,Female Breast Cancer
AFFECTS,Pregnancy review,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pregnancy review Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Zuclomiphene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Zuclomiphene Breast Carcinoma,Female Breast Cancer
DISRUPTS,EMD 16795,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EMD 16795 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Silicones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Silicones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Malignant Carcinoid Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant Carcinoid Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ergocornine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ergocornine Breast Carcinoma,Female Breast Cancer
CAUSES,Cisplatin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cisplatin Breast Carcinoma,Female Breast Cancer
CAUSES,2-Acetylaminofluorene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,2-Acetylaminofluorene Breast Carcinoma,Female Breast Cancer
AFFECTS,Hypolipidemia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Lipid,Hypolipidemia Breast Carcinoma,Female Breast Cancer
CAUSES,Retinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Retinoids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast Carcinoma,Female Breast Cancer
AFFECTS,Hormone manipulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone manipulation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Transgenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Transgenes Breast Carcinoma,Female Breast Cancer
AFFECTS,Microsatellite Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Microsatellite Repeats Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adipositas,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adipositas Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Drink,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Drink Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogen Replacements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Replacements Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplasm,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Neoplasm Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,ATM gene|ATM,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,ATM gene|ATM Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Noninfiltrating Intraductal Carcinoma,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,TP73|ARHGAP24,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,TP73|ARHGAP24 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,thermography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thermography Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Calcium Glucarate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Glucarate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Psychological Impact,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Psychological Impact Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,p65|RELA|SYT1|GORASP1|WNK1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,p65|RELA|SYT1|GORASP1|WNK1 Breast Carcinoma,Female Breast Cancer
AFFECTS,Dietary Fats,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Dietary Fats Breast Carcinoma,Female Breast Cancer
AFFECTS,PPARBP gene|MED1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPARBP gene|MED1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Insulin-Like Growth Factor I,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Breast Carcinoma,Female Breast Cancer
CAUSES,whey protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",whey protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TP53 gene|TP53,bilateral breast cancer,0.0,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 bilateral breast cancer,Female Breast Cancer
AFFECTS,Osteoclastic resorption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Osteoclastic resorption Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SYK gene|SYK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYK gene|SYK Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microsatellite Instability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Microsatellite Instability Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,2-chloroethyl ethyl sulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2-chloroethyl ethyl sulfide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Jogging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Jogging Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TFF1 gene|TFF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TFF1 gene|TFF1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Postmenopausal Hormone Replacement Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Postmenopausal Hormone Replacement Therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pregnenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pregnenes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,casein kinase II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,casein kinase II Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Overweight,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Overweight Breast Carcinoma,Female Breast Cancer
CAUSES,Tumor Angiogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Angiogenesis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,matrix metalloproteinase 26,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",matrix metalloproteinase 26 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,8-hydroxy-2'-deoxyguanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,8-hydroxy-2'-deoxyguanosine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,glutathione S-transferase pi|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase pi|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Germ-Line Mutation,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Familial cancer of breast,Female Breast Cancer
AFFECTS,Integrin alphaV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrin alphaV Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,alpha-Fetoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha-Fetoproteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BIN1 gene|BIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIN1 gene|BIN1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BIRC5 gene|BIRC5,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,BIRC5 gene|BIRC5 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Meat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to Unspecified general medical examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Encounter due to Unspecified general medical examination Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Neoplasm Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,ERBB2|NEU1|NEURL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,SLC39A6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SLC39A6 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Diet,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Diet Breast Carcinoma,Female Breast Cancer
CAUSES,Pollutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pollutant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Parkinson Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Parkinson Disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Menopausal hot flushes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menopausal hot flushes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD82 gene|CD82,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD82 gene|CD82 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Tumor Suppressor Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tumor Suppressor Proteins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Amphiregulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Amphiregulin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TNFSF10 gene|TNFSF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF10 gene|TNFSF10 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Transforming Growth Factor alpha|TGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor alpha|TGFA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tumor Suppressor Genes,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,"Diagnosis, Computer-Assisted",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diagnosis, Computer-Assisted Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,estrone sulfatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estrone sulfatase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABL2|RERE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bone Resorption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bone Resorption Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phytoestrogens,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Phytoestrogens Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,SNCG gene|SNCG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SNCG gene|SNCG Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"Fatty Acids, Monounsaturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Monounsaturated Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,H-ras Genes,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,H-ras Genes Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,Carcinoembryonic Antigen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Breast cancer metastatic,Female Breast Cancer
AUGMENTS,REL gene|REL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,REL gene|REL Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Selenium,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Selenium Breast Carcinoma,Female Breast Cancer
CAUSES,Ethylnitrosourea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Ethylnitrosourea Breast Carcinoma,Female Breast Cancer
CAUSES,"N,N-dimethyl-4-anisidine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"N,N-dimethyl-4-anisidine Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Tamoxifen,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Contralateral breast cancer,Female Breast Cancer
CAUSES,"BCAR1 protein, human|BCAR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BCAR1 protein, human|BCAR1 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,AKT3 gene|AKT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKT3 gene|AKT3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Surgical biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Surgical biopsy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Technetium Tc 99m Sestamibi,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Technetium Tc 99m Sestamibi Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Hexestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hexestrol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Opioid Peptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Opioid Peptide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,stanniocalcin 2|STC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,stanniocalcin 2|STC2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Early menarche,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Early menarche Female Breast Carcinoma,Female Breast Cancer
AUGMENTS,8-hydroxyguanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",8-hydroxyguanine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Fatty Acids, Omega-6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-6 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,"Receptor, Melatonin, MT1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptor, Melatonin, MT1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,"Antidepressive Agents, Tricyclic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Antidepressive Agents, Tricyclic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,LIG4 gene|LIG4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIG4 gene|LIG4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNCG gene|SNCG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNCG gene|SNCG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mitotic Activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitotic Activity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tamoxifen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Alpha heavy chain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alpha heavy chain Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"1,2-dibromo-3-chloropropane",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"1,2-dibromo-3-chloropropane Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Suppressor Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,BRCA1 Protein|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 Protein|BRCA1 Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,Soy Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Soy Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Slow acetylator status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Slow acetylator status Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ibandronate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Ibandronate Breast cancer metastatic,Female Breast Cancer
AFFECTS,"NOS2A protein, human|NOS2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NOS2A protein, human|NOS2 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,3' Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",3' Untranslated Regions Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinoma in Situ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PTEN gene|PTEN,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Familial cancer of breast,Female Breast Cancer
AFFECTS,Glutathione S-Transferase|SLCO6A1|GSTK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutathione S-Transferase|SLCO6A1|GSTK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Embolism, Tumor",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,"Embolism, Tumor Inflammatory Breast Carcinoma",Female Breast Cancer
AFFECTS,Therapeutic regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Therapeutic regimen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Myocardial Infarction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Myocardial Infarction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmaceutical Preparations,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,ATP12A|HK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ATP12A|HK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogenic effect,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Estrogenic effect Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,FGF3 gene|FGF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF3 gene|FGF3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,P-Cadherin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,P-Cadherin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Prenatal Exposure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Prenatal Exposure Breast Carcinoma,Female Breast Cancer
AFFECTS,BAG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BAG1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Eicosapentaenoic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Eicosapentaenoic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytokinesis of the fertilized ovum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Cytokinesis of the fertilized ovum Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,adjuvant therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,adjuvant therapy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Phosphorylcholine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphorylcholine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dydrogesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dydrogesterone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Calgranulin B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Calgranulin B Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,SPOCK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SPOCK2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RUNX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RUNX3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Obstruction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Obstruction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,8q24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,8q24 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Genes,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,Genes Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Folate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cold temperature,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,cold temperature Breast Carcinoma,Female Breast Cancer
AFFECTS,helicase|HFM1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,helicase|HFM1 Familial cancer of breast,Female Breast Cancer
AFFECTS,Epithelial Cell Proliferation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial Cell Proliferation Breast Carcinoma,Female Breast Cancer
AFFECTS,Radiation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Breast Carcinoma,Female Breast Cancer
AFFECTS,Fanconi's Anemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fanconi's Anemia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Atypia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Atypia Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Monocyte Chemoattractant Protein-1|CCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1|CCL2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TNF,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,TNF Familial cancer of breast,Female Breast Cancer
PREDISPOSES,RANTES|CCL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RANTES|CCL5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Recombinant Interleukin-8|CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Recombinant Interleukin-8|CXCL8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Angiotensin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiotensin Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,E-Cadherin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,E-Cadherin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Apigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Apigenin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Palmitic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Palmitic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"STK6 protein, human|AURKA",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","STK6 protein, human|AURKA Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
PREDISPOSES,AROMATICS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AROMATICS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,N-6 fatty acid intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-6 fatty acid intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tanshinone II A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tanshinone II A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant neoplasm of prostate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Puberty, Precocious",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Puberty, Precocious Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Chronic Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic Disease Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estrone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Oxidoreductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxidoreductase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elements Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TNFSF6 gene|FASLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF6 gene|FASLG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Delayed menopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Delayed menopause Malignant neoplasm of breast,Female Breast Cancer
CAUSES,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein tyrosine phosphatase 1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB3 gene|ERBB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB3 gene|ERBB3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Testosterone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Testosterone Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,PPAR gamma|PPARG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPAR gamma|PPARG Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Modulators Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MERTK gene|MERTK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MERTK gene|MERTK Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ASAP1|MYCBPAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ASAP1|MYCBPAP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glycol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glycol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PARP1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,PARP1 Breast Carcinoma,Female Breast Cancer
CAUSES,Oncogenes,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"Oncogenes Carcinoma, Ductal, Breast",Female Breast Cancer
DISRUPTS,polyphenon E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyphenon E Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemopreventive Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemopreventive Agent Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Activins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Activins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"RNA, Small Interfering",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Small Interfering Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,"Plants, Edible",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Plants, Edible Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Analgesics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Analgesics Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Disintegrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Disintegrins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,prohibitin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prohibitin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phosphatidylinositols,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Phosphatidylinositols Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paclitaxel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Conjugated Equine Estrogens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Conjugated Equine Estrogens Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,leucylproline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,leucylproline Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Antihormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Antihormone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Connexins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Connexins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,podocalyxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,podocalyxin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HIVEP2 gene|HIVEP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIVEP2 gene|HIVEP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Platelet-Derived Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Platelet-Derived Growth Factor Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Non-esterified cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Non-esterified cholesterol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERbetacx,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,ERbetacx Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Receptors, Cell Surface",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Cell Surface Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,GSDME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GSDME Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Norgestrel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Norgestrel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,reproductive hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,reproductive hormone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IFNG gene|IFNG,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,IFNG gene|IFNG Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Amphiregulin|AREG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Amphiregulin|AREG Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,bone morphogenetic protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Protein pp60 (c-src)|SRC Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Epidermal Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body mass index,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Body mass index Breast Carcinoma,Female Breast Cancer
AFFECTS,Specific antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Specific antibody Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CHEK2 gene|CHEK2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Female Breast Carcinoma,Female Breast Cancer
CAUSES,RAD50,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,RAD50 Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alleles Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CA-125 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CA-125 Antigen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Expression,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Gene Expression Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,EGLN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EGLN2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MTHFR gene|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTHFR gene|MTHFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glutathione S-Transferase|SLCO6A1|GSTK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutathione S-Transferase|SLCO6A1|GSTK1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CD24,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,CD24 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STK11 gene|STK11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK11 gene|STK11 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,anti-apoptosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,anti-apoptosis Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrogen Receptors,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Cell Communication,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Cell Communication Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,ERBB2 gene|ERBB2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,CTCFL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTCFL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LIN28A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LIN28A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Compound Q,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Compound Q Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Simvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Simvastatin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Human Chorionic Gonadotropin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Human Chorionic Gonadotropin Breast Carcinoma,Female Breast Cancer
AFFECTS,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein tyrosine phosphatase 1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HMMR gene|HMMR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMMR gene|HMMR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD70,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,CD70 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,OTP gene|OTP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OTP gene|OTP Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Janus kinase 2|JAK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Janus kinase 2|JAK2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MS2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Histologic type,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Histologic type Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Protein Expression,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Expression Ductal Breast Carcinoma,Female Breast Cancer
DISRUPTS,RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RUNX2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP1B1 gene|CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1B1 gene|CYP1B1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,nuclear receptor coactivator 1|SRC,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,nuclear receptor coactivator 1|SRC Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Convenience food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Convenience food Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Liposomes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Liposomes Breast cancer metastatic,Female Breast Cancer
AUGMENTS,KDM8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Cations, Divalent",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Cations, Divalent Breast cancer metastatic",Female Breast Cancer
AFFECTS,HMMR gene|HMMR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMMR gene|HMMR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Disulfiram,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Disulfiram Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LBX1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IDO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IDO1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Molecular Fingerprint of Tumor,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,Molecular Fingerprint of Tumor Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,healthful behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,healthful behavior Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"2,5-dichloro-4-bromophenol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"2,5-dichloro-4-bromophenol Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Cullin Proteins,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cullin Proteins Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRMS1 gene|BRMS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRMS1 gene|BRMS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PLXNB1 gene|PLXNB1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PLXNB1 gene|PLXNB1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RUNX2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"SMO protein, human|SMO",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SMO protein, human|SMO Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Lemon extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lemon extract Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,invariant chain|CD74,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,invariant chain|CD74 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,survivin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,survivin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Cell-cell adhesion molecule,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cell-cell adhesion molecule Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Introns,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Introns Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FAN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAN1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Apocrine adenocarcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Apocrine adenocarcinoma Breast Carcinoma,Female Breast Cancer
PREDISPOSES,FOXC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXC1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MYB gene|MYB,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,MYB gene|MYB Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Aluminum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aluminum Malignant neoplasm of breast,Female Breast Cancer
CAUSES,RBBP7,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,RBBP7 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,quinoxaline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,quinoxaline Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Germ-Line Mutation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Breast Carcinoma,Female Breast Cancer
PREDISPOSES,YBX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,YBX1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,isoflavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,isoflavonoids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Spontaneous abortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Spontaneous abortion Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Receptors, Nuclear",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Nuclear Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,PLG gene|PLG,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PLG gene|PLG Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,FASTK Gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,FASTK Gene Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,CYP2S1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP2S1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A11 gene|S100A11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A11 gene|S100A11 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fenretinide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fenretinide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDC25A gene|CDC25A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CDC25A gene|CDC25A Breast cancer metastatic,Female Breast Cancer
AUGMENTS,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AUSTRALIAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AUSTRALIAN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UTS2R|SLC14A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UTS2R|SLC14A2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RAD51,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,RAD51 Breast Carcinoma,Female Breast Cancer
AUGMENTS,NRDC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NRDC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S100A1|S100B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A1|S100B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemoprevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chemoprevention Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Field crops,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Field crops Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Core needle biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Core needle biopsy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NOV,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NOV Breast cancer metastatic,Female Breast Cancer
AFFECTS,TP53BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53BP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATM gene|ATM,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,ATM gene|ATM Contralateral breast cancer,Female Breast Cancer
AFFECTS,Pharmacologic Substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmacologic Substance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Mammary Neoplasms,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Mammary Neoplasms Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,NCOA7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NCOA7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ALCAM gene|ALCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALCAM gene|ALCAM Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SPDEF gene|SPDEF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPDEF gene|SPDEF Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ESR1 gene|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CXCR4 gene|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,"Receptors, Steroid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,"Receptors, Steroid Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta catenin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SERPINE1 gene|SERPINE1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SERPINE1 gene|SERPINE1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Cancer Promoting Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer Promoting Genes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Linoleic Acids, Conjugated Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Metabolic Marker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolic Marker Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CXCL10 gene|CXCL10,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL10 gene|CXCL10 Breast cancer metastatic,Female Breast Cancer
CAUSES,CBX7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CBX7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,caveolin 1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,caveolin 1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,MMP9 gene|MMP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP9 gene|MMP9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"TIMP2 protein, human|TIMP2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TIMP2 protein, human|TIMP2 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,BEX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BEX2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Growth,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Growth Breast cancer metastatic,Female Breast Cancer
AFFECTS,SOX18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOX18 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MAP Kinase Gene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MAP Kinase Gene Breast cancer metastatic,Female Breast Cancer
AFFECTS,CD44 gene|CD44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,intraoperative radiotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,intraoperative radiotherapy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Gallic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Gallic acid Breast cancer metastatic,Female Breast Cancer
AUGMENTS,ATP2B2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ATP2B2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KIT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAD51B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAD51B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lipids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Lipid,Lipids Breast cancer metastatic,Female Breast Cancer
DISRUPTS,FBXW7 gene|FBXW7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXW7 gene|FBXW7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ESR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,diindolylmethane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,diindolylmethane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S Phase Arrest,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S Phase Arrest Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MALAT1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ASAP1|MYCBPAP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ASAP1|MYCBPAP Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,hypercholesterolemia,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,hypercholesterolemia Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,Functional RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,COX7A2L gene|COX7A2L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COX7A2L gene|COX7A2L Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Gelsolin|GSN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelsolin|GSN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,F3 gene|F3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,F3 gene|F3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Primary Neoplasm,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Primary Neoplasm Breast cancer metastatic,Female Breast Cancer
AFFECTS,aurora kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aurora kinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCL22 gene|CCL22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL22 gene|CCL22 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vascular Endothelial Growth Factor C|VEGFA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C|VEGFA Breast cancer metastatic,Female Breast Cancer
AFFECTS,Primary carcinoma of the liver cells,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Primary carcinoma of the liver cells Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CRY1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CRY1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CIP2A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,CIP2A Breast Carcinoma,Female Breast Cancer
AUGMENTS,Berberine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Berberine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vimentin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Vimentin Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,IL2-inducible T-cell kinase|ITK|SLC22A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL2-inducible T-cell kinase|ITK|SLC22A3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,KIF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KIF11 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ATG4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ATG4B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chloroquine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chloroquine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TMEM88,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TMEM88 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tumor Suppressor Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Familial cancer of breast,Female Breast Cancer
CAUSES,Proto-Oncogene Proteins c-myc|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-myc|MYC Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cysteine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Cysteine Breast cancer metastatic,Female Breast Cancer
AFFECTS,RNA-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FGF1 gene|FGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF1 gene|FGF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SFRP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SFRP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PFN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PFN1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alport's syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Alport's syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERCC1 gene|ERCC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERCC1 gene|ERCC1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Diphosphonates,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Diphosphonates Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Overweight,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Overweight Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Collagen Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,STAT3 gene|STAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PARK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARK7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Malignant neoplasm of prostate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,molybdenum disulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,molybdenum disulfide Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,OIP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OIP5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHEST PATHOLOGY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CHEST PATHOLOGY Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,oleocanthal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,oleocanthal Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neuromedin U|NMU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neuromedin U|NMU Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CASP9 gene|CASP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASP9 gene|CASP9 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Angiopoietin-2|ANGPT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiopoietin-2|ANGPT2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DEAE-Dextran,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DEAE-Dextran Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Disaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Disaccharides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LEPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LEPR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ESR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,docetaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,docetaxel Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Reproductive History,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Reproductive History Contralateral breast cancer,Female Breast Cancer
AUGMENTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIK3CA|PIK3CB|PIK3CD|PIK3CG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,dieckol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dieckol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Lovastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lovastatin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic Touch,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Therapeutic Touch Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Smoking Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Smoking Status Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Phenformin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Phenformin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CCL13 gene|CCL13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL13 gene|CCL13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Taxanes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Taxanes Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,teleocalcin,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,teleocalcin Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,ligustilide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ligustilide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Biogenesis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,C-terminal binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-terminal binding protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TNFAIP8L3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,TNFAIP8L3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,LGR5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LGR5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immune response,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Immune response Breast cancer metastatic,Female Breast Cancer
AFFECTS,Malignant neoplasm of urinary bladder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of urinary bladder Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Polyaromatic hydrocarbon,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Polyaromatic hydrocarbon Breast Carcinoma,Female Breast Cancer
AFFECTS,matrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,matrine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein phosphatase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCR7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCR7 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Glucuronosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucuronosyltransferase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,interleukin-17E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-17E Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proto-Oncogene Proteins c-akt|AKT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,MAGEA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAGEA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Genes, Regulator",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Genes, Regulator Breast Carcinoma",Female Breast Cancer
AFFECTS,Inactivation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inactivation Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Somatostatin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatostatin Receptor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC9A3R1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC9A3R1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Docosahexaenoic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Docosahexaenoic Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDX2 gene|CDX2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CDX2 gene|CDX2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,RCCD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RCCD1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN34A gene|MIR34A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN34A gene|MIR34A Breast cancer metastatic,Female Breast Cancer
DISRUPTS,NBAT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NBAT1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Neuropilin-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neuropilin-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inflammation,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"kallikrein 5, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"kallikrein 5, human Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Inflammation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Breast cancer metastatic,Female Breast Cancer
AFFECTS,Endothelin-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endothelin-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast cancer invasive NOS,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Breast cancer metastatic,Female Breast Cancer
AFFECTS,Ethanol,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Ethanol Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Fatty Acids, Omega-3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-3 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,NSUN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NSUN2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Primary carcinoma of the liver cells,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Primary carcinoma of the liver cells Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lysine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cadherins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cadherins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MTA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTA3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Membrane Transport Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Transport Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Trichloroethylene,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Trichloroethylene Carcinoma of Male Breast,Male Breast Cancer
COMPLICATES,topical application,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",topical application Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"KLK5 protein, human|KLK5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","KLK5 protein, human|KLK5 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Non-alcoholic fatty liver,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Non-alcoholic fatty liver Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Age at menarche,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Age at menarche Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sleep behavior finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sleep behavior finding Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ESR2 gene|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR2 gene|ESR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NOD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NOD2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCL4 gene|CCL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL4 gene|CCL4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Oligonucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,receptor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,receptor Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Antiepileptic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antiepileptic Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Linoleic Acids, Conjugated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,GSTM3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GSTM3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SIRT7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SIRT7 Breast cancer metastatic,Female Breast Cancer
CAUSES,Neoplasm,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Neoplasm Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Progesterone level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone level Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Aptamer,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Aptamer Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,FABP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FABP4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,E2F7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,E2F7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,zinc-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",zinc-binding protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Proliferation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Cell Proliferation Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Hydroxyestrones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxyestrones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KRT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KRT5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Isoprostanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isoprostanes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coffee intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coffee intake Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Choline Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,WWOX,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,WWOX Breast cancer metastatic,Female Breast Cancer
AUGMENTS,PPM1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPM1D Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcriptional Regulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcriptional Regulation Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GATA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GATA4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,everolimus,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,everolimus Breast cancer metastatic,Female Breast Cancer
DISRUPTS,decorin|DCN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,decorin|DCN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epidermal Growth Factor Receptor|EGFR,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Dessert,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dessert Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PHF5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PHF5A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ITGA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ITGA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,thymoquinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thymoquinone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cucurbitacin B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cucurbitacin B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thyroid Hormone Receptor Alpha-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormone Receptor Alpha-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,dronedarone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dronedarone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FOXC1 gene|FOXC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,FOXC1 gene|FOXC1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Menarche,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Menarche Breast Carcinoma,Female Breast Cancer
DISRUPTS,kaempferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,kaempferol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Encounter due to prophylactic surgery, unspecified",Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,"Encounter due to prophylactic surgery, unspecified Familial cancer of breast",Female Breast Cancer
CAUSES,zileuton,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,zileuton Breast Carcinoma,Female Breast Cancer
AUGMENTS,APC,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,APC Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,Stanolone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Stanolone Breast Carcinoma,Female Breast Cancer
CAUSES,Loops,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Loops Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,polycylic aromatic hydrocarbons-DNA adduct,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",polycylic aromatic hydrocarbons-DNA adduct Malignant neoplasm of breast,Female Breast Cancer
CAUSES,XRCC1 gene|XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Fibronectins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Fibronectins Breast cancer metastatic,Female Breast Cancer
CAUSES,"Neoplastic Syndromes, Hereditary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Neoplastic Syndromes, Hereditary Malignant neoplasm of breast",Female Breast Cancer
CAUSES,APOE gene|APOE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APOE gene|APOE Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Ceramides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ceramides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ATP phosphohydrolase|DNAH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ATP phosphohydrolase|DNAH8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Metabolic syndrome,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Metabolic syndrome Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Angiogenesis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Angiogenesis Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1B gene|CDKN1B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Spectroscopy, Nuclear Magnetic Resonance",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Spectroscopy, Nuclear Magnetic Resonance Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Radiofrequency ablation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiofrequency ablation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ANAPC15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ANAPC15 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDC2 gene|CDK1|POLD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC2 gene|CDK1|POLD1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EZH2 gene|EZH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,lapatinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lapatinib Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Apolipoprotein A-I|APOA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein A-I|APOA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UGT1A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UGT1A6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Integrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CHES1 gene|FOXN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHES1 gene|FOXN3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A8 gene|S100A8,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,S100A8 gene|S100A8 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Emodin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Emodin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Raloxifene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Raloxifene Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Neoplasm progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm progression Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fasting,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fasting Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TOB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TOB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fatty fish,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fatty fish Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,caveolin 1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,caveolin 1 Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,RAD51C gene|RAD51C,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,RAD51C gene|RAD51C Familial cancer of breast,Female Breast Cancer
AFFECTS,Anti-Anxiety Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Anxiety Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Polyunsaturated Fatty Acids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,P-Glycoprotein,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",P-Glycoprotein Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Hormone replacement therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Hormone replacement therapy Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Recreation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Recreation Breast Carcinoma,Female Breast Cancer
CAUSES,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1A gene|CDKN1A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Endopeptidases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Endopeptidases Breast Carcinoma,Female Breast Cancer
CAUSES,BRCA1 gene|BRCA1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast Carcinoma,Female Breast Cancer
AFFECTS,Osteoporosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Osteoporosis Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrogen Replacement Therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Estrogen Replacement Therapy Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,LACRT gene|LACRT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LACRT gene|LACRT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phenelzine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phenelzine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Oral Contraceptives, Low-Dose",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Oral Contraceptives, Low-Dose Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Nortriptyline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nortriptyline Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Overweight,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Overweight Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Diet,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Diet Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Overoptimism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Overoptimism Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nonpuerperal mastitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nonpuerperal mastitis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Health promotion behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Health promotion behavior Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"IGFBP2 protein, human|IGFBP2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IGFBP2 protein, human|IGFBP2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Excision,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Excision Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,somatotropin-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",somatotropin-binding protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Behavioral change,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Behavioral change Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Smoking,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Smoking Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Alkaline Phosphatase,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Alkaline Phosphatase Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,RFC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RFC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Health-related behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Health-related behavior Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Androgen Receptor|AR,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Androgen Receptor|AR Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,phenylalanyl-glycyl-valyl-statyl-alanyl-phenylalanine methyl ester,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,phenylalanyl-glycyl-valyl-statyl-alanyl-phenylalanine methyl ester Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Aromatase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Aromatase Breast Carcinoma,Female Breast Cancer
AFFECTS,Gonadotropins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gonadotropins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Mutation bilateral breast cancer,Female Breast Cancer
PREDISPOSES,CCND1 gene|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,bexarotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bexarotene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Serum Albumin,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Body Substance,Serum Albumin Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,Diastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diastasis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diabetes type,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diabetes type Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ataxia Telangiectasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ataxia Telangiectasia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TMEM131L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TMEM131L Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MMP14 gene|MMP14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP14 gene|MMP14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,16q12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,16q12 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Macrophage Colony-Stimulating Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Macrophage Colony-Stimulating Factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Cycle Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cell Cycle Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Goserelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Goserelin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Air Pollution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Air Pollution Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biotinidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biotinidase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UBE2S,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UBE2S Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Carcinoma, Ductal, Breast",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,"Carcinoma, Ductal, Breast Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AFFECTS,Primary Lesion,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Primary Lesion Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Mastectomy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Mastectomy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Vincristine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vincristine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Punctate calcium deposition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Punctate calcium deposition Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hodgkin Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hodgkin Disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary Supplements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Supplements Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Endotoxins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Endotoxins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IRS1 gene|IRS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRS1 gene|IRS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Valine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,STN gene|EEF1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STN gene|EEF1A2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Excessive weight gain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Excessive weight gain Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Drinking pattern,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Drinking pattern Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prunes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prunes Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Thyroid Hormones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Thyroid Hormones Breast Carcinoma,Female Breast Cancer
AFFECTS,Cosmetic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cosmetic procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Drug Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Drug Exposure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCL5 gene|CCL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL5 gene|CCL5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Autoimmune hypothyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Autoimmune hypothyroidism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nuclear Receptor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nuclear Receptor Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcoholic Beverages,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Alcoholic Beverages Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,VASOMOTOR SYMPTOM,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,VASOMOTOR SYMPTOM Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,epigallocatechin gallate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,epigallocatechin gallate Breast Carcinoma,Female Breast Cancer
AFFECTS,agonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,agonists Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tipifarnib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tipifarnib Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Activins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Activins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MUC4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MUC4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Personal Satisfaction,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Personal Satisfaction Familial cancer of breast,Female Breast Cancer
CAUSES,PALB2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,PALB2 Familial cancer of breast,Female Breast Cancer
AFFECTS,lapatinib,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,lapatinib Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Interleukin-8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-8 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Steroidal Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroidal Estrogen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,trichostatin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,trichostatin A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLK5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLK5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Family history of breast cancer,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Family history of breast cancer Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Rare Diseases,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Rare Diseases Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,deceased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,deceased Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Telomere Maintenance Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Telomere Maintenance Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cyclin-dependent kinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclin-dependent kinase 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,conjugation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",conjugation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,overdiagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,overdiagnosis Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Sirolimus (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Sirolimus (substance) Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NR5A2|P2RX5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NR5A2|P2RX5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diabetes Mellitus,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Diabetes Mellitus Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,KRT20|C17orf97,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KRT20|C17orf97 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NR3C1 gene|NR3C1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR3C1 gene|NR3C1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Receptors, Progesterone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,zeaxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,zeaxanthin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BRCA3 gene|BRCA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA3 gene|BRCA3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,heparanase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,heparanase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CD40 Ligand|CD40LG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD40 Ligand|CD40LG Malignant neoplasm of breast,Female Breast Cancer
CAUSES,interleukin-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-19 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Calgranulin A|S100A8,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Calgranulin A|S100A8 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Physical therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physical therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Red Meat Consumption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Red Meat Consumption Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Muscular Dystrophy, Facioscapulohumeral",bilateral breast cancer,0.0,Female Breast Cancer,Other,"Muscular Dystrophy, Facioscapulohumeral bilateral breast cancer",Female Breast Cancer
PREDISPOSES,Instability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Instability Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diabetes Mellitus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diabetes Mellitus Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CSH2 gene|CSH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CSH2 gene|CSH2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Actin bundling protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Actin bundling protein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,IL8 gene|CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL8 gene|CXCL8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KIF2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KIF2A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Apoptosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Apoptosis Breast Carcinoma,Female Breast Cancer
AFFECTS,MTHFR gene|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTHFR gene|MTHFR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGA2 gene|HMGA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AKR1C4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AKR1C4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ABCC10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABCC10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCDC91,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCDC91 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ribonucleotide reductase M2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ribonucleotide reductase M2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1JP|MT1M|MT1L|MT1X|MTNR1A|ALG1|MT1IP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1JP|MT1M|MT1L|MT1X|MTNR1A|ALG1|MT1IP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cadmium Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Cadmium Compounds Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Female Breast Carcinoma,Female Breast Cancer
AFFECTS,psychological distress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,psychological distress Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PALB2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,PALB2 Female Breast Carcinoma,Female Breast Cancer
AUGMENTS,HIF1A gene|HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Insulin Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Alcohol products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alcohol products Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammography abnormal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mammography abnormal Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Copper,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Copper Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,germin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,germin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Smoking,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Smoking Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Pharmaceutical Preparations,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,Hyaluronan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyaluronan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,diindolylmethane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,diindolylmethane Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disorder of pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disorder of pregnancy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sleeplessness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sleeplessness Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RRM2 gene|RRM2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RRM2 gene|RRM2 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Sirolimus (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Sirolimus (substance) Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Soluble ErbB-1|EGFR,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Soluble ErbB-1|EGFR Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Silence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Silence Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gene Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Family Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PELP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PELP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fertility care,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fertility care Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MMP11 gene|MMP11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP11 gene|MMP11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic microcalcification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Mammographic microcalcification Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,MIRN93 gene|MIR93|MIR9-3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN93 gene|MIR93|MIR9-3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Urokinase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Urokinase Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Protein p53|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Protein p53|TP53 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Tumor Suppressor Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Rye flour,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rye flour Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Clusterin|CLU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Clusterin|CLU Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gonadal Steroid Hormones,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Gonadal Steroid Hormones Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Diffusion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diffusion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Co-morbid conditions,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Co-morbid conditions Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,regular physical activity,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,regular physical activity Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,C-KIT Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,C-KIT Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MICE gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,MICE gene Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Mitotic/Spindle Checkpoint,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitotic/Spindle Checkpoint Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Angiogenesis Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Alcohol consumption,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,claudin 6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,claudin 6 Breast Carcinoma,Female Breast Cancer
AUGMENTS,NEK2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"NEK2 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Somatotropin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatotropin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CHD5 gene|CHD5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHD5 gene|CHD5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glutamate-Cysteine Ligase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glutamate-Cysteine Ligase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PERP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PERP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,EGF gene|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGF gene|EGF Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammaplasty,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Mammaplasty Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Mammographic breast density,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Mammographic breast density Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Autoimmunity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Autoimmunity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sunlight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sunlight Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PARD6A|PWAR6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARD6A|PWAR6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cardanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cardanol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,None|SLC16A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,None|SLC16A3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinoma in situ of breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Carcinoma in situ of breast Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Corn Oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Corn Oil Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Zinc,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Zinc Carcinoma, Ductal, Breast",Female Breast Cancer
AUGMENTS,UCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UCA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CHEK1 protein, human|CHEK1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CHEK1 protein, human|CHEK1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Non-Viral Vector,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Non-Viral Vector Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,aglepristone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,aglepristone Breast Carcinoma,Female Breast Cancer
AFFECTS,White bread,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,White bread Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen effect Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Disability NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Disability NOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERCC2 gene|ERCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC2 gene|ERCC2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Disease,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Disease Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,"Calcium, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Calcium, Dietary Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Radiation,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Fluorodeoxyglucose F18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Fluorodeoxyglucose F18 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-18,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Interleukin-18 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,chemokine receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,chemokine receptor Breast cancer metastatic,Female Breast Cancer
AFFECTS,CCND1 Gene Amplification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND1 Gene Amplification Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Integrin alphaV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrin alphaV Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PROX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PROX1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Dioxins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dioxins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cisplatin/cyclophosphamide/etoposide protocol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cisplatin/cyclophosphamide/etoposide protocol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PINX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PINX1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,BST2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BST2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethanol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,aldehyde dehydrogenase 1|ALDH1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenase 1|ALDH1A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Membrane Transport Proteins,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Transport Proteins Contralateral breast cancer,Female Breast Cancer
DISRUPTS,Tryptophan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tryptophan Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Baresthesia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Baresthesia Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Taurine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Taurine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast arterial calcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast arterial calcification Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FBXW7 gene|FBXW7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXW7 gene|FBXW7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,palmitoleic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,palmitoleic acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,LPO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LPO Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Amphiregulin|AREG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Amphiregulin|AREG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PROTEIN KINASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,C14orf166 gene|RTRAF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,C14orf166 gene|RTRAF Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EGFR Protein Overexpression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",EGFR Protein Overexpression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RPS6KA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RPS6KA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FBXO31 gene|FBXO31,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO31 gene|FBXO31 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FABP4 gene|FABP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FABP4 gene|FABP4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Peroxisome Proliferator-Activated Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Peroxisome Proliferator-Activated Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GATA3 gene|GATA3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Breast Carcinoma,Female Breast Cancer
AFFECTS,Reexcision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reexcision Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to breast augmentation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Encounter due to breast augmentation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vimentin|VIM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vimentin|VIM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GAS5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MAPK12 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK12 gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,tacrolimus binding protein 4|FKBP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tacrolimus binding protein 4|FKBP4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,COPS5,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,COPS5 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,ZNF350,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF350 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Air Pollutants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Air Pollutants Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Hyperostosis, Diffuse Idiopathic Skeletal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Hyperostosis, Diffuse Idiopathic Skeletal Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,celecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,celecoxib Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD151,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CD151 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Fenretinide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fenretinide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signal Transduction Pathways,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Pathways Breast Carcinoma,Female Breast Cancer
AFFECTS,Breast Cancer Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cancer Model Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ellagic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ellagic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FGFR1 gene|FGFR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR1 gene|FGFR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunomodulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunomodulators Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ADA Breast Carcinoma,Female Breast Cancer
PREDISPOSES,HADHA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HADHA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,N-acetyltransferase 1|EREG|ESR1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,N-acetyltransferase 1|EREG|ESR1 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Antiplatelet therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antiplatelet therapy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA2 gene|BRCA2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,TIMELESS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TIMELESS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Annexin A2|ANXA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A2|ANXA2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Work stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Work stress Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cancer Promoting Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer Promoting Genes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RHBDD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RHBDD1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Heparan Sulfate Proteoglycan|HSPG2|SDC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heparan Sulfate Proteoglycan|HSPG2|SDC2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,LAMTOR5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LAMTOR5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MALAT1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PGD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PGD Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diabetes Mellitus, Non-Insulin-Dependent Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,"MAPK14 protein, human|MAPK14",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MAPK14 protein, human|MAPK14 Breast cancer invasive NOS",Female Breast Cancer
PREDISPOSES,Estrogen Receptor Status,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Status Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Liver Cirrhosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Liver Cirrhosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Brain Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Brain Neoplasms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Genes Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Oranges,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oranges Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Fatty Acids, Saturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Saturated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Edema,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Edema Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,SESTAMIBI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SESTAMIBI Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Aspirin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Aspirin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Onions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Onions Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lamins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Androstenedione,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Androstenedione Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body mass index,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Body mass index Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,LINC00518,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00518 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DDT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DDT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Overweight,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Overweight Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,ID2 gene|ID2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ID2 gene|ID2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,thrombospondin 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thrombospondin 4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Histone Deacetylase Inhibitor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Histone Deacetylase Inhibitor Breast cancer metastatic,Female Breast Cancer
DISRUPTS,AQP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AQP3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ranolazine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ranolazine Breast cancer metastatic,Female Breast Cancer
AFFECTS,mannuronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,mannuronic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KIF4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KIF4A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,exemestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,exemestane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Repeat Surgery,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Repeat Surgery Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,PIP5K1C,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"PIP5K1C Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,KRT19 gene|KRT19,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KRT19 gene|KRT19 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Luteolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Luteolin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ectopic Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ectopic Expression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SOCS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOCS1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,AQP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AQP5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MFAP5 gene|MFAP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MFAP5 gene|MFAP5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCL20 gene|CCL20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL20 gene|CCL20 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ENPP2|SMG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ENPP2|SMG1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FTO Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PDLIM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PDLIM2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SDC1 gene|SDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gamma-Linolenic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,gamma-Linolenic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Supportive care,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Supportive care Breast cancer metastatic,Female Breast Cancer
DISRUPTS,CD44 gene|CD44,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,RBMS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RBMS3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,VIPR1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,VIPR1 Breast Carcinoma,Female Breast Cancer
DISRUPTS,triptolide,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,triptolide Breast cancer metastatic,Female Breast Cancer
AFFECTS,targeting,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"targeting Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,Skin Lymphangiosarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Skin Lymphangiosarcoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coronary heart disease,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Coronary heart disease Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Metformin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Metformin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Phosphorus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphorus Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Rosacea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rosacea Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PUF60,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PUF60 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,YAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,YAP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MAFG gene|MAFG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MAFG gene|MAFG Breast Carcinoma,Female Breast Cancer
AFFECTS,"1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,oncostatin M|OSM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,oncostatin M|OSM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dexamethasone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Dexamethasone Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Phthalimides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phthalimides Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HDAC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HDAC9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VIM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VIM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CISH,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,CISH Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,ADAMTS1 gene|ADAMTS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAMTS1 gene|ADAMTS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Honey bee venom,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Honey bee venom Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Antigens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Antigens Breast cancer metastatic,Female Breast Cancer
AFFECTS,C-Phycocyanin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,C-Phycocyanin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NEAT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,ATP-Binding Cassette Transporters|ATP8A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ATP-Binding Cassette Transporters|ATP8A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antisense RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Antisense RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNHG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNHG1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Metals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metals Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mRNA Expression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",mRNA Expression Breast Carcinoma,Female Breast Cancer
AFFECTS,Anaplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anaplasia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABCA1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SDC1 gene|SDC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Breast cancer metastatic,Female Breast Cancer
CAUSES,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP1A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GLI3 gene|GLI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLI3 gene|GLI3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tissue-Specific Gene Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tissue-Specific Gene Expression Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Egg Food Product,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Food,Egg Food Product Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Hyperglycemia,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Hyperglycemia Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Valproic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Valproic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MDM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MDM4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proto-Oncogene Proteins c-jun|JUN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-jun|JUN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MDM2 gene|MDM2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,E-Cadherin|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,E-Cadherin|CDH1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pollutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pollutant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Medication use,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Medication use Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Chinese herbal medicine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chinese herbal medicine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TIMM13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TIMM13 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"PER2 protein, mammalian",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Cyclin-Dependent Kinase Inhibitor 2A|CDK4,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Cyclin-Dependent Kinase Inhibitor 2A|CDK4 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,silybin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,silybin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PCB 138,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 138 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP2C8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP2C8 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN192 gene|MIR192,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN192 gene|MIR192 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Extracellular Matrix Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Extracellular Matrix Proteins Breast cancer metastatic,Female Breast Cancer
AFFECTS,Phenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phenols Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRIM44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TRIM44 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Quinoxalines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quinoxalines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PXDNL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PXDNL Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Vitamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TUFT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TUFT1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,transcription factor PML,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",transcription factor PML Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Silence,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Silence Breast cancer metastatic,Female Breast Cancer
AFFECTS,Premenopause,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Premenopause Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,PTP4A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PTP4A3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDK12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDK12 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinosarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinosarcoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor stage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor stage Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Monocyte Chemoattractant Protein-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,JPH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,JPH1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Transcription Repressor/Corepressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Repressor/Corepressor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UBE2V1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,UBE2V1 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,RUNX2 gene|RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX2 gene|RUNX2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APRIN gene|PDS5B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,APRIN gene|PDS5B Breast cancer metastatic,Female Breast Cancer
AFFECTS,Chalcone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chalcone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BMX gene|BMX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMX gene|BMX Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mitogen-Activated Protein Kinase 3|MAPK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinase 3|MAPK3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,everolimus,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,everolimus Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Alternative Splicing,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Breast cancer metastatic,Female Breast Cancer
CAUSES,ethylene oxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ethylene oxide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FAM53A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAM53A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microbicides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Microbicides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GABRA3 gene|GABRA3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GABRA3 gene|GABRA3 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,paclitaxel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,paclitaxel Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,HULC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HULC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Trans Fatty Acids,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Chemical,Trans Fatty Acids estrogen receptor-negative breast cancer,Female Breast Cancer
AFFECTS,TGFB1 gene|TGFB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TGFB1 gene|TGFB1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,silence,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,silence Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Promoter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Promoter Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"nuclear receptor subfamily 1, group H, member 2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"nuclear receptor subfamily 1, group H, member 2 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,MIR30A wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR30A wt Allele Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nance-Horan syndrome,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Disease or Syndrome,Nance-Horan syndrome Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,intrauterine disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,intrauterine disorder Malignant neoplasm of breast,Female Breast Cancer
CAUSES,mercury,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,mercury Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CLDN11 gene|CLDN11,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CLDN11 gene|CLDN11 Breast Carcinoma,Female Breast Cancer
COMPLICATES,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","MicroRNAs Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,RHPN1-AS1 gene|RHPN1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHPN1-AS1 gene|RHPN1-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABCB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA2 gene|BRCA2,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 contralateral breast cancer,Female Breast Cancer
DISRUPTS,ibrutinib,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,ibrutinib Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Ubiquitin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Ubiquitin Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Copy Number Polymorphism,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Copy Number Polymorphism Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,"Antibodies, Blocking",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Antibodies, Blocking Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,TT genotype,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,TT genotype Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,opium alkaloids and derivative combination cough suppressants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",opium alkaloids and derivative combination cough suppressants Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tamoxifen,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Pharmacologic Substance,tamoxifen Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,letrozole,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Pharmacologic Substance,letrozole Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,Mutation,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Mutation contralateral breast cancer,Female Breast Cancer
AUGMENTS,SIRT4 gene|SIRT4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIRT4 gene|SIRT4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 Breast Carcinoma,Female Breast Cancer
AFFECTS,MIR221 gene|MIR221,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR221 gene|MIR221 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Invasive carcinoma of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Invasive carcinoma of breast Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00963 gene|LINC00963,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00963 gene|LINC00963 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,29+,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,29+ Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Polyunsaturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polyunsaturated fat Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Patient Derived Xenograft,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Patient Derived Xenograft Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,"TGFB1 protein, human|TGFB1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,MIR221 gene|MIR221,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR221 gene|MIR221 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BHLHE40-AS1 gene|BHLHE40-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BHLHE40-AS1 gene|BHLHE40-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLX4IP gene|SLX4IP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLX4IP gene|SLX4IP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,olaparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,olaparib Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Contrast enhanced spectral mammography,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,Contrast enhanced spectral mammography malignant neoplasm of breast staging,Female Breast Cancer
CAUSES,SFN,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,SFN Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,MTOR gene|MTOR,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,MTOR gene|MTOR Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,SOX21-AS1 gene|SOX21-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SOX21-AS1 gene|SOX21-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Detection,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Detection malignant neoplasm of breast staging,Female Breast Cancer
PREDISPOSES,STAT1 gene|STAT1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,STAT1 gene|STAT1 Basal-Like Breast Carcinoma,Female Breast Cancer
AUGMENTS,Transcriptome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transcriptome Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Macrolides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Macrolides Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Gonadal Steroid Hormones,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Rheumatoid Arthritis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rheumatoid Arthritis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fiber Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunohistochemistry,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Immunohistochemistry Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CISH protein, human|CISH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CISH protein, human|CISH Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,NOP2 gene|NOP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOP2 gene|NOP2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SNHG3 gene|SNHG3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNHG3 gene|SNHG3 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,MDC1 gene|MDC1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,MDC1 gene|MDC1 Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,FOXP1 gene|FOXP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXP1 gene|FOXP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UBE2M gene|UBE2M,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2M gene|UBE2M Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD44,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,CD44 Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Iodides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iodides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MLKL gene|MLKL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLKL gene|MLKL Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,prolactin,Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,Other,prolactin Triple-Negative Breast Carcinoma,Female Breast Cancer
AFFECTS,subharmonic imaging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,subharmonic imaging Breast Carcinoma,Female Breast Cancer
DISRUPTS,OSW 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,OSW 1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,STAT3 gene|STAT3,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,HER2-positive carcinoma of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2-positive carcinoma of breast Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Second line treatment,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Second line treatment Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Hemangiosarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hemangiosarcoma Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HEXIM1 gene|HEXIM1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HEXIM1 gene|HEXIM1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Hormone Receptor Positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Positive Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Genes, Modifier",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Modifier Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Proliferation (morphologic abnormality),Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Proliferation (morphologic abnormality) Breast Carcinoma,Female Breast Cancer
AUGMENTS,Suppressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Suppressor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WWTR1 protein, human|WWTR1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,LINC00160 gene|LINC00160,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,LINC00160 gene|LINC00160 estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,methanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methanol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOSB,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,FOSB Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,KLHL22 gene|KLHL22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLHL22 gene|KLHL22 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Postmenopausal state,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Postmenopausal state Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytotoxic Chemotherapy,HER2-negative breast cancer,0.0,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic Chemotherapy HER2-negative breast cancer,Female Breast Cancer
DISRUPTS,HSP90 Heat-Shock Proteins|HSP90AA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HSP90 Heat-Shock Proteins|HSP90AA1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Procedure findings:Finding:Point in time:^Patient:Narrative Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,risk factors,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,risk factors Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Cadherins,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Cadherins Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Pathogenic,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Virus,Pathogenic contralateral breast cancer,Female Breast Cancer
PREDISPOSES,information seeking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",information seeking Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RB1CC1 gene|RB1CC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RB1CC1 gene|RB1CC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RUNX3 gene|RUNX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX3 gene|RUNX3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic resonance imaging of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Magnetic resonance imaging of breast Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXCR2 gene|CXCR2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CXCR2 gene|CXCR2 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,SIRT6 gene|SIRT6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIRT6 gene|SIRT6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ion Channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ion Channel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Eukaryotic Initiation Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Eukaryotic Initiation Factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Flavanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavanol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epigallocatechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Epigallocatechin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SIRT1 gene|SIRT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIRT1 gene|SIRT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,apigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,apigenin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AGR2,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,AGR2 estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vitamin D3 24-Hydroxylase|CYP24A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 24-Hydroxylase|CYP24A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BHLHE40 gene|BHLHE40,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BHLHE40 gene|BHLHE40 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epicatechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Epicatechin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"KRT10 protein, human|KRT10",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","KRT10 protein, human|KRT10 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,UBE2D2 gene|UBE2D2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2D2 gene|UBE2D2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CST3 gene|CST3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CST3 gene|CST3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,P-Cadherin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,P-Cadherin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PRS gene|PRS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRS gene|PRS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Easy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Easy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,C8A gene|C8A,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,C8A gene|C8A HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Radionuclide Imaging,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Radionuclide Imaging malignant neoplasm of breast staging,Female Breast Cancer
CAUSES,CTBP1-AS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTBP1-AS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,silence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,silence Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cancer-Predisposing Gene,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Cancer-Predisposing Gene Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,NEAT1 gene|NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEAT1 gene|NEAT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Caffeinated coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Caffeinated coffee Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,steroid glycoside,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Steroid,steroid glycoside Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,5-methyltetrahydrofolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,5-methyltetrahydrofolate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypertrophy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypertrophy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNAI3 gene|SNAI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNAI3 gene|SNAI3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,lapatinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,lapatinib HER2-positive carcinoma of breast,Female Breast Cancer
CAUSES,rucaparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,rucaparib Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FZD7 gene|FZD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FZD7 gene|FZD7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cisplatin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Kynurenine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Kynurenine Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,ZFPM2-AS1 gene|ZFPM2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZFPM2-AS1 gene|ZFPM2-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Visual Accommodation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Visual Accommodation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,mTOR Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mTOR Inhibitor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Biological Markers Female Breast Carcinoma,Female Breast Cancer
COMPLICATES,CTHRC1 gene|CTHRC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTHRC1 gene|CTHRC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Crown-Like Structures of the Breast,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Crown-Like Structures of the Breast Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,UBR1 gene|UBR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBR1 gene|UBR1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NMU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NMU Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,xanthomicrol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,xanthomicrol Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Crown-Like Structures of the Breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Crown-Like Structures of the Breast Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"HLA Class I Histocompatibility Antigen, Alpha Chain G",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"HLA Class I Histocompatibility Antigen, Alpha Chain G Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"Receptors, Adrenergic, beta-1|ADRB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Adrenergic, beta-1|ADRB1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,angiotensin converting enzyme 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,angiotensin converting enzyme 2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"YAP1 protein, human|YAP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","YAP1 protein, human|YAP1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,polyphenols,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,polyphenols HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Lipids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Lipid,Lipids Breast Carcinoma,Female Breast Cancer
DISRUPTS,GPER1 gene|GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPER1 gene|GPER1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,rasagiline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,rasagiline Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,JMJD6 gene|JMJD6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JMJD6 gene|JMJD6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Regulatory Sequences, Nucleic Acid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Regulatory Sequences, Nucleic Acid Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,PPP2R2B gene|PPP2R2B,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,PPP2R2B gene|PPP2R2B HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cisplatin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neutrons,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Neutrons Breast Carcinoma,Female Breast Cancer
AFFECTS,HHEX gene|HHEX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HHEX gene|HHEX Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ERRFI1 gene|ERRFI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERRFI1 gene|ERRFI1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary Alcohol,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Dietary Alcohol Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,"CD9 protein, human|CD9",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD9 protein, human|CD9 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,ZFAS1 gene|ZFAS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZFAS1 gene|ZFAS1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"CREB1 protein, human|CREB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CREB1 protein, human|CREB1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,mannose receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mannose receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RCC2 gene|RCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RCC2 gene|RCC2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HER2-targeting Agent,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2-targeting Agent HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Anti-Angiogenesis Effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Anti-Angiogenesis Effect Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Volatile Organic Compounds,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Chemical,Volatile Organic Compounds Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,gemcitabine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,gemcitabine Triple Negative Breast Neoplasms,Female Breast Cancer
COMPLICATES,Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Obesity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pulmonary Metastasectomy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Pulmonary Metastasectomy Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATM,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Other,ATM Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
AFFECTS,Neoplasms by Site,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Neoplasms by Site Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Systemic Therapy,Locally advanced breast cancer,0.0,Female Breast Cancer,Other,Systemic Therapy Locally advanced breast cancer,Female Breast Cancer
DISRUPTS,MST1 gene|MST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MST1 gene|MST1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcohol dehydrogenase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol dehydrogenase Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TRIM6 gene|TRIM6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM6 gene|TRIM6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tissue Inhibitor of Metalloproteinase-3|TIMP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tissue Inhibitor of Metalloproteinase-3|TIMP3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,honokiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,honokiol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HNF1A-AS1 gene|HNF1A-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HNF1A-AS1 gene|HNF1A-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Low BMI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Low BMI Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,human MUC1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",human MUC1 protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ethanol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ethanol Breast Carcinoma,Female Breast Cancer
PREDISPOSES,GZMK gene|GZMK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GZMK gene|GZMK Malignant neoplasm of breast,Female Breast Cancer
CAUSES,pembrolizumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pembrolizumab Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,COL10A1 gene|COL10A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COL10A1 gene|COL10A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CHAF1A wt Allele|KAT2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CHAF1A wt Allele|KAT2B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,IFNG gene|IFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IFNG gene|IFNG Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Nicotinate-nucleotide pyrophosphorylase (carboxylating),Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinate-nucleotide pyrophosphorylase (carboxylating) Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,lipid mediator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,lipid mediator Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High birth weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,High birth weight Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mean score,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Mean score Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,VPS35 gene|VPS35,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VPS35 gene|VPS35 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,water channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,water channel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TNFRSF11A gene|TNFRSF11A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF11A gene|TNFRSF11A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC01977 gene|LINC01977,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01977 gene|LINC01977 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,vinorelbine,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,vinorelbine Carcinoma breast stage IV,Female Breast Cancer
CAUSES,Cytochrome P450|CYP2B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P450|CYP2B6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DEGS1 wt Allele|DEGS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DEGS1 wt Allele|DEGS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Atypical hyperplasia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Atypical hyperplasia Breast Carcinoma,Female Breast Cancer
AFFECTS,Second line treatment,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Second line treatment HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,WNT7B gene|WNT7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT7B gene|WNT7B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,Biological Markers malignant neoplasm of breast staging,Female Breast Cancer
CAUSES,Reactive Nitrogen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reactive Nitrogen Species Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Programmed cell death ligand 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Programmed cell death ligand 1 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,CYTOR gene|CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYTOR gene|CYTOR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin supplementation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vitamin supplementation Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR506 wt Allele,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,MIR506 wt Allele Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR31HG gene|MIR31HG Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR31HG gene|MIR31HG Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NF-kappa B,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,NF-kappa B Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MTERF3 gene|MTERF3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MTERF3 gene|MTERF3 Breast Carcinoma,Female Breast Cancer
AFFECTS,bisphenol A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bisphenol A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,lutein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lutein Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,estrogen receptor-positive breast cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",estrogen receptor-positive breast cancer Malignant neoplasm of breast,Female Breast Cancer
CAUSES,voacamine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,voacamine Breast Carcinoma,Female Breast Cancer
AUGMENTS,GLUCOSE-6-PHOSPHATASE,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Carbohydrate,GLUCOSE-6-PHOSPHATASE Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,atmospheric pollution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",atmospheric pollution Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sphingolipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Sphingolipids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,directive therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,directive therapy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Pathologic Neovascularization,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic Neovascularization Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"3,3'-diindolylmethane",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"3,3'-diindolylmethane Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,PFKFB4 gene|PFKFB4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PFKFB4 gene|PFKFB4 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Interferon-alpha,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Interferon-alpha Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Biological Response Modifiers,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Biological Response Modifiers estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Metastatic malignant neoplasm to brain,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Luminal B Breast Carcinoma,Female Breast Cancer
CAUSES,Angiogenesis Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FABP4 gene|FABP4,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,FABP4 gene|FABP4 Recurrent Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Imbalance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Imbalance Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Candidate Disease Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Chlorpyrifos,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chlorpyrifos Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Treatment Protocols,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Treatment Protocols estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Agent,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemical Viewed Functionally,Agent HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Long Intergenic Non-Protein Coding RNA,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Xenobiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Xenobiotics Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TRPV6 gene|TRPV6,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,TRPV6 gene|TRPV6 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,MMP11 gene|MMP11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP11 gene|MMP11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interstitial Collagenase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Interstitial Collagenase Breast Carcinoma,Female Breast Cancer
PREDISPOSES,AMD1 gene|AMD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AMD1 gene|AMD1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,E2F1 Transcription Factor|E2F1|UBE2L3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",E2F1 Transcription Factor|E2F1|UBE2L3 Breast Carcinoma,Female Breast Cancer
AFFECTS,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Transcription Factor|SOX2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proton Pump Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proton Pump Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,3F8 antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",3F8 antibody Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Increased prolactin level,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Increased prolactin level Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,PET/CT scan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PET/CT scan Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,UBA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UBA5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DEAD Box Helicase p68|DDX5|KHDRBS1|POLD3|GATAD2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DEAD Box Helicase p68|DDX5|KHDRBS1|POLD3|GATAD2B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Food, Organic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,"Food, Organic Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,rutecarpine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,rutecarpine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Epstein-Barr virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Epstein-Barr virus Malignant neoplasm of breast,Female Breast Cancer
CAUSES,bruceine D,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,bruceine D Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Breast Cancer Therapeutic Procedure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Breast Cancer Therapeutic Procedure Breast Carcinoma,Female Breast Cancer
AFFECTS,TBX15 gene|TBX15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TBX15 gene|TBX15 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Kynurenine 3-monooxygenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Kynurenine 3-monooxygenase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ovary; insufficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ovary; insufficiency Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PIM1 gene|PIM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIM1 gene|PIM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormone Therapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Hormone,Hormone Therapy Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,AIFM2 gene|AIFM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AIFM2 gene|AIFM2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZBTB7A|AKIRIN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZBTB7A|AKIRIN2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Trace Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trace Elements Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,MCM3AP-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MCM3AP-AS1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RPPH1 gene|RPPH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPPH1 gene|RPPH1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"protein tyrosine phosphatase, non-receptor type 1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","protein tyrosine phosphatase, non-receptor type 1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,estrogen use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogen use Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metronomic Chemotherapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Metronomic Chemotherapy Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,PALB2 gene|PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PALB2 gene|PALB2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,kinase inhibitor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Adriamycin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Adriamycin Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,epithelial to mesenchymal transition,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adverse Event Emergency Room Visit,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Phenomenon or Process,Adverse Event Emergency Room Visit Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,SNHG3 gene|SNHG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG3 gene|SNHG3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TUBA4A gene|TUBA4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TUBA4A gene|TUBA4A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WDR43 gene|WDR43,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,WDR43 gene|WDR43 estrogen receptor-negative breast cancer,Female Breast Cancer
PREDISPOSES,AMIGO2 gene|AMIGO2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,AMIGO2 gene|AMIGO2 HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,SNHG1 gene|SNHG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG1 gene|SNHG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Intronic Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intronic Mutation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammaplasty,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,Other,Mammaplasty Stage 0 Breast Carcinoma,Female Breast Cancer
CAUSES,"Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,glucose high,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,glucose high Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,aspirin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,aspirin Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Elevation procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elevation procedure Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GATA3 gene|GATA3,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TMEM130 gene|TMEM130,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMEM130 gene|TMEM130 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,oleyloxyethylphosphorylcholine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,oleyloxyethylphosphorylcholine Breast Carcinoma,Female Breast Cancer
AFFECTS,Plasma Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Plasma Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RASSF1 gene|RASSF1,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"RASSF1 gene|RASSF1 Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,BNIP3 gene|BNIP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BNIP3 gene|BNIP3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Overdiagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Overdiagnosis Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,erbB-2 Receptor|ERBB2,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Other,erbB-2 Receptor|ERBB2 Recurrent Breast Carcinoma,Recurrent Breast Cancer
AFFECTS,fibroblast activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",fibroblast activation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Elevated Expression,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Elevated Expression HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,COMT gene|COMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COMT gene|COMT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"leptin receptor, human|LEPR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"leptin receptor, human|LEPR Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,PTPN2 gene|PTPN2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTPN2 gene|PTPN2 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,FGFR4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,FGFR4 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,FERMT2 gene|FERMT2,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,FERMT2 gene|FERMT2 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,"Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4 Inflammatory Breast Carcinoma",Female Breast Cancer
AFFECTS,atezolizumab,Locally advanced breast cancer,0.0,Female Breast Cancer,Other,atezolizumab Locally advanced breast cancer,Female Breast Cancer
AFFECTS,Aromatase Inhibitors,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of female breast,Female Breast Cancer
AFFECTS,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEG3 gene|MEG3|FAM129B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Parity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parity Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,limonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,limonin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SHMT2 gene|SHMT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHMT2 gene|SHMT2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EIF3B gene|EIF3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EIF3B gene|EIF3B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MIR21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR21 gene|MIR21 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Suspensions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Suspensions Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ultrasound Tomography,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Ultrasound Tomography Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Parallel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parallel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mRNA editing,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",mRNA editing estrogen receptor-positive breast cancer,Female Breast Cancer
CAUSES,Transcription Coactivator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Coactivator Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lymphatic Invasion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lymphatic Invasion Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Precision Medicine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Precision Medicine Triple Negative Breast Neoplasms,Female Breast Cancer
COMPLICATES,Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,IRAK1 gene|IRAK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRAK1 gene|IRAK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TSPAN8 gene|TSPAN8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSPAN8 gene|TSPAN8 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genetic Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Loci Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ergocalciferol,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,ergocalciferol Invasive carcinoma of breast,Female Breast Cancer
COMPLICATES,Lymphedema,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lymphedema Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nicotinate-nucleotide pyrophosphorylase (carboxylating),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinate-nucleotide pyrophosphorylase (carboxylating) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Confirmation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Confirmation Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ALDH2 gene|ALDH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALDH2 gene|ALDH2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,interleukin-21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-21 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NTN4 gene|NTN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NTN4 gene|NTN4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor necrosis factor receptor 11b Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CCL18 gene|CCL18,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,CCL18 gene|CCL18 Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,TLN1 gene|TLN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TLN1 gene|TLN1 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Cell-Free DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cell-Free DNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Low health literacy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Low health literacy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,genistein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TIMM8A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,TIMM8A Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Free triiodothyronine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Free triiodothyronine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HAUS5 gene|HAUS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HAUS5 gene|HAUS5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC01315 gene|LINC01315,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC01315 gene|LINC01315 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Targeted Therapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Targeted Therapy Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,DLGAP1-AS2 gene|DLGAP1-AS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DLGAP1-AS2 gene|DLGAP1-AS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chromosomal translocation,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Chromosomal translocation Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,SOX10 gene|SOX10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOX10 gene|SOX10 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,lipid mediator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,lipid mediator Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,terminal differentiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",terminal differentiation Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,UBE2T gene|UBE2T,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2T gene|UBE2T Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Male fertility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Male fertility Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Intraoperative Radiation Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intraoperative Radiation Therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Uptake,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Uptake Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,GHET1 gene|GHET1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GHET1 gene|GHET1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,PGM5P3-AS1 gene|PGM5P3-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PGM5P3-AS1 gene|PGM5P3-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,exenatide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,exenatide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cancer care,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cancer care Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hereditary Breast and Ovarian Cancer Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hereditary Breast and Ovarian Cancer Syndrome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Mortality, Premature",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Mortality, Premature Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,ZNF582-DT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF582-DT gene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Receptor, PAR-1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptor, PAR-1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,EBF1 gene|EBF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EBF1 gene|EBF1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Recurrent infections,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recurrent infections Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CENPW gene|CENPW,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CENPW gene|CENPW Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GP5 gene|GP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GP5 gene|GP5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CYP2W1 gene|CYP2W1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2W1 gene|CYP2W1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Matrix Metalloproteinases,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,CDK6 gene|CDK6,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,CDK6 gene|CDK6 Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MFNG gene|MFNG,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MFNG gene|MFNG Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"Amino Acids, Branched-Chain",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Amino Acids, Branched-Chain Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Fast Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Fast Foods Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,asparaginylendopeptidase,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,asparaginylendopeptidase Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MCM10 gene|MCM10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM10 gene|MCM10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"SFN protein, human|SFN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SFN protein, human|SFN Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,CD44,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,CD44 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tao hong si wu decoction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tao hong si wu decoction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KDM4A gene|KDM4A,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,KDM4A gene|KDM4A Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prolactin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Asbestos,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Asbestos Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FOXF2 gene|FOXF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXF2 gene|FOXF2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CENPW gene|CENPW,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CENPW gene|CENPW Breast Carcinoma,Female Breast Cancer
PREDISPOSES,somatostatin receptor 1|SSTR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,somatostatin receptor 1|SSTR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GJA1 gene|GJA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GJA1 gene|GJA1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"RNA, Long Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,MELK gene|MELK,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,MELK gene|MELK Basal-Like Breast Carcinoma,Female Breast Cancer
DISRUPTS,TIMM8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TIMM8A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CASP9 gene|CASP9,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,CASP9 gene|CASP9 Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Blood group AB,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Blood group AB Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Cooking Practices,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cooking Practices Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mean score,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mean score Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Phytochemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemicals Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PFKFB3 gene|PFKFB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PFKFB3 gene|PFKFB3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemicals,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemical,Chemicals HER2-positive carcinoma of breast,Female Breast Cancer
COMPLICATES,Acquired Immunodeficiency Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Acquired Immunodeficiency Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Acute infectious disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Acute infectious disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLC6A14 gene|SLC6A14,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC6A14 gene|SLC6A14 Breast Carcinoma,Female Breast Cancer
DISRUPTS,RPS6KB1 gene|RPS6KB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPS6KB1 gene|RPS6KB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SULT1A1 gene|SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULT1A1 gene|SULT1A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dysbiosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dysbiosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alkaloids,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Alkaloids Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,medication use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,medication use Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chemokine CXCL12,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Chemokine CXCL12 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Oral intake,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Oral intake estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,AMACR wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AMACR wt Allele Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,calreticulin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,calreticulin Breast Carcinoma,Female Breast Cancer
AFFECTS,CUEDC2 gene|CUEDC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CUEDC2 gene|CUEDC2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,NU 7441,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,NU 7441 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Prognostic Factors,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Prognostic Factors Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Purinoceptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Purinoceptor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,sorafenib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sorafenib Malignant neoplasm of breast,Female Breast Cancer
CAUSES,trichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,trichloroethylene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,estrogens,Advanced breast cancer diagnosis,0.0,Female Breast Cancer,Hormone,estrogens Advanced breast cancer diagnosis,Female Breast Cancer
AFFECTS,"LATS1 protein, human|LATS1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","LATS1 protein, human|LATS1 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,KIF11 gene|KIF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF11 gene|KIF11 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,nesiritide|NPPB,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,nesiritide|NPPB Breast Carcinoma,Female Breast Cancer
AUGMENTS,IRS2 gene|IRS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRS2 gene|IRS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Expression,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Gene Expression Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CHEK2 gene|CHEK2,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Lymph-vascular invasion,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Lymph-vascular invasion Invasive Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,NR1H3 gene|NR1H3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR1H3 gene|NR1H3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,isoleucylvaline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,isoleucylvaline Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"HMGB3 protein, human|HMGB3",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HMGB3 protein, human|HMGB3 Breast Carcinoma",Female Breast Cancer
PREDISPOSES,MTNR1B gene|MTNR1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTNR1B gene|MTNR1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Morbidity - disease rate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Morbidity - disease rate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"DNA Breaks, Double-Stranded",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA Breaks, Double-Stranded Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Observation - diagnostic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Observation - diagnostic procedure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Histone Demethylases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histone Demethylases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Therapeutic procedure Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,maintenance of pluripotency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,maintenance of pluripotency Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Female Breast Carcinoma,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Female Breast Carcinoma Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Tumor Microenvironment,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,MIR382 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR382 wt Allele Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hepatocyte Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Hepatocyte Growth Factor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SAFB2 gene|SAFB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SAFB2 gene|SAFB2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,trichostatin A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,trichostatin A Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,MicroRNA 367-3p,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 367-3p Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,selenium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Flash,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flash Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Substance P Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Substance P Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Autophagy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Autophagy Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,sauchinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sauchinone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Vascular Endothelial Growth Factors|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factors|VEGFA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PARP9 gene|PARP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARP9 gene|PARP9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sentinel node (disorder),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sentinel node (disorder) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"interleukin-1, beta",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,"interleukin-1, beta Inflammatory Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Prolactin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cancer/Testis Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer/Testis Antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DDX3X gene|DDX3X,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,DDX3X gene|DDX3X Carcinoma of Male Breast,Female Breast Cancer
DISRUPTS,parecoxib sodium,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,parecoxib sodium HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,PTPN13 gene|PTPN13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN13 gene|PTPN13 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vigorous physical activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vigorous physical activity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biomodulin T,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Biomodulin T Breast Carcinoma,Female Breast Cancer
AUGMENTS,KAT7 gene|KAT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KAT7 gene|KAT7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vigorous physical activity,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Vigorous physical activity estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Ocular Cicatricial Pemphigoid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ocular Cicatricial Pemphigoid Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"RNA, Circular",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,IMPACT gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IMPACT gene Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,IGF2BP1 gene|IGF2BP1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,IGF2BP1 gene|IGF2BP1 Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Chalcone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Chalcone Breast Carcinoma,Female Breast Cancer
AFFECTS,Degenerative polyarthritis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Degenerative polyarthritis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PRMT2 gene|PRMT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRMT2 gene|PRMT2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PCAT19 gene|PCAT19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT19 gene|PCAT19 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genes,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,Genes Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
AUGMENTS,SFXN1 gene|SFXN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFXN1 gene|SFXN1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,glycyrrhetinic acid,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Chemical,glycyrrhetinic acid Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TWIST1 gene|TWIST1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Psychosocial procedure,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Psychosocial procedure Early-Stage Breast Carcinoma,Female Breast Cancer
AUGMENTS,SFXN2 gene|SFXN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFXN2 gene|SFXN2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proliferation (morphologic abnormality),HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Proliferation (morphologic abnormality) HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,hydrochloride,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,hydrochloride Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Reproductive tract infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive tract infection Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Apolipoprotein A-I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein A-I Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoadjuvant Systemic Therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Neoadjuvant Systemic Therapy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1R gene|IGF1R Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SOX9 gene|SOX9,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SOX9 gene|SOX9 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Anthropometric Measures:-:Point in time:^Patient:-,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anthropometric Measures:-:Point in time:^Patient:- Malignant neoplasm of breast,Female Breast Cancer
CAUSES,triclosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,triclosan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ETV7 gene|ETV7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ETV7 gene|ETV7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Luteolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Luteolin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"FRAP1 protein, human|MTOR",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,New Target Lesion Identification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",New Target Lesion Identification Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sirolimus,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,sirolimus Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,SMIM10L2A gene|SMIM10L2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMIM10L2A gene|SMIM10L2A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adrenergic beta-Antagonists Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Premenstrual Tension,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Premenstrual Tension Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CDK7 protein, human|CDK7",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDK7 protein, human|CDK7 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,LINC02568 gene|LINC02568,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,LINC02568 gene|LINC02568 estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,morusin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,morusin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Invasive carcinoma of breast,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Invasive carcinoma of breast Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,quinacrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,quinacrine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,polyphenols,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,polyphenols Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Challenge:Type:Point in time:^Patient:Nominal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Challenge:Type:Point in time:^Patient:Nominal Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Emodin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Emodin Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KCNQ1OT1 gene|KCNQ1OT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KCNQ1OT1 gene|KCNQ1OT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Angiotensin II receptor antagonist,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiotensin II receptor antagonist Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,propofol,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,propofol Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2 gene|ERBB2,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Cardiac dysfunction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cardiac dysfunction Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNHG11 gene|SNHG11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNHG11 gene|SNHG11 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,glucose Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mental disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Mental disorders Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC7A11 gene|SLC7A11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC7A11 gene|SLC7A11 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tn antigen,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,Tn antigen Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TIPARP gene|TIPARP,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TIPARP gene|TIPARP Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,pirarubicin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,pirarubicin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"TNK2 protein, human|TNK2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNK2 protein, human|TNK2 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Trichorhinophalangeal dysplasia type I Female Breast Carcinoma,Female Breast Cancer
CAUSES,Lymph Node Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymph Node Metastasis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,glycosylation,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",glycosylation Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adrenergic beta-Antagonists Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,beta-Glucans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-Glucans Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,rebastinib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,rebastinib Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Indicators,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIR182 gene|MIR182,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR182 gene|MIR182 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,receptor for advanced glycation endproducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",receptor for advanced glycation endproducts Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATP2C1 gene|ATP2C1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP2C1 gene|ATP2C1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,malignant disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,malignant disease Malignant neoplasm of breast,Female Breast Cancer
CAUSES,zoledronate,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,zoledronate Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Hypofractionated radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypofractionated radiation therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,berberine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,berberine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXA1 gene|FOXA1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FOXA1 gene|FOXA1 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Synapsin I,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Synapsin I Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,interleukin-8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,postmenopausal syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,postmenopausal syndrome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,thymidine kinase 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,thymidine kinase 1 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,metformin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SIGLEC15 gene|SIGLEC15,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SIGLEC15 gene|SIGLEC15 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,formononetin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,formononetin Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,MIDEAS gene|ELMSAN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIDEAS gene|ELMSAN1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Amino Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amino Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,OTUB1 gene|OTUB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OTUB1 gene|OTUB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,leptin receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,leptin receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,High Density Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoproteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dried fruit intake,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Dried fruit intake estrogen receptor-positive breast cancer,Female Breast Cancer
CAUSES,VEGFA gene|VEGFA,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,VEGFA gene|VEGFA Invasive Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,LAYN gene|LAYN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAYN gene|LAYN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PIK3CB gene|PIK3CB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CB gene|PIK3CB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Raw vegetable,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Raw vegetable Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Genes Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,RHOT1 gene|RHOT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOT1 gene|RHOT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Inflammatory Response,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Other,Inflammatory Response Invasive Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,STAT3 gene|STAT3,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Carcinoma breast stage IV,Female Breast Cancer
CAUSES,polyphyllin II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyphyllin II Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SB 203580,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SB 203580 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,hydnocarpin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,hydnocarpin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,UHRF1 gene|UHRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UHRF1 gene|UHRF1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PAXX gene|PAXX,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PAXX gene|PAXX Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Decreasing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Decreasing Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,venetoclax,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,venetoclax Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,doxorubicin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,doxorubicin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Consideration,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Consideration Breast Carcinoma,Female Breast Cancer
DISRUPTS,ANXA9 gene|ANXA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANXA9 gene|ANXA9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SF3B1 gene|SF3B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SF3B1 gene|SF3B1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chest asymmetry,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chest asymmetry Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Positive Regulation of Oxidative Stress Process,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Positive Regulation of Oxidative Stress Process estrogen receptor-positive breast cancer,Female Breast Cancer
CAUSES,CERS4 gene|CERS4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CERS4 gene|CERS4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"MMP11 protein, human|MMP11",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MMP11 protein, human|MMP11 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,"MAP3K8 protein, human|MAP3K8",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MAP3K8 protein, human|MAP3K8 Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AUGMENTS,Androgens,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Androgens estrogen receptor-positive breast cancer,Female Breast Cancer
CAUSES,takinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,takinib Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Squalene monooxygenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Squalene monooxygenase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RIN2 gene|RIN2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RIN2 gene|RIN2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,G protein-coupled receptor kinase 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G protein-coupled receptor kinase 4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proteome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proteome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABCB1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,ABCB1 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,"Diet, Western",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diet, Western Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF1 gene|YTHDF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,INSM1 gene|INSM1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,INSM1 gene|INSM1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"PTGS2 protein, human|PTGS2",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTGS2 protein, human|PTGS2 Invasive carcinoma of breast",Female Breast Cancer
AFFECTS,AZGP1 gene|AZGP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AZGP1 gene|AZGP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,directive therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,directive therapy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CIB1 gene|CIB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CIB1 gene|CIB1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Carney Complex,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Carney Complex Breast Carcinoma,Female Breast Cancer
DISRUPTS,NCBP1 gene|NCBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCBP1 gene|NCBP1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NEU1 gene|NEU1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEU1 gene|NEU1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,factor XIII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,factor XIII Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ELAVL2 gene|ELAVL2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast-Conserving Surgery,Locally advanced breast cancer,0.0,Female Breast Cancer,Other,Breast-Conserving Surgery Locally advanced breast cancer,Female Breast Cancer
AFFECTS,momordicoside K,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,momordicoside K Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Soybeans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Soybeans Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,APOBEC3A gene|APOBEC3A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APOBEC3A gene|APOBEC3A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ROS1 gene|ROS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ROS1 gene|ROS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,SNORD49B gene|SNORD49B,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,SNORD49B gene|SNORD49B Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,ezrin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,ezrin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Details of education,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Details of education Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MYC gene|MYC,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,MYC gene|MYC Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SIPA1 gene|SIPA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SIPA1 gene|SIPA1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"ORF74 protein, Human herpesvirus 8",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ORF74 protein, Human herpesvirus 8 Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,RBM24 gene|RBM24,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RBM24 gene|RBM24 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,FOXO3 gene|FOXO3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FOXO3 gene|FOXO3 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,NT5DC2 gene|NT5DC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NT5DC2 gene|NT5DC2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CERNA2 gene|CERNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CERNA2 gene|CERNA2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PTPRG-AS1 gene|PTPRG-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPRG-AS1 gene|PTPRG-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgen Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmaceutical Preparations,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Genes Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SF3A2 gene|SF3A2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SF3A2 gene|SF3A2 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,SLC7A11 gene|SLC7A11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SLC7A11 gene|SLC7A11 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,PDK1 gene|PDK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDK1 gene|PDK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Reproductive History,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Reproductive History Breast Carcinoma,Female Breast Cancer
AFFECTS,Lipidome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Lipidome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BAIAP2L1 gene|BAIAP2L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BAIAP2L1 gene|BAIAP2L1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cell Cycle Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cell Cycle Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endocrine System Diseases,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,Endocrine System Diseases HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Viscosity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Viscosity Breast Carcinoma,Female Breast Cancer
AFFECTS,Hormone Receptor,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Hormone,Hormone Receptor malignant neoplasm of breast staging,Female Breast Cancer
DISRUPTS,NUDT1 gene|NUDT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUDT1 gene|NUDT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CONOTRUNCAL ANOMALY FACE SYNDROME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,CONOTRUNCAL ANOMALY FACE SYNDROME Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Corticotropin-Releasing Hormone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Corticotropin-Releasing Hormone Breast Carcinoma,Female Breast Cancer
AFFECTS,receptor for advanced glycation endproducts,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",receptor for advanced glycation endproducts Breast cancer metastatic,Female Breast Cancer
CAUSES,Intravascular Metastasis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Intravascular Metastasis Breast cancer metastatic,Female Breast Cancer
CAUSES,MAPK8 gene|MAPK8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK8 gene|MAPK8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PDZK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PDZK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,tibolone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,tibolone Breast cancer invasive NOS,Female Breast Cancer
CAUSES,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CpG Islands Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CXCL12 gene|CXCL12,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"CXCL12 gene|CXCL12 Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,ATF3 gene|ATF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATF3 gene|ATF3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Soy Milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Soy Milk Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRPM7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TRPM7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neuregulin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neuregulin 1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BCL-2 Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",BCL-2 Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TRAF4 gene|TRAF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRAF4 gene|TRAF4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast cancer metastatic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer metastatic Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chronic inflammation,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Chronic inflammation Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,EPHA10 gene|EPHA10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EPHA10 gene|EPHA10 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,STAT3 gene|STAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GSTO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GSTO2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"FRAP1 protein, human|MTOR",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Breast cancer metastatic",Female Breast Cancer
PREDISPOSES,"CYP2B6 protein, human|CYP2B6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CYP2B6 protein, human|CYP2B6 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,LECT2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,LECT2 Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transferase Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Transferase Gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA repair protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",DNA repair protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,p-hydroxycinnamaldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,p-hydroxycinnamaldehyde Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,maspin|SERPINB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,maspin|SERPINB5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,arginylarginine|ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arginylarginine|ABL2|RERE Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Biosensors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biosensors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NCOA1 gene|NCOA1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,NCOA1 gene|NCOA1 Breast cancer recurrent,Female Breast Cancer
CAUSES,SRC gene|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRC gene|SRC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXD3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Secondary malignant neoplasm of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lung Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ARF6,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,ARF6 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GPER1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,arsenite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arsenite Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,catalpol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,catalpol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRANCE protein,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein Breast Carcinoma,Female Breast Cancer
DISRUPTS,pigment epithelium-derived factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,pigment epithelium-derived factor Breast cancer metastatic,Female Breast Cancer
AUGMENTS,AMOT gene|AMOT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AMOT gene|AMOT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Health behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Health behavior Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,3' Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",3' Untranslated Regions Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogen Receptor beta|EREG|ESR1,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|EREG|ESR1 Female Breast Carcinoma,Female Breast Cancer
AFFECTS,CYP2C19 gene|CYP2C19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2C19 gene|CYP2C19 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NFKB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NFKB1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GIT1 gene|GIT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,GIT1 gene|GIT1 Breast cancer metastatic,Female Breast Cancer
CAUSES,mammaglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mammaglobin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Angiotensin II Type 1 Receptor Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiotensin II Type 1 Receptor Blockers Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogens,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Hormone,Estrogens Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,LIN28A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,LIN28A Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,25-hydroxyvitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,25-hydroxyvitamin D Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diet good,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diet good Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mdm2 protein|MDM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mdm2 protein|MDM4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BMP4|BMP4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,BMP4|BMP4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Signal Pathways,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Signal Pathways Breast Carcinoma,Female Breast Cancer
AFFECTS,YBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,YBX1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,deferiprone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,deferiprone Breast Carcinoma,Female Breast Cancer
AFFECTS,Medroxyprogesterone 17-Acetate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Breast cancer metastatic,Female Breast Cancer
AFFECTS,Detection,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Detection Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,"Carcinogens, Environmental",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Carcinoma of Male Breast",Male Breast Cancer
AUGMENTS,Genistein,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Genistein Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,3/4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,3/4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXP2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,FOXP2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Smoking,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Smoking Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,WWTR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWTR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Microcalcification,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Tungsten,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Tungsten Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Botanicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Botanicals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HNRPM gene|HNRNPM,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,HNRPM gene|HNRNPM Breast cancer metastatic,Female Breast Cancer
DISRUPTS,RAB22A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,RAB22A Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,PARP1 gene|PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARP1 gene|PARP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,docetaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,docetaxel Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,BIRC7 gene|BIRC7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BIRC7 gene|BIRC7 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,BCL2L11 gene|BCL2L11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BCL2L11 gene|BCL2L11 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Squamous cell carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Squamous cell carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Heme,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heme Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,fraxetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fraxetin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Seafood,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Seafood Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Animal fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Animal fat Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GATA3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Molecular Chaperones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Molecular Chaperones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,lard,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lard Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mammographic microcalcification Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MicroRNAs,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","MicroRNAs Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,"Genes, Suppressor",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Suppressor Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Neoplasm,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Neoplasm Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Intercellular adhesion molecule 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intercellular adhesion molecule 1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Colorectal Cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Colorectal Cancer Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S100 Proteins|S100A1|S100B,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",S100 Proteins|S100A1|S100B Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,BRCA3 gene|BRCA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA3 gene|BRCA3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,S100A8 gene|S100A8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A8 gene|S100A8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pteridines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pteridines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Finding of antibody titer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Finding of antibody titer Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hemorrhage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hemorrhage Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Evolution,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Evolution Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,PCSK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCSK6 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Reserpine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reserpine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interleukin-6,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Interleukin-6 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,MIRN10B gene|MIR10B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN10B gene|MIR10B Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CTSL gene|CTSL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTSL gene|CTSL Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ERBB2 gene|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,ERBB4 gene|ERBB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB4 gene|ERBB4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Positive Test Result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Positive Test Result Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Selective Estrogen Receptor Modulators,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Estriol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estriol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Serum Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serum Proteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Genome,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genome Breast Carcinoma,Female Breast Cancer
AFFECTS,Detection,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Detection Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Selenium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nitric Oxide,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Nitric Oxide Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,Aromatase Inhibitors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Aromatase Inhibitors Breast cancer metastatic,Female Breast Cancer
CAUSES,Study models,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Study models Breast Carcinoma,Female Breast Cancer
AUGMENTS,Prostate-Specific Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Prostate-Specific Antigen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FABP7|MAS1L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FABP7|MAS1L Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERBB2 gene|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast Carcinoma,Female Breast Cancer
AFFECTS,Retinoblastoma Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Retinoblastoma Genes Breast Carcinoma,Female Breast Cancer
CAUSES,leukemia inhibitory factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leukemia inhibitory factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phytochemical,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Phytochemical Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Lactoylglutathione Lyase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lactoylglutathione Lyase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA2 gene|BRCA2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,Flap Endonuclease-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flap Endonuclease-1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Gastrointestinal Neoplasms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Gastrointestinal Neoplasms Breast Carcinoma,Female Breast Cancer
DISRUPTS,TNFSF11 gene|TNFSF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF11 gene|TNFSF11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,E-Cadherin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,E-Cadherin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,thymalfasin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,thymalfasin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Progestogen only oral contraceptive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Progestogen only oral contraceptive Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Vegetables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vegetables Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Technetium Tc 99m Sestamibi,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Technetium Tc 99m Sestamibi Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Potato,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Potato Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Deletion Mutation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Deletion Mutation Breast Carcinoma,Female Breast Cancer
AFFECTS,Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Syndrome Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Integrin beta3|EEF1B2P2|BHLHE22,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Integrin beta3|EEF1B2P2|BHLHE22 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,NLRP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NLRP3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gynecomastia,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Gynecomastia Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,DNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast Carcinoma,Female Breast Cancer
AFFECTS,Fluorouracil,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Fluorouracil Breast cancer metastatic,Female Breast Cancer
AFFECTS,Mammary Neoplasms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Mammary Neoplasms Breast Carcinoma,Female Breast Cancer
DISRUPTS,Chemopreventive Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemopreventive Agent Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Arginine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Blind Vision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Blind Vision Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,family background,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,family background Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antispasmodics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antispasmodics Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Chromosome 11 Short Arm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chromosome 11 Short Arm Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Caffeine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Caffeine Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Hydralazine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydralazine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Skin problem,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Skin problem Breast Carcinoma,Female Breast Cancer
PREDISPOSES,N-Acetylneuraminic Acid,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,N-Acetylneuraminic Acid Breast Carcinoma,Female Breast Cancer
AFFECTS,cell motility,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,cell motility Breast Carcinoma,Female Breast Cancer
AFFECTS,Intraductal Hyperplasia,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Intraductal Hyperplasia Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Fibroadenoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fibroadenoma Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant Neoplasms,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Milk Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Milk Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ductal Carcinoma,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Ductal Carcinoma Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Buserelin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Buserelin Breast Carcinoma,Female Breast Cancer
AFFECTS,ASK Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ASK Gene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinoma,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Carcinoma Carcinoma of Male Breast,Male Breast Cancer
CAUSES,benzanthracene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,benzanthracene Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CHEST PATHOLOGY,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,CHEST PATHOLOGY Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Thiotepa,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thiotepa Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Milk, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Milk, Human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Fibronectins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibronectins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CEACAM5 gene|CEACAM5,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,CEACAM5 gene|CEACAM5 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,HPR gene|HPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HPR gene|HPR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mitoxantrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitoxantrone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Polyomavirus Middle T Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,Polyomavirus Middle T Antigens Breast Carcinoma,Female Breast Cancer
AFFECTS,trastuzumab,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,trastuzumab Breast Carcinoma,Female Breast Cancer
DISRUPTS,Peanut Agglutinin,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Peanut Agglutinin Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,PREMARIN USE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PREMARIN USE Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"VEGF protein, human|VEGFA",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Androsterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androsterone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,limonene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,limonene Breast Carcinoma,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|EGFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Histologic type,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Histologic type Breast Carcinoma,Female Breast Cancer
DISRUPTS,Angiostatins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiostatins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,sex hormone-binding globulin receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,sex hormone-binding globulin receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Leucine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leucine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Indicators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tumor Suppressor Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast Carcinoma,Female Breast Cancer
AUGMENTS,PBP gene|DOCK3|PEBP1|PKD1|MED1|PPBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PBP gene|DOCK3|PEBP1|PKD1|MED1|PPBP Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,rac-PK beta|AKT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,rac-PK beta|AKT2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Immunoconjugates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunoconjugates Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NME2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,NME2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Glycoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glycoproteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,National origin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",National origin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Candidate Disease Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antigens,Breast cancer stage II,0.0,Female Breast Cancer,Immunologic Factor,Antigens Breast cancer stage II,Female Breast Cancer
AFFECTS,Fetal Growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fetal Growth Malignant neoplasm of breast,Female Breast Cancer
CAUSES,tumor growth,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,tumor growth Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,alpha-Linolenic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,alpha-Linolenic Acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Protease Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Protease Inhibitor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,formestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,formestane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Equine laminitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Equine laminitis Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Protease Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Protease Inhibitor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cell Cycle Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cell Cycle Proteins Breast Carcinoma,Female Breast Cancer
AFFECTS,CD4 gene|CD4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD4 gene|CD4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,CA-15-3 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CA-15-3 Antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSPB8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSPB8 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Growth Factor Receptors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Androgens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Androgens Breast Carcinoma,Female Breast Cancer
AFFECTS,Endometrial Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endometrial Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Telomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Telomerase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,perlecan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,perlecan Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Amphiregulin|AREG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Amphiregulin|AREG Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cyclin D1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Study models,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Study models Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Vascular Endothelial Growth Factor Receptor-2|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-2|VEGFA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,riboflavin-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",riboflavin-binding protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Progesterone increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone increased Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-18,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Interleukin-18 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Brain Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Brain Neoplasms Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Micronutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Micronutrients Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP1A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Detection,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Detection Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,c-myc Proto-Oncogenes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Proto-Oncogenes|MYC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Therapy responder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Therapy responder Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenesis Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Epithelial-Stromal Communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial-Stromal Communication Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunization,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Immunization Breast Carcinoma,Female Breast Cancer
CAUSES,Hydrocarbons,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydrocarbons Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NF-kappa B,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,NF-kappa B Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2|NEU1|NEURL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Punctate inner choroidopathy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Punctate inner choroidopathy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,resveratrol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,resveratrol Breast Carcinoma,Female Breast Cancer
AUGMENTS,17q23,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,17q23 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Preventive Services - Orthodontics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Preventive Services - Orthodontics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sphingosine kinase-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sphingosine kinase-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endopeptidases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endopeptidases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Environmental Pollutants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Environmental Pollutants Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EPSTI1 gene|EPSTI1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,EPSTI1 gene|EPSTI1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Brain hemorrhage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Brain hemorrhage Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Molecular Pathology,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Molecular Pathology Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Thrombus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thrombus Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,response,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,response Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,AKT2 gene|AKT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKT2 gene|AKT2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transgenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Transgenes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Protein Kinase C|PRRT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinase C|PRRT2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Serpins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Serpins Breast Carcinoma,Female Breast Cancer
CAUSES,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast Carcinoma,Female Breast Cancer
AFFECTS,Endocrine therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Endocrine therapy Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Uterine activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Uterine activity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carotene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Transcript,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Transcript Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,fulvestrant,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,fulvestrant Breast Carcinoma,Female Breast Cancer
AFFECTS,"CBFB protein, human|CBFB|NFYA|NFYB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CBFB protein, human|CBFB|NFYA|NFYB Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,MSN gene|MSN,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MSN gene|MSN Breast Carcinoma,Female Breast Cancer
DISRUPTS,Human Chorionic Gonadotropin|CGA|HTC2|CGB5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Human Chorionic Gonadotropin|CGA|HTC2|CGB5 Breast Carcinoma,Female Breast Cancer
CAUSES,Colony-Stimulating Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Colony-Stimulating Factors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VEGF gene|VEGFA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Breast cancer metastatic,Female Breast Cancer
CAUSES,BARD1 gene|BARD1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BARD1 gene|BARD1 Breast Carcinoma,Female Breast Cancer
CAUSES,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Renal tubular disorder,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Renal tubular disorder Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Dinucleotide Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Dinucleotide Repeats Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Isothiocyanates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isothiocyanates Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GADD45A gene|GADD45A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GADD45A gene|GADD45A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TSG101 gene|TSG101,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,TSG101 gene|TSG101 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Fanconi's Anemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fanconi's Anemia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,progesterone analog,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone analog Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mouse mammary tumor virus infection,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Mouse mammary tumor virus infection Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Abnormal digestive tract function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Abnormal digestive tract function Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LRRC15,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,LRRC15 Breast Carcinoma,Female Breast Cancer
AFFECTS,Angiotensinogen|AGT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiotensinogen|AGT Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Malignant neoplasm of breast",Female Breast Cancer
COMPLICATES,Poland Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Poland Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,STK11 gene|STK11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK11 gene|STK11 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BIN1 gene|BIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIN1 gene|BIN1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,4-nonylphenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,4-nonylphenol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,P-Selectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,P-Selectin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CLSPN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CLSPN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Doxazosin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Doxazosin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LZTS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LZTS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dopamine Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Dopamine Antagonists Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IL6ST gene|IL6ST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL6ST gene|IL6ST Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cell Adhesion Molecules,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cell Adhesion Molecules Breast Carcinoma,Female Breast Cancer
AUGMENTS,Fibrinogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrinogen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,adduct,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,adduct Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tomography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tomography Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Clusterin|CLU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Clusterin|CLU Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hereditary Malignant Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hereditary Malignant Neoplasm Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CASP8 gene|CASP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASP8 gene|CASP8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Acne,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acne Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Wine intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Wine intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coumestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coumestrol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Lymphoid neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lymphoid neoplasm Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pulmonary toxicity,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Hazardous or Poisonous Substance,Pulmonary toxicity Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,"Xeroderma pigmentosum, group C",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Xeroderma pigmentosum, group C Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,IGFBP1 gene|IGFBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGFBP1 gene|IGFBP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Membrane receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Membrane receptor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinogenicity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenicity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APOE gene|APOE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APOE gene|APOE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pulmonary Embolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pulmonary Embolism Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,5'-AMP-activated protein kinase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",5'-AMP-activated protein kinase Breast Carcinoma,Female Breast Cancer
DISRUPTS,Transforming Growth Factor beta Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Receptors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,E2F4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,E2F4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mucinous Neoplasm,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Mucinous Neoplasm Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Paroxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paroxetine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,syndecan 1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",syndecan 1 protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Recombinant Transforming Growth Factor-Beta 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Recombinant Transforming Growth Factor-Beta 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PSMA5|AP5Z1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PSMA5|AP5Z1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RHOC gene|RHOC,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,Neoplasm,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Neoplasm Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Body mass index,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Body mass index Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,CXCR4 Receptors|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CXCR4 Receptors|CXCR4 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Farnesyl Transferase Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Farnesyl Transferase Inhibitor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antihypertensive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antihypertensive Agents Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Ethylene Oxide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Ethylene Oxide Breast Carcinoma,Female Breast Cancer
DISRUPTS,Cysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cysteine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,catenin p120(ctn) protein|CTNND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",catenin p120(ctn) protein|CTNND1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Homologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Homologous Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PTN gene|PTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTN gene|PTN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SCTR gene|SCTR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SCTR gene|SCTR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Complex Extracts,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Complex Extracts Breast Carcinoma,Female Breast Cancer
AFFECTS,Biopsy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Biopsy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Repetitive Region,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Repetitive Region Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NBS1 gene|NBN|NLRP2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,NBS1 gene|NBN|NLRP2 Familial cancer of breast,Female Breast Cancer
AFFECTS,Quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quercetin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL6R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL6R Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast Carcinoma,Female Breast Cancer
AFFECTS,Stromal Cell-Derived Factor 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Stromal Cell-Derived Factor 1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,SULT1A1|SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SULT1A1|SLC45A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ethylene Oxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethylene Oxide Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BEX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BEX2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,steroid hormone receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,steroid hormone receptor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,semapimod,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,semapimod Breast cancer metastatic,Female Breast Cancer
AFFECTS,Excretory function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Excretory function Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyphenols Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hamartoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hamartoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Serum Folate Level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Serum Folate Level Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,of 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,of 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid Breast cancer metastatic,Female Breast Cancer
AFFECTS,Nucleotide Excision Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nucleotide Excision Repair Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Plasmin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Plasmin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Focal Adhesion Protein-Tyrosine Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,bone morphogenetic protein 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tobacco smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tobacco smoke Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammaplasty,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Mammaplasty Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,PES1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PES1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Transgenes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Transgenes Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,INPPL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,INPPL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dyslipidemias,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Dyslipidemias Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,KL gene|KL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KL gene|KL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,nucleic acid inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,nucleic acid inhibitor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KLLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLLN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PIWIL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,PIWIL1 Breast Carcinoma,Female Breast Cancer
CAUSES,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,chemokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,chemokine Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Estrogens,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,Estrogens Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CYP3A5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP3A5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,adjuvant therapy,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"adjuvant therapy Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,Breast cancer metastatic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer metastatic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Medical care, unspecified",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,"Medical care, unspecified Carcinoma of Male Breast",Female Breast Cancer
AUGMENTS,Proto-Oncogene Proteins c-akt,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TWIST2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TWIST2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,estrogen receptor gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",estrogen receptor gamma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADIPOQ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADIPOQ Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ZNF703,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF703 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Progestins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Progestins Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,PELP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PELP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MAPK8 gene|MAPK8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK8 gene|MAPK8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FGFR2 gene|FGFR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR2 gene|FGFR2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphotransferases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,P-Glycoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",P-Glycoprotein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sarcoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Annexin A6|ANXA6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A6|ANXA6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,thymidine kinase 1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"thymidine kinase 1 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Chromosome 10 Short Arm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chromosome 10 Short Arm Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Protein phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein phosphatase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD44 gene|CD44,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,CD24,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"CD24 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,butylbenzyl phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,butylbenzyl phthalate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transcription Factor 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Factor 3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MAPK12 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK12 gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Plasminogen Activator Inhibitor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Plasminogen Activator Inhibitor 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A2 gene|S100A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A2 gene|S100A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,antiangiogenesis therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,antiangiogenesis therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Monocyte Chemoattractant Protein-1|CCL2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1|CCL2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,SIX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SIX1 Breast cancer metastatic,Female Breast Cancer
CAUSES,Heat Shock Protein 27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat Shock Protein 27 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dipyridamole,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Dipyridamole Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Transforming Growth Factor Beta 2|NEUROD1|TUBB4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor Beta 2|NEUROD1|TUBB4B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PARD6A|PWAR6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PARD6A|PWAR6 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,TUBB4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TUBB4A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,plumbagin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,plumbagin Breast cancer metastatic,Female Breast Cancer
DISRUPTS,SIX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SIX1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,6-bromo-2-naphthyl sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6-bromo-2-naphthyl sulfate Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"FRAP1 protein, human|MTOR",Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Female Breast Carcinoma",Female Breast Cancer
DISRUPTS,beta catenin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,beta catenin Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,KLF9 gene|KLF9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF9 gene|KLF9 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin-Dependent Kinase 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin-Dependent Kinase 4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FOXO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXO3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TNFRSF10B gene|TNFRSF10B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TNFRSF10B gene|TNFRSF10B Breast cancer metastatic,Female Breast Cancer
AFFECTS,corrigendum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,corrigendum Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Beta-glucuronidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beta-glucuronidase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CLDND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CLDND1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Germ-Line Mutation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Breast cancer metastatic,Female Breast Cancer
AFFECTS,Dietary Supplements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Supplements Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,plumbagin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,plumbagin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNHG12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNHG12 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Fibroblast Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Ion Channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ion Channel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metabolic syndrome,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Metabolic syndrome Breast cancer metastatic,Female Breast Cancer
AFFECTS,Evolution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Evolution Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Ceruloplasmin|CP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ceruloplasmin|CP Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Promoter Regions (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Promoter Regions (Genetics) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,interleukin-22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-22 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOX17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOX17 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pyruvate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pyruvate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cholesterol levels raised,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,Cholesterol levels raised Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,MC1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MC1R Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Signaling Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Signaling Molecule Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,Protein C Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein C Inhibitor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dichlorodiphenyldichloroethane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dichlorodiphenyldichloroethane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nicotinamide adenine dinucleotide (NAD),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinamide adenine dinucleotide (NAD) Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NR4A1 gene|NR4A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR4A1 gene|NR4A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dexamethasone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dexamethasone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TWIST1 gene|TWIST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NUCB2 gene|NUCB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NUCB2 gene|NUCB2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Risk Reduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Risk Reduction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MSI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MSI2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Diethylstilbestrol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Diethylstilbestrol Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,IL33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL33 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXCL9 gene|CXCL9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL9 gene|CXCL9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRPV4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,TRPV4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Berries,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Berries Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Margarine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Margarine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1R gene|IGF1R Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GPR116 gene|ADGRF5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,GPR116 gene|ADGRF5 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Docosahexaenoic Acids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Docosahexaenoic Acids Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Protein phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein phosphatase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Colorectal Cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Colorectal Cancer Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GIT1 gene|GIT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GIT1 gene|GIT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA Adducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Adducts Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,chemoprotection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",chemoprotection Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation therapy,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,RGS2 gene|RGS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RGS2 gene|RGS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ABCB6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABCB6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NUP155,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NUP155 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,atorvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,atorvastatin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Signaling Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Signaling Molecule Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,kinase inhibitor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,kinase inhibitor Breast cancer metastatic,Female Breast Cancer
AFFECTS,Adenomatous Polyposis Coli,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adenomatous Polyposis Coli Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glioma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glioma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm progression,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm progression Breast cancer metastatic,Female Breast Cancer
DISRUPTS,UBE3A,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,UBE3A Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,CLDN2 gene|CLDN2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CLDN2 gene|CLDN2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,NUMB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NUMB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,liraglutide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,liraglutide Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BRMS1 gene|BRMS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRMS1 gene|BRMS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Acute myocardial infarction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acute myocardial infarction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammography finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mammography finding Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,radiosensitization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",radiosensitization Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP2B6 gene|CYP2B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2B6 gene|CYP2B6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,membrane-type 1 matrix metalloproteinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",membrane-type 1 matrix metalloproteinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thiamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thiamine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PLAT gene|PLAT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PLAT gene|PLAT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor Status,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Estrogen Receptor Status Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,TARDBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TARDBP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Zinc Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PIWIL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIWIL1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MMP,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,MMP Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Hyperinsulinism,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Hyperinsulinism Breast cancer metastatic,Female Breast Cancer
DISRUPTS,KLF17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLF17 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SHARPIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SHARPIN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DACT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DACT2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APBA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,APBA3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Benzoic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Benzoic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYC1 gene|CYC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYC1 gene|CYC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Late pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Late pregnancy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,jatrophone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,jatrophone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"ABCG2 protein, human|ABCG2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ABCG2 protein, human|ABCG2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Thiazolidinediones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thiazolidinediones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CISH,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,CISH Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,PPM1D,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,PPM1D Breast Carcinoma,Female Breast Cancer
CAUSES,tumor growth,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,tumor growth Breast Carcinoma,Female Breast Cancer
AUGMENTS,calmodulin-dependent protein kinase II|CAMK2G,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",calmodulin-dependent protein kinase II|CAMK2G Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,calmodulin-dependent protein kinase II|CAMK2G,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",calmodulin-dependent protein kinase II|CAMK2G Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Oncogenes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogenes Breast cancer metastatic,Female Breast Cancer
COMPLICATES,Fibrosing adenosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrosing adenosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BCYRN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BCYRN1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FGF2 gene|FGF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF2 gene|FGF2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KRAS gene|KRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KRAS gene|KRAS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CXCL1 gene|CXCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL1 gene|CXCL1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Amino Acids, Branched-Chain",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Amino Acids, Branched-Chain Malignant neoplasm of breast",Female Breast Cancer
CAUSES,ALDH1A3 gene|ALDH1A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALDH1A3 gene|ALDH1A3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prostaglandin-Endoperoxide Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Prostaglandin-Endoperoxide Synthase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,nucleolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,nucleolin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Arachidonic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Arachidonic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vitamin D Analog,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Food,Vitamin D Analog Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,caveolin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caveolin 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anaphylaxis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anaphylaxis Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Parabens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parabens Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ARRDC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ARRDC3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MST1R gene|MST1R,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MST1R gene|MST1R Breast cancer metastatic,Female Breast Cancer
AFFECTS,SENP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SENP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BCL2 gene|BCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL2 gene|BCL2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,grasp,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,grasp Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Endogenous Retroviruses,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Endogenous Retroviruses Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCR7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CCR7 Breast cancer metastatic,Female Breast Cancer
AFFECTS,PRLR gene|PRLR|PTP4A3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Esters Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"ESR1 protein, human|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR1 protein, human|ESR1 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Manganese Superoxide Dismutase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lasso,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lasso Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIK3R1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PIK3R1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,PTHLH gene|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,uptake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,uptake Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Proto-Oncogene Proteins c-jun|JUN,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-jun|JUN Breast cancer metastatic,Female Breast Cancer
AFFECTS,Collagen Type IV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Collagen Type IV Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Recombinant Interferon-gamma|IFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Recombinant Interferon-gamma|IFNG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GGN gene|GGN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GGN gene|GGN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADH1C|ADH5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADH1C|ADH5 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CLOCK gene|CLOCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLOCK gene|CLOCK Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PARP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARP9 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ATF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ATF4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Taxol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Taxol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Receptors, LH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, LH Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Liposomes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Liposomes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tobacco use,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Tobacco use Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,BCAS3 gene|BCAS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAS3 gene|BCAS3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,N NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,N NOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sentinel Lymph Node Biopsy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Sentinel Lymph Node Biopsy Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,wogonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,wogonin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MCM10 gene|MCM10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM10 gene|MCM10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glutamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glutamine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Embryonic Development,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Embryonic Development Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tobacco smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tobacco smoke Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pentabromodiphenyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pentabromodiphenyl ether Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aromatase,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Enzyme,Aromatase Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,OIP5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OIP5-AS1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Linoleic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Linoleic Acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TRANSCRIPTION FACTOR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Breast cancer metastatic,Female Breast Cancer
AFFECTS,Dietary Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Oils Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NF-kappa B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NF-kappa B Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Rest,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rest Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ARNT2 gene|ARNT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARNT2 gene|ARNT2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Black tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Black tea Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,lysophosphatidic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,lysophosphatidic acid Breast cancer metastatic,Female Breast Cancer
AUGMENTS,PTK6 gene|PTK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTK6 gene|PTK6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,response,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,response Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,ESR1 gene|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Nuclease Sensitive Element Binding Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclease Sensitive Element Binding Protein 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,norethindrone acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,norethindrone acetate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IQGAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IQGAP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNAs,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","MicroRNAs Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,Oxytocin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Oxytocin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Galactosamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Galactosamine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A9 gene|S100A9,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,S100A9 gene|S100A9 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NAMPT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIRN205 gene|MIR205,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN205 gene|MIR205 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Homeo Box Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Homeo Box Sequence Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Viral Tumor Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Viral Tumor Antigens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Early Diagnosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Early Diagnosis Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,SNW1 Gene|SNW1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNW1 Gene|SNW1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Carcinogens, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,RBX1 gene|RBX1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,RBX1 gene|RBX1 Breast Carcinoma,Female Breast Cancer
AFFECTS,Apoptosis,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Apoptosis Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CEACAM5 gene|CEACAM5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CEACAM5 gene|CEACAM5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chromosome 15 Short Arm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chromosome 15 Short Arm Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Superoxides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Superoxides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIP,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,PIP Breast Carcinoma,Female Breast Cancer
DISRUPTS,Immunoglobulin Fc Fragments,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Immunoglobulin Fc Fragments Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Cytostatic Agents,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Cytostatic Agents Breast Carcinoma,Female Breast Cancer
DISRUPTS,vigilin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,vigilin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTPN13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PTPN13 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FADS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FADS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fish Oils,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Fish Oils Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antibodies Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Vascular Endothelial Growth Factor Receptor-3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Atypical hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atypical hyperplasia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Heat-Shock Proteins 70|HSPA4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat-Shock Proteins 70|HSPA4 Breast Carcinoma,Female Breast Cancer
AFFECTS,stromelysin 3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,stromelysin 3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Carrier of disorder,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Carrier of disorder Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,FMO5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FMO5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endostatins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Endostatins Breast Carcinoma,Female Breast Cancer
AFFECTS,Loss of Heterozygosity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Loss of Heterozygosity Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Optimistic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Optimistic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adrenergic Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adrenergic Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ions Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Mammary Carcinoma, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Mammary Carcinoma, Human Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Serine Proteinase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serine Proteinase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tumor Necrosis Factor Ligand Superfamily Member 6|FAS,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Tumor Necrosis Factor Ligand Superfamily Member 6|FAS Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Atypical proliferation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Atypical proliferation Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,SULT1A1|SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SULT1A1|SULT1A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,C-Peptide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-Peptide Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Lecithin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lecithin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BONE MASS,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,BONE MASS Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,celecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,celecoxib Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CAMP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CAMP Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Freund's Adjuvant,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Freund's Adjuvant Breast Carcinoma,Female Breast Cancer
AUGMENTS,PTGS2 gene|PTGS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Low Birth Weights,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Low Birth Weights Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,letrozole,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,letrozole Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Rh Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rh Factors Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Total cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Total cholesterol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoprotein Cholesterol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SSM,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,SSM Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Contraceptives, Oral",bilateral breast cancer,0.0,Female Breast Cancer,Other,"Contraceptives, Oral bilateral breast cancer",Female Breast Cancer
AFFECTS,Contraceptive methods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Contraceptive methods Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Multivitamin preparation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Multivitamin preparation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,letrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,letrozole Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NAMPT Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR519D,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,MIR519D Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Puberty stage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Puberty stage Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERCC5 gene|ERCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC5 gene|ERCC5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Butter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Butter Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Non-infiltrating lobular carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Non-infiltrating lobular carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Heat-Shock Proteins 70|HSPA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat-Shock Proteins 70|HSPA4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vegetable Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vegetable Oils Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Speaking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Speaking Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Weakly positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Weakly positive Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,adjuvant therapy,Breast cancer stage II,0.0,Female Breast Cancer,Other,adjuvant therapy Breast cancer stage II,Female Breast Cancer
PREDISPOSES,Growth Factor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Breast Fibrocystic Change, Proliferative Type",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"Breast Fibrocystic Change, Proliferative Type Breast Carcinoma",Female Breast Cancer
AFFECTS,"Transcription, Genetic",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,"Transcription, Genetic Breast cancer recurrent",Recurrent Breast Cancer
PREDISPOSES,poor health,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,poor health Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,nimesulide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,nimesulide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Eicosapentaenoic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Eicosapentaenoic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Flavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic Resonance Imaging,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Magnetic Resonance Imaging Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Adrenal Cortex Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Adrenal Cortex Hormones Malignant neoplasm of breast,Female Breast Cancer
CAUSES,tibolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tibolone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Short Tandem Repeat Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Short Tandem Repeat Polymorphism Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Long chain fatty acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Long chain fatty acid Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Antibiotics Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADRB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADRB3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Magnetic Resonance Spectroscopy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Magnetic Resonance Spectroscopy Breast Carcinoma,Female Breast Cancer
AFFECTS,Biopsy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Biopsy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Specific antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Specific antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GPR30 gene|GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPR30 gene|GPER1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ill-at-ease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ill-at-ease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Detection,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Detection Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,pterostilbene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pterostilbene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PKP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PKP3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Protein pp60 (c-src)|SRC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ethanol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Ethanol Breast cancer metastatic,Female Breast Cancer
AFFECTS,Contralateral breast cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Contralateral breast cancer Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GDI2 gene|GDI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GDI2 gene|GDI2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cadherins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cadherins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Osteogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Osteogenesis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Klinefelter's Syndrome,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Klinefelter's Syndrome Carcinoma of Male Breast,Male Breast Cancer
AUGMENTS,Acetaldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetaldehyde Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ezrin|EZR,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,ezrin|EZR Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,LIG4 gene|LIG4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIG4 gene|LIG4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Silence,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Silence Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Hypertension induced by pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypertension induced by pregnancy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APOB gene|APOB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APOB gene|APOB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Asleep,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Asleep Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Obesity,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Obesity Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Interleukin-17,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Interleukin-17 Sporadic Breast Carcinoma,Female Breast Cancer
DISRUPTS,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LPCAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LPCAT3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic procedure,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Therapeutic procedure Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Neoplasm progression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm progression Breast Carcinoma,Female Breast Cancer
DISRUPTS,CALML3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CALML3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ODAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ODAM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MRE11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MRE11 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RPS6KB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RPS6KB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Macrophage Chemotactic Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Macrophage Chemotactic Factors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cytokine,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Biologically Active Substance,cytokine Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Vitamin B12 intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B12 intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,butein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,butein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,heparanase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,heparanase Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,estrone sulfate,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,estrone sulfate Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,atovaquone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,atovaquone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CYP24A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP24A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemokine (C-X-C Motif) Ligand 1|CXCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chemokine (C-X-C Motif) Ligand 1|CXCL1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estradiol,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Estradiol Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Proliferating Cell Nuclear Antigen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Computed Tomographic Colonography,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Computed Tomographic Colonography Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,VASOMOTOR SYMPTOM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VASOMOTOR SYMPTOM Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Folic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,osteopontin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,osteopontin Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,cadherin 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cadherin 5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Steroid hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroid hormone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,aldehyde dehydrogenase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenase 1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Connexin 43,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Connexin 43 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fruit intake,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Fruit intake Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,Interleukin-12,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Interleukin-12 Breast cancer metastatic,Female Breast Cancer
AFFECTS,biological_process,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Phenomenon or Process,biological_process Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,ADAM29,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADAM29 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TYRP1 gene|TYRP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TYRP1 gene|TYRP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estradiol + norethindrone acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estradiol + norethindrone acetate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GAL3ST1|SLC35A1|CASZ1|CST12P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GAL3ST1|SLC35A1|CASZ1|CST12P Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogen Receptor alpha,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,HORMONE REPLACEMENT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,HORMONE REPLACEMENT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemotherapy-Oncologic Procedure,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Chemotherapy-Oncologic Procedure Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,EMSY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EMSY Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Atypical hyperplasia,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Atypical hyperplasia Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Dinoprost,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dinoprost Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Chemotherapy, Adjuvant",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,"Chemotherapy, Adjuvant Carcinoma of Male Breast",Male Breast Cancer
PREDISPOSES,Insulin Resistance,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Insulin Resistance Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Cytokeratin 18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytokeratin 18 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Disease Breast cancer metastatic,Female Breast Cancer
CAUSES,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic,Female Breast Cancer
AFFECTS,Residual Cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Residual Cancer Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interstitial Collagenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interstitial Collagenase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nickel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nickel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Feeding,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Breast Feeding Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,BCCIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BCCIP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHI3L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CHI3L1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antigens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Immunologic Factor,Antigens Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast cancer recurrent",Recurrent Breast Cancer
AFFECTS,Somatostatin analog|SST,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Somatostatin analog|SST Breast Carcinoma,Female Breast Cancer
CAUSES,Interferon Type II|IFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interferon Type II|IFNG Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Mixed Function Oxygenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mixed Function Oxygenases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL1RN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL1RN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin D1|CCND1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cyclin D1|CCND1 Breast Carcinoma,Female Breast Cancer
AFFECTS,"Breast Fibrocystic Change, Proliferative Type",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Breast Fibrocystic Change, Proliferative Type Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,S100A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,sake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sake Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Protein Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Family Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MDM4 gene|MDM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM4 gene|MDM4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cadmium,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Inorganic Chemical,Cadmium Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Xq25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Xq25 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,XRCC5 gene|XRCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC5 gene|XRCC5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,transduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",transduction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Infectious Mononucleosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Infectious Mononucleosis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oils Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EGFL7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EGFL7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PROM1,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,PROM1 Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,DCSTAMP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DCSTAMP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,gefitinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gefitinib Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GLIS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GLIS3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,trastuzumab,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,trastuzumab Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,AXILLARY LYMPH NODE METASTASIS,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,AXILLARY LYMPH NODE METASTASIS Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Sleep Apnea Syndromes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sleep Apnea Syndromes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Water Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,regional differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",regional differences Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,perfluorooctane sulfonate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,perfluorooctane sulfonate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Isoenzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Isoenzymes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Riboflavin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Riboflavin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HP gene|HP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HP gene|HP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast cancer invasive NOS,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Carcinoma in situ of breast,Female Breast Cancer
AFFECTS,Second Primary Cancers,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Second Primary Cancers Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Alcoholic Beverages,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Alcoholic Beverages Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Infant feeding method NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Infant feeding method NOS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Weight Gain,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Weight Gain Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,Methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methionine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DMD|BEST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DMD|BEST1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Localized Malignant Neoplasm,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Localized Malignant Neoplasm Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Wine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Wine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Physical function Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Metaplasia,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Metaplasia Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Aldehydes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aldehydes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biopsy,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Biopsy Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Estradiol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Estradiol Breast Carcinoma,Female Breast Cancer
AUGMENTS,snail transcription factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",snail transcription factors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,phenethyl isothiocyanate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phenethyl isothiocyanate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Black tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Black tea Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Performance,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Performance Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,oridonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,oridonin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,claudin 1 protein,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",claudin 1 protein Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alleles Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,volatile substances,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Substance,volatile substances Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Poultry Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Poultry Meat Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammography,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Mammography Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Diabetes, Gestational",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes, Gestational Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Cognitive Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cognitive Therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,high-dose chemotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,high-dose chemotherapy Breast cancer metastatic,Female Breast Cancer
CAUSES,Oxytocin Receptor|OXTR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxytocin Receptor|OXTR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,S100A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Does hit,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Does hit Breast Carcinoma,Female Breast Cancer
AFFECTS,Fine needle aspiration biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fine needle aspiration biopsy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Large Neutral Amino Acid-Transporter 1|SLC7A5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Large Neutral Amino Acid-Transporter 1|SLC7A5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Iodine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iodine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Monomeric GTP-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monomeric GTP-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APEX1 gene|APEX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APEX1 gene|APEX1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Primary disease,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Disease or Syndrome,Primary disease Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,pigment epithelium-derived factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pigment epithelium-derived factor Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Phyllodes Tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phyllodes Tumor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diphosphonates,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Diphosphonates Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,SOSTDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOSTDC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"EZH2 protein, human|EZH2",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Inflammatory Breast Carcinoma",Female Breast Cancer
DISRUPTS,Blood Coagulation Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Blood Coagulation Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Catechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catechin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Night sweats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Night sweats Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Seeks information,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Seeks information Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,Flavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adverse event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Adverse event Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,hydroxytyrosol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,hydroxytyrosol Breast Carcinoma,Female Breast Cancer
AUGMENTS,REXO1|ZFP42,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,REXO1|ZFP42 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VEGFA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,VEGFA Breast cancer metastatic,Female Breast Cancer
AUGMENTS,FOLR1 gene|FOLR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOLR1 gene|FOLR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Night Nurse,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Night Nurse Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL8RB gene|CXCR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL8RB gene|CXCR2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NEK2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Female,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Female Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Inflammation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Body Weight decreased,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Body Weight decreased Breast Carcinoma,Female Breast Cancer
AFFECTS,Aminolevulinic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Aminolevulinic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cerebrovascular accident,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cerebrovascular accident Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Powerlessness, low",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Powerlessness, low Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Diffusion Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diffusion Magnetic Resonance Imaging Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypoglycemic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Hypoglycemic Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Echocardiography, Three-Dimensional",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Echocardiography, Three-Dimensional Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Pregnancy,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Pregnancy Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Atypical lobular hyperplasia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Atypical lobular hyperplasia Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Endothelin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endothelin Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHEK2 gene|CHEK2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Polymerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polymerase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic breast density,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Mammographic breast density Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,ESTROGEN+PROGESTERONE RECEPTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,ESTROGEN+PROGESTERONE RECEPTOR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Lasofoxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lasofoxifene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hormones,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,Hormones Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Mammography,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Mammography Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estrus Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alkylating Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Alkylating Agents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prevention,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Prevention Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,breast implant procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biomedical or Dental Material,breast implant procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Analgesics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Analgesics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adenosine Triphosphate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adenosine Triphosphate Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Anti-Anxiety Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Anxiety Agents Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Mitoxantrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitoxantrone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,PVT1 gene|PVT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PVT1 gene|PVT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RNA-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Solid tumor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Solid tumor Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Homologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Homologous Gene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,protopanaxadiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,protopanaxadiol Breast cancer metastatic,Female Breast Cancer
AFFECTS,CDCA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDCA4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SDCBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SDCBP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTPN1 gene|PTPN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN1 gene|PTPN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,no positive axillary nodes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,no positive axillary nodes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gout,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gout Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sugar candy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sugar candy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tyrosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tyrosine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Acetaminophen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetaminophen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TRIM33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TRIM33 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC50A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC50A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FUT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FUT2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC01638,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC01638 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PIMREG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIMREG Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Interleukin-17,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Interleukin-17 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,strictinin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,strictinin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,phenyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phenyl ether Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Plasma glucose result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Plasma glucose result Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,advanced disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,advanced disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Atypical proliferation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Atypical proliferation Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,SLC50A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC50A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ezrin|EZR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ezrin|EZR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,beta catenin|CTNNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta catenin|CTNNB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Coal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coal Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RNF115,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RNF115 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,S100B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SP1 gene|SP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SP1 gene|SP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,activated RNA polymerase II transcription cofactor 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",activated RNA polymerase II transcription cofactor 4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Progesterone Receptor Status,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Progesterone Receptor Status Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,HCP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HCP5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,nitric oxide receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,nitric oxide receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RUSC1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RUSC1-AS1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Glucocorticoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucocorticoids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anticholesteremic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anticholesteremic Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TSC1 gene|TSC1|CCL26,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSC1 gene|TSC1|CCL26 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Materials,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Substance,Materials Breast cancer metastatic,Female Breast Cancer
CAUSES,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"CHEK2 protein, human|CHEK2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CHEK2 protein, human|CHEK2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Juvenile carcinoma of the breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Juvenile carcinoma of the breast Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease recurrence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease recurrence Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TFF3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,TFF3 Breast Carcinoma,Female Breast Cancer
AUGMENTS,HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HOTAIR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Collagen Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Collagen Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCB 180,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 180 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gold,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gold Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA Excision Repair Protein ERCC-5|ERCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",DNA Excision Repair Protein ERCC-5|ERCC5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,XBP1 gene|XBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XBP1 gene|XBP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Burden,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Burden Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Energy Balance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Energy Balance Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Immunity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Immunity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2 gene|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,HIF1alpha protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HIF1alpha protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HAX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,HAX1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,LARP4 gene|LARP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LARP4 gene|LARP4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"RNA, circular",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, circular Breast cancer metastatic",Female Breast Cancer
CAUSES,angiotensin II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,angiotensin II Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cedrelone,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,cedrelone Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Flavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavones Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Catechol O-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catechol O-Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phototherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phototherapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SMAD4 gene|SMAD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD4 gene|SMAD4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant Neoplasms,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Neoadjuvant Therapy,Breast cancer stage III,0.0009990009990009,Female Breast Cancer,Other,Neoadjuvant Therapy Breast cancer stage III,Female Breast Cancer
AFFECTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nicotinamide Phosphoribosyltransferase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","E2F1 protein, human|E2F1|UBE2L3 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,LOXL1-AS1 gene|LOXL1-AS1,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,LOXL1-AS1 gene|LOXL1-AS1 Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,"2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,punicalagin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,punicalagin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PAK4 gene|PAK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAK4 gene|PAK4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FAM83H-AS1 gene|FAM83H-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FAM83H-AS1 gene|FAM83H-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,folic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,folic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Late menarche,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Late menarche Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,STARD8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,STARD8 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Cream,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cream Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Protein Isoforms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Isoforms Malignant neoplasm of breast,Female Breast Cancer
CAUSES,chalcomoracin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chalcomoracin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"PTGS2 protein, human|PTGS2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTGS2 protein, human|PTGS2 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Phosphoglycerate dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoglycerate dehydrogenase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genome,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Genome Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Hexokinase 2|HK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hexokinase 2|HK2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,insulin detemir,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,insulin detemir Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"PKN1 protein, human|PKN1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PKN1 protein, human|PKN1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,ELF5 gene|ELF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELF5 gene|ELF5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Mutant Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mutant Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,apolipoprotein D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein D Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prophylactic treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prophylactic treatment Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TRANSCRIPTION FACTOR,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Fibromyalgia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibromyalgia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KISS1R gene|KISS1R,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KISS1R gene|KISS1R Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Genes,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Genes Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,compromise,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,compromise Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Sentinel node (disorder),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sentinel node (disorder) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Sleep Apnea, Obstructive",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Sleep Apnea, Obstructive Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Chlorpyrifos,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chlorpyrifos Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CCL5,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,CCL5 Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,CTCb regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTCb regimen Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phosphoric Monoester Hydrolases,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Phosphoric Monoester Hydrolases Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,aluminum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aluminum Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SLCO6A1|GSTK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLCO6A1|GSTK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insoluble fiber (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Insoluble fiber (substance) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carbon Ion Radiotherapy,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Ion Radiotherapy Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,H19 gene|H19|HILS1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,risk factors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,risk factors Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Prolactin Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Prolactin Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,BCL11A gene|BCL11A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BCL11A gene|BCL11A Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,PPFIA1 gene|PPFIA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPFIA1 gene|PPFIA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Polybrominated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polybrominated Biphenyls Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PPFIA1 gene|PPFIA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPFIA1 gene|PPFIA1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PARP1 gene|PARP1,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,PARP1 gene|PARP1 Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
DISRUPTS,SOX9 gene|SOX9,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SOX9 gene|SOX9 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Primary care provider:Identifier:Point in time:Provider:Nominal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Primary care provider:Identifier:Point in time:Provider:Nominal Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBR3-AS1 gene|CBR3-AS1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,limited use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,limited use Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Polycystic Ovary Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Polycystic Ovary Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RNF111 gene|RNF111,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNF111 gene|RNF111 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,steroid receptor coactivator AIB1|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,steroid receptor coactivator AIB1|NCOA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,betaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,betaine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,risk factors,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,risk factors Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Multiparametric Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Multiparametric Magnetic Resonance Imaging Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,new information,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",new information Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,Pharmacotherapy Luminal B Breast Carcinoma,Female Breast Cancer
AFFECTS,Lyophilized powder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lyophilized powder Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,genistein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Blood Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Blood Glucose Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S-adenosylmethionine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",S-adenosylmethionine Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Malignant Neoplasms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Polypeptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Polypeptides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MNX1-AS1 gene|MNX1-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MNX1-AS1 gene|MNX1-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,removal technique,Stage IV Inflammatory Breast Carcinoma,0.0,Female Breast Cancer,Other,removal technique Stage IV Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,N-Myc Downstream Regulated Protein 1|NDRG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",N-Myc Downstream Regulated Protein 1|NDRG1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Dicarboxylic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Dicarboxylic Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,glycerin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,glycerin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ENC1 gene|ENC1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,ENC1 gene|ENC1 Carcinoma breast stage IV,Female Breast Cancer
CAUSES,acetylcysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,acetylcysteine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NORAD gene|NORAD,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NORAD gene|NORAD Breast Carcinoma,Female Breast Cancer
CAUSES,Mammary Tumorigenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Mammary Tumorigenesis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Biological Markers Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,CXCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CXCL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Transcription Factor|SOX2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Genes,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,Genes estrogen receptor-negative breast cancer,Female Breast Cancer
PREDISPOSES,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEG3 gene|MEG3|FAM129B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CA10 gene|CA10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CA10 gene|CA10 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NME1 gene|NME1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Biological Response Modifiers Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MIR326 gene|MIR326,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR326 gene|MIR326 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Interferons,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Other,Interferons Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Scoliosis, unspecified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Scoliosis, unspecified Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,PART1 gene|PART1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PART1 gene|PART1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,erbB-2 Receptor|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,MIR451A wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR451A wt Allele Malignant neoplasm of breast,Female Breast Cancer
CAUSES,YTHDF3 gene|YTHDF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF3 gene|YTHDF3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Pharmacotherapy HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,leptin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,leptin Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,S100A14 gene|S100A14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A14 gene|S100A14 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Biopolymers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biopolymers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TMPRSS13 gene|TMPRSS13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMPRSS13 gene|TMPRSS13 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,nervous system disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,nervous system disorder Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,folate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRIO gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIO gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSD17B4 gene|HSD17B4,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,HSD17B4 gene|HSD17B4 HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Carcinoma of Male Breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma of Male Breast Malignant neoplasm of breast,Male Breast Cancer
DISRUPTS,Luteolin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Luteolin HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,"CCND2 protein, human|CCND2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CCND2 protein, human|CCND2 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Piperlongumine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Piperlongumine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,thidiazuron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thidiazuron Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,methylate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methylate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasms by Site,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neoplasms by Site Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Behaviorial Habits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Behaviorial Habits Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,UBR1 gene|UBR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBR1 gene|UBR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCR5 gene|CCR5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCR5 gene|CCR5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,CAVIN3 gene|CAVIN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAVIN3 gene|CAVIN3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,epithelial to mesenchymal transition,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Carcinoma breast stage IV,Female Breast Cancer
CAUSES,mitoxantrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mitoxantrone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"TFF1 protein, human|TFF1",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF1 protein, human|TFF1 estrogen receptor-positive breast cancer",Female Breast Cancer
CAUSES,Neoplasm Metastasis,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,Polysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polysaccharides Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,estrogens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hormone,estrogens Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WWTR1 protein, human|WWTR1 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Transforming Growth Factor beta,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Inflammatory Breast Carcinoma,Female Breast Cancer
COMPLICATES,contralateral breast cancer,Right-Sided Breast Neoplasms,0.0,Female Breast Cancer,Neoplastic Process,contralateral breast cancer Right-Sided Breast Neoplasms,Female Breast Cancer
AFFECTS,Systemic Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Systemic Therapy HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,PRMT5 gene|PRMT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRMT5 gene|PRMT5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA replication checkpoint,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",DNA replication checkpoint Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Fermented Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Fermented Foods Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NF2 gene|NF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NF2 gene|NF2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PLEKHA7 gene|PLEKHA7,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,PLEKHA7 gene|PLEKHA7 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Ultraviolet B radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ultraviolet B radiation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,B3GNT2|B3GNTL1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,B3GNT2|B3GNTL1 Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,STRN3 gene|STRN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STRN3 gene|STRN3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Transcription factor genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Transcription factor genes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ZMYND8 gene|ZMYND8,Refractory Breast Carcinoma,0.0,Other,Gene or Genome,ZMYND8 gene|ZMYND8 Refractory Breast Carcinoma,Female Breast Cancer
AUGMENTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SOX6 gene|SOX6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOX6 gene|SOX6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RSPO2 gene|RSPO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RSPO2 gene|RSPO2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PEBP1 gene|PEBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PEBP1 gene|PEBP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thymidylate Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thymidylate Synthase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Screening mammography,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,Screening mammography malignant neoplasm of breast staging,Female Breast Cancer
PREDISPOSES,RARRES2 gene|RARRES2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,RARRES2 gene|RARRES2 Breast Carcinoma,Female Breast Cancer
AFFECTS,EIF4A1 gene|EIF4A1,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,EIF4A1 gene|EIF4A1 Invasive carcinoma of breast,Female Breast Cancer
DISRUPTS,CA13 gene|CA13,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,CA13 gene|CA13 Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Mouse Model,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Other,Mouse Model Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,Adverse event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Adverse event Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXK1 gene|FOXK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXK1 gene|FOXK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NUP43 gene|NUP43,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUP43 gene|NUP43 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MYCN gene|MYCN,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYCN gene|MYCN Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,tamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,tamoxifen Breast Carcinoma,Female Breast Cancer
AFFECTS,sanguinarine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sanguinarine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HNRNPK gene|HNRNPK,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,HNRNPK gene|HNRNPK Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,ERRFI1 gene|ERRFI1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ERRFI1 gene|ERRFI1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,STUB1 gene|STUB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STUB1 gene|STUB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S100A7 gene|S100A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A7 gene|S100A7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Clinical Significance,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Clinical Significance Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Breast size,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Breast size Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Elevated C-reactive protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Elevated C-reactive protein Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Triple Negative Breast Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Triple Negative Breast Neoplasms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BTNL9 gene|BTNL9,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BTNL9 gene|BTNL9 Breast Carcinoma,Female Breast Cancer
DISRUPTS,CDC25C gene|CDC25C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC25C gene|CDC25C Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Profilin 2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Profilin 2 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,HMGB1 Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HMGB1 Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Performance,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Other,Performance Recurrent Breast Carcinoma,Recurrent Breast Cancer
DISRUPTS,PDCD4 gene|PDCD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDCD4 gene|PDCD4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,dendrophenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dendrophenol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MDM2 gene|MDM2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydrogel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Hydrogel Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,"Receptors, Opioid, kappa",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Opioid, kappa Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,ZNF132 gene|ZNF132,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF132 gene|ZNF132 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Pathogenic Variant,"Breast Cancer, Familial",0.0,Female Breast Cancer,Virus,"Pathogenic Variant Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,Physical stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physical stress Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NRBP2 gene|NRBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRBP2 gene|NRBP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCAT1 gene|PCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT1 gene|PCAT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Disease or Syndrome,Disease Female Breast Carcinoma,Female Breast Cancer
AFFECTS,metoclopramide,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,metoclopramide Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Borg Category-Ratio 10 Perceived Exertion Score 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Borg Category-Ratio 10 Perceived Exertion Score 5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TPT1-AS1 gene|TPT1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPT1-AS1 gene|TPT1-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KIAA1755 gene|KIAA1755,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,KIAA1755 gene|KIAA1755 Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,LINC00467 gene|LINC00467,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00467 gene|LINC00467 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormone Therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Hormone Therapy Breast Carcinoma,Female Breast Cancer
CAUSES,Homeobox Protein ARX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Homeobox Protein ARX Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tripterine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tripterine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NORAD gene|NORAD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NORAD gene|NORAD Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HAGLR gene|HAGLR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HAGLR gene|HAGLR Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Proto-Oncogene Proteins c-sis|PDGFB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-sis|PDGFB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Cycle Checkpoints,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cell Cycle Checkpoints Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inhibitor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Inhibitor Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Reaching,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reaching Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,nucleoside diphosphate kinase A|NME1,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,nucleoside diphosphate kinase A|NME1 Invasive carcinoma of breast,Female Breast Cancer
DISRUPTS,Antibodies,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Antibodies HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Cytochrome P-450 CYP1A1|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP1A1|CYP19A1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00894 gene|LINC00894,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00894 gene|LINC00894 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR373 gene|MIR373,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIR373 gene|MIR373 Breast Carcinoma,Female Breast Cancer
AFFECTS,Monoclonal Antibodies,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Monoclonal Antibodies HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,BABAM2-AS1 gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BABAM2-AS1 gene Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"Migration, Cell",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Migration, Cell Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,melatonin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,melatonin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,docetaxel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,docetaxel Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CXCL13 gene|CXCL13,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL13 gene|CXCL13 Breast Carcinoma,Female Breast Cancer
AFFECTS,METTL3 gene|METTL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL3 gene|METTL3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cigarette smoke (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Cigarette smoke (substance) Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oncogene Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene Proteins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,nucleolin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,nucleolin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"Benzimidazole derivatives, antinematodal",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"Benzimidazole derivatives, antinematodal Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,OVOL1 gene|OVOL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OVOL1 gene|OVOL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transforming Growth Factor beta,Carcinoma breast stage IV,0.0,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Matrix Metalloproteinase 3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Moderate risk,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Moderate risk contralateral breast cancer,Female Breast Cancer
PREDISPOSES,PTPN11 gene|PTPN11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTPN11 gene|PTPN11 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,DPP9 gene|DPP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP9 gene|DPP9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STAU2 gene|STAU2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAU2 gene|STAU2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,peroxiredoxin I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,peroxiredoxin I Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,OMA1 gene|OMA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OMA1 gene|OMA1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IL17RB gene|IL17RB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL17RB gene|IL17RB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Extraction,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Extraction Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Protein-Lysine 6-Oxidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-Lysine 6-Oxidase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypermethylation,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Hypermethylation estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,RABIF gene|RABIF,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RABIF gene|RABIF Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,calreticulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,calreticulin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,piperine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,piperine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cultured Milk Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cultured Milk Products Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Biological Response Modifiers Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,NEIL2 gene|NEIL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEIL2 gene|NEIL2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hesperidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hesperidin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,AKR1C1 gene|AKR1C1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKR1C1 gene|AKR1C1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC01094 gene|LINC01094,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01094 gene|LINC01094 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Copy Number Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Copy Number Polymorphism Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Matrix,Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,Other,Matrix Triple-Negative Breast Carcinoma,Female Breast Cancer
PREDISPOSES,cannabinoid receptor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,cannabinoid receptor Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,CASQ2 gene|CASQ2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASQ2 gene|CASQ2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Pharmaceutical Preparations,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,LRP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LRP6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Platinum Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Platinum Compounds Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Very rare,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Very rare Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Raw Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Raw Foods Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CBR3-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VEGFA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TUBA1C gene|TUBA1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TUBA1C gene|TUBA1C Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,LINC02381 gene|LINC02381,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC02381 gene|LINC02381 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LGALS3BP,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,LGALS3BP HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Abnormality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Abnormality Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SH3BGRL gene|SH3BGRL,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SH3BGRL gene|SH3BGRL Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RGMA gene|RGMA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RGMA gene|RGMA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SARS-CoV-2 P.1 variant,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,SARS-CoV-2 P.1 variant Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SEMA6D gene|SEMA6D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEMA6D gene|SEMA6D Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HSPA5 gene|HSPA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPA5 gene|HSPA5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mucin-1 Antigen,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Immunologic Factor,Mucin-1 Antigen Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,BARD1 gene|BARD1,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"BARD1 gene|BARD1 Breast Cancer, Familial",Female Breast Cancer
DISRUPTS,NDRG2 gene|NDRG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NDRG2 gene|NDRG2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXP3 gene|FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXP3 gene|FOXP3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell secretion,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cell secretion Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Inhibitor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Inhibitor Breast Carcinoma,Female Breast Cancer
DISRUPTS,oleuropein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,oleuropein Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HSPA5 gene|HSPA5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HSPA5 gene|HSPA5 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Pharmacotherapy,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Pharmacotherapy contralateral breast cancer,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Histological type,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histological type Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BACH1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,BACH1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,monooxyethylene trimethylolpropane tristearate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,monooxyethylene trimethylolpropane tristearate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LPAR6 gene|LPAR6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LPAR6 gene|LPAR6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,interferon type II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interferon type II Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PELI1 gene|PELI1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PELI1 gene|PELI1 Breast Carcinoma,Female Breast Cancer
DISRUPTS,KPNA2 gene|KPNA2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,KPNA2 gene|KPNA2 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZMIZ2 gene|ZMIZ2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZMIZ2 gene|ZMIZ2 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,UBA6-AS1 gene|UBA6-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,UBA6-AS1 gene|UBA6-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,calcitriol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,calcitriol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nutritional status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nutritional status Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MALAT1 gene|MALAT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MALAT1 gene|MALAT1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,tanshinone,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,tanshinone Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,anhydroicaritin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,anhydroicaritin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,interleukin-10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 6|IGFBP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 6|IGFBP6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Agonist,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Agonist Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,kinase targeted therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,kinase targeted therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cancer-Predisposing Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ANKDD1A gene|ANKDD1A,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,ANKDD1A gene|ANKDD1A Early-Stage Breast Carcinoma,Female Breast Cancer
DISRUPTS,Inhibitor,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Inhibitor Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,BNIP3 gene|BNIP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BNIP3 gene|BNIP3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Candidate Disease Gene,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HCAR1 gene|HCAR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HCAR1 gene|HCAR1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MED1 gene|MED1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,MED1 gene|MED1 estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Environmental Estrogen,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,Environmental Estrogen estrogen receptor-positive breast cancer,Female Breast Cancer
CAUSES,PROX1 gene|PROX1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PROX1 gene|PROX1 Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Histone deacetylase inhibitor,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Other,Histone deacetylase inhibitor Basal-Like Breast Carcinoma,Female Breast Cancer
AUGMENTS,perilipin 2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,perilipin 2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,estradiol high,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estradiol high Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Stat3 protein,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Immune Checkpoint Inhibitors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Immune Checkpoint Inhibitors Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,ZFR gene|ZFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZFR gene|ZFR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNMT1 gene|DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNMT1 gene|DNMT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RUNX2 gene|RUNX2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,RUNX2 gene|RUNX2 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signal Transduction,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,dinaciclib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dinaciclib Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cholecalciferol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HSPBP1 gene|HSPBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPBP1 gene|HSPBP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MAP Kinase Kinase 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAP Kinase Kinase 5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mouse Model,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Mouse Model Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,MSH2 gene|MSH2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MSH2 gene|MSH2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,First relationship,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",First relationship Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDK1 gene|CDK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK1 gene|CDK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tumor suppressor activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tumor suppressor activity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Acute Promyelocytic Leukemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acute Promyelocytic Leukemia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,B3GNT5 gene|B3GNT5,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,B3GNT5 gene|B3GNT5 Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Incomplete penetrance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Incomplete penetrance Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,pioglitazone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pioglitazone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,quercetin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,quercetin Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Tumor Suppressor Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Hydrogel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydrogel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LINC00662 gene|LINC00662,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00662 gene|LINC00662 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KIF4A gene|KIF4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF4A gene|KIF4A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Inflammation Mediators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Mediators Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Hypothalamic inhibiting factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypothalamic inhibiting factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,aucubin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,aucubin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Citrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Citrates Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cyclin D1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin D1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC01234 gene|LINC01234,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01234 gene|LINC01234 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ethanol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Copy Number Polymorphism,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Copy Number Polymorphism Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Therapeutic immunosuppression,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic immunosuppression Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,polyethylene glycols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,polyethylene glycols Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Ryanodine Receptor 2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Ryanodine Receptor 2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,RAD51D gene|RAD51D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51D gene|RAD51D Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ALYREF gene|ALYREF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALYREF gene|ALYREF Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Measurement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast Measurement Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,perfluorononanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorononanoic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"POSTN protein, human|POSTN",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","POSTN protein, human|POSTN Breast Carcinoma",Female Breast Cancer
PREDISPOSES,RAD51B gene|RAD51B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51B gene|RAD51B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PNO1 gene|PNO1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PNO1 gene|PNO1 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Oncogenes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Oncogenes Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,PIK3R1 gene|PIK3R1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3R1 gene|PIK3R1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MicroRNAs,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,OTUD6A gene|OTUD6A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OTUD6A gene|OTUD6A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEG3 gene|MEG3|FAM129B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CXCL14 gene|CXCL14,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CXCL14 gene|CXCL14 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CDKN2A gene|CDKN2A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Immunoregulation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Immunoregulation HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Complement System Proteins,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Complement System Proteins Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Negative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Negative Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Large Neutral Amino Acid-Transporter 1|SLC7A5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Large Neutral Amino Acid-Transporter 1|SLC7A5 Breast Carcinoma,Female Breast Cancer
DISRUPTS,plumbagin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,plumbagin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MYC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Serum autoantibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Serum autoantibodies Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00520 gene|LINC00520,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,LINC00520 gene|LINC00520 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TPD52L2 gene|TPD52L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPD52L2 gene|TPD52L2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Glucosephosphate Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glucosephosphate Dehydrogenase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ATP6AP1 gene|ATP6AP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP6AP1 gene|ATP6AP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR1294 gene|MIR1294,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR1294 gene|MIR1294 Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Psychosocial Intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Psychosocial Intervention Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SLC31A1 gene|SLC31A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC31A1 gene|SLC31A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RNase P,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNase P Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,TGFB2-AS1 gene|TGFB2-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TGFB2-AS1 gene|TGFB2-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,inhibitor-of-apoptosis protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",inhibitor-of-apoptosis protein Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,MYCL gene|MYCL,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYCL gene|MYCL Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypoxia,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Hypoxia Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,DIO3OS gene|DIO3OS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DIO3OS gene|DIO3OS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,centromere protein F,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",centromere protein F Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,N4BP3 gene|N4BP3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,N4BP3 gene|N4BP3 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOD2 gene|SOD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOD2 gene|SOD2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF667-AS1 gene|ZNF667-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF667-AS1 gene|ZNF667-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Free Energy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Free Energy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Inhibitor,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Inhibitor estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,Parafibromin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parafibromin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RECQL5 gene|RECQL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RECQL5 gene|RECQL5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RBCK1 gene|RBCK1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RBCK1 gene|RBCK1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Dietary Fatty Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Dietary Fatty Acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR506 gene|MIR506,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR506 gene|MIR506 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZSWIM1 gene|ZSWIM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZSWIM1 gene|ZSWIM1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vascular Endothelial Growth Factors|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factors|VEGFA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MIR21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR21 gene|MIR21 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PALB2 gene|PALB2,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,PALB2 gene|PALB2 contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Genes,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,Genes contralateral breast cancer,Female Breast Cancer
PREDISPOSES,MCF2L-AS1 gene|MCF2L-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCF2L-AS1 gene|MCF2L-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Low Dose Radiation Therapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Low Dose Radiation Therapy Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,"pregna-4,17-diene-3,16-dione, (17Z)-isomer",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","pregna-4,17-diene-3,16-dione, (17Z)-isomer Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Osteoporosis,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Osteoporosis Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,Histone deacetylase inhibitor|HDAC9,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Histone deacetylase inhibitor|HDAC9 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,NR1H3 gene|NR1H3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR1H3 gene|NR1H3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Inflammation,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Aryl Hydrocarbon Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ALDH2 gene|ALDH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALDH2 gene|ALDH2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cytotoxic T-lymphocyte antigen 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,cytotoxic T-lymphocyte antigen 4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PCSK1 gene|PCSK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCSK1 gene|PCSK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Drug Repositioning,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacologic Substance,Drug Repositioning Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,YBX1 gene|YBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YBX1 gene|YBX1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Plasmids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Plasmids Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00536 gene|LINC00536,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00536 gene|LINC00536 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HNF1A gene|HNF1A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HNF1A gene|HNF1A Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,CALML5 gene|CALML5,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,CALML5 gene|CALML5 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,SOY ISOFLAVONES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOY ISOFLAVONES Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vimentin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vimentin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RBCK1 gene|RBCK1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,RBCK1 gene|RBCK1 estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,MYO6 gene|MYO6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYO6 gene|MYO6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Metric (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Metric (substance) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Clusterin,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Clusterin Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Hydroxymethylglutaryl-CoA reductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA reductase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TLE5 gene|AES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TLE5 gene|AES Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Light Exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Light Exercise Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Drinker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Drinker Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CREB1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,CREB1 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,bufalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bufalin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Alanine Aminotransferase 1, human",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,"Alanine Aminotransferase 1, human Secondary malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,cytidylyl-3'-5'-guanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cytidylyl-3'-5'-guanosine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Snacks,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Snacks Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HAR1A gene|HAR1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HAR1A gene|HAR1A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TMED3 gene|TMED3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMED3 gene|TMED3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anaplastic carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Anaplastic carcinoma Breast Carcinoma,Female Breast Cancer
DISRUPTS,NUMB gene|NUMB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUMB gene|NUMB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,internal risk factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",internal risk factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fasting blood sugar result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Fasting blood sugar result Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CENPL gene|CENPL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CENPL gene|CENPL Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BRCA2 gene|BRCA2,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
AFFECTS,First line treatment,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,First line treatment Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Long Intergenic Non-Protein Coding RNA,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,glabridin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,glabridin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Toothache,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Toothache Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCAT19 gene|PCAT19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT19 gene|PCAT19 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Food antioxidant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food antioxidant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,oleanolic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,oleanolic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Increased risk,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Increased risk contralateral breast cancer,Female Breast Cancer
DISRUPTS,quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,quercetin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC2A1 gene|SLC2A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EIF4A3 gene|EIF4A3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EIF4A3 gene|EIF4A3 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Antibody-Drug Conjugates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Antibody-Drug Conjugates Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SOD1 gene|SOD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOD1 gene|SOD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"ANGPT1 protein, human|ANGPT1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ANGPT1 protein, human|ANGPT1 Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Resistance Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Resistance Process Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,caveolin 1,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,caveolin 1 contralateral breast cancer,Female Breast Cancer
CAUSES,CYP1B1 gene|CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1B1 gene|CYP1B1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Global Longitudinal Strain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Global Longitudinal Strain Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoadjuvant Chemotherapy,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,Neoadjuvant Chemotherapy Luminal B Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Degenerative polyarthritis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Degenerative polyarthritis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coherent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coherent Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ethanol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Matrix Metalloproteinase 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GPR141 gene|GPR141,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPR141 gene|GPR141 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HFM1 gene|HFM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HFM1 gene|HFM1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,tamoxifen,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,tamoxifen estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,LGALS3 gene|LGALS3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LGALS3 gene|LGALS3 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Neoadjuvant Chemotherapy,HER2-negative breast cancer,0.0,Female Breast Cancer,Other,Neoadjuvant Chemotherapy HER2-negative breast cancer,Female Breast Cancer
AFFECTS,Physiologic calcification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Physiologic calcification Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,ZSCAN18 gene|ZSCAN18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZSCAN18 gene|ZSCAN18 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NNAT gene|NNAT,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,NNAT gene|NNAT estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Radioimmunotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Radioimmunotherapy Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Patient age,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Patient age Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,CREBZF gene|CREBZF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CREBZF gene|CREBZF Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,OTUD1 gene|OTUD1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,OTUD1 gene|OTUD1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,HMMR gene|HMMR,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,HMMR gene|HMMR Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elements Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Natural Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Natural Products Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,dihydroartemisinin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dihydroartemisinin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RNA Sequence,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Nucleotide Sequence,RNA Sequence Breast Carcinoma,Female Breast Cancer
AFFECTS,Luteolin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Luteolin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Severe (severity modifier),Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Severe (severity modifier) Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BCKDK gene|BCKDK,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,BCKDK gene|BCKDK Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Noninfiltrating Intraductal Carcinoma,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,"Anesthetics, Inhalation",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Anesthetics, Inhalation Secondary malignant neoplasm of breast",Female Breast Cancer
CAUSES,Tumor Antigens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Tumor Antigens Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,disulfiram,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,disulfiram Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Caffeic Acid Phenethyl Ester,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Caffeic Acid Phenethyl Ester Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Immune Tolerance,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Immune Tolerance Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Menstrual status:Type:Point in time:^Patient:Nominal:Stated,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Menstrual status:Type:Point in time:^Patient:Nominal:Stated Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MicroRNAs,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Neoadjuvant Chemotherapy,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Neoadjuvant Chemotherapy Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,INSM1 gene|INSM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,INSM1 gene|INSM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FUNDC2 gene|FUNDC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FUNDC2 gene|FUNDC2 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Parafibromin|CDC73,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parafibromin|CDC73 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ubiquitin-protein ligase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ubiquitin-protein ligase Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,euphorbia factor L1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,euphorbia factor L1 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammary Neoplasms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Mammary Neoplasms Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,NOX4 gene|NOX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOX4 gene|NOX4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Stereotactic Body Radiation Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stereotactic Body Radiation Therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NT5E gene|NT5E,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NT5E gene|NT5E Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,FOXQ1 gene|FOXQ1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXQ1 gene|FOXQ1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERBB2 Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 Gene Mutation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLRB1 gene|KLRB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLRB1 gene|KLRB1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF1 gene|YTHDF1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Micelles,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Micelles Carcinoma breast stage IV,Female Breast Cancer
CAUSES,MAPK1 gene|MAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK1 gene|MAPK1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,platinum,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,platinum Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CD160,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD160 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Polygenic Traits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polygenic Traits Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transfer RNA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Transfer RNA Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,e protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",e protein Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,METTL3 gene|METTL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL3 gene|METTL3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Basis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Basis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,graphdiyne,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,graphdiyne Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Collagen Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Collagen Diseases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,DNAJA1 gene|DNAJA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJA1 gene|DNAJA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SMAD4 gene|SMAD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD4 gene|SMAD4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Obesity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Obesity Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Biological Response Modifiers,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Biological Response Modifiers Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Hippo Signaling Pathway,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hippo Signaling Pathway Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,beta sitosterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta sitosterol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LRRC37A2 gene|LRRC37A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LRRC37A2 gene|LRRC37A2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FZD8 gene|FZD8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FZD8 gene|FZD8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF148,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF148 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Possible,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Other,Possible estrogen receptor-negative breast cancer,Female Breast Cancer
DISRUPTS,quercetin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,quercetin Breast Carcinoma,Female Breast Cancer
AFFECTS,Tumor Microenvironment,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment estrogen receptor-negative breast cancer,Female Breast Cancer
AFFECTS,VASP gene|VASP,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,VASP gene|VASP Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Responsive Disease,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Responsive Disease Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Clinical Significance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Clinical Significance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nail-Patella Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Nail-Patella Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CREB3L1 gene|CREB3L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CREB3L1 gene|CREB3L1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DHP107,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DHP107 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PSME3 gene|PSME3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PSME3 gene|PSME3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MDH2 gene|MDH2,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,MDH2 gene|MDH2 Recurrent Breast Carcinoma,Recurrent Breast Cancer
PREDISPOSES,FZR1 wt Allele|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FZR1 wt Allele|CDH1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PFKP gene|PFKP,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PFKP gene|PFKP Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,RNF185 gene|RNF185,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNF185 gene|RNF185 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Microenvironment,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,interleukin-1 alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,interleukin-1 alpha Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RNA I,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA I Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Cheese intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cheese intake Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genes,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Genes Invasive Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Oncogene Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Oncogene Proteins Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,PARD3 gene|PARD3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PARD3 gene|PARD3 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,USP4 gene|USP4,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,USP4 gene|USP4 Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,STING1 gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,STING1 gene Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Origin of Life,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Origin of Life Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tyrosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tyrosine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,mitogen-activated protein kinase p38,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mitogen-activated protein kinase p38 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SLC38A3 gene|SLC38A3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SLC38A3 gene|SLC38A3 Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,METTL7A gene|METTL7A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL7A gene|METTL7A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TNF protein, human|TNF",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Secondary malignant neoplasm of breast",Female Breast Cancer
AFFECTS,ASAH2 gene|ASAH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ASAH2 gene|ASAH2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DCTD gene|DCTD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DCTD gene|DCTD Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malate dehydrogenase (decarboxylating),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Malate dehydrogenase (decarboxylating) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AICARDI-GOUTIERES SYNDROME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,AICARDI-GOUTIERES SYNDROME Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,dasatinib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,dasatinib Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,DNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunogenic Cell Death,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Immunogenic Cell Death Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carboplatin/Etoposide/Melphalan Regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Carboplatin/Etoposide/Melphalan Regimen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Genes Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,ST14 gene|ST14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ST14 gene|ST14 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RENBP gene|RENBP,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,RENBP gene|RENBP Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cigarette smoke (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Cigarette smoke (substance) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NAT10 gene|NAT10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAT10 gene|NAT10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pubertal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pubertal Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hypoxia,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Hypoxia Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNORD16 gene|SNORD16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNORD16 gene|SNORD16 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ARID1A gene|ARID1A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ARID1A gene|ARID1A Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,NUDCD1 gene|NUDCD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUDCD1 gene|NUDCD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PKD2 gene|PKD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PKD2 gene|PKD2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,phosphatidylethanolamines,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,phosphatidylethanolamines estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphoric Monoester Hydrolases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body composition measure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body composition measure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplastic Cell Transformation,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Neoplastic Cell Transformation Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ZMIZ1 gene|ZMIZ1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZMIZ1 gene|ZMIZ1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Emotional hypersensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Emotional hypersensitivity Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Withanolides,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Withanolides Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,HER2-positive carcinoma of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2-positive carcinoma of breast Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KDM1A gene|KDM1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM1A gene|KDM1A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Triterpenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Triterpenes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,nervous system disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,nervous system disorder Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PRMT6 gene|PRMT6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRMT6 gene|PRMT6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,YY1 gene|YY1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,YY1 gene|YY1 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIRN181A gene|MIR181A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN181A gene|MIR181A2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Huntington Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Huntington Disease Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cyanidin 3-O-glucoside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyanidin 3-O-glucoside Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Rare Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Rare Diseases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,equol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,equol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,OGG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OGG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypoxia-Inducible Factor 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Hypoxia-Inducible Factor 1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Ultrasonography,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Ultrasonography Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,DYRK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DYRK2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast cancer metastatic,Female Breast Cancer
AFFECTS,Mitomycin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Mitomycin Breast cancer metastatic,Female Breast Cancer
AFFECTS,Leukotrienes,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Eicosanoid,Leukotrienes Ductal Breast Carcinoma,Female Breast Cancer
AUGMENTS,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,miltefosine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,miltefosine Breast Carcinoma,Female Breast Cancer
AFFECTS,FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Heparitin Sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heparitin Sulfate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Collagen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 gene|BRCA1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Ovulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovulation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoplasm Metastasis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Breast Carcinoma,Female Breast Cancer
DISRUPTS,PSD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PSD4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gamma synuclein|SNCG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gamma synuclein|SNCG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCAAT-Enhancer-Binding Protein-beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CCAAT-Enhancer-Binding Protein-beta Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,camalexin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,camalexin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ESR1 gene|ESR1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,CUL3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CUL3 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Streams,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Streams Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TOX3,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,TOX3 Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,FLT1 gene|FLT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,FLT1 gene|FLT1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Annexin A2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Annexin A2 Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,ORAI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ORAI3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fluvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fluvastatin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,KDM6B,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,KDM6B Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,"CRK protein, human|CRK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CRK protein, human|CRK Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,"Progestational Hormones, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Progestational Hormones, Synthetic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,CCR5 gene|CCR5,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,CCR5 gene|CCR5 Breast cancer invasive NOS,Female Breast Cancer
CAUSES,HOXD10 gene|HOXD10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXD10 gene|HOXD10 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TRPV6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,TRPV6 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,bexarotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bexarotene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RAC-Alpha Serine/Threonine Kinase|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAC-Alpha Serine/Threonine Kinase|AKT1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,dihydroceramide desaturase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dihydroceramide desaturase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CIP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CIP2A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Creatinine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Creatinine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Stearates,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Stearates Breast cancer metastatic,Female Breast Cancer
AFFECTS,Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast Carcinoma,Female Breast Cancer
CAUSES,PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIK3CA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KLF8 gene|KLF8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF8 gene|KLF8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Supplementation,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Supplementation Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,methylcobalamin-coenzyme M methyltransferase|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,methylcobalamin-coenzyme M methyltransferase|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Ubiquitin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ubiquitin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Protein Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Family Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast cancer recurrent",Recurrent Breast Cancer
AFFECTS,Angiotensin II Type 1 Receptor Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiotensin II Type 1 Receptor Blockers Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,anthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,anthracene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MYC Family Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC Family Genes|MYC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RBBP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RBBP8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beverages Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HSP90 Heat-Shock Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HSP90 Heat-Shock Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fat graft,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fat graft Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,mitogen-activated protein kinase p38|CRK|MAPK14|MAPK1|AIMP2|GRAP2|AHSA1|POLDIP2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mitogen-activated protein kinase p38|CRK|MAPK14|MAPK1|AIMP2|GRAP2|AHSA1|POLDIP2 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Ki antigen|PSME3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Ki antigen|PSME3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hormone Receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Hormone Receptor Breast cancer metastatic,Female Breast Cancer
AFFECTS,Benzimidazoles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benzimidazoles Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IRAK4 gene|IRAK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRAK4 gene|IRAK4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Heart Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Heart Diseases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,lysophosphatidylethanolamine,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"lysophosphatidylethanolamine Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Does hit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Does hit Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,cDNA Library,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cDNA Library Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Flavonoids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Flavonoids Breast cancer metastatic,Female Breast Cancer
AUGMENTS,osteoblast cadherin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,osteoblast cadherin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,HOXD@,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,HOXD@ Breast cancer metastatic,Female Breast Cancer
AFFECTS,TFF3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,TFF3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Lovastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lovastatin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EPHB2|MAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EPHB2|MAPK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AXILLARY LYMPH NODE METASTASIS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AXILLARY LYMPH NODE METASTASIS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APOA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,APOA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,genistin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,genistin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GRPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GRPR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRIM62,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TRIM62 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,tau Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tau Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"NAT1 protein, human|NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NAT1 protein, human|NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,tipifarnib,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,tipifarnib Breast Carcinoma,Female Breast Cancer
AFFECTS,low protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",low protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,C-KIT Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",C-KIT Mutation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Autophagy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Autophagy Breast Carcinoma,Female Breast Cancer
PREDISPOSES,LRIG1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,LRIG1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,erlotinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erlotinib Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dimethyl sulfone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dimethyl sulfone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"TRIP10 protein, human|TRIP10",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIP10 protein, human|TRIP10 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,SRD5A2 gene|SRD5A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRD5A2 gene|SRD5A2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Acetate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Acetate Breast cancer metastatic,Female Breast Cancer
AFFECTS,Tumor Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Markers Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,XRCC2 gene|XRCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC2 gene|XRCC2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Thrombospondin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thrombospondin 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCNA2 gene|CCNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNA2 gene|CCNA2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Proline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proline Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,icaritin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,icaritin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MDC1 gene|MDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDC1 gene|MDC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gene polymorphism,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,gene polymorphism Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Biopsy finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biopsy finding Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TWIST1 gene|TWIST1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"NOS3 protein, human|NOS3",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NOS3 protein, human|NOS3 Breast cancer metastatic",Female Breast Cancer
AUGMENTS,GFRA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GFRA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prolactin|PRL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Prolactin|PRL Breast Carcinoma,Female Breast Cancer
AFFECTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,CDKN1A|TCEAL1|NSG1|H3F3AP6 Breast Carcinoma,Female Breast Cancer
CAUSES,dehydroepiandrosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dehydroepiandrosterone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast cancer invasive NOS",Female Breast Cancer
AFFECTS,formononetin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,formononetin Breast cancer metastatic,Female Breast Cancer
AUGMENTS,8q22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,8q22 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Effective communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Effective communication Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phospholipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Phospholipids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ataxia Telangiectasia,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Ataxia Telangiectasia Female Breast Carcinoma,Female Breast Cancer
CAUSES,Common Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Common Carcinoma Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,DNA,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Stress,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Stress Breast Carcinoma,Female Breast Cancer
AFFECTS,peptide hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",peptide hormone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,retinyl methyl ether,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,retinyl methyl ether Breast Carcinoma,Female Breast Cancer
AFFECTS,PROTEIN KINASE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Negative Finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Negative Finding Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aneuploidy,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Aneuploidy Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,"technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Ethinyl Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ethinyl Estradiol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"SOD2 protein, human|SOD2",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SOD2 protein, human|SOD2 Breast Carcinoma",Female Breast Cancer
AUGMENTS,E-Selectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,E-Selectin Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Neoplasm Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Exogenous hormones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Exogenous hormones Breast Carcinoma,Female Breast Cancer
AFFECTS,"Fruit, Citrus",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Fruit, Citrus Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,ETV4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ETV4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LMO7 gene|LMO7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LMO7 gene|LMO7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antigens,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Immunologic Factor,Antigens Female Breast Carcinoma,Female Breast Cancer
AUGMENTS,Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,peptide hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",peptide hormone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Glutaminase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glutaminase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cheese,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cheese Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Androgenic precursors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgenic precursors Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TP53 gene|TP53,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,HOXA1 gene|HOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXA1 gene|HOXA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,dihydroxy-vitamin D3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Food,dihydroxy-vitamin D3 Breast Carcinoma,Female Breast Cancer
CAUSES,Virus,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,Virus Breast Carcinoma,Female Breast Cancer
CAUSES,spasmolytic polypeptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",spasmolytic polypeptide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aminoglutethimide,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Aminoglutethimide Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Monoclonal Antibodies,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Monoclonal Antibodies Breast Carcinoma,Female Breast Cancer
AFFECTS,3-hydroxytamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,3-hydroxytamoxifen Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Relate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Relate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Histological finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histological finding Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Steroid Use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroid Use Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Low-Density Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Low-Density Lipoproteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ESTROGEN USE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,ESTROGEN USE Breast Carcinoma,Female Breast Cancer
AFFECTS,Prednisone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prednisone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Prolactin|PRL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Prolactin|PRL Breast Carcinoma,Female Breast Cancer
DISRUPTS,Caffeine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Caffeine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperplasia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic Abortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic Abortion Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Fatty Acids, Nonesterified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Nonesterified Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Augmentation mammoplasty,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Augmentation mammoplasty Breast Carcinoma,Female Breast Cancer
CAUSES,Malignant neoplasm of breast,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Contralateral breast cancer,Female Breast Cancer
AFFECTS,MICE gene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MICE gene Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Smoking History,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Smoking History Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sialyltransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sialyltransferases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CATHEPSIN D|CTSD,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CATHEPSIN D|CTSD Breast cancer metastatic,Female Breast Cancer
CAUSES,Monoclonal Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Monoclonal Antibodies Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Genes, vpr",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, vpr Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"Genome, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genome, Human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,mucinous carcinoma-associated antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mucinous carcinoma-associated antigen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Polymerase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Polymerase Breast Carcinoma,Female Breast Cancer
CAUSES,Dietary Fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Fiber Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Insulin Receptor|INSR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin Receptor|INSR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Non-smoker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Non-smoker Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mixed Function Oxygenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mixed Function Oxygenases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estradiol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PCAF gene|KAT2B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PCAF gene|KAT2B Breast Carcinoma,Female Breast Cancer
AUGMENTS,CCND1 gene|CCND1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Breast Carcinoma,Female Breast Cancer
AFFECTS,Fluphenazine Hydrochloride,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fluphenazine Hydrochloride Breast Carcinoma,Female Breast Cancer
AFFECTS,SHBG gene|SHBG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHBG gene|SHBG Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Lymphoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lymphoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NODULAR DENSITY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NODULAR DENSITY Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinoembryonic Antigen,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Ionizing radiation,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Ionizing radiation Carcinoma of Male Breast,Male Breast Cancer
CAUSES,Serine Protease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Serine Protease Breast Carcinoma,Female Breast Cancer
CAUSES,SH Protease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,SH Protease Breast Carcinoma,Female Breast Cancer
CAUSES,Breast cancer recurrent,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Breast cancer recurrent Carcinoma, Ductal, Breast",Recurrent Breast Cancer
AFFECTS,3-hydroxytamoxifen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,3-hydroxytamoxifen Breast cancer metastatic,Female Breast Cancer
CAUSES,Study models,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Study models Ductal Breast Carcinoma,Female Breast Cancer
AUGMENTS,Glucagon,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Glucagon Breast Carcinoma,Female Breast Cancer
AUGMENTS,Insulin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Insulin Breast Carcinoma,Female Breast Cancer
CAUSES,Secondary malignant neoplasm of liver,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of liver Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Autologous bone marrow transplant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Autologous bone marrow transplant Malignant neoplasm of breast,Female Breast Cancer
CAUSES,cytokine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast Carcinoma,Female Breast Cancer
CAUSES,Histocompatibility Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Histocompatibility Antigens Breast Carcinoma,Female Breast Cancer
AFFECTS,PGR gene|PGR,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,PGR gene|PGR Sporadic Breast Carcinoma,Female Breast Cancer
CAUSES,Epidermal Growth Factor|EGF,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Breast Carcinoma,Female Breast Cancer
AFFECTS,beta-Chemokines,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,beta-Chemokines Breast Carcinoma,Female Breast Cancer
CAUSES,PIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vascular Endothelial Growth Factor C,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C Breast cancer metastatic,Female Breast Cancer
CAUSES,Signaling Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Signaling Molecule Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like-Growth Factor I Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microsatellite Instability,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Microsatellite Instability Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,Genes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Genes Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,DNA Polymerase I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Polymerase I Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ZNF217 gene|ZNF217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF217 gene|ZNF217 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Laminin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Laminin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,riboflavin-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",riboflavin-binding protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Raw vegetable,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Raw vegetable Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinoma in Situ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transferase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CDKN2A|CDKN2D|F9|REG1A|IL23A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDKN2A|CDKN2D|F9|REG1A|IL23A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EIF3S6 gene|EIF3E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EIF3S6 gene|EIF3E Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Inositol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inositol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SULT1A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SAFB gene|SAFB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SAFB gene|SAFB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenesis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Angiogenesis Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,Primary Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Primary Carcinoma Breast Carcinoma,Female Breast Cancer
DISRUPTS,Inositol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Inositol Breast Carcinoma,Female Breast Cancer
AFFECTS,Differential Diagnosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Differential Diagnosis Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Tumor Markers,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Markers Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,PRMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRMT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Folate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aneuploidy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Aneuploidy Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Mitogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitogens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyperlipidemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Hyperlipidemia Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Bilirubin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bilirubin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,cyclin E2|CCNE2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclin E2|CCNE2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SPARC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SPARC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ID-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ID-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Germ-Line Mutation,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Carcinoma of Male Breast,Female Breast Cancer
DISRUPTS,Globo-H,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Globo-H Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MYC gene|MYC,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,MYC gene|MYC Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Metformin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Metformin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,"TACC1 protein, human|TACC1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACC1 protein, human|TACC1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"Hydrocarbons, Halogenated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Halogenated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Genetic syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic syndrome Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hormones,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Hormones Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,Platinum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Platinum Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EGb 761,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EGb 761 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,celecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,celecoxib Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nulliparity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nulliparity Malignant neoplasm of breast,Female Breast Cancer
CAUSES,B-pyridine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,B-pyridine Breast Carcinoma,Female Breast Cancer
AFFECTS,Pathologic Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Pathologic Processes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ELF3 gene|ELF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELF3 gene|ELF3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Meal pattern NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Meal pattern NOS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diastasis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PLAUR gene|PLAUR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PLAUR gene|PLAUR Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Fumarate Hydratase|FH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fumarate Hydratase|FH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vidal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vidal Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thyrotropin-Releasing Hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyrotropin-Releasing Hormone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,E-Cadherin|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,E-Cadherin|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AXIN2 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AXIN2 gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCL2 gene|CCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL2 gene|CCL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fluoxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fluoxetine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|ESR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,bone sialoprotein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bone sialoprotein Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Thiazolidinediones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Thiazolidinediones Breast Carcinoma,Female Breast Cancer
AUGMENTS,EZH2 gene|EZH2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,antireticular cytotoxic serum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,antireticular cytotoxic serum Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERA-923,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ERA-923 Breast Carcinoma,Female Breast Cancer
AUGMENTS,CD151,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD151 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,restriction enzyme,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",restriction enzyme Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tretinoin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tretinoin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Multiparity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Multiparity Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Tankyrase|TNKS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tankyrase|TNKS Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SEPT9 gene|SEPT9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEPT9 gene|SEPT9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Beans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beans Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Steroids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Steroid,Steroids Breast Carcinoma,Female Breast Cancer
PREDISPOSES,betaIG-H3 protein|TGFBI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",betaIG-H3 protein|TGFBI Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,integrin-linked kinase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,integrin-linked kinase Breast cancer metastatic,Female Breast Cancer
CAUSES,Tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tea Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTHLH gene|PTHLH,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Breast cancer metastatic,Female Breast Cancer
CAUSES,T gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,T gene Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,zeaxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,zeaxanthin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Vitamin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Gonadal Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Smoking,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Smoking Familial cancer of breast,Female Breast Cancer
PREDISPOSES,CD109,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,CD109 Breast Carcinoma,Female Breast Cancer
AFFECTS,ERBB2|NEU1|NEURL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,IRS2 gene|IRS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,IRS2 gene|IRS2 Breast cancer metastatic,Female Breast Cancer
CAUSES,SRC,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,SRC Breast Carcinoma,Female Breast Cancer
AFFECTS,Small RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Small RNA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Heterocyclic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heterocyclic Amines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PSIP1 gene|PSIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSIP1 gene|PSIP1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Aromatic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aromatic Amines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TBX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TBX3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CA9 gene|CA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CA9 gene|CA9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Integrin alpha6beta1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Integrin alpha6beta1 Breast Carcinoma,Female Breast Cancer
AUGMENTS,Angiopoietin-2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Angiopoietin-2 Breast cancer metastatic,Female Breast Cancer
CAUSES,LMO4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LMO4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antidepressive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antidepressive Agents Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IGF2 gene|IGF2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,IGF2 gene|IGF2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,SCTR gene|SCTR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SCTR gene|SCTR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fetus size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fetus size Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogens,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,Estrogens Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,"Shc1 protein, mouse|SHC1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Shc1 protein, mouse|SHC1 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,ERbetacx,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,ERbetacx Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,multicatalytic endopeptidase complex,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,multicatalytic endopeptidase complex Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Abnormal result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Abnormal result Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Environmental Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Environmental Estrogen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Selective Estrogen Receptor Modulators,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Breast cancer metastatic,Female Breast Cancer
AFFECTS,PP5 protein-serine-threonine phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PP5 protein-serine-threonine phosphatase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lesion,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Lesion Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,IGFBP3 gene|IGFBP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGFBP3 gene|IGFBP3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vascular Endothelial Growth Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,N-3 fatty acid intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-3 fatty acid intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cell invasion,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",cell invasion Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,TRANCE protein|TNFSF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein|TNFSF11 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Genes, Homeobox|LBX1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Homeobox|LBX1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,WISP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WISP2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,WWP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Water Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NDRG1 gene|NDRG1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,NDRG1 gene|NDRG1 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Combination Drug Therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Combination Drug Therapy Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Eating habit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Eating habit Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,alanylalanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alanylalanine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MUC5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MUC5B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary malignant neoplasm of bone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Breast cancer metastatic,Female Breast Cancer
AFFECTS,genetic element,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,genetic element Breast Carcinoma,Female Breast Cancer
AFFECTS,"DICER1 protein, human|DICER1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Cyclophosphamide,Breast cancer stage II,0.0,Female Breast Cancer,Other,Cyclophosphamide Breast cancer stage II,Female Breast Cancer
PREDISPOSES,"Nuclear Receptor Subfamily 4, Group A, Member 1",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,"Nuclear Receptor Subfamily 4, Group A, Member 1 Breast cancer recurrent",Female Breast Cancer
CAUSES,Xanthine Dehydrogenase|XDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xanthine Dehydrogenase|XDH Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NOTCH1 gene,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,NOTCH1 gene Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Bloody nipple discharge,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bloody nipple discharge Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Adhesion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Adhesion Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CCL18 gene|CCL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL18 gene|CCL18 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,trans-resveratrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,trans-resveratrol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,phospholipase C beta2|NEUROD1|TUBB4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phospholipase C beta2|NEUROD1|TUBB4B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PTK2B gene|PTK2B,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,PTK2B gene|PTK2B Breast cancer recurrent,Female Breast Cancer
PREDISPOSES,ABCB1 gene|ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCB1 gene|ABCB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytochrome P-450 CYP2D6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP2D6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signal Transduction Pathways,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Pathways Breast cancer metastatic,Female Breast Cancer
CAUSES,Prolactin Receptor|PRLR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Prolactin Receptor|PRLR Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CCL2 gene|CCL2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCL2 gene|CCL2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Receptor Protein-Tyrosine Kinases,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,RGS Proteins|PITX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RGS Proteins|PITX2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TNFSF11 gene|TNFSF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF11 gene|TNFSF11 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PRS gene|PRS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRS gene|PRS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclin D1|CCND1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Cyclin D1|CCND1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,ADIPOR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADIPOR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bone remodeling,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Bone remodeling Breast cancer metastatic,Female Breast Cancer
AUGMENTS,ADRA1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADRA1D Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypoxia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Hypoxia Breast Carcinoma,Female Breast Cancer
CAUSES,"Receptors, Progesterone|EREG|ESR1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Breast Carcinoma",Female Breast Cancer
AFFECTS,Pharmacotherapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Pharmacotherapy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,osteopontin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,osteopontin Breast cancer metastatic,Female Breast Cancer
AFFECTS,cell fate determination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cell fate determination Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,N-Cadherins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,N-Cadherins Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,LSP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LSP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Stromal hyperplasia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Stromal hyperplasia Breast Carcinoma,Female Breast Cancer
AFFECTS,Gene Expression Alteration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Expression Alteration Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cessation of life,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cessation of life Breast Carcinoma,Female Breast Cancer
AUGMENTS,UNC45A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,UNC45A Breast cancer metastatic,Female Breast Cancer
CAUSES,Human Papilloma Virus Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Human Papilloma Virus Vaccine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,JTB gene|JTB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JTB gene|JTB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CISH,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,CISH Female Breast Carcinoma,Female Breast Cancer
CAUSES,Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Process Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein Overexpression,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Overexpression Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Systemic disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Systemic disease Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IGF1R Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Candidate Disease Gene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Breast cancer metastatic,Female Breast Cancer
AFFECTS,artesunate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,artesunate Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Adrenergic beta-Antagonists,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Adrenergic beta-Antagonists Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,Selectins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Selectins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Paraffin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paraffin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Extravasation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extravasation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alkaline phosphatase isoenzyme,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Enzyme,Alkaline phosphatase isoenzyme Breast cancer metastatic,Female Breast Cancer
AFFECTS,heparanase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,heparanase Breast cancer metastatic,Female Breast Cancer
AFFECTS,Hormone Receptor Test,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Test Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Calcium, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Calcium, Dietary Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Interleukin Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Interleukin Gene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,denbinobin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,denbinobin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Proline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proline Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AXL gene|AXL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AXL gene|AXL Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FAT4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAT4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,prophylactics use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prophylactics use Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD100 antigen|SEMA4D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD100 antigen|SEMA4D Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TIAM1 gene|TIAM1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TIAM1 gene|TIAM1 Breast Carcinoma,Female Breast Cancer
AFFECTS,HDAC9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,HDAC9 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Tumor Suppressor Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast cancer metastatic,Female Breast Cancer
AFFECTS,ERBB2 gene|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Stiff-Person Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Stiff-Person Syndrome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TAZ gene|TAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAZ gene|TAZ Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ethanol,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Ethanol Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,COPS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,COPS5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KDM1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KDM1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cigarette Smoking,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Cigarette Smoking Contralateral breast cancer,Female Breast Cancer
AUGMENTS,CBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CBX1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,metabolic abnormality assessment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,metabolic abnormality assessment Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolism Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,UHRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UHRF1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Ethacrynic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ethacrynic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,asparaginylendopeptidase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,asparaginylendopeptidase Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Transcript,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Transcript Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6 Breast cancer recurrent,Female Breast Cancer
PREDISPOSES,UHRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UHRF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sweet's Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sweet's Syndrome Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,heparanase|HPSE,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,heparanase|HPSE Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Prions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prions Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PTPN12 gene|PTPN12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN12 gene|PTPN12 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Antigens, CD25",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"Antigens, CD25 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,PLK1 gene|PLK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PLK1 gene|PLK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NUCB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NUCB2 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Fibroblast Growth Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Keratin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Keratin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PER1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Intercellular adhesion molecule 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Intercellular adhesion molecule 1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,5'-AMP-activated protein kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",5'-AMP-activated protein kinase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Metals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Polyethylene Glycols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polyethylene Glycols Malignant neoplasm of breast,Female Breast Cancer
CAUSES,flavanone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,flavanone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,WT1 gene|WT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WT1 gene|WT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Acetaldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetaldehyde Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC2A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physiologic Responses,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physiologic Responses Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,SMYD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SMYD2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIRN96 gene|MIR96,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN96 gene|MIR96 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Dimethylformamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dimethylformamide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PVT1 gene|PVT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PVT1 gene|PVT1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Systemic poison,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Systemic poison Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Stereotactic radiotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stereotactic radiotherapy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Receptors, Progesterone|PGR",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Breast Carcinoma",Female Breast Cancer
AUGMENTS,CD47 gene|CD47,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD47 gene|CD47 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,mitogen-activated protein kinase 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mitogen-activated protein kinase 7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TGFBR2 gene|TGFBR2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TGFBR2 gene|TGFBR2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Reactive Oxygen Species,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Breast cancer metastatic,Female Breast Cancer
AFFECTS,"ESR2 protein, human|ESR2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR2 protein, human|ESR2 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,lard,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lard Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiotensins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiotensins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CPEB4 gene|CPEB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CPEB4 gene|CPEB4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,triplet codon-amino acid adaptor activity,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Amino Acid, Peptide, or Protein",triplet codon-amino acid adaptor activity Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Nicotine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nicotine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,osthol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,osthol Breast cancer metastatic,Female Breast Cancer
AFFECTS,ginkgetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ginkgetin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HOXD13,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,HOXD13 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,diallyl trisulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,diallyl trisulfide Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,citrate lyase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,citrate lyase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,Breast cancer stage III,0.0009990009990009,Female Breast Cancer,Other,Pharmacotherapy Breast cancer stage III,Female Breast Cancer
DISRUPTS,PPP2R1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPP2R1A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Breast cancer metastatic",Female Breast Cancer
DISRUPTS,Hydroxamic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Hydroxamic Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ADIPOR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADIPOR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor necrosis factor receptor 11b Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phospholipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Phospholipids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin-1 alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-1 alpha Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Infrared radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infrared radiation therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MMP12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MMP12 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"STC1 protein, human|STC1",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein","STC1 protein, human|STC1 Breast cancer recurrent",Female Breast Cancer
DISRUPTS,DANCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DANCR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,baicalein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,baicalein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HMGA2 gene|HMGA2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,HMGA2 gene|HMGA2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Benzodiazepines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benzodiazepines Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Breast cancer stage III,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer stage III Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Glycerol-3-Phosphate Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glycerol-3-Phosphate Dehydrogenase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adhesions,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Adhesions Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Neprilysin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neprilysin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WBP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"MFNG protein, human|MFNG",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MFNG protein, human|MFNG Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Placental Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Placental Growth Factor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Anthocyanins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Anthocyanins Breast cancer metastatic,Female Breast Cancer
AFFECTS,Mesothelioma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mesothelioma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lipopolysaccharides,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Lipopolysaccharides Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"Dysplasia, fibrous",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Dysplasia, fibrous Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,HGF gene|HGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HGF gene|HGF Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RBBP1L1 Protein|ARID4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RBBP1L1 Protein|ARID4B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TERT gene|TERT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TERT gene|TERT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,hypercholesterolemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,hypercholesterolemia Malignant neoplasm of breast,Female Breast Cancer
CAUSES,RETN gene|RETN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RETN gene|RETN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SYNJ2BP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SYNJ2BP Breast cancer metastatic,Female Breast Cancer
AFFECTS,phenylpyruvate tautomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phenylpyruvate tautomerase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LIMK1 gene|LIMK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIMK1 gene|LIMK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Camellia sinensis extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Camellia sinensis extract Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutant Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mutant Proteins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Dioxygenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dioxygenases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SRCIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SRCIN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Receptors, Calcium-Sensing",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptors, Calcium-Sensing Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,17beta-HSD 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,17beta-HSD 7 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,RET gene|RET,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,RET gene|RET Breast Carcinoma,Female Breast Cancer
AFFECTS,Immunotoxins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Immunotoxins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PNPLA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PNPLA2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,DNA,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Familial cancer of breast,Female Breast Cancer
CAUSES,NRF1 gene|NRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRF1 gene|NRF1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,L-2-amino-4-phosphonobutyrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,L-2-amino-4-phosphonobutyrate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"8-oxoguanine-DNA glycosylase, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","8-oxoguanine-DNA glycosylase, human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,PCDH10 gene|PCDH10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCDH10 gene|PCDH10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"NOS3 protein, human|NOS3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NOS3 protein, human|NOS3 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,RUNX2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,RUNX2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Mitosis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Mitosis Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,NOTCH1 gene,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"NOTCH1 gene Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,CDK4 gene|CDK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK4 gene|CDK4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Riluzole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Riluzole Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Androgens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Androgens Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Prostaglandins E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Prostaglandins E Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CD4 gene|CD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD4 gene|CD4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tiron,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Tiron Breast Carcinoma,Female Breast Cancer
CAUSES,TOLLIP gene|TOLLIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOLLIP gene|TOLLIP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CASP10 gene|CASP10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASP10 gene|CASP10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sorafenib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sorafenib Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Paclitaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Paclitaxel Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Pharmaceutical Preparations,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer metastatic,Female Breast Cancer
AFFECTS,Cytochrome P-450 CYP2E1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP2E1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CCNB1 gene|CCNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNB1 gene|CCNB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dendritic Cell Vaccine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Dendritic Cell Vaccine Breast cancer metastatic,Female Breast Cancer
AUGMENTS,cyclin B2|CCNB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclin B2|CCNB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,receptor Breast cancer metastatic,Female Breast Cancer
AUGMENTS,atamestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,atamestane Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BARD1 gene|BARD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BARD1 gene|BARD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,N-(4-aminophenethyl)spiroperidol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,N-(4-aminophenethyl)spiroperidol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GACAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GACAT3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Aspartate Transaminase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aspartate Transaminase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Therapeutic Intervention,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic Intervention Breast cancer metastatic,Female Breast Cancer
AUGMENTS,UBAP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UBAP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FOXC1 gene|FOXC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXC1 gene|FOXC1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Bombesin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bombesin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRIP1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,BRIP1 Familial cancer of breast,Female Breast Cancer
CAUSES,Homologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Homologous Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,indole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,indole Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AKTIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AKTIP Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LMO4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LMO4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alternative Therapies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Therapies Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SIRT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SIRT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,JAG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,JAG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"NAT2 protein, human|NAT2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NAT2 protein, human|NAT2 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Acetylcysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetylcysteine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Diet,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Diet Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,LTB4R2 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LTB4R2 gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fisetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fisetin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dopamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Dopamine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,chemokine receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chemokine receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth-Factor-Binding Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth-Factor-Binding Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 gene|BRCA1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,XPA gene|XPA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XPA gene|XPA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,rhodioloside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,rhodioloside Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HOXB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HOXB5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nitric Oxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nitric Oxide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,YBX1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,YBX1 Breast cancer invasive NOS,Female Breast Cancer
CAUSES,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1B gene|CDKN1B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,proteomic profiling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,proteomic profiling Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mastectomy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Mastectomy Breast cancer metastatic,Female Breast Cancer
DISRUPTS,MIRN384 gene|MIR384,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN384 gene|MIR384 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SNAI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNAI1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MFAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MFAP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MAL gene|CD8A|MAL|MKL1|TIRAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAL gene|CD8A|MAL|MKL1|TIRAP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hyperinsulinism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperinsulinism Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MTDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTDH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diabetic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diabetic Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TRANCE protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Genistein,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Genistein Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CD24,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,CD24 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Breast hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast hyperplasia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,mixed drink,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mixed drink Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thrombospondin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thrombospondin 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hodgkin Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hodgkin Disease Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Diet,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Diet Breast Carcinoma,Female Breast Cancer
AFFECTS,CYP2A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP2A6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Wound Healing,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Wound Healing Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Candidate Disease Gene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Breast Carcinoma,Female Breast Cancer
CAUSES,Depo-Provera,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Depo-Provera Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Hydrocortisone,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Hydrocortisone Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Estrogen receptor negative,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor negative Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Malnutrition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Malnutrition Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Breast Carcinoma,Female Breast Cancer
AFFECTS,Violence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Violence Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Methotrexate,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Methotrexate Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,BP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BP3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Antigens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Permeability,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Permeability Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Transplantation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transplantation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CISH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CISH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor I,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Breast Carcinoma,Female Breast Cancer
AFFECTS,SULT1A1|SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SULT1A1|SULT1A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Tumor Promoters,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Tumor Promoters Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,tibolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tibolone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Indicators,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Menopausal Status,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Menopausal Status Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,HYAL1 gene|HYAL1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,HYAL1 gene|HYAL1 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Cell division,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell division Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SFRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SFRP2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,letrozole,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,letrozole Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast cancer metastatic,Female Breast Cancer
AUGMENTS,SLC13A2|SLC13A5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC13A2|SLC13A5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sexual function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sexual function Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,bone metabolism,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,bone metabolism Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Androgens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Androgens Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Carcinoma in Situ,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,MIRN21 gene|MIR21,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,MIRN21 gene|MIR21 Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,Lactate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lactate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,telomerase activity,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,telomerase activity Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Seasoning,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Seasoning Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinoembryonic Antigen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Atypia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Atypia Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Test Result,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Test Result Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Pathologic stage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pathologic stage Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Janus kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Janus kinase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PRL gene|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRL gene|PRL Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,B VARIANT NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,B VARIANT NOS Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Shock,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Shock Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RARA gene|RARA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RARA gene|RARA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antioxidants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antioxidants Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gonadorelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gonadorelin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,progesterone receptor B|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone receptor B|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,biological_process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,biological_process Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MAP Kinase Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAP Kinase Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Breast cancer invasive NOS",Female Breast Cancer
CAUSES,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,VEGFA,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,VEGFA Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,soy protein isolate,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,"Polycyclic Hydrocarbons, Aromatic",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Carcinoma of Male Breast",Male Breast Cancer
AUGMENTS,MED28,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,MED28 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Selenium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Immunoglobulin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunoglobulin A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MED28,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MED28 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ARHI gene|DIRAS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHI gene|DIRAS3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,claudin 6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,claudin 6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Superior Vena Cava Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Superior Vena Cava Syndrome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,S100 Proteins|S100A1|S100B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",S100 Proteins|S100A1|S100B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Precancerous lesions,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Precancerous lesions Ductal Breast Carcinoma,Female Breast Cancer
AUGMENTS,PLEKHF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PLEKHF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Associated symptom,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Associated symptom Malignant neoplasm of breast,Female Breast Cancer
CAUSES,WNT5A gene|WNT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT5A gene|WNT5A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,2q34,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2q34 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fucoidan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fucoidan Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,5-7-oxo-zeaenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,5-7-oxo-zeaenol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"ESR1 protein, human|ESR1",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR1 protein, human|ESR1 Breast cancer invasive NOS",Female Breast Cancer
AUGMENTS,EGFR|ENAH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EGFR|ENAH Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,coactivator-associated arginine methyltransferase 1|CARM1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,coactivator-associated arginine methyltransferase 1|CARM1 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,ACKR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ACKR3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Chloroquine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chloroquine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa|UBASH3B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Ribosomal Protein S6 Kinases, 70-kDa|UBASH3B Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Does play,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Does play Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Weight maintenance regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Weight maintenance regimen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RAP1GDS1|KIFAP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAP1GDS1|KIFAP3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methionine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LPO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LPO Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIP,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,PIP Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,ING1 gene|ING1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ING1 gene|ING1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,proneurotensin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,proneurotensin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dehydroepiandrosterone Sulfate,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Dehydroepiandrosterone Sulfate Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,PRKD1 gene|PRKD1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PRKD1 gene|PRKD1 Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,EGb 761,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EGb 761 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TIAM1 gene|TIAM1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,TIAM1 gene|TIAM1 Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,mortalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mortalin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PTEN gene|PTEN,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,CACNA1A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CACNA1A Breast cancer metastatic,Female Breast Cancer
AFFECTS,osteopontin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,osteopontin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,biological_process,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Phenomenon or Process,biological_process Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,XIST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,XIST Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CISH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CISH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interleukin-6|IL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-6|IL6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,COX5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,COX5B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adenoid Cystic Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenoid Cystic Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AHNAK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AHNAK Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MRPS18A gene|MRPS18A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MRPS18A gene|MRPS18A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,no positive axillary nodes,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,no positive axillary nodes Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Vitamin B2 intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B2 intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,chitotriosidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chitotriosidase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PROSTATE SPECIFIC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PROSTATE SPECIFIC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adjuvant response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adjuvant response Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,E-Cadherin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,E-Cadherin Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Platinum salt,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Platinum salt Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Insulin Receptor|INSR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Insulin Receptor|INSR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATM gene|ATM,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,ATM gene|ATM Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Mineralocorticoid Receptor|DHCR24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Mineralocorticoid Receptor|DHCR24 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CREB3L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CREB3L1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Melatonin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antilipemic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antilipemic Agents Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ITK gene|ITK,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ITK gene|ITK Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CXCL10 gene|CXCL10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL10 gene|CXCL10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibroadenoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibroadenoma Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MicroRNAs,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,FANCM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FANCM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,6/6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6/6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Thyroxine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thyroxine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,antibody therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",antibody therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gastrin|GAST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gastrin|GAST Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Peanuts - dietary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Peanuts - dietary Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pancreatic carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pancreatic carcinoma Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KIF4A gene|KIF4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF4A gene|KIF4A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA Repair Gene,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,DNA Repair Gene Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Microcalcification,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Breast Carcinoma,Female Breast Cancer
AUGMENTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Compete,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Compete Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL1B gene|IL1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL1B gene|IL1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL4R gene|IL4R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL4R gene|IL4R Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Crystallins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Crystallins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MSX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MSX2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,YBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,YBX1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,valdecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,valdecoxib Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Mitomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitomycin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Enhancing Lesion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Enhancing Lesion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PRRT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRRT2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Sulfuric Acid Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfuric Acid Esters Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EGFL7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EGFL7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CXCL13 gene|CXCL13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL13 gene|CXCL13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Contralateral breast cancer,Female Breast Cancer
AUGMENTS,beta catenin,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"beta catenin Carcinoma, Ductal, Breast",Female Breast Cancer
AUGMENTS,ERBB3 gene|ERBB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB3 gene|ERBB3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LRRC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LRRC3B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Nitric Oxide Synthase Type II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nitric Oxide Synthase Type II Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Thromboplastin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Thromboplastin Breast cancer invasive NOS,Female Breast Cancer
CAUSES,Amyloid beta-Protein Precursor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amyloid beta-Protein Precursor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD24 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CAPN9 gene|CAPN9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAPN9 gene|CAPN9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KIAA1199 gene|CEMIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIAA1199 gene|CEMIP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BMP1|PRCP|PGPEP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BMP1|PRCP|PGPEP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,baicalein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,baicalein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ACE gene|ACE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ACE gene|ACE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,alpha2HS glycoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha2HS glycoprotein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PFAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PFAS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Microdissection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Microdissection Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VEGF gene|VEGFA,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Diet,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Diet Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,tibolone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,tibolone Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,collagenase 3|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,collagenase 3|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Histopathology,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Histopathology Breast Carcinoma,Female Breast Cancer
AFFECTS,Chondroitin Sulfates,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Chondroitin Sulfates Breast cancer metastatic,Female Breast Cancer
CAUSES,Malathion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Malathion Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"VEGF protein, human|VEGFA",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Inflammatory Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cholecalciferol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,phenethyl isothiocyanate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,phenethyl isothiocyanate Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Encounter due to breast reduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Encounter due to breast reduction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Detection,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Detection Familial cancer of breast,Female Breast Cancer
DISRUPTS,CYLD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYLD Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TBX3,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,TBX3 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Elongation Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elongation Factor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FOXC1 gene|FOXC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXC1 gene|FOXC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,patient retention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",patient retention Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,gefitinib,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,gefitinib Breast cancer metastatic,Female Breast Cancer
AFFECTS,USF1 gene|USF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USF1 gene|USF1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oxytocin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxytocin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,WWOX gene|WWOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WWOX gene|WWOX Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,usnic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,usnic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ferritin level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ferritin level Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Folic Acid Antagonists,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Folic Acid Antagonists Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Norethindrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Norethindrone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,toxicant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,toxicant Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DACH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DACH1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cacodylic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Cacodylic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyperinsulinism,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Hyperinsulinism Breast cancer metastatic,Female Breast Cancer
AFFECTS,Venous Thrombosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Venous Thrombosis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,WWOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWOX Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,USH2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,USH2A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cigarette smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cigarette smoke Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,c-myc Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Genes|MYC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Antirheumatic Drugs, Disease-Modifying",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,"Antirheumatic Drugs, Disease-Modifying Breast cancer recurrent",Recurrent Breast Cancer
PREDISPOSES,PTH gene|PTH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTH gene|PTH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NET1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NET1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SDC1 gene|SDC1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Breast Carcinoma,Female Breast Cancer
AFFECTS,MXD1|MAD1L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MXD1|MAD1L1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Flavonols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Flavonols Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Pancreatic leak,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Pancreatic leak Ductal Breast Carcinoma,Female Breast Cancer
AUGMENTS,TOP2A gene|TOP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOP2A gene|TOP2A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bilateral oophorectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bilateral oophorectomy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Depo-Provera,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Depo-Provera Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GSTM1 gene|GSTM1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,GSTM1 gene|GSTM1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Neck Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neck Neoplasms Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,gamma-Glutamyl Hydrolase,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,gamma-Glutamyl Hydrolase Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,CATALASE,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,CATALASE Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Estrogen Receptor alpha,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Leeks (dietary),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leeks (dietary) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thromboembolic event,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Phenomenon or Process,Thromboembolic event Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Vasospasm,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Vasospasm Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,G-T mismatch-binding protein|MSH6,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-T mismatch-binding protein|MSH6 Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Therapeutic Intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic Intervention Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Response Modifiers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP2D6 gene|CYP2D6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CYP2D6 gene|CYP2D6 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Micellar Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Micellar Paclitaxel Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oxalates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxalates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"PHEMX protein, human|TSPAN32",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PHEMX protein, human|TSPAN32 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,MED19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MED19 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Performance,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Performance Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,ECT2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,ECT2 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,LINC00461,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00461 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,USP1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,USP1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,DKK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DKK1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIP5K1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIP5K1C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Abnormal protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Abnormal protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Feeding and dietary regimes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Feeding and dietary regimes Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Malignant meningitis,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Malignant meningitis Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,ENPP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ENPP2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SMAD7 gene|SMAD7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMAD7 gene|SMAD7 Breast cancer metastatic,Female Breast Cancer
AFFECTS,"NRIP1 protein, human|NRIP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NRIP1 protein, human|NRIP1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,BITTER MELON FRUIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BITTER MELON FRUIT Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD71 antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD71 antigen Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Factor VIII-Related Antigen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Factor VIII-Related Antigen Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,PVR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PVR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Juice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Juice Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glucocorticoids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Glucocorticoids Breast cancer metastatic,Female Breast Cancer
DISRUPTS,CYGB gene|CYGB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYGB gene|CYGB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Food,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Food,Food Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,LRP6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,LRP6 Breast cancer metastatic,Female Breast Cancer
CAUSES,Relapse,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Relapse Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cyclin-dependent kinase inhibitor 1B|CDKN1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclin-dependent kinase inhibitor 1B|CDKN1B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Manual reduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Manual reduction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Natural Products,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Natural Products Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Paraoxonase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paraoxonase 1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Interleukin-1 beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-1 beta Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PARVA gene|PARVA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARVA gene|PARVA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ZEB2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZEB2-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CKS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CKS2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Anthracycline Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Anthracycline Antibiotics Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,beta-elemene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,beta-elemene Breast cancer metastatic,Female Breast Cancer
DISRUPTS,mammaglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mammaglobin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lipocalin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lipocalin 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,caspase-8|CASP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caspase-8|CASP8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pancreatic Polypeptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Pancreatic Polypeptide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"MPP3 protein, human|MPP3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MPP3 protein, human|MPP3 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,IL17F,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL17F Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,claudin 6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,claudin 6 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Gangliosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gangliosides Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Apolipoprotein A-I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein A-I Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AFAP1L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AFAP1L2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Doxorubicin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AMD3465,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,AMD3465 Breast cancer metastatic,Female Breast Cancer
AFFECTS,CCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCAT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,shogaol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,shogaol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Osteoporosis, Postmenopausal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Osteoporosis, Postmenopausal Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Translocase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Translocase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Taking medication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Taking medication Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,N-Acetylneuraminic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-Acetylneuraminic Acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Collagen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MicroRNAs,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,CYP2C8 gene|CYP2C8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2C8 gene|CYP2C8 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EZR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EZR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Monoacylglycerol Lipases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Monoacylglycerol Lipases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABRAXAS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABRAXAS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Heat-Shock Proteins 70,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat-Shock Proteins 70 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,bone morphogenetic protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,parathyroid hormone-related protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Breast cancer metastatic,Female Breast Cancer
AFFECTS,HULC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HULC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PARITY,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,PARITY Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Proanthocyanidins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proanthocyanidins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cell transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cell transformation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thyroid Hormone Receptor Beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormone Receptor Beta Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Anthocyanidins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anthocyanidins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,26S proteasome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,26S proteasome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Macrophage Activation Syndrome,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Macrophage Activation Syndrome Invasive carcinoma of breast,Female Breast Cancer
DISRUPTS,LINC00665,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00665 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Enrich (product),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Enrich (product) Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"interleukin-1, beta",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"interleukin-1, beta Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"CEACAM5 protein, human|CEACAM5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CEACAM5 protein, human|CEACAM5 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Neurophysiology - biologic function,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Neurophysiology - biologic function Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,rucaparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,rucaparib Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,zoledronic acid,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Chemical,zoledronic acid Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,Metaplastic carcinoma of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metaplastic carcinoma of breast Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fucoidan,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,fucoidan Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,ERBB3 gene|ERBB3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ERBB3 gene|ERBB3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,LINC00520 gene|LINC00520,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00520 gene|LINC00520 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,TRIP6 gene|TRIP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIP6 gene|TRIP6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Enzyme Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Enzyme Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cholesterol hydroxylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol hydroxylase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,anastrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,anastrozole Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Thromboplastin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Thromboplastin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,MIR182 gene|MIR182,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR182 gene|MIR182 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ROR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ROR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,COL10A1 gene|COL10A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COL10A1 gene|COL10A1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CpG Islands Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,chloroxoquinoline,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,chloroxoquinoline Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,ZNF10 gene|ZNF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF10 gene|ZNF10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KDM5B gene|KDM5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM5B gene|KDM5B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genome,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Genome Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,bis(4-hydroxyphenyl)sulfone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bis(4-hydroxyphenyl)sulfone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sex Hormone-Binding Globulin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGA2 gene|HMGA2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PAQR4 gene|PAQR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAQR4 gene|PAQR4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZFP36L1|BRF1|MST1L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZFP36L1|BRF1|MST1L Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Hydrogel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydrogel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,nobiletin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,nobiletin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CALCIUM HOMEOSTASIS,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,CALCIUM HOMEOSTASIS Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Targeted Therapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Targeted Therapy Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,PTTG1 gene|PTTG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTTG1 gene|PTTG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormones,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Hormones Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,"Breast Cancer, Familial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Breast Cancer, Familial Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Aptamer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aptamer Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Xenograft type of graft,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Xenograft type of graft Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ASAP1 gene|ASAP1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ASAP1 gene|ASAP1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"Genes, Essential",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Essential Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Risk Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Risk Behavior Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Graft acceptance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Graft acceptance Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,TRPM4 gene|TRPM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRPM4 gene|TRPM4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNORA71B gene|SNORA71B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNORA71B gene|SNORA71B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,marizomib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,marizomib Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MARS gene|MARS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MARS gene|MARS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ergocalciferol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,ergocalciferol Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transcriptome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transcriptome Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Positive Transcriptional Elongation Factor B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positive Transcriptional Elongation Factor B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ENO1 gene|ENO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ENO1 gene|ENO1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SCUBE2 gene|SCUBE2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SCUBE2 gene|SCUBE2 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Cell Proliferation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cell Proliferation Breast Carcinoma,Female Breast Cancer
PREDISPOSES,AGR2,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Other,AGR2 estrogen receptor-negative breast cancer,Female Breast Cancer
DISRUPTS,DLG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DLG3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mevalonate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mevalonate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MKI67 gene|MKI67,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MKI67 gene|MKI67 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,dinoprost,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dinoprost Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epicatechin-3-Gallate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Epicatechin-3-Gallate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pathologic Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pathologic Response Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"T-Cell Surface Glycoprotein CD4, human|CD4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","T-Cell Surface Glycoprotein CD4, human|CD4 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,TMEM165 gene|TMEM165,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TMEM165 gene|TMEM165 Breast Carcinoma,Female Breast Cancer
CAUSES,Tumor-Associated Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor-Associated Process Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PROM1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,PROM1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Contralateral Prophylactic Mastectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Contralateral Prophylactic Mastectomy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDC2 Protein Kinase|CDK1,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CDC2 Protein Kinase|CDK1 Luminal B Breast Carcinoma,Female Breast Cancer
AUGMENTS,MMP10 gene|MMP10,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,MMP10 gene|MMP10 estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Androgen Receptor,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Androgen Receptor Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,ENC1 gene|ENC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ENC1 gene|ENC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Xenograft Model,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Xenograft Model Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Cytologic atypia,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,Cytologic atypia Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,"AGR3 protein, human|AGR3",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","AGR3 protein, human|AGR3 estrogen receptor-positive breast cancer",Female Breast Cancer
PREDISPOSES,Smoked food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Smoked food Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GA-Binding Protein Transcription Factor|GABPA|NFE2L2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,platinum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,platinum Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HLCS gene|HLCS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HLCS gene|HLCS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Functional Food,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Functional Food Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,UNC5B gene|UNC5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UNC5B gene|UNC5B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ITPKC gene|ITPKC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ITPKC gene|ITPKC Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,cyclophosphamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclophosphamide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Stat3 protein,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Basal-Like Breast Carcinoma,Female Breast Cancer
DISRUPTS,DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DNMT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Unlikely,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Unlikely Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CXCL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PART1 gene|PART1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PART1 gene|PART1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SPRY4-IT1 gene|SPRY4-IT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPRY4-IT1 gene|SPRY4-IT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cyclovirobuxine D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclovirobuxine D Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Salts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Salts Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Extranodal Extension,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extranodal Extension Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ADAMTS8 gene|ADAMTS8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAMTS8 gene|ADAMTS8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Obstruction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Obstruction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fluid intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fluid intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Periodontitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Periodontitis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chronic Obstructive Airway Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic Obstructive Airway Disease Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mammary gland involution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mammary gland involution Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR100HG gene|MIR100HG,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR100HG gene|MIR100HG Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,PALB2 gene|PALB2,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"PALB2 gene|PALB2 Breast Cancer, Familial",Female Breast Cancer
AFFECTS,MIR497 gene|MIR497,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR497 gene|MIR497 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,YY1 gene|YY1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YY1 gene|YY1 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Ganetespib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Ganetespib HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,Phosphoinositide Phosphatases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphoinositide Phosphatases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HAND2-AS1 gene|HAND2-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HAND2-AS1 gene|HAND2-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Expression procedure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Expression procedure Breast Carcinoma,Female Breast Cancer
AFFECTS,Mastectomy,Stage IV Inflammatory Breast Carcinoma,0.0,Female Breast Cancer,Other,Mastectomy Stage IV Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Iodides,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Iodides Invasive carcinoma of breast,Female Breast Cancer
DISRUPTS,SRCIN1 gene|SRCIN1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,SRCIN1 gene|SRCIN1 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Eicosanoids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Eicosanoid,Eicosanoids Breast Carcinoma,Female Breast Cancer
DISRUPTS,ciclesonide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ciclesonide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adipose Tissue Deposition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adipose Tissue Deposition Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PLEKHA7 gene|PLEKHA7,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,PLEKHA7 gene|PLEKHA7 Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,CDC25B gene|CDC25B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC25B gene|CDC25B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast normal,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Breast normal Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Neoadjuvant Systemic Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Neoadjuvant Systemic Therapy HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,MKI67 gene|MKI67,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,MKI67 gene|MKI67 Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,estrogens,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,estrogens Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Ferritin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ferritin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"RNA, Circular",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,"Transcription, Genetic",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,"Transcription, Genetic Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,HLA-F-AS1 gene|HLA-F-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HLA-F-AS1 gene|HLA-F-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Red Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Red Meat Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DSCAM-AS1 gene|DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DSCAM-AS1 gene|DSCAM-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APLN gene|APLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APLN gene|APLN Malignant neoplasm of breast,Female Breast Cancer
CAUSES,heparanase,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,heparanase Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,RING1 gene|RING1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RING1 gene|RING1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,K-ras Oncogene|KRAS,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Invasive Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Patient age,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Patient age Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Metabolic Process, Cellular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,"Metabolic Process, Cellular Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Digital Mammography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Digital Mammography Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,EIF3A gene|EIF3A,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,EIF3A gene|EIF3A Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,PFKL gene|PFKL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PFKL gene|PFKL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genes,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,Genes Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
PREDISPOSES,"Sleep Disorders, Circadian Rhythm",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,"Sleep Disorders, Circadian Rhythm Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,No effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,No effect Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGA2 gene|HMGA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Insulin Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Insulin Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,leptin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EPHA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EPHA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,rutin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,rutin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemotherapy Regimen or Agent Combination,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Chemotherapy Regimen or Agent Combination Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,ZEB1 gene|ZEB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Long Interspersed Nucleotide Element-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Long Interspersed Nucleotide Element-1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Decreasing,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Other,Decreasing Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,Heat shock proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat shock proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MLN4924,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MLN4924 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDKN2B gene|CDKN2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2B gene|CDKN2B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin-Dependent Kinase 4,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Cyclin-Dependent Kinase 4 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Ataxia Telangiectasia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Ataxia Telangiectasia Breast Carcinoma,Female Breast Cancer
AFFECTS,Mutation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,ACTL8 gene|ACTL8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ACTL8 gene|ACTL8 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,BCL6 gene|BCL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6 gene|BCL6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dietary Modification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Modification Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,SIRT3 gene|SIRT3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SIRT3 gene|SIRT3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,FOXO6 gene|FOXO6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXO6 gene|FOXO6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pathologic Complete Response,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Pathologic Complete Response HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,"Neoplasm, Residual",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Neoplasm, Residual Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Glucocorticoid Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Glucocorticoid Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,METTL3 gene|METTL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL3 gene|METTL3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"STK11 protein, human|STK11",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","STK11 protein, human|STK11 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Transferrin,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Other,Transferrin estrogen receptor-negative breast cancer,Female Breast Cancer
AFFECTS,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,KIF18B gene|KIF18B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF18B gene|KIF18B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PDLIM7 gene|PDLIM7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDLIM7 gene|PDLIM7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RFX5 gene|RFX5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RFX5 gene|RFX5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,other medicated shampoos in ATC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,other medicated shampoos in ATC Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Nicotinamide Phosphoribosyltransferase Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,PUM1 gene|PUM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PUM1 gene|PUM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gene interaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,gene interaction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,prevention effectiveness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",prevention effectiveness Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FGFR1 wt Allele|FGFR1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,FGFR1 wt Allele|FGFR1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,AFAP1-AS1 gene|AFAP1-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,AFAP1-AS1 gene|AFAP1-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,IMPACT gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,IMPACT gene Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Medical record number:ID:Pt:^Patient:Nom,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Medical record number:ID:Pt:^Patient:Nom Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EEF1E1 gene|EEF1E1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EEF1E1 gene|EEF1E1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CD69 protein, human|CD69",Malignant neoplasm of female breast,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of female breast",Female Breast Cancer
PREDISPOSES,Interleukin-12 Subunit p35,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-12 Subunit p35 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,HIF1A gene|HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Transformation, function",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope","Transformation, function estrogen receptor-positive breast cancer",Female Breast Cancer
AFFECTS,Dovitinib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Dovitinib Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CASC16 gene|CASC16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASC16 gene|CASC16 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,CDC20 gene|CDC20,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDC20 gene|CDC20 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,multidrug resistance-associated protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",multidrug resistance-associated protein 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"CD9 protein, human|CD9",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD9 protein, human|CD9 Breast Carcinoma",Female Breast Cancer
AFFECTS,physiological aspects,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,physiological aspects Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Possible,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Possible Breast Carcinoma,Female Breast Cancer
AFFECTS,cell cycle regulator,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,cell cycle regulator Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,MIR937 gene|MIR937,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR937 gene|MIR937 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2 gene|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CBR3-AS1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RAD54B gene|RAD54B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD54B gene|RAD54B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Luteolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Luteolin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"GPER protein, human|GPER1",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Amino Acid, Peptide, or Protein","GPER protein, human|GPER1 Carcinoma of Male Breast",Female Breast Cancer
AFFECTS,LRP6 gene|LRP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LRP6 gene|LRP6 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MEG3|FAM129B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Recurrent pregnancy loss,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Recurrent pregnancy loss Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pregnancy-Associated Plasma Protein-A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Pregnancy-Associated Plasma Protein-A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SCUBE2 gene|SCUBE2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,SCUBE2 gene|SCUBE2 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Physical function,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Physical function contralateral breast cancer,Female Breast Cancer
PREDISPOSES,Disaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Disaccharides Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MORC2 gene|MORC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MORC2 gene|MORC2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,G-Protein-Coupled Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ACTG2 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ACTG2 wt Allele Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GATA3 Transcription Factor|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Transcription Factor|GATA3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL18 gene|IL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL18 gene|IL18 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABI1 gene|ABI1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ABI1 gene|ABI1 Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"BCAR3 protein, human|BCAR3",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BCAR3 protein, human|BCAR3 Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AFFECTS,Cell Growth,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Cell Growth Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,SHARPIN gene|SHARPIN,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SHARPIN gene|SHARPIN Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,COVID-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,COVID-19 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibrillar Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrillar Collagen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antitumor Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antitumor Response Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"DKK3 protein, human|DKK3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DKK3 protein, human|DKK3 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Matrix Metalloproteinase 13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 13 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LIG3 gene|LIG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIG3 gene|LIG3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,cadmium Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phosphotransferases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Phosphotransferases Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,WLS gene|WLS,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,WLS gene|WLS HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,collagen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Positron-Emission Tomography,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Positron-Emission Tomography Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,PLB1 gene|PLB1,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,PLB1 gene|PLB1 estrogen receptor-negative breast cancer,Female Breast Cancer
PREDISPOSES,USP41 gene|USP41,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USP41 gene|USP41 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,REPLETE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,REPLETE Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SMYD3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,SMYD3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,SP7 gene|SP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SP7 gene|SP7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"CDK7 protein, human|CDK7",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDK7 protein, human|CDK7 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Oligonucleotides,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotides Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,Alkaloids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alkaloids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BCL6B gene|BCL6B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6B gene|BCL6B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TWSG1 gene|TWSG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TWSG1 gene|TWSG1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SPARC gene|SPARC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPARC gene|SPARC Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CTNNB1 gene|CTNNB1,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,CTNNB1 gene|CTNNB1 Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,BCL6B gene|BCL6B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6B gene|BCL6B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Whole Grains,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Whole Grains Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ergocalciferol,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,ergocalciferol Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Limonins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Limonins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ipatasertib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,ipatasertib Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MYD88 gene|MYD88,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYD88 gene|MYD88 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,genistein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Poly-L-lactic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Poly-L-lactic acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,rosuvastatin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,rosuvastatin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Hormone Therapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hormone,Hormone Therapy Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Reproductive Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Reproductive Behavior Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TNFSF13 protein, human|TNFSF13","Breast Cancer, Familial",0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNFSF13 protein, human|TNFSF13 Breast Cancer, Familial",Female Breast Cancer
CAUSES,"RNA, Long Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Biological Markers,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Biological Markers Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Modulators Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Effective Communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Effective Communication Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,glucose oxidase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Carbohydrate,glucose oxidase Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estradiol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR10B gene|MIR10B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR10B gene|MIR10B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIR139 gene|MIR139,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR139 gene|MIR139 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,CDC20 gene|CDC20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC20 gene|CDC20 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,1 time,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,1 time Luminal B Breast Carcinoma,Female Breast Cancer
AUGMENTS,"CTGF protein, human|CTGF",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CTGF protein, human|CTGF Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,"CD69 protein, human|CD69",Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Triple-Negative Breast Carcinoma",Female Breast Cancer
AFFECTS,paclitaxel liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,paclitaxel liposome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TPI1 gene|TPI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPI1 gene|TPI1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Acclimatization,Malignant neoplasm of female breast,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Acclimatization Malignant neoplasm of female breast,Female Breast Cancer
AFFECTS,imipramine,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,imipramine estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,AMACR wt Allele,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,AMACR wt Allele Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,MKI67 gene|MKI67,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MKI67 gene|MKI67 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TPI1 gene|TPI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPI1 gene|TPI1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,limited use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,limited use Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CDK6 gene|CDK6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDK6 gene|CDK6 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,MAP1LC3C gene|MAP1LC3C,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MAP1LC3C gene|MAP1LC3C Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Pathogenic Variant,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,Pathogenic Variant estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,Pseudogenes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Pseudogenes Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,cyclin B2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclin B2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TTYH3 gene|TTYH3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TTYH3 gene|TTYH3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,cyclooxygenase 2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Breast Carcinoma,Female Breast Cancer
AFFECTS,Proliferation (morphologic abnormality),Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Proliferation (morphologic abnormality) Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,HSPG2 gene|HSPG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPG2 gene|HSPG2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ATM Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC01234 gene|LINC01234,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01234 gene|LINC01234 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Individual Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Individual Exposure Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ELP3 gene|ELP3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ELP3 gene|ELP3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Methylation Site,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Methylation Site Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Experimental Result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Experimental Result Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pneumocystis jiroveci pneumonia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pneumocystis jiroveci pneumonia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DST gene|DST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DST gene|DST Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CYP2S1 gene|CYP2S1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2S1 gene|CYP2S1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High glycemic index food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,High glycemic index food Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RNA-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GTF2H1 gene|GTF2H1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Tomography, Emission-Computed",Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Tomography, Emission-Computed Carcinoma breast stage IV",Female Breast Cancer
AFFECTS,ginsenoside Rg3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ginsenoside Rg3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ULBP2 gene|ULBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ULBP2 gene|ULBP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MEF2C gene|MEF2C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEF2C gene|MEF2C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antioxidants,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Antioxidants HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,skill,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,skill Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Plasma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Plasma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,alpha Karyopherins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha Karyopherins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Mammary Carcinoma, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Mammary Carcinoma, Human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Bioavailable testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Bioavailable testosterone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SPOP gene|SPOP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPOP gene|SPOP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Anthropometric Measures:-:Point in time:^Patient:-,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Anthropometric Measures:-:Point in time:^Patient:- Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,CUL4B gene|CUL4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CUL4B gene|CUL4B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MMP13 gene|MMP13,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,MMP13 gene|MMP13 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,TaqI POLYMORPHISM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TaqI POLYMORPHISM Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Anthracycline Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Anthracycline Antibiotics Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TIMM8A gene|TIMM8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIMM8A gene|TIMM8A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"TRIM25 protein, human|TRIM25",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,inhibitors,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,inhibitors HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Pathologic Response,Locally advanced breast cancer,0.0,Female Breast Cancer,Other,Pathologic Response Locally advanced breast cancer,Female Breast Cancer
AUGMENTS,RET,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,RET Breast Carcinoma,Female Breast Cancer
AFFECTS,Contrast used,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Contrast used Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNA 205-5p,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 205-5p Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CLIC1 gene|CLIC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLIC1 gene|CLIC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSPA8 gene|HSPA8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HSPA8 gene|HSPA8 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,aflatoxin B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,aflatoxin B1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"ZFP36 protein, human|ZFP36",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ZFP36 protein, human|ZFP36 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Decreased Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Decreased Expression Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2 gene|ERBB2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00473 gene|LINC00473,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00473 gene|LINC00473 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,clopidogrel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,clopidogrel Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"3,3'-diindolylmethane",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"3,3'-diindolylmethane Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Alkaloids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alkaloids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,vemurafenib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,vemurafenib Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WBP2 gene|WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WBP2 gene|WBP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Histone deacetylase inhibitor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Histone deacetylase inhibitor Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ezrin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,ezrin Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,microphthalmia-associated transcription factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",microphthalmia-associated transcription factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WNT9B gene|WNT9B,Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,WNT9B gene|WNT9B Triple-Negative Breast Carcinoma,Female Breast Cancer
AUGMENTS,beta-2 Adrenergic Receptors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,beta-2 Adrenergic Receptors Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Menopausal syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Menopausal syndrome Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CXCR4 gene|CXCR4,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,testosterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00667 gene|LINC00667,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00667 gene|LINC00667 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation Abnormality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Abnormality Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,lycorine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lycorine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Performance,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Performance Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Operative Surgical Procedures,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Operative Surgical Procedures HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Animal feed (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Animal feed (substance) Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SPON2 gene|SPON2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SPON2 gene|SPON2 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Mucosa-Associated Lymphoid Tissue Lymphoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mucosa-Associated Lymphoid Tissue Lymphoma Malignant neoplasm of breast,Female Breast Cancer
CAUSES,mannose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,mannose Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MTOR wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MTOR wt Allele Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CRABP2 gene|CRABP2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CRABP2 gene|CRABP2 Breast Carcinoma,Female Breast Cancer
DISRUPTS,BTG4 gene|BTG4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BTG4 gene|BTG4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Alanine Aminotransferase 1, human",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,"Alanine Aminotransferase 1, human Secondary malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,ZSCAN1 gene|ZSCAN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZSCAN1 gene|ZSCAN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,USP20 gene|USP20,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,USP20 gene|USP20 Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,AFAP1-AS1 gene|AFAP1-AS1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,AFAP1-AS1 gene|AFAP1-AS1 Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,KMT2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KMT2A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PFKFB3 gene|PFKFB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PFKFB3 gene|PFKFB3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,treatment options,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",treatment options Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,MCAM gene|MCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCAM gene|MCAM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,hydroxybenzoic acid,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,hydroxybenzoic acid Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,20-40 years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,20-40 years Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Retinoblastoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Retinoblastoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lipoproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Treatment Protocols,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Other,Treatment Protocols Luminal B Breast Carcinoma,Female Breast Cancer
CAUSES,Toxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Toxin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diesel Exhaust,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diesel Exhaust Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunoregulation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Immunoregulation Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Problem,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Problem Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Singlet Oxygen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Singlet Oxygen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BARRIER,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BARRIER Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bone Morphogenetic Protein Receptors,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Bone Morphogenetic Protein Receptors Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,ZNF451 gene|ZNF451,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZNF451 gene|ZNF451 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,taxifolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,taxifolin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,RAD52 gene|RAD52,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD52 gene|RAD52 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CCR7 gene|CCR7,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCR7 gene|CCR7 Breast Carcinoma,Female Breast Cancer
AFFECTS,macroautophagy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,macroautophagy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXXC5 gene|CXXC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXXC5 gene|CXXC5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Androgen Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Androgen Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Increased risk,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Increased risk Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,TYMSOS gene|TYMSOS,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TYMSOS gene|TYMSOS Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,systemic administration,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",systemic administration HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,cinobufagin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,cinobufagin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Cancer Relapse,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Relapse Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Increased size (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Increased size (finding) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IMPACT gene,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,IMPACT gene Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Axillary node METASTASIS,Breast cancer stage II,0.0,Female Breast Cancer,Neoplastic Process,Axillary node METASTASIS Breast cancer stage II,Female Breast Cancer
DISRUPTS,NR1D1 gene|NR1D1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR1D1 gene|NR1D1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD103|ITGAE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD103|ITGAE Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genes,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Genes Breast Cancer, Familial",Female Breast Cancer
AFFECTS,anastrozole,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,anastrozole estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,risk factors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,risk factors Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,brusatol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,brusatol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hepatitis C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hepatitis C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Menopause,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Menopause estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,Suppressor,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Suppressor Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,HLA-G gene|HLA-G,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HLA-G gene|HLA-G Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,DLGAP5 gene|DLGAP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DLGAP5 gene|DLGAP5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,bruceine A,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,bruceine A Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"IL5 protein, human|IL5",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL5 protein, human|IL5 HER2-positive carcinoma of breast",Female Breast Cancer
AFFECTS,pimavanserin tartrate,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,pimavanserin tartrate Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Histone deacetylase inhibitor|HDAC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histone deacetylase inhibitor|HDAC9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Transformation, function",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","Transformation, function Triple Negative Breast Neoplasms",Female Breast Cancer
DISRUPTS,BCPR Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCPR Gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,hydroxypropylbetadex (0.58-0.68 MS),Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,hydroxypropylbetadex (0.58-0.68 MS) Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Piperlongumine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Piperlongumine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Immune,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Immune Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EZH2 gene|EZH2,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,BHLHE41 gene|BHLHE41,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BHLHE41 gene|BHLHE41 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,medroxyprogesterone acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,medroxyprogesterone acetate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SHC4 gene|SHC4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SHC4 gene|SHC4 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,USP4 gene|USP4,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,USP4 gene|USP4 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnosis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Diagnosis Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Anoikis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anoikis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dichloroethylenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dichloroethylenes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SRRM4 gene|SRRM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRRM4 gene|SRRM4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Not significant,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Not significant Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,paraffin,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Other,paraffin Invasive Ductal Breast Carcinoma,Female Breast Cancer
AUGMENTS,multicatalytic endopeptidase complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,multicatalytic endopeptidase complex Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PTK2 gene|PTK2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTK2 gene|PTK2 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Screening mammography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Screening mammography Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,SKP2 gene|SKP2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SKP2 gene|SKP2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,USP30 gene|USP30,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USP30 gene|USP30 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,thyme oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thyme oil Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AIMP2 gene|AIMP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AIMP2 gene|AIMP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,maduramicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,maduramicin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FOXO1 gene|FOXO1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FOXO1 gene|FOXO1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,TWIST1 gene|TWIST1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,"PIK3CB protein, human|PIK3CB",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Secondary malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cholecalciferol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TLR2 protein, human|TLR2",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TLR2 protein, human|TLR2 HER2-positive carcinoma of breast",Female Breast Cancer
AFFECTS,NSUN2 gene|NSUN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NSUN2 gene|NSUN2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXA2 gene|FOXA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXA2 gene|FOXA2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FBXO8 gene|FBXO8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO8 gene|FBXO8 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNORA73B gene|SNORA73B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNORA73B gene|SNORA73B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Present,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Present Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,SCARNA4 gene|SCARNA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SCARNA4 gene|SCARNA4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PLK4 gene|PLK4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PLK4 gene|PLK4 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MIR130A gene|MIR130A,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Gene or Genome,MIR130A gene|MIR130A malignant neoplasm of breast staging,Female Breast Cancer
PREDISPOSES,fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fiber Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"membrane protein, SARS-CoV-2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","membrane protein, SARS-CoV-2 Triple Negative Breast Neoplasms",Female Breast Cancer
CAUSES,Mutant Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mutant Proteins Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Bacteroides fragilis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bacteroides fragilis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,epiberberine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,epiberberine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,progesterone,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,progesterone estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Benign foot rot,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benign foot rot Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Protease Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Protease Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Bloody nipple discharge,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Bloody nipple discharge Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,decanoylcarnitine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,decanoylcarnitine Triple Negative Breast Neoplasms,Female Breast Cancer
COMPLICATES,Fibrous Dysplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrous Dysplasia Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RBMS3 gene|RBMS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBMS3 gene|RBMS3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Non-infiltrating lobular carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Non-infiltrating lobular carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tegafur,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tegafur Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SF3A2 gene|SF3A2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SF3A2 gene|SF3A2 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Xenobiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Xenobiotics Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,COL5A1 gene|COL5A1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,COL5A1 gene|COL5A1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Signs and Symptoms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Signs and Symptoms Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Score,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Score Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Multiple Sclerosis,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Multiple Sclerosis estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,NF-kappa B,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,NF-kappa B HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,MTA1 gene|MTA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MTA1 gene|MTA1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Increased risk,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Increased risk estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,obeticholic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,obeticholic acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Hypolipidemic Agents,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical Viewed Functionally,Hypolipidemic Agents Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Cessation of life,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cessation of life Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,ETNK1 gene|ETNK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ETNK1 gene|ETNK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Antigens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Receptor, Melatonin, MT1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Receptor, Melatonin, MT1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Steroids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Steroid,Steroids Breast Carcinoma,Female Breast Cancer
AUGMENTS,Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Behavior,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Behavior Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Folic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,protein-tyrosine kinase c-src|SRC,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein-tyrosine kinase c-src|SRC Breast cancer metastatic,Female Breast Cancer
AFFECTS,Human Papilloma Virus Vaccine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,Human Papilloma Virus Vaccine Breast Carcinoma,Female Breast Cancer
AFFECTS,Testosterone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Testosterone Breast Carcinoma,Female Breast Cancer
DISRUPTS,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Warfarin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Warfarin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MAD2L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAD2L1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Bicarbonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bicarbonates Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinomatous peritonitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinomatous peritonitis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Deoxycytidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Deoxycytidine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,phosphatidylinositol 3-kinase gamma,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,phosphatidylinositol 3-kinase gamma Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Fluorouracil,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fluorouracil Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PITPNM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PITPNM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Psoralens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Psoralens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RAI3 gene|GPRC5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAI3 gene|GPRC5A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BRD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BRD4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Janus kinase 1|JAK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Janus kinase 1|JAK1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Metastasis Suppressor Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Metastasis Suppressor Genes Breast cancer metastatic,Female Breast Cancer
DISRUPTS,exemestane,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,exemestane Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,invariant chain|CD74,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,invariant chain|CD74 Breast cancer metastatic,Female Breast Cancer
AFFECTS,helicase|HFM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,helicase|HFM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VIP gene|VIP,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,VIP gene|VIP Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,STK11 gene|STK11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK11 gene|STK11 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,C-Peptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-Peptide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Breast Carcinoma,Female Breast Cancer
AFFECTS,GPR161,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GPR161 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IRF2 gene|IRF2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,IRF2 gene|IRF2 Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,"Embolism, Tumor",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,"Embolism, Tumor Inflammatory Breast Carcinoma",Female Breast Cancer
AUGMENTS,DNA Methyltransferase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Methyltransferase Breast Carcinoma,Female Breast Cancer
DISRUPTS,Brain-Derived Neurotrophic Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Brain-Derived Neurotrophic Factor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SOD3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SOD3 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Blood flow,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Blood flow Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Pyrones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pyrones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SMAD2 gene|SMAD2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMAD2 gene|SMAD2 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic,Female Breast Cancer
DISRUPTS,BRCA2|BLID,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA2|BLID Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,neuropeptide Y|NPY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",neuropeptide Y|NPY Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SIX2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SIX2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,SMAD2 gene|SMAD2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMAD2 gene|SMAD2 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,"DNA, Double-Stranded",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Double-Stranded Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,SMAD3 gene|SMAD3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMAD3 gene|SMAD3 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,HIF1A gene|HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogens Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Systemic disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Systemic disease Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Genes, Immunoglobulin",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Immunoglobulin Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,TUNAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TUNAR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,andrographolide,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,andrographolide Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Progesterone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Progesterone Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,HOXB13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HOXB13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DDX26 gene|INTS6|DDX56,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DDX26 gene|INTS6|DDX56 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,UBE2I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UBE2I Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ADORA2B gene|ADORA2B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ADORA2B gene|ADORA2B Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,chymotrypsin A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,chymotrypsin A Breast Carcinoma,Female Breast Cancer
AFFECTS,Oral Solution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oral Solution Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Spironolactone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Spironolactone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ceramides,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Ceramides Carcinoma, Ductal, Breast",Female Breast Cancer
DISRUPTS,Nitric Oxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nitric Oxide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IGF1R gene|IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1R gene|IGF1R Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutation,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Mutation Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,Adriamycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adriamycin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MIRN205 gene|MIR205,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN205 gene|MIR205 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ATP6V1C1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ATP6V1C1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Therapeutic procedure,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Therapeutic procedure Familial cancer of breast,Female Breast Cancer
AFFECTS,Red meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Red meat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fusion Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fusion Protein Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Hepatitis C virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Hepatitis C virus Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Invasive Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Eukaryotic Initiation Factor-4E|EIF4E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Eukaryotic Initiation Factor-4E|EIF4E Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of gastrointestinal tract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of gastrointestinal tract Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like-Growth Factor I Receptor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN200B gene|MIR200B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN200B gene|MIR200B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TP53BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53BP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pharmaceutical Preparations,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Contralateral breast cancer,Female Breast Cancer
AUGMENTS,Iron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Iron Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MAGEC2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,MAGEC2 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Thiopurine S-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thiopurine S-Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATP1B2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ATP1B2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NANOG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NANOG Breast cancer metastatic,Female Breast Cancer
AFFECTS,Pteridines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pteridines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,combretastatin A-4 disodium phosphate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,combretastatin A-4 disodium phosphate Breast Carcinoma,Female Breast Cancer
AUGMENTS,MMP14 gene|MMP14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP14 gene|MMP14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chronic heart failure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chronic heart failure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Receptors, Tumor Necrosis Factor, Type II",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Receptors, Tumor Necrosis Factor, Type II Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Ro 48-8071,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ro 48-8071 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TAAR5|NR2E3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,TAAR5|NR2E3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,FGF1 gene|FGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF1 gene|FGF1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lymphatic Diseases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Lymphatic Diseases Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Placebos,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Placebos Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VEGFC gene|VEGFC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGFC gene|VEGFC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of cervix uteri,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of cervix uteri Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOX2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Oxidoreductase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Oxidoreductase Breast Carcinoma,Female Breast Cancer
AFFECTS,DOCK1 gene|DOCK1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,DOCK1 gene|DOCK1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,GAD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GAD2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Galactosyltransferases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Galactosyltransferases Breast Carcinoma,Female Breast Cancer
AFFECTS,proteomic profiling,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"proteomic profiling Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Gynecologic Surgical Procedures,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gynecologic Surgical Procedures Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,beta-cryptoxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-cryptoxanthin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NDP,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,NDP Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,MIRN203 gene|MIR203A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN203 gene|MIR203A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Promoter Regions (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Promoter Regions (Genetics) Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Multiple Myeloma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Multiple Myeloma Breast Carcinoma,Female Breast Cancer
CAUSES,Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Norepinephrine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Norepinephrine Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Tuberculosis, Pulmonary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Tuberculosis, Pulmonary Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Retinoid X Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Retinoid X Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,aldehyde dehydrogenase 1|ALDH1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenase 1|ALDH1A1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Prolactin|PRL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Prolactin|PRL Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Integrin beta3|ITGB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrin beta3|ITGB3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CD29 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD29 Antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Calcitonin Receptor|CALCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcitonin Receptor|CALCR Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PTHLH gene|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prolactin|PRL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Prolactin|PRL Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrogen Antagonists,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Estrogen Antagonists Breast cancer metastatic,Female Breast Cancer
AFFECTS,ABCC1 gene|ABCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCC1 gene|ABCC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tamoxifen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer metastatic,Female Breast Cancer
AUGMENTS,KIF20A gene|KIF20A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF20A gene|KIF20A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Glucosephosphate Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glucosephosphate Dehydrogenase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Leucovorin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Leucovorin Breast cancer metastatic,Female Breast Cancer
AFFECTS,MLLT11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MLLT11 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA2 gene|BRCA2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Carcinoma of Male Breast,Male Breast Cancer
CAUSES,WBP2 gene|WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WBP2 gene|WBP2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Aspirin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Aspirin Breast Carcinoma,Female Breast Cancer
AFFECTS,particle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,particle Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,6p12,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,6p12 Breast Carcinoma,Female Breast Cancer
AFFECTS,E-Cadherin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,E-Cadherin Breast cancer metastatic,Female Breast Cancer
CAUSES,Endobronchial metastases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endobronchial metastases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Regulatory Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Regulatory Protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibrinogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrinogen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mdm2 protein|SLURP1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mdm2 protein|SLURP1 Breast Carcinoma,Female Breast Cancer
CAUSES,Cholangiocarcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cholangiocarcinoma Breast Carcinoma,Female Breast Cancer
CAUSES,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Mutation,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,Gene Mutation Carcinoma of Male Breast,Male Breast Cancer
CAUSES,Fruit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fruit Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,IGFBP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IGFBP7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diabetes Insipidus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diabetes Insipidus Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid Breast cancer metastatic",Female Breast Cancer
PREDISPOSES,Relationship problems,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Relationship problems Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary malignant neoplasm of axilla,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of axilla Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Free Radicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Free Radicals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLOPE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLOPE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Calcitonin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Calcitonin Breast cancer metastatic,Female Breast Cancer
AFFECTS,Adrenalectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adrenalectomy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adriamycin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Adriamycin Breast cancer metastatic,Female Breast Cancer
CAUSES,16 alpha-hydroxyestrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,16 alpha-hydroxyestrone Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Estriol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Estriol Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant disease Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Large Cell Lymphoblastic Lymphoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Large Cell Lymphoblastic Lymphoma Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Caseins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Caseins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Orchitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Orchitis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FCE 21336,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,FCE 21336 Breast Carcinoma,Female Breast Cancer
CAUSES,leukemia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,leukemia Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TAG 12,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,TAG 12 Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Body measure result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Body measure result Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,S-Phase Fraction,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",S-Phase Fraction Female Breast Carcinoma,Female Breast Cancer
CAUSES,Idarubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Idarubicin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,alpha-Lactalbumin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,alpha-Lactalbumin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Fucose,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fucose Breast Carcinoma,Female Breast Cancer
DISRUPTS,sterculic acid,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,sterculic acid Breast Carcinoma,Female Breast Cancer
AFFECTS,"Nuclear Receptor Subfamily 4, Group A, Member 1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Nuclear Receptor Subfamily 4, Group A, Member 1 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Difluoromethylornithine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Difluoromethylornithine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Aflatoxin B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Aflatoxin B1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,fibrosarcoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,fibrosarcoma Breast Carcinoma,Female Breast Cancer
AFFECTS,Shock,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Shock Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Doxorubicin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Enovid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Enovid Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Platinum,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Platinum Breast Carcinoma,Female Breast Cancer
PREDISPOSES,ERVW-1|ERVK-20|ERVK-18|ERVK-32,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ERVW-1|ERVK-20|ERVK-18|ERVK-32 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Interferons,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interferons Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypophysectomy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Hypophysectomy Breast Carcinoma,Female Breast Cancer
AUGMENTS,Cellular Retinoic Acid Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cellular Retinoic Acid Binding Protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cerebellar degeneration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cerebellar degeneration Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Response Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Response Elements Malignant neoplasm of breast,Female Breast Cancer
CAUSES,dromostanolone propionate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",dromostanolone propionate Breast Carcinoma,Female Breast Cancer
AUGMENTS,Stimulant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stimulant Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Trace Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trace Elements Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Clinical finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Clinical finding Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BAG3,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,BAG3 Female Breast Carcinoma,Female Breast Cancer
DISRUPTS,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Linoleic Acids, Conjugated Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Ductal Breast Carcinoma,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Ductal Breast Carcinoma Female Breast Carcinoma,Female Breast Cancer
CAUSES,Telomerase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Telomerase Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Readiness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Readiness Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FGFR1 gene|FGFR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR1 gene|FGFR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Manganese Superoxide Dismutase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Operative Surgical Procedures,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Operative Surgical Procedures Familial cancer of breast,Female Breast Cancer
PREDISPOSES,blood lipid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,blood lipid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,placental protein 11|ENDOU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",placental protein 11|ENDOU Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTHLH gene|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Immune status,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Immune status Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Antihistamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antihistamines Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Pleural effusion disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pleural effusion disorder Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,butyrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,butyrate Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NCOA3 gene|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA3 gene|NCOA3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Specific antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Specific antibody Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Sulfhydryl Compounds,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Chemical,Sulfhydryl Compounds Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,stanniocalcin 2|STC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,stanniocalcin 2|STC2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Genital Diseases, Female",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,"Genital Diseases, Female Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,fluoranthene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fluoranthene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,17q21,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,17q21 Breast Carcinoma,Female Breast Cancer
AUGMENTS,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Sterically Stabilized Liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sterically Stabilized Liposome Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Nitrosamines,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Nitrosamines Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,Early Diagnosis,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Early Diagnosis Carcinoma of Male Breast,Male Breast Cancer
CAUSES,Small T-Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Small T-Antigen Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NME1 gene|NME1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Serine Protease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Serine Protease Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mutagens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Mutagens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,sarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sarcoma Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Prostate-Specific Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Prostate-Specific Antigen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cyclin Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cyclin Gene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Immunotoxins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Immunotoxins Breast cancer metastatic,Female Breast Cancer
AUGMENTS,RNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Histidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histidine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Androgens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Androgens Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Silicones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Silicones Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Tumor Suppressor Genes,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Somatropin|GH1|GGH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatropin|GH1|GGH Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast",Female Breast Cancer
COMPLICATES,Radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NRG1 gene|NRG1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NRG1 gene|NRG1 Breast Carcinoma,Female Breast Cancer
AFFECTS,"Ether, Ethyl",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"Ether, Ethyl Breast Carcinoma",Female Breast Cancer
AUGMENTS,cyclooxygenase 2,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Carcinoma in situ of breast,Female Breast Cancer
AFFECTS,c-myc Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Genes|MYC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nucleic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nucleic Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,small molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,small molecule Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,factor C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,factor C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Plants, Edible",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Plants, Edible Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Raloxifene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,COMT gene|COMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COMT gene|COMT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Genes, Homeobox",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Homeobox Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,"Risk factor, cardiovascular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Risk factor, cardiovascular Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Pregnancy History,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pregnancy History Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AR gene|AR,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,AR gene|AR Carcinoma of Male Breast,Male Breast Cancer
CAUSES,SHBG gene|SHBG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHBG gene|SHBG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,telomerase activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,telomerase activity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mutant Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Amplification,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Gene Amplification Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Watermelon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Watermelon Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Transcriptional Repression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcriptional Repression Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LTA gene|LTA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LTA gene|LTA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genomic Instability,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Genomic Instability Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Nuclear Matrix-Associated Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Matrix-Associated Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSD17B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSD17B1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Fibrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SLC39A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC39A6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neuropeptide Y Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Neuropeptide Y Receptor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,AVP,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,AVP Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Chocolate milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chocolate milk Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"ESR1 protein, human|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR1 protein, human|ESR1 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,fulvestrant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fulvestrant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coping Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coping Behavior Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Testosterone Propionate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Testosterone Propionate Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Peptide Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptide Hydrolases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,dominant allele,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,dominant allele Breast Carcinoma,Female Breast Cancer
AFFECTS,Matrix Metalloproteinases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Breast cancer metastatic,Female Breast Cancer
AUGMENTS,SLIT3|SLIT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLIT3|SLIT2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CTCFL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTCFL Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,5-lipoxygenase-activating protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",5-lipoxygenase-activating protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thyroid Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Thyroid Diseases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Therapeutic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Therapeutic procedure Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tissue-Inhibitor of Metalloproteinase-1|TIMP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tissue-Inhibitor of Metalloproteinase-1|TIMP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VEGF gene|VEGFA,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Sporadic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Metalloproteases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cheese,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cheese Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Manganese Superoxide Dismutase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WNT5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WNT5B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fluctuation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fluctuation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnostic radiologic examination,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic radiologic examination Breast cancer metastatic,Female Breast Cancer
AFFECTS,Alanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alanine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CXC Chemokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CXC Chemokines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adhesions,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Adhesions Breast Carcinoma,Female Breast Cancer
DISRUPTS,SLC3A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC3A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EP300 gene|EP300,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,EP300 gene|EP300 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,PTN gene|PTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTN gene|PTN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of prostate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Breast Carcinoma,Female Breast Cancer
CAUSES,Ha-ras Oncogenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Ha-ras Oncogenes Breast Carcinoma,Female Breast Cancer
AUGMENTS,Gonadotropins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gonadotropins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Testicular Diseases,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Testicular Diseases Carcinoma of Male Breast,Male Breast Cancer
AUGMENTS,Endopeptidases,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Endopeptidases Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,"Receptors, Progesterone|PGR",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Breast cancer metastatic",Female Breast Cancer
DISRUPTS,Tissue factor antibody,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Tissue factor antibody Breast cancer metastatic,Female Breast Cancer
AFFECTS,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"LGALS3BP protein, human|LGALS3BP",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","LGALS3BP protein, human|LGALS3BP Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,cysteinylglycine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cysteinylglycine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Aspirin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Aspirin Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,myricetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,myricetin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin E,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Food,Vitamin E Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Adriamycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adriamycin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,prolyl-proline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prolyl-proline Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hormone Receptor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Hormone Receptor Breast Carcinoma,Female Breast Cancer
AFFECTS,Heterocyclic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heterocyclic Amines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Eating,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Eating Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Siramesine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Siramesine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CALCIUM PHOSPHATE CRYSTALS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CALCIUM PHOSPHATE CRYSTALS Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Quantitative Trait Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quantitative Trait Loci Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LGI1 gene|LGI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LGI1 gene|LGI1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BMI1 gene|BMI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMI1 gene|BMI1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,5-Trimethoxyamphetamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,5-Trimethoxyamphetamine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,5'-NUCLEOTIDASE|TRIM33,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,5'-NUCLEOTIDASE|TRIM33 Breast Carcinoma,Female Breast Cancer
AUGMENTS,ADAMTS4|ADAMTS3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ADAMTS4|ADAMTS3 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,alpha 1-Antitrypsin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha 1-Antitrypsin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prolactin Receptor|PRLR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Receptor|PRLR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Benzodiazepine Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benzodiazepine Receptor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antibodies Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SKI gene|SKI,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,SKI gene|SKI Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,LFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LFNG Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Functional RNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,TNFSF11 gene|TNFSF11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TNFSF11 gene|TNFSF11 Breast cancer metastatic,Female Breast Cancer
AFFECTS,gemcitabine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,gemcitabine Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Encounter due to drug use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Encounter due to drug use Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Receptors, Progesterone|EREG|ESR1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Dancing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dancing Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,valylvaline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,valylvaline Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Toremifene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Toremifene Breast cancer metastatic,Female Breast Cancer
DISRUPTS,glypican 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,glypican 3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Gelatinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,doxifluridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,doxifluridine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Doxorubicin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Doxorubicin Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Transient Receptor Potential Channels,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transient Receptor Potential Channels Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Phosphorylcholine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphorylcholine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Fruit, Citrus",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Fruit, Citrus Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Stanolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stanolone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,4-octylphenol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,4-octylphenol Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Aromatase Inhibitors,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Hormone,Aromatase Inhibitors Contralateral breast cancer,Female Breast Cancer
CAUSES,RA 25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RA 25 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pressure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pressure Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,letrozole,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,letrozole Contralateral breast cancer,Female Breast Cancer
AUGMENTS,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GATA3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AURKA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AURKA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glucocorticoid Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucocorticoid Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AIP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estrogens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Estrogens Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,MCAM gene|MCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCAM gene|MCAM Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SKP2 gene|SKP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SKP2 gene|SKP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IL2 gene|IL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL2 gene|IL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PARP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARP2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TP53 gene|TP53,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Apigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Apigenin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Histiocytoma, Malignant Fibrous",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Histiocytoma, Malignant Fibrous Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,cellular process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,cellular process Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADIPOR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADIPOR2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ALK gene|ALK,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,ALK gene|ALK Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Drug resistance,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Drug resistance Breast cancer metastatic,Female Breast Cancer
AUGMENTS,17q21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,17q21 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BHLHE41,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,BHLHE41 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,"Cholesterol, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,"Cholesterol, Dietary Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,HIF1A gene|HIF1A,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,arrestin3|ARR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arrestin3|ARR3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LDL Cholesterol Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",LDL Cholesterol Lipoproteins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB4 gene|ERBB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB4 gene|ERBB4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,versican|VCAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,versican|VCAN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Insulin, Regular, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Insulin, Regular, Human Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,vinorelbine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,vinorelbine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HRAS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HOXB9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HOXB9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Retinoblastoma Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Retinoblastoma Genes Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Tumor Suppressor Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Phosphatidylinositols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphatidylinositols Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,thyroid microsomal antibodies|TPO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,thyroid microsomal antibodies|TPO Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"DNA, Single-Stranded",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Single-Stranded Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,bakuchiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bakuchiol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Estrogens Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Herceptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Herceptin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FABP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FABP7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLF10 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,epidermal growth factor receptor VIII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,epidermal growth factor receptor VIII Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenesis Inhibitors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Angiogenesis Inhibitors Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,GAPD gene|GAPDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAPD gene|GAPDH Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,HRG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HRG Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Oncogene ErbB2|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,PANDAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PANDAR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Lymphoma, Large-Cell, Diffuse",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"Lymphoma, Large-Cell, Diffuse Breast Carcinoma",Female Breast Cancer
PREDISPOSES,Proto-Oncogene Proteins p21(ras),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins p21(ras) Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,protein kinase C zeta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase C zeta Breast cancer metastatic,Female Breast Cancer
AUGMENTS,parathyroid hormone-related protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CNS disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,CNS disorder Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,"Antiretroviral Therapy, Highly Active",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Antiretroviral Therapy, Highly Active Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Cytotoxic T-Lymphocyte-Associated Protein 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic T-Lymphocyte-Associated Protein 4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vitamin D Deficiency,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Food,Vitamin D Deficiency Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,APP gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APP gene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IL4 gene|IL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL4 gene|IL4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KLF8 gene|KLF8,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KLF8 gene|KLF8 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Membrane Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Proteins Breast cancer metastatic,Female Breast Cancer
AUGMENTS,KNG1 gene|KNG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KNG1 gene|KNG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proteome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proteome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,germacrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,germacrone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ADAR1|ADAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADAR1|ADAR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fibroblast Growth Factor Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Acute inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acute inflammation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Proteins,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,COX7A2L gene|COX7A2L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COX7A2L gene|COX7A2L Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,chemokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,chemokine Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,PORPHOBILINOGEN SYNTHASE|ALAD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PORPHOBILINOGEN SYNTHASE|ALAD Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Clinical Treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Clinical Treatment Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyaluronan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyaluronan Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,DDX3X,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,DDX3X Breast cancer metastatic,Female Breast Cancer
AFFECTS,[M]Skin appendage adenoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,[M]Skin appendage adenoma Breast Carcinoma,Female Breast Cancer
AFFECTS,mead acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,mead acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Metabolic syndrome,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Disease or Syndrome,Metabolic syndrome Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Protein antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein antigen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SLC19A3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SLC19A3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,May-Hegglin anomaly,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,May-Hegglin anomaly Breast cancer recurrent,Female Breast Cancer
PREDISPOSES,ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ANXA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIRN182 gene|MIR182,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN182 gene|MIR182 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sulfonylurea Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfonylurea Compounds Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,bone morphogenetic protein 4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 4 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,multicatalytic endopeptidase complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,multicatalytic endopeptidase complex Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BMI1 gene|BMI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMI1 gene|BMI1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta catenin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,angiogenin|ANG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,angiogenin|ANG Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,DOK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DOK7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NKX2-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NKX2-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antihypertensive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antihypertensive Agents Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,apolipoprotein E-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein E-2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pyridoxine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pyridoxine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GPR55,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,GPR55 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Dyslipidemias,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Lipid,Dyslipidemias Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,"Cystadenocarcinoma, Serous",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Cystadenocarcinoma, Serous Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Cathepsin L|CTSL,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Cathepsin L|CTSL Breast cancer metastatic,Female Breast Cancer
CAUSES,Adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adenosine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anthracyclines,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Anthracyclines Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Inflammatory disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Inflammatory disorder Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CCT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCT2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DEFA1|CBX5|DEFA1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DEFA1|CBX5|DEFA1B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MFAP5 gene|MFAP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MFAP5 gene|MFAP5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stopped work,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stopped work Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cyclin-dependent kinase 3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,cyclin-dependent kinase 3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,preference,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,preference Familial cancer of breast,Female Breast Cancer
AFFECTS,Gene Expression,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Gene Expression Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,DMPK|IGHD1-7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DMPK|IGHD1-7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NF-kappa B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NF-kappa B Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,TRIM28,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,TRIM28 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Consanguinous Mating,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Consanguinous Mating Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Biotin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biotin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PAQR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PAQR3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PTF1A,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"PTF1A Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,temozolomide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,temozolomide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Disease Progression Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SUMO1P3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SUMO1P3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SMAD3 gene|SMAD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD3 gene|SMAD3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secretory Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secretory Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cilium biogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,cilium biogenesis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Echinococcosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Echinococcosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fatty Acid-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fatty Acid-Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immune defect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immune defect Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC4A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC4A7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Benzene,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hazardous or Poisonous Substance,Benzene Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,5'-NUCLEOTIDASE|NT5E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,5'-NUCLEOTIDASE|NT5E Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumorigenesis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumorigenesis Breast cancer metastatic,Female Breast Cancer
AFFECTS,KISS1 gene|KISS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KISS1 gene|KISS1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Sleep Disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sleep Disorders Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,copper-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",copper-binding protein Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ID2 gene|ID2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ID2 gene|ID2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MIRN21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN21 gene|MIR21 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PRDX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRDX2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,phospholipase C delta 1|DLK1|DLL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phospholipase C delta 1|DLK1|DLL1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tamoxifen,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Interleukin-18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-18 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ARHGEF5 gene|ARHGEF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGEF5 gene|ARHGEF5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCAT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCAT2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SENP2 gene|SENP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SENP2 gene|SENP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Acetate,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Acetate Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Fibroblast Growth Factor Receptor 1|FGFR1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 1|FGFR1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,TRPS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TRPS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,nuclear receptor coactivator 1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,nuclear receptor coactivator 1 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Thioctic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Thioctic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA amplification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA amplification Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,inorganic phosphate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,inorganic phosphate Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RBM38,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,RBM38 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,F2-Isoprostanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,F2-Isoprostanes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,stromelysin 3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,stromelysin 3 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,IkappaB Kinase beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IkappaB Kinase beta Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,BCL2 gene|BCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL2 gene|BCL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transforming Growth Factor beta,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Pathogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Pathogenesis Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADAMTS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADAMTS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinogenesis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,ETS1 gene|ETS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ETS1 gene|ETS1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Cantaloupes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cantaloupes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Need for isolation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Need for isolation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Colorectal cancer metastatic,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Colorectal cancer metastatic Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Quinones,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Quinones Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Glucocorticoid Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucocorticoid Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,D4-GDI,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,D4-GDI Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Benzodiazepine Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benzodiazepine Receptor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,E2F4 gene|E2F4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F4 gene|E2F4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DMBT1 gene|DMBT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DMBT1 gene|DMBT1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,retinoic acid receptor beta 2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemical,retinoic acid receptor beta 2 Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,alpha Catenin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,alpha Catenin Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Phosphoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphoproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclic AMP-Responsive DNA-Binding Protein|CAMP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclic AMP-Responsive DNA-Binding Protein|CAMP Breast cancer metastatic,Female Breast Cancer
AFFECTS,BANCR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,BANCR Breast cancer metastatic,Female Breast Cancer
AUGMENTS,LINC00310,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00310 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gonadotropins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gonadotropins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SIRT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SIRT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,attenuation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",attenuation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quercetin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Smoking,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Smoking Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Rice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rice Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PTGER1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PTGER1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Pancreatitis,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Pancreatitis Carcinoma, Ductal, Breast",Female Breast Cancer
DISRUPTS,PHGDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PHGDH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,fulvestrant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fulvestrant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3|IGFBP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3|IGFBP3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GAB2 gene|GAB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAB2 gene|GAB2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant Neoplasms,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Female Breast Carcinoma,Female Breast Cancer
AUGMENTS,Lysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lysine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Is informed,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Is informed Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NFKB1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,NFKB1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Tumor Promoters,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Tumor Promoters Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Signaling Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Signaling Molecule Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fatty fish,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fatty fish Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Combined Oral Contraceptives,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Combined Oral Contraceptives Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Serpins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Serpins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA1 Protein|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 Protein|BRCA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hydroxyl Radical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydroxyl Radical Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lindane,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Lindane Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Irritable Mood,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Irritable Mood Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cytochrome P-450 CYP1A1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cytochrome P-450 CYP1A1 Breast Carcinoma,Female Breast Cancer
AUGMENTS,Gelatinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transcription Repressor/Corepressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Repressor/Corepressor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Local excision,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Local excision Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transcript Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TWSG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TWSG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Endometriosis, site unspecified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Endometriosis, site unspecified Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,G22P1 gene|XRCC6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,G22P1 gene|XRCC6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Invasive Lesion,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Invasive Lesion Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,PTGIS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PTGIS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Disease Progression,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Disease Progression Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,nuclear receptor coactivator 1|SRC,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,nuclear receptor coactivator 1|SRC Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"7,3'-dihydroxy-4'-methoxyisoflavone Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,TBXAS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TBXAS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"TERT protein, human|TERT","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TERT protein, human|TERT Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,CBS gene|CBS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBS gene|CBS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,childhood brain tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,childhood brain tumor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MNX1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,MNX1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MMP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MMP Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EEF1A2 gene|EEF1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EEF1A2 gene|EEF1A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Light,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Light Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coconut milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coconut milk Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gonadal Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Hormones Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SKP2 gene|SKP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SKP2 gene|SKP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Carcinoma Breast Carcinoma,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,bilateral breast cancer,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast bilateral breast cancer,Female Breast Cancer
AFFECTS,Epithelial hyperplasia,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Epithelial hyperplasia Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Alcohol consumption,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Female Breast Carcinoma,Female Breast Cancer
CAUSES,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Testosterone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Testosterone Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,FAU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAU Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GLO1 gene|GLO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLO1 gene|GLO1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Smoke Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GNRHR gene|GNRHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GNRHR gene|GNRHR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"RNA, Messenger","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,PPAR gamma|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPAR gamma|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,2-hydroxyestrone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,2-hydroxyestrone Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Non-Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Non-Aspirin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACSTD2 protein, human|TACSTD2 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,TACSTD2 gene|TACSTD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TACSTD2 gene|TACSTD2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bioluminescence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bioluminescence Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CXCR3 gene|CXCR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR3 gene|CXCR3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epstein-Barr Virus Infections,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epstein-Barr Virus Infections Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RUNX2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,RUNX2 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,MED28,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"MED28 Carcinoma, Ductal, Breast",Female Breast Cancer
DISRUPTS,Proteins,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Proteins Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,IL23R gene|IL23R,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,IL23R gene|IL23R Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Family problems,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Family problems Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TOX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TOX3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,BRCA2 gene|BRCA2,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Contralateral breast cancer,Female Breast Cancer
AUGMENTS,MIRN27A gene|MIR27A,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,MIRN27A gene|MIR27A Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,C19orf12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,C19orf12 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AR gene|AR,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,AR gene|AR Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Sexual exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sexual exposure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,vitamin supplement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,vitamin supplement Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Physical therapy exercises,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physical therapy exercises Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,prohibitin|PHB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prohibitin|PHB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DDX3X,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DDX3X Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RHOC gene|RHOC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neprilysin|MME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neprilysin|MME Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ionizing radiation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Ionizing radiation Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Vaccination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vaccination Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,WNT2 gene|WNT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT2 gene|WNT2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,daidzein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,daidzein Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Agent,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Agent Breast cancer metastatic,Female Breast Cancer
AUGMENTS,XRCC3 gene|XRCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA Sequence,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Breast Carcinoma,Female Breast Cancer
AUGMENTS,VEGFA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,VEGFA Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Inorganic arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Inorganic arsenic Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prolactin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Prolactin Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,drospirenone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,drospirenone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SLC5A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC5A7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STK11 gene|STK11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,STK11 gene|STK11 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Norethindrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Norethindrone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ADM gene|ADM,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ADM gene|ADM Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Vascular Endothelial Growth Factor C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gonadal Steroid Hormones,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Gonadal Steroid Hormones Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,chronic stressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chronic stressor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Expressed Sequence Tags,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Expressed Sequence Tags Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Metformin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Metformin Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,FOS gene|FOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOS gene|FOS Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MIRN370 gene|MIR370,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN370 gene|MIR370 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,mRNA Expression,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",mRNA Expression Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ADAM12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADAM12 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Lamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lamins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Homologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Homologous Gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Insulin, Regular, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Insulin, Regular, Human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Metric,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,Metric Familial cancer of breast,Female Breast Cancer
AFFECTS,"Chemotherapy, Adjuvant",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,"Chemotherapy, Adjuvant Breast cancer invasive NOS",Female Breast Cancer
AFFECTS,ixabepilone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ixabepilone Breast cancer metastatic,Female Breast Cancer
AFFECTS,pertuzumab,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,pertuzumab Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,BAG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BAG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Bulimia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bulimia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tissue Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tissue Model Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"2-methyl-5,6-cyclopentapyrimidine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"2-methyl-5,6-cyclopentapyrimidine Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like-Growth Factor I Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,crocetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,crocetin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Study models,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Study models Breast cancer metastatic,Female Breast Cancer
AFFECTS,DIO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DIO3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prevention,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Prevention Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,French fries,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,French fries Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclooxygenase 2 Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Opioids,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Opioids Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,FOXP3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,FOXP3 Breast Carcinoma,Female Breast Cancer
AUGMENTS,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Estrogen Receptors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Digoxin,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Digoxin Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,AGAP2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AGAP2-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aspirin,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Aspirin Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,CNTN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CNTN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prolactin|PRL,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Prolactin|PRL Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Androgens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epirubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Epirubicin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IL1A gene|IL1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL1A gene|IL1A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,allograft inflammatory factor-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,allograft inflammatory factor-1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic,Female Breast Cancer
CAUSES,Tobacco smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tobacco smoke Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Genes Familial cancer of breast,Female Breast Cancer
PREDISPOSES,matriptase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,matriptase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant neoplasm of breast,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Olive oil - dietary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Olive oil - dietary Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VDR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VDR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,apolipoprotein E-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein E-4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast Carcinoma",Female Breast Cancer
AUGMENTS,FOXQ1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,FOXQ1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,letrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,letrozole Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antimony,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antimony Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sirolimus (substance),Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Substance,Sirolimus (substance) Breast Carcinoma,Female Breast Cancer
AFFECTS,Cessation of life,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cessation of life Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,proto-oncogene protein c-crk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,proto-oncogene protein c-crk Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Antipsychotic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Telomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Telomerase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gelatinase B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sterically Stabilized Liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sterically Stabilized Liposome Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Materials,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Materials Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TCF4 gene|TCF4|TCF7L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TCF4 gene|TCF4|TCF7L2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Functional RNA,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Familial cancer of breast,Female Breast Cancer
CAUSES,Insulin-Like Growth Factor I|IGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I|IGF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phosphatidylethanolamine Binding Protein|ZHX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphatidylethanolamine Binding Protein|ZHX2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PGLS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PGLS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,2'-Deoxythymidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2'-Deoxythymidine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunoliposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Immunoliposome Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Fibroblast Growth Factor 7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 7 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,YARS gene|YARS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YARS gene|YARS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,inhibin B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,inhibin B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Interleukin-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHEK2 gene|CHEK2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Female Breast Carcinoma,Female Breast Cancer
CAUSES,Cysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cysteine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Harvest of stem cells,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Harvest of stem cells Breast Carcinoma,Female Breast Cancer
AFFECTS,calcification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",calcification Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Dioxins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dioxins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TGM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TGM2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,methionine synthase reductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",methionine synthase reductase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinoma in Situ,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,GC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Positive Lymph Node,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Positive Lymph Node Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,perchlorate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,perchlorate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ASAP1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ASAP1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Calcium Channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Channel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sexual Dysfunction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sexual Dysfunction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FTY 720,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FTY 720 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIRN210 gene|MIR210,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN210 gene|MIR210 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,C1QBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,C1QBP Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MCAM gene|MCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCAM gene|MCAM Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CCL2 gene|CCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL2 gene|CCL2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PITX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PITX2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KISS1 gene|KISS1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,KISS1 gene|KISS1 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Dissociation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dissociation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mammography,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Mammography Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,"PTTG1 protein, human|PTTG1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTTG1 protein, human|PTTG1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,CA-15-3 Antigen,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Immunologic Factor,CA-15-3 Antigen Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Protein Expression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Expression Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"PER2 protein, mammalian",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian Breast cancer recurrent",Recurrent Breast Cancer
AFFECTS,bilateral breast cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bilateral breast cancer Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor Status,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Status Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,TP53 gene|TP53,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,MAPK12 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK12 gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,membership,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,membership Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,astaxanthine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,astaxanthine Breast Carcinoma,Female Breast Cancer
AFFECTS,tomography,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,tomography Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,CD151,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD151 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HSPA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSPA5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Promoter (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Promoter (Genetics) Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,thrombocytosis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,thrombocytosis Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CHD8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CHD8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Single Nucleotide Polymorphism,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Contralateral breast cancer,Female Breast Cancer
CAUSES,Endometrial Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endometrial Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Aryl Hydrocarbon Receptor|AHR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor|AHR Breast Carcinoma,Female Breast Cancer
AUGMENTS,aldehyde dehydrogenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenases Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Environmental Tobacco Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Environmental Tobacco Smoke Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AOX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AOX1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTGS2 gene|PTGS2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,hepcidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hepcidin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RHBDD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RHBDD1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Obesity,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Obesity Contralateral breast cancer,Female Breast Cancer
AFFECTS,GABARAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GABARAP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SEMA4C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SEMA4C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Systemic Therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Systemic Therapy Breast cancer recurrent,Recurrent Breast Cancer
AUGMENTS,E2F5 gene|E2F5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F5 gene|E2F5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gynecological history NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gynecological history NOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Disease,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Disease or Syndrome,Disease Contralateral breast cancer,Female Breast Cancer
DISRUPTS,Fertility Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Fertility Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibrinogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrinogen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TOP2A gene|TOP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOP2A gene|TOP2A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cataract,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Cataract Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Antithrombin III,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antithrombin III Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYTOR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,METHOTREXATE TREATMENT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,METHOTREXATE TREATMENT Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Glutamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glutamine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SP7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCND1 gene|CCND1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,disorder control,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,disorder control Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Environmental Tobacco Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Environmental Tobacco Smoke Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,citron rho-interacting kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,citron rho-interacting kinase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MUTYH,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,MUTYH Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Opioids,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Opioids Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,IMPAD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IMPAD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTPRC gene|PTPRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPRC gene|PTPRC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,desires,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,desires Contralateral breast cancer,Female Breast Cancer
AFFECTS,CXCL14 gene|CXCL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL14 gene|CXCL14 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TMEM68,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TMEM68 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ovariectomy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Ovariectomy Contralateral breast cancer,Female Breast Cancer
AUGMENTS,Bone Morphogenetic Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Bone Morphogenetic Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ENPP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ENPP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,syringin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,syringin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,KPNA2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,KPNA2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Propofol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Propofol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ELK3 gene|ELK3|KCNH8,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ELK3 gene|ELK3|KCNH8 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,"Metabolic Detoxication, Drug",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Metabolic Detoxication, Drug Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,FRZB,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,FRZB Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Therapeutic regimen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Therapeutic regimen Breast Carcinoma,Female Breast Cancer
AUGMENTS,PSMD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PSMD3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CYP4Z1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP4Z1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FOXP3,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,FOXP3 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Infiltration,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Nuclear Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Proteins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNHG6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNHG6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,beta-Chemokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-Chemokines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Redness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Redness Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CYP4Z2P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP4Z2P Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RANTES|CCL5,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,RANTES|CCL5 Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,PDCD1 gene|PDCD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDCD1 gene|PDCD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CST1|CLSTN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CST1|CLSTN1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Azurin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Azurin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Macrophage Chemotactic Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Macrophage Chemotactic Factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Peptide YY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptide YY Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LINC00968,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00968 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Intraductal Hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Intraductal Hyperplasia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Moderate Exercise,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Moderate Exercise Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Malignant neoplasm of breast Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PHLDB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PHLDB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitronectin|VTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vitronectin|VTN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LINC00707,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC00707 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Glucocorticoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucocorticoids Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,C1orf106,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,C1orf106 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sedentary lifestyle,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Sedentary lifestyle Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,CUL2 gene|CUL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CUL2 gene|CUL2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,heparanase|HPSE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,heparanase|HPSE Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"PIK3CA protein, human|PIK3CA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CA protein, human|PIK3CA Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,metabolomics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,metabolomics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lymphocytic infiltration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lymphocytic infiltration Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Porifera,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Porifera Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carbon Dioxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Dioxide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,survivin|BIRC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,survivin|BIRC5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phosphotransferases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Phosphotransferases Breast cancer metastatic,Female Breast Cancer
DISRUPTS,ADCY4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADCY4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SRC Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CLDN1 gene|CLDN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLDN1 gene|CLDN1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SIDT1 gene|SIDT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIDT1 gene|SIDT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Respiration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Respiration Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Minerals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Minerals Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Translation, Genetic",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Translation, Genetic Breast cancer metastatic",Female Breast Cancer
AUGMENTS,Integrin alpha4beta1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Integrin alpha4beta1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,E-Cadherin,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"E-Cadherin Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Ablation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Ablation Breast cancer metastatic,Female Breast Cancer
AFFECTS,tacrolimus binding protein 4|FKBP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tacrolimus binding protein 4|FKBP4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"FBXW7 protein, human|FBXW7",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FBXW7 protein, human|FBXW7 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,protein kinase C nu|DIO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase C nu|DIO3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Toll-Like Receptor 5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Toll-Like Receptor 5 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"Genes, Regulator",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Regulator Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,LINC01614,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC01614 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RASAL2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EIF4A1|EIF4A2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,EIF4A1|EIF4A2 Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,SFN gene|SFN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFN gene|SFN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,B lymphocyte-induced maturation protein 1|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",B lymphocyte-induced maturation protein 1|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Immunity Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Desire for food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Desire for food Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Short Sleeper Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Short Sleeper Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,other medicated shampoos in ATC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,other medicated shampoos in ATC Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Matrix Metalloproteinase 9,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 9 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,Minisatellite Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Minisatellite Repeats Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,derivatives,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,derivatives Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"RNA, Messenger",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,Pharmaceutical Preparations,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,stevioside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,stevioside Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TP53,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,TP53 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Breast Microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"CD69 protein, human|CD69",Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Carcinoma breast stage IV",Female Breast Cancer
PREDISPOSES,hydroxybenzoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hydroxybenzoic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Household composition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Household composition Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ELAVL1 gene|ELAVL1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ELAVL1 gene|ELAVL1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MicroRNA 335-5p,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 335-5p Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Stat3 protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Healthy Lifestyle,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Healthy Lifestyle Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,copper,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Other,copper Lobular carcinoma in situ of breast,Female Breast Cancer
PREDISPOSES,"RNA, Long Untranslated",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Breast Carcinoma",Female Breast Cancer
AFFECTS,gamma-Tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gamma-Tocopherol Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,TSIX gene|TSIX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSIX gene|TSIX Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,multiple pathologies,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,multiple pathologies Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adiponectin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,peer support,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,peer support Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCL18 gene|CCL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL18 gene|CCL18 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,rasagiline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,rasagiline Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"ITK protein, human|ITK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ITK protein, human|ITK Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,DOK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DOK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RPS6KA6 gene|RPS6KA6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPS6KA6 gene|RPS6KA6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Growth Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Growth Hormone Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,veliparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,veliparib Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,elements of cancer genetics risk assessment and counseling,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"elements of cancer genetics risk assessment and counseling Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,Clinical information:Finding:Point in time:^Patient:Narrative,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Clinical information:Finding:Point in time:^Patient:Narrative Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,artesunate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,artesunate Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Pads,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pads Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cannabinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cannabinoids Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Checkpoint kinase 1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Checkpoint kinase 1 HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,PLSCR1 gene|PLSCR1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,PLSCR1 gene|PLSCR1 Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,vinorelbine,HER2-negative breast cancer,0.0,Female Breast Cancer,Other,vinorelbine HER2-negative breast cancer,Female Breast Cancer
PREDISPOSES,CXXC5 gene|CXXC5,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,CXXC5 gene|CXXC5 estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,MYH10 gene|MYH10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYH10 gene|MYH10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Marital Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Marital Status Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Single Nucleotide Polymorphism,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism contralateral breast cancer,Female Breast Cancer
PREDISPOSES,assessment.initial,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,assessment.initial Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ethyl acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ethyl acetate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,N-acetyltransferase 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,N-acetyltransferase 1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,BRCA1 Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 Gene Mutation Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PROM1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,PROM1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Adjuvant Therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Adjuvant Therapy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Genes,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Ductal Breast Carcinoma,Female Breast Cancer
DISRUPTS,CLDN15,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,CLDN15 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,DNASE1L2 gene|DNASE1L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNASE1L2 gene|DNASE1L2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Syndrome,"Breast Cancer, Familial",0.0,Female Breast Cancer,Disease or Syndrome,"Syndrome Breast Cancer, Familial",Female Breast Cancer
AUGMENTS,diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,diethylstilbestrol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,WDR41 gene|WDR41,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,WDR41 gene|WDR41 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,NEUROD1 gene|NEUROD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEUROD1 gene|NEUROD1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZNF326 gene|ZNF326,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZNF326 gene|ZNF326 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Multiple malignancy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Multiple malignancy Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,C5 gene|C5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,C5 gene|C5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","E2F1 protein, human|E2F1|UBE2L3 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,water Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Fatty Acids, Essential",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,"Fatty Acids, Essential Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,catechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,catechin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Energy Metabolism,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Energy Metabolism Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,methacrylamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methacrylamide Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TGFB1 gene|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TGFB1 gene|TGFB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypersensitivity,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Hypersensitivity HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,NEDD9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NEDD9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SHC3 wt Allele|GDF1|RNH1|PPP1R13L|SHC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SHC3 wt Allele|GDF1|RNH1|PPP1R13L|SHC3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,timosaponin AIII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,timosaponin AIII Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RCC2-AS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RCC2-AS1 gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SPX gene|SPX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPX gene|SPX Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNF5 gene|RNF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNF5 gene|RNF5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MVP wt Allele|RPSA|LRP1|PTPRA|MVP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MVP wt Allele|RPSA|LRP1|PTPRA|MVP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mastitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mastitis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Insulin Resistance,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Insulin Resistance Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,phosphorus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phosphorus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chronic inflammatory disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic inflammatory disorder Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tumor Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Antigens Breast Carcinoma,Female Breast Cancer
CAUSES,Peptide Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptide Hydrolases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Anticoagulants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anticoagulants Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Human cells,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Human cells Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Beta protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Beta protein Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,paclitaxel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AGTR1 gene|AGTR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AGTR1 gene|AGTR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Educational Status,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Educational Status malignant neoplasm of breast staging,Female Breast Cancer
AFFECTS,LINC01705 gene|LINC01705,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01705 gene|LINC01705 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATF3 gene|ATF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATF3 gene|ATF3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pseudouridine synthase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pseudouridine synthase 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CONOTRUNCAL ANOMALY FACE SYNDROME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,CONOTRUNCAL ANOMALY FACE SYNDROME Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AXL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AXL Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,parathyroid hormone,Carcinoma breast stage IV,0.0,Female Breast Cancer,Hormone,parathyroid hormone Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,PTTG1 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PTTG1 wt Allele Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PDCD4-AS1 gene|PDCD4-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PDCD4-AS1 gene|PDCD4-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,MIR30E gene|MIR30E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR30E gene|MIR30E Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"SLC6A2 protein, human|SLC6A2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SLC6A2 protein, human|SLC6A2 Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,cytokine,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Biologically Active Substance,cytokine estrogen receptor-negative breast cancer,Female Breast Cancer
PREDISPOSES,SETD5 gene|SETD5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SETD5 gene|SETD5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CPEB1 gene|CPEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CPEB1 gene|CPEB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIR497 gene|MIR497,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR497 gene|MIR497 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SYVN1 gene|SYVN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SYVN1 gene|SYVN1 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Heating,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Heating Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SOX4 gene|SOX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOX4 gene|SOX4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYP27A1 gene|CYP27A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP27A1 gene|CYP27A1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SEMA7A gene|SEMA7A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEMA7A gene|SEMA7A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Hemeproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Hemeproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cellular signal transduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cellular signal transduction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FABP7 gene|FABP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FABP7 gene|FABP7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Advanced Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Advanced Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,metformin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZC3H13 gene|ZC3H13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZC3H13 gene|ZC3H13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ING4 gene|ING4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ING4 gene|ING4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glucocorticoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Glucocorticoids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GAS6 gene|GAS6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS6 gene|GAS6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NUDT3 gene|NUDT3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NUDT3 gene|NUDT3 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,hormone response element,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,hormone response element Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADIPOQ wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADIPOQ wt Allele Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Risk Scores,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Risk Scores Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Neoadjuvant Chemotherapy,Locally advanced breast cancer,0.0,Female Breast Cancer,Other,Neoadjuvant Chemotherapy Locally advanced breast cancer,Female Breast Cancer
PREDISPOSES,Geographic pattern,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Geographic pattern Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC00511 gene|LINC00511,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00511 gene|LINC00511 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IQGAP1 gene|IQGAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IQGAP1 gene|IQGAP1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CARNS1 gene|CARNS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CARNS1 gene|CARNS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,dihydroartemisinin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,dihydroartemisinin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TWIST1 gene|TWIST1,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 estrogen receptor-negative breast cancer,Female Breast Cancer
AUGMENTS,IMPACT gene,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Gene or Genome,IMPACT gene malignant neoplasm of breast staging,Female Breast Cancer
AFFECTS,HNF1A-AS1 gene|HNF1A-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HNF1A-AS1 gene|HNF1A-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,cyclic compound,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,cyclic compound Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GFUS gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GFUS gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TP53,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,TP53 Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
AFFECTS,SEMA7A gene|SEMA7A,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,SEMA7A gene|SEMA7A estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,LINC00665 gene|LINC00665,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00665 gene|LINC00665 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Biological Factors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Biological Factors Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,LINC00665 gene|LINC00665,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00665 gene|LINC00665 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lupus Coagulation Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lupus Coagulation Inhibitor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"GAS41 protein, human|YEATS4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GAS41 protein, human|YEATS4 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Bariatric Surgery,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bariatric Surgery Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,hippo signaling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hippo signaling Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,valine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Social Risk Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Social Risk Factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Sodium metavanadate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sodium metavanadate Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Anthracyclines,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Anthracyclines Carcinoma breast stage IV,Female Breast Cancer
CAUSES,Epigenome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Epigenome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,prenatal exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prenatal exposure Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Post-mastectomy radiotherapy,Locally advanced breast cancer,0.0,Female Breast Cancer,Other,Post-mastectomy radiotherapy Locally advanced breast cancer,Female Breast Cancer
AUGMENTS,PCAT1 gene|PCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT1 gene|PCAT1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABCC9 gene|ABCC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCC9 gene|ABCC9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Piwi-Interacting RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Piwi-Interacting RNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prognosis bad,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Other,Prognosis bad estrogen receptor-negative breast cancer,Female Breast Cancer
AFFECTS,Imaging Techniques,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Imaging Techniques Breast Carcinoma,Female Breast Cancer
CAUSES,Paste,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paste Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNHG6 gene|SNHG6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG6 gene|SNHG6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,POU4F1 gene|POU4F1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,POU4F1 gene|POU4F1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"PPARGC1B protein, human|PPARGC1B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PPARGC1B protein, human|PPARGC1B Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,multiple pathologies,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,multiple pathologies Breast Carcinoma,Female Breast Cancer
CAUSES,Neurofibromatosis 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neurofibromatosis 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00511 gene|LINC00511,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00511 gene|LINC00511 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Syndecan-4,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Other,Syndecan-4 estrogen receptor-negative breast cancer,Female Breast Cancer
CAUSES,MicroRNAs,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Vitiligo,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vitiligo Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Matrix Metalloproteinase 9,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 9 Breast Carcinoma,Female Breast Cancer
CAUSES,R & C,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,R & C Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Negative,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Negative Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MIR137 gene|MIR137,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR137 gene|MIR137 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,FZD2 gene|FZD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FZD2 gene|FZD2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NME1 gene|NME1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,triclosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,triclosan Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MALAT1 gene|MALAT1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,MALAT1 gene|MALAT1 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,IMPACT gene,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,IMPACT gene Recurrent Breast Carcinoma,Recurrent Breast Cancer
AFFECTS,lapatinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,lapatinib HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,DNAJA1 gene|DNAJA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJA1 gene|DNAJA1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,hyaluronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hyaluronic acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Handling,"Breast Cancer, Familial",0.0,Female Breast Cancer,Other,"Handling Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,pamidronate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pamidronate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LRRC3B gene|LRRC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LRRC3B gene|LRRC3B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Non-Cancer Related Death,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Non-Cancer Related Death Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSP90AA2P gene|HSP90AA2P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSP90AA2P gene|HSP90AA2P Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,estrophilin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,estrophilin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,STAT5A gene|STAT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT5A gene|STAT5A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"IL5 protein, human|IL5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL5 protein, human|IL5 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,FOXP3 gene|FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXP3 gene|FOXP3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"WWTR1 protein, human|WWTR1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WWTR1 protein, human|WWTR1 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,Very Important,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Very Important Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDKL3 gene|CDKL3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDKL3 gene|CDKL3 Triple Negative Breast Neoplasms,Female Breast Cancer
COMPLICATES,FBXL16 gene|FBXL16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXL16 gene|FBXL16 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fulvestrant,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,fulvestrant HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,"CD69 protein, human|CD69",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AUGMENTS,Primary MicroRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Primary MicroRNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDH4 gene|CDH4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH4 gene|CDH4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SEPTIN9 gene|SEPT9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEPTIN9 gene|SEPT9 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,cadmium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,everolimus,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,everolimus HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,RUNX2 gene|RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX2 gene|RUNX2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Stat3 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Teratogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Teratogenesis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FBXL20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FBXL20 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZNF24 gene|ZNF24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF24 gene|ZNF24 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,6-Phosphofructokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6-Phosphofructokinase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases|DNMT1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,phytochlorin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phytochlorin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SNAI2 gene|SNAI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNAI2 gene|SNAI2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CK-34 beta E12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CK-34 beta E12 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,H1-5 gene|HIST1H1B,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,H1-5 gene|HIST1H1B Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,STC1 gene|STC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STC1 gene|STC1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinomatosis,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Carcinomatosis Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Interleukin-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TRIM31 gene|TRIM31,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM31 gene|TRIM31 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin-Dependent Kinase Inhibitor Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclin-Dependent Kinase Inhibitor Proteins Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,DNA Modification Methylases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Integral Membrane Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Integral Membrane Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,>65 years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,>65 years Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,cholesterol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Lipid,cholesterol Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Functional modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional modification Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,YAP1 gene|YAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YAP1 gene|YAP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Monosaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Monosaccharides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Aurora Kinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aurora Kinase A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antral Follicle Count,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Antral Follicle Count Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,mifepristone,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,mifepristone Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Aquaporin 1|AQP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aquaporin 1|AQP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,removal technique,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,removal technique Ductal Breast Carcinoma,Female Breast Cancer
DISRUPTS,UNC 0638,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UNC 0638 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MCM4 gene|MCM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM4 gene|MCM4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EIF4EBP1 gene|EIF4EBP1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EIF4EBP1 gene|EIF4EBP1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Stat3 protein,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,echinacoside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,echinacoside Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Protein Phosphatase 2A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Phosphatase 2A Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,CDK1 gene|CDK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK1 gene|CDK1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Growth Differentiation Factor 15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Growth Differentiation Factor 15 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Metabolite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Metabolite Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CI 994,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CI 994 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aryl Hydrocarbon Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast Cancer Model,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Breast Cancer Model Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,VEGFA gene|VEGFA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VEGFA gene|VEGFA Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"Promoter Regions, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Promoter Regions, Genetic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,rasagiline,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,rasagiline Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Early Diagnosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Early Diagnosis Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,SP6 gene|SP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SP6 gene|SP6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TRIM32 gene|TRIM32,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TRIM32 gene|TRIM32 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,tissue markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tissue markers Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ATP11B gene|ATP11B,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ATP11B gene|ATP11B Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ATG4A gene|ATG4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATG4A gene|ATG4A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"TFF3 protein, human|TFF3",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF3 protein, human|TFF3 Breast Carcinoma",Female Breast Cancer
AFFECTS,ATP2B1 gene|ATP2B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP2B1 gene|ATP2B1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MRPS30-DT gene|MRPS30-DT,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MRPS30-DT gene|MRPS30-DT Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MIR342 gene|MIR342,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR342 gene|MIR342 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"BMI1 protein, human|BMI1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BMI1 protein, human|BMI1 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,"Antibodies, Anti-Idiotypic",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,"Antibodies, Anti-Idiotypic Secondary malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Hepatitis B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hepatitis B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypoxia,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Hypoxia Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,STING1 gene,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,STING1 gene Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CLTC gene|CLTC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLTC gene|CLTC Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,WTAP gene|WTAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WTAP gene|WTAP Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PPP1R14C gene|PPP1R14C,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PPP1R14C gene|PPP1R14C Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,liraglutide,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,liraglutide Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,DSTN gene|DSTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DSTN gene|DSTN Malignant neoplasm of breast,Female Breast Cancer
CAUSES,norethindrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,norethindrone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TRIM28 gene|TRIM28,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TRIM28 gene|TRIM28 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PSAT1 gene|PSAT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PSAT1 gene|PSAT1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,LINC00466 gene|LINC00466,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00466 gene|LINC00466 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,NAA25 gene|NAA25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAA25 gene|NAA25 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CD29 Antigen|B3GNT2|B3GNTL1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,CD29 Antigen|B3GNT2|B3GNTL1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,TLN1 gene|TLN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TLN1 gene|TLN1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ergocalciferol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,ergocalciferol Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,vexibinol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,vexibinol Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,DANCR gene|DANCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DANCR gene|DANCR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic Breast Density,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Other,Mammographic Breast Density contralateral breast cancer,Female Breast Cancer
DISRUPTS,WASF3 gene|WASF3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,WASF3 gene|WASF3 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJB4 gene|DNAJB4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Diet, Healthy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Diet, Healthy Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Radiation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Triple Negative Breast Neoplasms,Female Breast Cancer
COMPLICATES,Acne,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Acne estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,"Peroxisome Proliferator-Activated Receptor Gamma, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Peroxisome Proliferator-Activated Receptor Gamma, human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,ATP6AP2 gene|ATP6AP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP6AP2 gene|ATP6AP2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PINK1 gene|PINK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PINK1 gene|PINK1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AKAP3 gene|AKAP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKAP3 gene|AKAP3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Diet, High-Fat",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"Diet, High-Fat Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,SETDB1 gene|SETDB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SETDB1 gene|SETDB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KLF8 gene|KLF8,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,KLF8 gene|KLF8 Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Late chronotype,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Late chronotype Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ginsenoside M1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,ginsenoside M1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,VARIANT OF UNKNOWN SIGNIFICANCE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VARIANT OF UNKNOWN SIGNIFICANCE Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NEK2 gene|NEK2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NEK2 gene|NEK2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Interleukin-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Catabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Catabolism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,pimozide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pimozide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Aurora Kinase A,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Aurora Kinase A Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,andrographolide,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,andrographolide estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,Apoptosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Apoptosis Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MAFG-DT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAFG-DT gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FOXD3-AS1 gene|FOXD3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXD3-AS1 gene|FOXD3-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protac,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Protac Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ADGRF1 gene|ADGRF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ADGRF1 gene|ADGRF1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Liver Cirrhosis,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Liver Cirrhosis Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Breast present,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Breast present Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MND1 gene|MND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MND1 gene|MND1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,1 time,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,1 time Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,survivin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,survivin Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,MAFG-DT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAFG-DT gene Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,calcium,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,calcium estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,CDK11A gene|CDK11A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK11A gene|CDK11A Malignant neoplasm of breast,Female Breast Cancer
CAUSES,oleanolic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,oleanolic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MBNL1-AS1 gene|MBNL1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MBNL1-AS1 gene|MBNL1-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"SDC1 protein, human|SDC1",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SDC1 protein, human|SDC1 Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
PREDISPOSES,LINC02620 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC02620 gene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Scorpion Venoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Scorpion Venoms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Toxic Epidermal Necrolysis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Toxic Epidermal Necrolysis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Primary Sj??gren's syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Primary Sj??gren's syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRIM4 gene|TRIM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM4 gene|TRIM4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Oxysterols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxysterols Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MFNG gene|MFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MFNG gene|MFNG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Disease,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Disease or Syndrome,Disease Malignant neoplasm of female breast,Female Breast Cancer
PREDISPOSES,Heat-Shock Proteins 70,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat-Shock Proteins 70 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CBL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CBL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,erbB-2 Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,erbB-2 Receptor Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Cytochrome P450,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P450 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenic Process,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Phenomenon or Process,Angiogenic Process Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MAZ gene|MAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAZ gene|MAZ Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FANCM gene|FANCM,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"FANCM gene|FANCM Breast Cancer, Familial",Female Breast Cancer
AFFECTS,BIRC5 gene|BIRC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC5 gene|BIRC5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,NR2E1 gene|NR2E1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NR2E1 gene|NR2E1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,TNFRSF9 gene|TNFRSF9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF9 gene|TNFRSF9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,multiple pathologies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,multiple pathologies Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NAT10 gene|NAT10,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NAT10 gene|NAT10 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,caveolin 1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,caveolin 1 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IGHE gene|IGHE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGHE gene|IGHE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hematoxylin,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,Hematoxylin malignant neoplasm of breast staging,Female Breast Cancer
COMPLICATES,NUP210 gene|NUP210,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NUP210 gene|NUP210 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Elective Surgical Procedures,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Elective Surgical Procedures Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,MIR409 gene|MIR409,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR409 gene|MIR409 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CENPK gene|CENPK,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CENPK gene|CENPK Breast Carcinoma,Female Breast Cancer
AFFECTS,Operation on breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Operation on breast Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,metformin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,metformin HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,TRIO gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TRIO gene Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Positron Emission Tomography and Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positron Emission Tomography and Magnetic Resonance Imaging Malignant neoplasm of breast,Female Breast Cancer
CAUSES,JMJD6 gene|JMJD6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,JMJD6 gene|JMJD6 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,MCAM gene|MCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCAM gene|MCAM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ROS1 wt Allele|ROS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ROS1 wt Allele|ROS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,UBE2C gene|UBE2C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2C gene|UBE2C Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ROBO3 gene|ROBO3,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,ROBO3 gene|ROBO3 Basal-Like Breast Carcinoma,Female Breast Cancer
DISRUPTS,carbidopa,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,carbidopa estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,"TRIM25 protein, human|TRIM25",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 estrogen receptor-positive breast cancer",Female Breast Cancer
AFFECTS,trastuzumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,trastuzumab HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,"GTP-Binding Nuclear Protein Ran, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GTP-Binding Nuclear Protein Ran, Human Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,stigmasterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,stigmasterol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Small Molecule,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Small Molecule Breast Carcinoma,Female Breast Cancer
DISRUPTS,Polypeptides,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Polypeptides Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Coitus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coitus Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD274,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD274 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTPN7 gene|PTPN7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN7 gene|PTPN7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,COL11A1 gene|COL11A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COL11A1 gene|COL11A1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZNF217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF217 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,benzopyrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,benzopyrene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Endometriosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endometriosis Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GNG5 gene|GNG5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GNG5 gene|GNG5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Acclimatization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acclimatization Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Response Modifier Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Response Modifier Therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,iron increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,iron increased Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ICOS gene|ICOS,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ICOS gene|ICOS Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Neonicotinoid insecticide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Invertebrate,Neonicotinoid insecticide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SYNJ2BP-COX16 gene|SYNJ2BP-COX16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYNJ2BP-COX16 gene|SYNJ2BP-COX16 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,IL1RN gene|IL1RN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL1RN gene|IL1RN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,WFDC21P gene|WFDC21P,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,WFDC21P gene|WFDC21P Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,ST8SIA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,ST8SIA1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Dietary Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Selenium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TBATA gene|TBATA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TBATA gene|TBATA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WNT9B gene|WNT9B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,WNT9B gene|WNT9B Breast Carcinoma,Female Breast Cancer
AFFECTS,olaparib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,olaparib Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Benign Prostatic Hyperplasia,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Benign Prostatic Hyperplasia Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SAV1 gene|SAV1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SAV1 gene|SAV1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,pyridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pyridine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RNF126 gene|RNF126,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,RNF126 gene|RNF126 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FAC1 protein|PDC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",FAC1 protein|PDC Malignant neoplasm of breast,Female Breast Cancer
CAUSES,lapatinib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,lapatinib Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Hormones,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Hormone,Hormones Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNA Binding Agent,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Binding Agent Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Neuregulins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neuregulins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PFKP gene|PFKP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PFKP gene|PFKP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ultrasound-Guided Core Biopsy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Ultrasound-Guided Core Biopsy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,ADCY5 gene|ADCY5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADCY5 gene|ADCY5 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PRDM16 gene|PRDM16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRDM16 gene|PRDM16 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adult Liver Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adult Liver Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IGF2BP2 gene|IGF2BP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF2BP2 gene|IGF2BP2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lignans Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cancer/Testis Antigen,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Cancer/Testis Antigen Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ABCB1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,acrylamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,acrylamide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adverse reaction to drug,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Adverse reaction to drug Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lymphatic Invasion,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Lymphatic Invasion Invasive Ductal Breast Carcinoma,Female Breast Cancer
AFFECTS,Uveitis,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,Uveitis Early-Stage Breast Carcinoma,Female Breast Cancer
AFFECTS,laser irradiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",laser irradiation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Amides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Amides Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endocrine Disruptors,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,Endocrine Disruptors estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,"DNA, Catalytic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Catalytic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,PHGDH gene|PHGDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PHGDH gene|PHGDH Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High Level,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,High Level estrogen receptor-positive breast cancer,Female Breast Cancer
CAUSES,Selective Estrogen Receptor Down Regulator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Down Regulator Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adjuvant Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adjuvant Therapy Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"PON2 protein, human|PON2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PON2 protein, human|PON2 Triple Negative Breast Neoplasms",Female Breast Cancer
CAUSES,KLF9 gene|KLF9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF9 gene|KLF9 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,pimagedine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pimagedine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNF43 gene|RNF43,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RNF43 gene|RNF43 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,myosin VI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,myosin VI Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,doxorubicin liposome,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,doxorubicin liposome Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR31HG gene|MIR31HG Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Proteome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proteome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Place of Birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Place of Birth Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CLDN4 gene|CLDN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLDN4 gene|CLDN4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogen Receptor alpha,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of endometrium,hereditary breast/ovarian cancer - BRCA1,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of endometrium hereditary breast/ovarian cancer - BRCA1,Female Breast Cancer
PREDISPOSES,CHMP4A gene|CHMP4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHMP4A gene|CHMP4A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PCAT19 gene|PCAT19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT19 gene|PCAT19 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of lung,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of lung HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,vitamin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,vitamin E Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Very low density lipoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Very low density lipoprotein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"NEK9 protein, human|NEK9",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NEK9 protein, human|NEK9 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,PZP gene|PZP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PZP gene|PZP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fixatives,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Fixatives HER2-positive carcinoma of breast,Female Breast Cancer
CAUSES,ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ethanol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AEBP1 gene|AEBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AEBP1 gene|AEBP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,dose-response relationship,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",dose-response relationship Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|ERBB2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GABRD gene|GABRD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GABRD gene|GABRD Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR93 gene|MIR93|MIR9-3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR93 gene|MIR93|MIR9-3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,benzopyrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,benzopyrene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antisense RNA,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Antisense RNA Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,3 times,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,3 times Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RNA,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Tn antigen,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,Tn antigen Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,royal jelly,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,royal jelly Malignant neoplasm of breast,Female Breast Cancer
CAUSES,BARRIER,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,BARRIER Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Apoptosis Inhibiting Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Inhibiting Proteins Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Aurora Kinase A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Aurora Kinase A Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cell-Free DNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cell-Free DNA Breast Carcinoma,Female Breast Cancer
AFFECTS,Structural modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Structural modification Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,KRT1 gene|KRT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KRT1 gene|KRT1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Poly(ADP-ribose) Polymerase Inhibitors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,personal health,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,personal health Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,metformin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,metformin Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SOAT1 gene|SOAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOAT1 gene|SOAT1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,interferon type II|IFNG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,interferon type II|IFNG Breast Carcinoma,Female Breast Cancer
DISRUPTS,bruceine D,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,bruceine D Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,bone morphogenesis,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,bone morphogenesis Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Proto-Oncogene Proteins p21(ras)|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins p21(ras)|CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Feces,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Feces Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cervical Cancer Screening,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cervical Cancer Screening Breast Carcinoma,Female Breast Cancer
AFFECTS,Ultrasonography,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Ultrasonography Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,SNHG11 gene|SNHG11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNHG11 gene|SNHG11 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,sevoflurane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sevoflurane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Postoperative chemotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Postoperative chemotherapy HER2-positive carcinoma of breast,Female Breast Cancer
DISRUPTS,Peptides,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,calcium,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,calcium Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Dietary Zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Zinc Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Platelets, CTCAE",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"Platelets, CTCAE Breast Carcinoma",Female Breast Cancer
AFFECTS,"Analgesics, Opioid",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"Analgesics, Opioid Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,hydrocortisone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,hydrocortisone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Osteopenia,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Other,Osteopenia Malignant neoplasm of female breast,Female Breast Cancer
AFFECTS,cantharidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cantharidin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CD24 gene|CD24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD24 gene|CD24 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,pregnane X receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,pregnane X receptor Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MIR195 gene|MIR195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR195 gene|MIR195 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,White meat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,White meat intake Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"7,3'-dihydroxy-4'-methoxyisoflavone Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,SPATA13 gene|SPATA13,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,SPATA13 gene|SPATA13 estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,"RNA, Untranslated",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Inflammatory Breast Carcinoma",Female Breast Cancer
AUGMENTS,Carcinoembryonic Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RARB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RARB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJB4 gene|DNAJB4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"IL7 protein, human|IL7",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL7 protein, human|IL7 HER2-positive carcinoma of breast",Female Breast Cancer
CAUSES,fos-related antigen 1|FOS,Carcinoma breast stage IV,0.0,Female Breast Cancer,Immunologic Factor,fos-related antigen 1|FOS Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,USP10 gene|USP10,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,USP10 gene|USP10 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Aurora Kinase A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Aurora Kinase A Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,risk factors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,risk factors Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Stat3 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,echinacoside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,echinacoside Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Administration, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Administration, Oral Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Matrix,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Matrix Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,CKS2 gene|CKS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CKS2 gene|CKS2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CYP3A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYP3A4 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,abemaciclib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,abemaciclib Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cell markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cell markers Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,beta-eudesmol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-eudesmol Malignant neoplasm of breast,Female Breast Cancer
CAUSES,TIPARP gene|TIPARP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIPARP gene|TIPARP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CDC2 Protein Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CDC2 Protein Kinase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,LILRB1 gene|LILRB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LILRB1 gene|LILRB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,antineoplaston A10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,antineoplaston A10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TENM1 gene|TENM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TENM1 gene|TENM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,vasomotor symptom,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,vasomotor symptom Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lindane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lindane Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant neoplasm of breast,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,ULBP2 gene|ULBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ULBP2 gene|ULBP2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PDGFRB gene|PDGFRB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDGFRB gene|PDGFRB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tumor Suppressor Genes,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes estrogen receptor-negative breast cancer,Female Breast Cancer
AUGMENTS,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,doxorubicin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHRNA6 gene|CHRNA6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CHRNA6 gene|CHRNA6 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,LINC-ROR gene|LINC-ROR,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,GPNMB gene|GPNMB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPNMB gene|GPNMB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Decreased Immunologic Activity [PE],Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Decreased Immunologic Activity [PE] Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,POU4F1 gene|POU4F1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,POU4F1 gene|POU4F1 Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,BCSC-1 Protein|VWA5A,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",BCSC-1 Protein|VWA5A Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Intrapartum fetal hypoxia,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Intrapartum fetal hypoxia Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,FNDC5 gene|FNDC5,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FNDC5 gene|FNDC5 Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNORA73B gene|SNORA73B,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,SNORA73B gene|SNORA73B Early-Stage Breast Carcinoma,Female Breast Cancer
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,"9,10-Dimethyl-1,2-benzanthracene Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AFFECTS,"PIK3CB protein, human|PIK3CB",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,metacresol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,metacresol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,paired basic amino acid cleaving enzyme,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",paired basic amino acid cleaving enzyme Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Hypolipidemic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Hypolipidemic Agents Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HDAC2 gene|HDAC2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,HDAC2 gene|HDAC2 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cancer Prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Prevention Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,elongin B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,elongin B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"BSG protein, human|BSG",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BSG protein, human|BSG Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,astaxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,astaxanthin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"Receptor, PAR-1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"Receptor, PAR-1 Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,HINT1 gene|HINT1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,HINT1 gene|HINT1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,LILRB2 gene|LILRB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LILRB2 gene|LILRB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Comorbidity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Comorbidity Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"glutamate carboxypeptidase II, human|FOLH1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"glutamate carboxypeptidase II, human|FOLH1 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,pyruvate dehydrogenase kinase 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pyruvate dehydrogenase kinase 4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Low-Density Lipoproteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Low-Density Lipoproteins Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Fat-free mass,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fat-free mass Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"PKN1 protein, human|PKN1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PKN1 protein, human|PKN1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Estrogen Receptors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,cyclooxygenase 2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,"N-succinyl-1,2-dioleoylphosphatidylethanolamine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"N-succinyl-1,2-dioleoylphosphatidylethanolamine Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,alpha-adrenergic receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha-adrenergic receptor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Oral form sodium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oral form sodium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phentolamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phentolamine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TET1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TET1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,caffeic acid phenethyl ester,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,caffeic acid phenethyl ester Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Secondary malignant neoplasm of skin NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of skin NOS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin-Dependent Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin-Dependent Kinases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"MCL1 protein, human|MCL1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MCL1 protein, human|MCL1 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,BUB1 gene|BUB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BUB1 gene|BUB1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Pharmaceutical Preparations,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CCAAT-Enhancer-Binding Proteins|EBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CCAAT-Enhancer-Binding Proteins|EBP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methylation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Methylation Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,EB 1089,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EB 1089 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,RAD51C gene|RAD51C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51C gene|RAD51C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RARRES1|GPRC5A|MED15,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,RARRES1|GPRC5A|MED15 Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,heparanase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,heparanase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Quantitative Trait Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quantitative Trait Loci Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,alkylglycerophosphoethanolamine phosphodiesterase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alkylglycerophosphoethanolamine phosphodiesterase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Biological Phenomena,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Biological Phenomena Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CDK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDK7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibrosing adenosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrosing adenosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FGF10 gene|FGF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF10 gene|FGF10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TACC2 gene|TACC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TACC2 gene|TACC2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Anticoagulants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Anticoagulants Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,targeted prevention,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",targeted prevention Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,pigment epithelium-derived factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pigment epithelium-derived factor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MicroRNAs,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MIRN23A gene|MIR23A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN23A gene|MIR23A Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vitamin D,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Food,Vitamin D Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,NEDD9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NEDD9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vegetable Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Vegetable Proteins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,XBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,XBP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RBM5 gene|RBM5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBM5 gene|RBM5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,perfluorooctanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorooctanoic acid Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Docosahexaenoic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Docosahexaenoic Acids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RECK,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,RECK Breast cancer metastatic,Female Breast Cancer
AFFECTS,Agent,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Chemical Viewed Functionally,Agent Familial cancer of breast,Female Breast Cancer
AFFECTS,MIRN326 gene|MIR326,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN326 gene|MIR326 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,GRN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GRN Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HOTAIR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,HOTAIR Breast cancer metastatic,Female Breast Cancer
DISRUPTS,SP1 gene|SP1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,SP1 gene|SP1 Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Mucins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mucins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Chemotherapeutic agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemotherapeutic agent Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phosphatidylethanolamine N-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphatidylethanolamine N-Methyltransferase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Carcinogens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Carcinoma of Male Breast,Male Breast Cancer
AUGMENTS,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SP1 gene|SP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SP1 gene|SP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,discoidin domain receptor 2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,discoidin domain receptor 2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Annexin A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Excision,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Excision Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,ABL2|RERE,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,ABL2|RERE Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,SPAG5,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,SPAG5 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Benign ovarian cyst,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Benign ovarian cyst Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,hormonal changes,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,hormonal changes Carcinoma of Male Breast,Male Breast Cancer
AUGMENTS,PKM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PKM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Methylnitrosourea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Methylnitrosourea Breast Carcinoma,Female Breast Cancer
AFFECTS,THY1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,THY1 Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,Weaning,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Weaning Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Adaptor Signaling Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Adaptor Signaling Protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PARP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HOXA9 gene|HOXA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXA9 gene|HOXA9 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIRN195 gene|MIR195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN195 gene|MIR195 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,XRCC5 gene|XRCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC5 gene|XRCC5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PAWR gene|PAWR,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,PAWR gene|PAWR Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,N-Acetylneuraminic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-Acetylneuraminic Acid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,IGKV1-16|FAM49B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IGKV1-16|FAM49B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FOXA1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,FOXA1 Breast Carcinoma,Female Breast Cancer
DISRUPTS,Metalloproteases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Breast cancer metastatic,Female Breast Cancer
AFFECTS,Paclitaxel,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Paclitaxel Breast Carcinoma,Female Breast Cancer
AUGMENTS,Radioisotopes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radioisotopes Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PITPNM3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PITPNM3 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,HIC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HIC1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CpG Islands Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Organochlorine pesticide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Organochlorine pesticide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MCM3AP|FIG4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MCM3AP|FIG4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TNFRSF12A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,TNFRSF12A Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CTSG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTSG Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Sporadic Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sporadic Breast Carcinoma Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MYC Family Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC Family Genes|MYC Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Kinesin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Kinesin Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB2 gene|ERBB2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Phosphatidylinositols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphatidylinositols Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IL33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL33 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Developmental Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Developmental Process Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,OPRM1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,OPRM1 Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,K-ras Oncogene|KRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transforming Growth Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Growth Factor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Growth Factor Gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High energy food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,High energy food Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Medical follow-up,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Medical follow-up Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ADGRF5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ADGRF5 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,sulfamate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sulfamate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Malondialdehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Malondialdehyde Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"3,4-Methylenedioxyamphetamine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"3,4-Methylenedioxyamphetamine Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Malignant transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant transformation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nucleic Acids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Nucleic Acids Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,pioglitazone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pioglitazone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interleukin-8,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Interleukin-8 Breast cancer metastatic,Female Breast Cancer
AFFECTS,rosiglitazone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,rosiglitazone Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Telomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Telomerase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cocci,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cocci Breast Carcinoma,Female Breast Cancer
PREDISPOSES,KRT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KRT5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CCL28,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CCL28 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,calusterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,calusterone Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,"Leukemia, Myelocytic, Acute",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Leukemia, Myelocytic, Acute Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Metals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metals Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Soy Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Soy Proteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Serine Proteinase Inhibitors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serine Proteinase Inhibitors Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,DELIVER,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DELIVER Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,bone sialoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bone sialoprotein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical findings,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Physical findings Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,prohibitin|PHB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prohibitin|PHB Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Maximal Voluntary Ventilation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Maximal Voluntary Ventilation Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NCOA2 gene|NCOA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA2 gene|NCOA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hepatocyte Growth Factor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,Hepatocyte Growth Factor Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Acylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acylation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Primary biliary cirrhosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Primary biliary cirrhosis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ELP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ELP3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,DDT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DDT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Conception,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Conception Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Lactalbumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lactalbumin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,paclitaxel liposome,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,paclitaxel liposome Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,CTU1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CTU1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glucose Transporter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Transporter Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Drug resistance,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Drug resistance Breast Carcinoma,Female Breast Cancer
DISRUPTS,Thrombospondins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thrombospondins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cesarean section (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cesarean section (finding) Malignant neoplasm of breast,Female Breast Cancer
CAUSES,particle,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,particle Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Thrombospondin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thrombospondin 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GSTO2 gene|GSTO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTO2 gene|GSTO2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Running,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Running Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Asthenia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Asthenia Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,midkine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,midkine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Prolactinoma,bilateral breast cancer,0.0,Female Breast Cancer,Other,Prolactinoma bilateral breast cancer,Female Breast Cancer
AFFECTS,Misonidazole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Misonidazole Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Abdominal obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Abdominal obesity Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Complement System Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Complement System Proteins Malignant neoplasm of breast,Female Breast Cancer
CAUSES,cholanthrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cholanthrene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adriamycin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Adriamycin Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Lymph Node Involvement,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Lymph Node Involvement Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrogen Receptors|EREG|ESR1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors|EREG|ESR1 Breast Carcinoma,Female Breast Cancer
AFFECTS,Caffeine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Caffeine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Carcinoma, Cribriform","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Carcinoma, Cribriform Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,"3,4-Methylenedioxyamphetamine",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"3,4-Methylenedioxyamphetamine Breast Carcinoma",Female Breast Cancer
AFFECTS,Dietary Fats,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Dietary Fats Breast cancer metastatic,Female Breast Cancer
AFFECTS,Endocrine Surgical Procedures,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Endocrine Surgical Procedures Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PROTEIN INTAKE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN INTAKE Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ras Oncogene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ras Oncogene Breast Carcinoma,Female Breast Cancer
COMPLICATES,Malignant Neoplasms,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast cancer metastatic,Female Breast Cancer
AUGMENTS,Cholestyramine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cholestyramine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diethylstilbestrol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Immunologic Deficiency Syndromes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Immunologic Deficiency Syndromes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Estrogenic,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogenic Breast Carcinoma,Female Breast Cancer
AFFECTS,radical mastectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,radical mastectomy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Markers, DNA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Markers, DNA Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Serum,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Body Substance,Serum Breast Carcinoma,Female Breast Cancer
AFFECTS,Rheumatoid Arthritis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Rheumatoid Arthritis Breast Carcinoma,Female Breast Cancer
CAUSES,ptaquiloside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ptaquiloside Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,monoclonal antibody CC49,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",monoclonal antibody CC49 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fibroblast Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Breast cancer invasive NOS,Female Breast Cancer
AUGMENTS,Prolactin|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin|PRL Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cycasin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cycasin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Bromocriptine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Bromocriptine Breast Carcinoma,Female Breast Cancer
PREDISPOSES,impaired glucose tolerance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,impaired glucose tolerance Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prolonged periods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolonged periods Malignant neoplasm of breast,Female Breast Cancer
CAUSES,leukemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leukemia Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transferase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Transferase Breast Carcinoma,Female Breast Cancer
DISRUPTS,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Prolactin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Trimetrexate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Trimetrexate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Stabilization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stabilization Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ras Oncogene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ras Oncogene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Paroxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Paroxetine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Bone Density,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Bone Density Breast Carcinoma,Female Breast Cancer
AUGMENTS,PTPRF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PTPRF Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,N-Acetylneuraminic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-Acetylneuraminic Acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Breast Carcinoma,Female Breast Cancer
AFFECTS,SYK gene|SYK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYK gene|SYK Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,heparanase|HPSE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,heparanase|HPSE Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Fenretinide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fenretinide Breast Carcinoma,Female Breast Cancer
CAUSES,"Estrogens, Catechol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Catechol Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Metalloproteases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Proline,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Proline Breast Carcinoma,Female Breast Cancer
CAUSES,Free Radicals,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Free Radicals Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Sedentary lifestyle,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Sedentary lifestyle Breast Carcinoma,Female Breast Cancer
AFFECTS,Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Acetate Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Vitamin E intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin E intake Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Physical activity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Physical activity Breast Carcinoma,Female Breast Cancer
AFFECTS,parathyroid hormone-related protein|PTHLH,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein|PTHLH Breast Carcinoma,Female Breast Cancer
DISRUPTS,alpha-Linolenic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,alpha-Linolenic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BCAS2 gene|BCAS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAS2 gene|BCAS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Nitrites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nitrites Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ingestion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ingestion Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Endopeptidases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Endopeptidases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,P-Glycoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",P-Glycoprotein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sarcoidosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sarcoidosis Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,LGD 1069,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,LGD 1069 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Tetranucleotide Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Tetranucleotide Repeats Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Endometrial adenocarcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endometrial adenocarcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,chemokine receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,chemokine receptor Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,"polio, NOS",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"polio, NOS Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,SMAD4 gene|SMAD4,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"SMAD4 gene|SMAD4 Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,ETS Variant Gene 6 Protein|ETV6,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ETS Variant Gene 6 Protein|ETV6 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,parathyroid hormone-related protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Leukemia P388,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Leukemia P388 Breast Carcinoma,Female Breast Cancer
AFFECTS,Cardiovascular Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Cardiovascular Diseases Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Peptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Treatment/Psychosocial Effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Treatment/Psychosocial Effects Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Silicones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Silicones Malignant neoplasm of breast,Female Breast Cancer
CAUSES,chromosome 11q,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chromosome 11q Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Chemotherapeutic agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemotherapeutic agent Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Lymphocyte antigen CD82|CD82,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Lymphocyte antigen CD82|CD82 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,6-nitrochrysene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,6-nitrochrysene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,GSTP1 gene|GSTP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTP1 gene|GSTP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,17q23,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,17q23 Breast Carcinoma,Female Breast Cancer
CAUSES,Tenascin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tenascin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,PTEN gene|PTEN,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Breast Carcinoma,Female Breast Cancer
AFFECTS,Dissection,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Dissection Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,WWOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWOX Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cytochrome P-450 CYP1A1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Agent,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Chemical Viewed Functionally,Agent Carcinoma of Male Breast,Male Breast Cancer
CAUSES,beta-hexachlorocyclohexane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,beta-hexachlorocyclohexane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,inhibitors,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,inhibitors Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLC12A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SLC12A3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Epidermal Growth Factor Receptor|EGF,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGF Sporadic Breast Carcinoma,Female Breast Cancer
AFFECTS,Adrenalectomy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Adrenalectomy Breast Carcinoma,Female Breast Cancer
AFFECTS,Thyroidectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thyroidectomy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant Neoplasms,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,BCL2 gene|BCL2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"BCL2 gene|BCL2 Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Polyamines,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Polyamines Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Restriction fragment length polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Restriction fragment length polymorphism Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Transforming Growth Factor alpha,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor alpha Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Fats, Unsaturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Fats, Unsaturated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Prostaglandins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Prostaglandins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,WWOX gene|WWOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WWOX gene|WWOX Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Selective Estrogen Receptor Modulators,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Premature Birth,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Premature Birth Female Breast Carcinoma,Female Breast Cancer
CAUSES,"Cell Transformation, Neoplastic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Cell Transformation, Neoplastic Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,"PRSS8 protein, human|PRSS8",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PRSS8 protein, human|PRSS8 Breast cancer invasive NOS",Female Breast Cancer
AFFECTS,Axillary Lymph Node Dissection,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Axillary Lymph Node Dissection Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,Radioisotopes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radioisotopes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenic Switch,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiogenic Switch Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,"Liver Failure, Acute",Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,"Liver Failure, Acute Ductal Breast Carcinoma",Female Breast Cancer
CAUSES,Estradiol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Estradiol Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Gene Amplification,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Gene Amplification Breast cancer metastatic,Female Breast Cancer
AFFECTS,Gene Mutation,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Gene Mutation Familial cancer of breast,Female Breast Cancer
PREDISPOSES,CD55|TCN2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,CD55|TCN2 Female Breast Carcinoma,Female Breast Cancer
AFFECTS,Pharmaceutical Adjuvants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Adjuvants Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Durapatite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Durapatite Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cysteine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Protein Tyrosine Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Tyrosine Kinase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Estrogens, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Synthetic Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Growth Factor Receptors,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,SELPLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SELPLG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Gruyere cheese,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Gruyere cheese Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Study models,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Study models Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,chemokine receptor D6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chemokine receptor D6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DPYS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DPYS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HFE,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,HFE Carcinoma of Male Breast,Male Breast Cancer
DISRUPTS,"Linoleic Acids, Conjugated",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,"Linoleic Acids, Conjugated Breast Carcinoma",Female Breast Cancer
CAUSES,Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NUCLEAR MITOTIC APPARATUS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NUCLEAR MITOTIC APPARATUS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CLEC14A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CLEC14A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thrombospondins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thrombospondins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Angiotensinogen|AGT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Angiotensinogen|AGT Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Sermorelin|GH1|GGH,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Sermorelin|GH1|GGH Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Night shift worker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Night shift worker Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ASAP1|MYCBPAP,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,ASAP1|MYCBPAP Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,NELFB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NELFB Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ITGB3BP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ITGB3BP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ubiquitin-protein ligase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ubiquitin-protein ligase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,isopeptidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,isopeptidase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Specific antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Specific antigen Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Breast radiotherapies,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Breast radiotherapies Contralateral breast cancer,Female Breast Cancer
AUGMENTS,glutathione S-transferase pi,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase pi Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfate",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfate Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Tumor Suppressor Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tumor Suppressor Proteins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADH1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADH1C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Adenomatous Polyposis Coli,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Adenomatous Polyposis Coli Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,methyl group,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methyl group Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,gamma-Tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gamma-Tocopherol Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Polymorphism, Genetic",Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,"Polymorphism, Genetic Sporadic Breast Carcinoma",Female Breast Cancer
AFFECTS,CXCL12 gene|CXCL12,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL12 gene|CXCL12 Breast cancer metastatic,Female Breast Cancer
CAUSES,Fibroblast Growth Factor Receptor 2|FGF7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 2|FGF7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STK6 gene|AURKA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK6 gene|AURKA Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Tocopherols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tocopherols Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Regulatory Sequences, Nucleic Acid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Regulatory Sequences, Nucleic Acid Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,Environmental Estrogen,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Hormone,Environmental Estrogen Female Breast Carcinoma,Female Breast Cancer
AUGMENTS,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Genistein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Disease,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Disease Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,exemestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,exemestane Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PREDICTED,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,PREDICTED Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,RNF115,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,RNF115 Breast cancer metastatic,Female Breast Cancer
CAUSES,Aromatic Amines,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Aromatic Amines Breast Carcinoma,Female Breast Cancer
PREDISPOSES,NOD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NOD2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hyperandrogenism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hyperandrogenism Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDK10 gene|CDK10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK10 gene|CDK10 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-tyrosine kinase inhibitor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Grapes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Grapes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PDIA6,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,PDIA6 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Thalidomide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thalidomide Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,multicatalytic endopeptidase complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,multicatalytic endopeptidase complex Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Benzene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Benzene Breast Carcinoma,Female Breast Cancer
AFFECTS,andrographolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,andrographolide Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Atrophy of vagina,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atrophy of vagina Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,APC gene|APC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APC gene|APC Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,docetaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,docetaxel Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"FOLR1 protein, human|FOLR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FOLR1 protein, human|FOLR1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,RIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RIN1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HBP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HSD17B2 gene|HSD17B2|HSD17B7P2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSD17B2 gene|HSD17B2|HSD17B7P2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Dietary Modification,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Modification Familial cancer of breast,Female Breast Cancer
PREDISPOSES,Aborted pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Aborted pregnancy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Second Primary Cancers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Second Primary Cancers Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,5'-NUCLEOTIDASE|NT5E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,5'-NUCLEOTIDASE|NT5E Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glial Fibrillary Acidic Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glial Fibrillary Acidic Protein Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Oncogene Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogene Proteins Breast Carcinoma,Female Breast Cancer
AFFECTS,Interleukin-8|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-8|EREG|ESR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SNAI1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,SNAI1 Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,Tumor proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tumor proteins Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PPIA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPIA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CYP2C19 gene|CYP2C19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2C19 gene|CYP2C19 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S-Adenosylmethionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S-Adenosylmethionine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alpha tocopheryl succinate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Alpha tocopheryl succinate Breast Carcinoma,Female Breast Cancer
AUGMENTS,NCSTN gene|NCSTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCSTN gene|NCSTN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Stearates,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Stearates Breast Carcinoma,Female Breast Cancer
CAUSES,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor|AHR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,estrone sulfate,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,estrone sulfate Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,DEK gene|DEK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DEK gene|DEK Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dihydrofolate Reductase|DHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dihydrofolate Reductase|DHFR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Acrylamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acrylamide Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Silicon,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Silicon Breast cancer recurrent,Recurrent Breast Cancer
DISRUPTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Breast Carcinoma,Female Breast Cancer
AFFECTS,Xenograft procedure,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Xenograft procedure Breast cancer metastatic,Female Breast Cancer
AFFECTS,Long chain fatty acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Long chain fatty acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERBB2 gene|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Prognostic Factor,bilateral breast cancer,0.0,Female Breast Cancer,Other,Prognostic Factor bilateral breast cancer,Female Breast Cancer
PREDISPOSES,RAB27B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAB27B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PARP1|COL11A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PARP1|COL11A2 Breast cancer metastatic,Female Breast Cancer
AFFECTS,D4-GDI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,D4-GDI Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TIMM17A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TIMM17A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Heat shock proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat shock proteins Breast Carcinoma,Female Breast Cancer
CAUSES,ADM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,erbB-2 Receptor|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,docetaxel,Breast cancer stage II,0.0,Female Breast Cancer,Other,docetaxel Breast cancer stage II,Female Breast Cancer
AUGMENTS,BCAR1 gene|BCAR1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BCAR1 gene|BCAR1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,exemestane,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,exemestane Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,SOX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOX4 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TEK gene|TEK,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TEK gene|TEK Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Alleles,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Alleles Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Sleep Deprivation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sleep Deprivation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MST1R gene|MST1R,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MST1R gene|MST1R Breast cancer metastatic,Female Breast Cancer
DISRUPTS,ITGA5 gene|ITGA5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ITGA5 gene|ITGA5 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Interstitial Collagenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interstitial Collagenase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,epithelial cell differentiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",epithelial cell differentiation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Human Papilloma Virus Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Human Papilloma Virus Vaccine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Quinones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Quinones Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ERBB2|NEU1|NEURL1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"ERBB2|NEU1|NEURL1 Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,Garlic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Garlic Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,VCP gene|VCP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VCP gene|VCP Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GLI1 gene|GLI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLI1 gene|GLI1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VEGFA,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"VEGFA Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Body mass index procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Body mass index procedure Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,"PTH protein, human|PTH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTH protein, human|PTH Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,AVP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AVP Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast cancer metastatic,Female Breast Cancer
AUGMENTS,SPDYA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,SPDYA Breast Carcinoma,Female Breast Cancer
AFFECTS,CD24,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,CD24 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,cytochrome P-450 CYP1B1|CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cytochrome P-450 CYP1B1|CYP1B1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ORALIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ORALIT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lithium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lithium Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,nuclear receptor coactivator 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,nuclear receptor coactivator 1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,phenylalanylphenylalanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,phenylalanylphenylalanine Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Norepinephrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Norepinephrine Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Carcinoid Tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoid Tumor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,High Density Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IL8 gene|CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL8 gene|CXCL8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast Carcinoma,Female Breast Cancer
DISRUPTS,caveolin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caveolin 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MAPK15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAPK15 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Velcade,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Velcade Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNAJA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNAJA3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GATA3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,GATA3 Breast cancer metastatic,Female Breast Cancer
AFFECTS,collagenase 3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,collagenase 3 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,HSPA1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSPA1A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"progesterone, micronized",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"progesterone, micronized Malignant neoplasm of breast",Female Breast Cancer
CAUSES,"Carcinoma, Ductal, Breast",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Carcinoma, Ductal, Breast Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,casein kinase II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,casein kinase II Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Paget's Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Paget's Disease Breast Carcinoma,Female Breast Cancer
AFFECTS,Tristetraprolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tristetraprolin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SUSD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SUSD3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"[M]Adenocarcinoma, metastatic, NOS",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,"[M]Adenocarcinoma, metastatic, NOS Inflammatory Breast Carcinoma",Female Breast Cancer
AUGMENTS,"CTTN protein, human|CTTN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CTTN protein, human|CTTN Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,iturin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,iturin A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SNX9 gene|SNX9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SNX9 gene|SNX9 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,PSPHP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PSPHP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PML gene|PML,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PML gene|PML Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Post-Transcriptional Regulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Post-Transcriptional Regulation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Genistein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Genistein Breast cancer metastatic,Female Breast Cancer
AFFECTS,Naphthalene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Naphthalene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Purines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Purines Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,toll-like receptor 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,toll-like receptor 4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Interleukin 6 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin 6 Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Epstein-Barr virus DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Epstein-Barr virus DNA Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Growth stimulant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Growth stimulant Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLOPE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,SLOPE Breast Carcinoma,Female Breast Cancer
PREDISPOSES,CLOCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CLOCK Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PTGER2|SPAG11B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PTGER2|SPAG11B Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Vitamin D Deficiency,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Food,Vitamin D Deficiency Breast cancer metastatic,Female Breast Cancer
CAUSES,BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MIRN10A gene|MIR10A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN10A gene|MIR10A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SULF2 gene|SULF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULF2 gene|SULF2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Metaplastic carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Metaplastic carcinoma Breast Carcinoma,Female Breast Cancer
AFFECTS,CD4 gene|CD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD4 gene|CD4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AMOTL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AMOTL1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tubeimoside I,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,tubeimoside I Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,1/24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1/24 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RORA gene|RORA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RORA gene|RORA Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,SH3PXD2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SH3PXD2A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LY6K,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LY6K Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"DICER1 protein, human|DICER1","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,cofilin|CFL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,cofilin|CFL1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Little's Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Little's Disease Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MLLT11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,MLLT11 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FOXP3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Uridine Diphosphate Sugars,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Uridine Diphosphate Sugars Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FBXO42,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FBXO42 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CMTS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CMTS Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ARGININOSUCCINATE LYASE|ASL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ARGININOSUCCINATE LYASE|ASL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Functional RNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast Carcinoma,Female Breast Cancer
AFFECTS,Mitogen-Activated Protein Kinase 13|MAPK13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinase 13|MAPK13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Platinum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Platinum Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,9-deoxy-delta-9-prostaglandin D2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Eicosanoid,9-deoxy-delta-9-prostaglandin D2 Breast cancer metastatic,Female Breast Cancer
DISRUPTS,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Ribosomal Protein S6 Kinases, 70-kDa Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Transcript,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Transcript Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,bone morphogenetic protein 6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 6 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,SOD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SOD1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vitamin B1 Intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B1 Intake Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CDKN1C gene|CDKN1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1C gene|CDKN1C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TP53 gene|TP53,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast cancer metastatic,Female Breast Cancer
AFFECTS,ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ESR2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RHOC gene|RHOC,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Breast cancer metastatic,Female Breast Cancer
DISRUPTS,costunolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,costunolide Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LATS2 gene|LATS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LATS2 gene|LATS2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RELN gene|RELN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RELN gene|RELN Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,anthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,anthracene Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MEG3|FAM129B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,chemokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chemokine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF143,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF143 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibrosing adenosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibrosing adenosis Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EIF2S1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EIF2S1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cytokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Increased effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Increased effect Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"PER2 protein, mammalian|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,NF-Kappa B p65,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NF-Kappa B p65 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Hazards, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Hazards, Environmental Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,mitochondrial DNA replication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mitochondrial DNA replication Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NF-AT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NF-AT Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,peptide T amide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",peptide T amide Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,ERBB2 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"HDAC5 protein, human|HDAC5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HDAC5 protein, human|HDAC5 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,indoleamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,indoleamine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FYN gene|FYN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FYN gene|FYN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FOXO3A gene|FOXO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXO3A gene|FOXO3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,EHMT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EHMT2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ethylene glycol,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,ethylene glycol Carcinoma of Male Breast,Male Breast Cancer
PREDISPOSES,Pasta intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pasta intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Beads,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beads Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thioridazine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thioridazine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SCARA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SCARA5 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CDCA7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CDCA7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,DDAVP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,DDAVP Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Pyruvate Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pyruvate Kinase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,hepatitis B virus X protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",hepatitis B virus X protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Prolactin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Prolactin Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,nicotinamide phosphoribosyltransferase|NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,nicotinamide phosphoribosyltransferase|NAMPT Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Morphine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Morphine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYTOR Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NOTCH1 gene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,NOTCH1 gene Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Doxorubicin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Doxorubicin Breast Carcinoma,Female Breast Cancer
AFFECTS,Estrogens,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Hormone,"Estrogens Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,LAPTM4B gene|LAPTM4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAPTM4B gene|LAPTM4B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2|NEU1|NEURL1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Activated-Leukocyte Cell Adhesion Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Activated-Leukocyte Cell Adhesion Molecule Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,B-pyridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,B-pyridine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Alkanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alkanes Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Fusion Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fusion Protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Prior Therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Prior Therapy Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,SNHG14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SNHG14 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,parathyroid hormone-related protein|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein|PTHLH Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ACKR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ACKR3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,LACTB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LACTB Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IkappaB Kinase beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IkappaB Kinase beta Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PAWR gene|PAWR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAWR gene|PAWR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Granulocyte Colony-Stimulating Factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Granulocyte Colony-Stimulating Factor Breast cancer metastatic,Female Breast Cancer
CAUSES,BCL6 gene|BCL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6 gene|BCL6 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Growth Factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Breast cancer metastatic,Female Breast Cancer
AFFECTS,"Diet, Fat-Restricted",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,"Diet, Fat-Restricted Breast cancer recurrent",Recurrent Breast Cancer
PREDISPOSES,ITGB3 gene|ITGB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ITGB3 gene|ITGB3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIRN423 gene|MIR423,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN423 gene|MIR423 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NNT-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NNT-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KISS1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KISS1R Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IL32,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IL32 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ferrocene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ferrocene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PPP2R2A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PPP2R2A Breast cancer metastatic,Female Breast Cancer
AFFECTS,schizandrin B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,schizandrin B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CHI3L1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,CHI3L1 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,osteoactivin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,osteoactivin Breast cancer metastatic,Female Breast Cancer
CAUSES,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Phosphoric Monoester Hydrolases Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,N-myristoyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,N-myristoyltransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,caspase-3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caspase-3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Platelet Factor 4|PF4,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Platelet Factor 4|PF4 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Chromosomal Rearrangement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Chromosomal Rearrangement Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Tomography, Emission-Computed",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Tomography, Emission-Computed Breast Carcinoma",Female Breast Cancer
DISRUPTS,P3H1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,P3H1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lymphocyte product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lymphocyte product Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DICER1 gene|DICER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DICER1 gene|DICER1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,IkappaB Kinase epsilon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,IkappaB Kinase epsilon Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Peutz-Jeghers Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Peutz-Jeghers Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pancreatic carcinoma,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Pancreatic carcinoma Carcinoma, Ductal, Breast",Female Breast Cancer
CAUSES,SYK gene|SYK,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SYK gene|SYK Breast Carcinoma,Female Breast Cancer
PREDISPOSES,ZNF326,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZNF326 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ZIC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ZIC1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Polymerase|ERVK-9|ERVK-19|ERVK-11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Polymerase|ERVK-9|ERVK-19|ERVK-11 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HNRPM gene|HNRNPM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HNRPM gene|HNRNPM Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LBH589,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LBH589 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmaceutical Preparations,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,ADRA1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADRA1D Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Saethre-Chotzen Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Saethre-Chotzen Syndrome Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"UBD protein, human|UBD",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","UBD protein, human|UBD Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,8-hydroxy-2'-deoxyguanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,8-hydroxy-2'-deoxyguanosine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thromboplastin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thromboplastin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,WWC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,WWC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mammographic breast density,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Mammographic breast density Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,PGC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PGC Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ERR1 protein|ESRRA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ERR1 protein|ESRRA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Estradiol Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Estradiol Receptors Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Oncogenes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Oncogenes Breast cancer invasive NOS,Female Breast Cancer
COMPLICATES,Sterol Regulatory Element Binding Protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Sterol Regulatory Element Binding Protein 2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cryptochrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cryptochrome Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,MMP2 gene|MMP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP2 gene|MMP2 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,alpha-Fetoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha-Fetoproteins Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Fusion Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fusion Protein Breast cancer metastatic,Female Breast Cancer
AFFECTS,BLM gene|BLM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BLM gene|BLM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DDR2 gene|DDR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DDR2 gene|DDR2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SMYD3 gene|SMYD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMYD3 gene|SMYD3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"HDAC5 protein, human|HDAC5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HDAC5 protein, human|HDAC5 Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,TAZ gene|TAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAZ gene|TAZ Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,REPS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,REPS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ARHI gene|DIRAS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHI gene|DIRAS3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Somatostatin analog|SST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Somatostatin analog|SST Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CYP2B6 gene|CYP2B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2B6 gene|CYP2B6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Atherosclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Atherosclerosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,versican|VCAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,versican|VCAN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Urokinase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Urokinase Breast Carcinoma,Female Breast Cancer
DISRUPTS,ARHI gene|DIRAS3,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ARHI gene|DIRAS3 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,participation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",participation Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Tenascin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tenascin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Organic solvent product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Organic solvent product Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fat tissue increased,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Fat tissue increased Breast Carcinoma,Female Breast Cancer
AFFECTS,Androgen Receptor|AR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Androgen Receptor|AR Breast Carcinoma,Female Breast Cancer
AFFECTS,Tegafur,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Tegafur Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Desipramine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Desipramine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Serpins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Serpins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Angiogenesis Factor,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Angiogenesis Factor Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Size of lymph node,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Size of lymph node Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADH1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ADH1B Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Malignant neoplasm of prostate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Breast cancer metastatic,Female Breast Cancer
AFFECTS,"Transcription, Genetic",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Transcription, Genetic Breast Carcinoma",Female Breast Cancer
PREDISPOSES,decisiveness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,decisiveness Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Vaccines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vaccines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,caffeinated beverage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,caffeinated beverage Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,High Density Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoproteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pharmacotherapy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Pharmacotherapy Contralateral breast cancer,Female Breast Cancer
AFFECTS,Monocyte Chemoattractant Protein-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Gene Products, Protein",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Gene Products, Protein Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,RAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Oncogene, RET|RET",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Oncogene, RET|RET Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,cultural differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cultural differences Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Epiregulin|EREG,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Epiregulin|EREG Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Fertility,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Fertility Breast cancer metastatic,Female Breast Cancer
AFFECTS,Buformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Buformin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RGS17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RGS17 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,protein kinase D,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase D Breast cancer invasive NOS,Female Breast Cancer
DISRUPTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adrenergic beta-Antagonists Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"CHEK1 protein, human|CHEK1",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CHEK1 protein, human|CHEK1 Breast cancer metastatic",Female Breast Cancer
AFFECTS,RGS17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RGS17 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Vitamin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin E Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytochrome P-450 CYP2D6,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Cytochrome P-450 CYP2D6 Breast cancer recurrent,Recurrent Breast Cancer
CAUSES,Invasive Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Breast Carcinoma,Female Breast Cancer
AUGMENTS,Nucleolar Organizer Region,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nucleolar Organizer Region Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Mayonnaise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mayonnaise Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ING1|LTB|CENPK,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,ING1|LTB|CENPK Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Hormone level abnormal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone level abnormal Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibromyalgia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fibromyalgia Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Signal Pathways,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Signal Pathways Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Body mass index,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Body mass index Contralateral breast cancer,Female Breast Cancer
AFFECTS,Increased Metabolic Rate,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Increased Metabolic Rate Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,PROM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PROM1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,monocyte activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",monocyte activation Malignant neoplasm of breast,Female Breast Cancer
CAUSES,retinoic acid receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,retinoic acid receptor alpha Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Signaling Molecule,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Signaling Molecule Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,STARD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,STARD3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estratest,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Estratest Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
CAUSES,Nucleosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nucleosides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GLO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GLO1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Myristic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Myristic Acid Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cell Cycle Checkpoint Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cell Cycle Checkpoint Genes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Gonadotropin-Releasing Hormone Analog,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadotropin-Releasing Hormone Analog Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Doxorubicin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Doxorubicin Breast cancer metastatic,Female Breast Cancer
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Hydroxymethylglutaryl-CoA Reductase Inhibitors Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,BMP4|BMP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BMP4|BMP4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NOS3 gene|NOS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOS3 gene|NOS3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Recreation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Recreation Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Malignant neoplasm of thyroid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of thyroid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Primigravida,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Primigravida Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Alcohol consumption,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,PPARGC1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PPARGC1B Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CD4 gene|CD4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD4 gene|CD4 Breast Carcinoma,Female Breast Cancer
AFFECTS,DDIT4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DDIT4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Axillary Lymph Node Involvement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Axillary Lymph Node Involvement Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor beta|ESR2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Estrogen Receptor beta|ESR2 Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Leukocyte Elastase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Leukocyte Elastase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,[D]Mammogram abnormal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,[D]Mammogram abnormal Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NEUROD1|TUBB4B,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,NEUROD1|TUBB4B Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Hay fever,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hay fever Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Down-Regulation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Down-Regulation Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Recombinant Interferon-gamma|IFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Recombinant Interferon-gamma|IFNG Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,URI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,URI1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LAPTM4B gene|LAPTM4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAPTM4B gene|LAPTM4B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ABCC5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ABCC5 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,IL17F,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Other,IL17F Sporadic Breast Carcinoma,Female Breast Cancer
AUGMENTS,POP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,POP4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CSH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CSH1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,patient characteristics,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,patient characteristics Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,Smoking Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Smoking Behavior Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"PSMD10 protein, human|PSMD10",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PSMD10 protein, human|PSMD10 Breast cancer metastatic",Female Breast Cancer
DISRUPTS,CLDN1 gene|CLDN1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,CLDN1 gene|CLDN1 Breast cancer invasive NOS,Female Breast Cancer
CAUSES,XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,XRCC1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Estrone Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,PRL gene|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRL gene|PRL Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sex Hormone-Binding Globulin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,Liver and Intrahepatic Biliary Tract Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Liver and Intrahepatic Biliary Tract Carcinoma Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mangifera indica extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mangifera indica extract Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cytotoxic agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic agent Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NAP1L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,NAP1L2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNAJC27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNAJC27 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secondary malignant neoplasm of lymph node,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lymph node Breast Carcinoma,Female Breast Cancer
AFFECTS,Endocrine therapy,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hormone,Endocrine therapy Inflammatory Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TRANSCRIPTION FACTOR,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,RBL2 gene|RBL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBL2 gene|RBL2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Folate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MASS LESION,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",MASS LESION Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,"Anesthesia, Conduction",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope","Anesthesia, Conduction Breast cancer recurrent",Recurrent Breast Cancer
PREDISPOSES,TGFBR2 gene|TGFBR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TGFBR2 gene|TGFBR2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Stathmin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Stathmin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sequela of disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sequela of disorder Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cigarette Smoking,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Cigarette Smoking Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,astragaloside IV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,astragaloside IV Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PRRX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PRRX2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,crocin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,crocin Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ING5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ING5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Radiation therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Breast cancer metastatic,Female Breast Cancer
CAUSES,Annexin A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Microcalcification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Endocrine Gland Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Gland Neoplasms Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TRANSCRIPTION FACTOR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Breast Carcinoma,Female Breast Cancer
AFFECTS,Proton therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Proton therapy Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,brucine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,brucine Breast cancer metastatic,Female Breast Cancer
CAUSES,Oncogenic Viruses,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Oncogenic Viruses Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,histone deacetylase 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,histone deacetylase 3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Encounter due to Screening for malignant neoplasm of breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Encounter due to Screening for malignant neoplasm of breast Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Infiltration,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FTO Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SDC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Metals, Heavy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,KLHL7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,KLHL7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RETN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RETN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIP Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Glutamic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Glutamic Acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,stem cell therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,stem cell therapy Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibroblast Growth Factor 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,genetic element,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic element Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"SBEM protein, human|MUCL1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SBEM protein, human|MUCL1 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,WT1 gene|WT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WT1 gene|WT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytochrome P-450 CYP2D6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Cytochrome P-450 CYP2D6 Breast cancer metastatic,Female Breast Cancer
AFFECTS,PTGS2 gene|PTGS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CHES1 gene|FOXN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHES1 gene|FOXN3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ACACA|BMS1,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,ACACA|BMS1 Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,decorin|DCN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,decorin|DCN Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,inhibitors,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,inhibitors Familial cancer of breast,Female Breast Cancer
DISRUPTS,Phospholipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Phospholipids Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Financial circumstances,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Financial circumstances Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,beta catenin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,beta catenin Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,2q33-q34,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,2q33-q34 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PERP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PERP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,XRCC5 gene|XRCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC5 gene|XRCC5 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,NEK2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,NEK2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Interleukin-10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Interleukin-10 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Osteonectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Osteonectin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Candidate Disease Gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene|AR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Carcinoma in situ of breast,Female Breast Cancer
PREDISPOSES,"Subarachnoid Hemorrhage, Aneurysmal",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,"Subarachnoid Hemorrhage, Aneurysmal Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
PREDISPOSES,Placental Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Placental Hormones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,thiopurine,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,thiopurine Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,NFKBIA gene|NFKBIA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NFKBIA gene|NFKBIA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Body mass index,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Other,"Body mass index Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,Mutation,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,Cholesterol Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol Esters Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP17A1 gene|CYP17A1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Boiled potato,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Boiled potato Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypothyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hypothyroidism Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TNFRSF1B gene|TNFRSF1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF1B gene|TNFRSF1B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CHEST SYMPTOM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CHEST SYMPTOM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ERBB2|NEU1|NEURL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ERBB2|NEU1|NEURL1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Morphogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Morphogenesis Breast Carcinoma,Female Breast Cancer
DISRUPTS,Ritonavir,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ritonavir Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Estrogen-progestin preparation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen-progestin preparation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Soluble ErbB-1|EGFR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Soluble ErbB-1|EGFR Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,RANTES,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,RANTES Breast Carcinoma,Female Breast Cancer
AFFECTS,Microsatellite Repeats,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Microsatellite Repeats Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,CCAAT-Enhancer-Binding Protein-delta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CCAAT-Enhancer-Binding Protein-delta Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Local Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Local Therapy Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Thymidylate Synthase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Thymidylate Synthase Breast Carcinoma,Female Breast Cancer
DISRUPTS,CD68,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CD68 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DES EXPOSURE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DES EXPOSURE Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF365 gene|ZNF365,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF365 gene|ZNF365 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LHX1 gene|LHX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LHX1 gene|LHX1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ERCC3 gene|ERCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC3 gene|ERCC3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,RNASE3L gene|DROSHA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNASE3L gene|DROSHA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SABER,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,SABER Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,BABAM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BABAM1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Estrogenic,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogenic Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Xenobiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Xenobiotics Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ductal Carcinoma,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Ductal Carcinoma Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,oncoprotein p21|CDKN1A|SLC12A9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",oncoprotein p21|CDKN1A|SLC12A9 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hematoxylin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hematoxylin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Single Nucleotide Polymorphism,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Breast Carcinoma,Female Breast Cancer
AFFECTS,Dietary Modification,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Dietary Modification Breast cancer recurrent,Recurrent Breast Cancer
AFFECTS,Mitogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mitogens Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SCREEN TECHNIQUES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SCREEN TECHNIQUES Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,erbB-2 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Adenomatous goiter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adenomatous goiter Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PFKFB4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,PFKFB4 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Mutagens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Mutagens Malignant neoplasm of breast,Female Breast Cancer
CAUSES,ETV4 gene|ETV4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ETV4 gene|ETV4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ovulation Induction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovulation Induction Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SRC gene|SRC,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,SRC gene|SRC Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Disintegrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Disintegrins Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FCGR3A gene|FCGR3A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FCGR3A gene|FCGR3A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,S 1 (combination),Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",S 1 (combination) Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,CONSTITUTIONAL ORIGIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CONSTITUTIONAL ORIGIN Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HSPA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,HSPA5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Abdominal circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Abdominal circumference Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,tibolone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,tibolone Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,LAMTOR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LAMTOR3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DSCAM-AS1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Bone Morphogenetic Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Bone Morphogenetic Proteins Breast cancer metastatic,Female Breast Cancer
AFFECTS,Epstein-Barr Virus Infections,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Epstein-Barr Virus Infections Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Cooking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cooking Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lymphedema,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lymphedema Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Diuretics,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Diuretics Breast Carcinoma,Female Breast Cancer
PREDISPOSES,TRANCE protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Trihalomethanes,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Trihalomethanes Female Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Syndrome,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Syndrome Breast Carcinoma,Female Breast Cancer
CAUSES,Angiogenesis Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Factor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PMS2 gene|PMS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PMS2 gene|PMS2 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,fatty acid amide hydrolase,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical,fatty acid amide hydrolase Breast cancer invasive NOS,Female Breast Cancer
PREDISPOSES,Histologic type,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Histologic type Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Endocrine System Diseases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Endocrine System Diseases Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Iron, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Iron, Dietary Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,JMJD6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,JMJD6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cadaverine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cadaverine Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,cytokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,XRCC1 gene|XRCC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,FRA16D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FRA16D Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,S100A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100A7 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Thioglucosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thioglucosides Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary fat intake,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,Dietary fat intake Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,PNU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PNU Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MED19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MED19 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CYTOR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Phytoestrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Phytoestrogens Breast Carcinoma,Female Breast Cancer
PREDISPOSES,ID2 gene|ID2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ID2 gene|ID2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Fruit,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Other,Fruit Breast cancer recurrent,Recurrent Breast Cancer
PREDISPOSES,UBE2N,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,UBE2N Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,GJB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GJB2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Chemotherapy, Adjuvant",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,"Chemotherapy, Adjuvant Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AFFECTS,LATS1 gene|LATS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LATS1 gene|LATS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MDM2 gene|MDM2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,ENPP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ENPP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KRT8,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Other,KRT8 Breast cancer invasive NOS,Female Breast Cancer
AFFECTS,PTCSC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PTCSC3 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ubiquitin-protein ligase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ubiquitin-protein ligase Breast cancer metastatic,Female Breast Cancer
CAUSES,Arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Arsenic Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,AQP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AQP4 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,salinomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,salinomycin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,HMGN2 Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HMGN2 Protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Proliferating Cell Nuclear Antigen Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mandibular right first molar abutment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Mandibular right first molar abutment Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Genome, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genome, Human Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Cathepsins B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cathepsins B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,FAM84B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAM84B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,AQP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AQP7 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Ca(2+)-Transporting ATPase|CA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ca(2+)-Transporting ATPase|CA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,therapeutic use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,therapeutic use Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GJB2 gene|GJB2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"GJB2 gene|GJB2 Carcinoma, Ductal, Breast",Female Breast Cancer
AFFECTS,verbenone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,verbenone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PTH-Parathyroid hormone level result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,PTH-Parathyroid hormone level result Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Recurrent Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Recurrent Carcinoma Malignant neoplasm of breast,Recurrent Breast Cancer
PREDISPOSES,moderate drinking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,moderate drinking Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,RBM12B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RBM12B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CASC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CASC9 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EIF4EBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EIF4EBP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MIRN106A gene|MIR106A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN106A gene|MIR106A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FUT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FUT1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,1-Phosphatidylinositol 4-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,1-Phosphatidylinositol 4-Kinase Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cullin 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,Cullin 1 Breast cancer metastatic,Female Breast Cancer
AFFECTS,Transferrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Transferrin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PIEZO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PIEZO2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vinegar,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Vinegar Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,v-myb Genes|MYB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,v-myb Genes|MYB Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Interferon Type I,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Interferon Type I Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,UCHL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,UCHL3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Kinesin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Kinesin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,BCL11A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,BCL11A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Circadian Rhythm Disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Circadian Rhythm Disorders Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Dipeptidyl-Peptidase IV|DPP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dipeptidyl-Peptidase IV|DPP4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,lysyllysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,lysyllysine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDK6-associated protein p18,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CDK6-associated protein p18 Breast cancer metastatic,Female Breast Cancer
AFFECTS,ubiquitin-protein ligase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ubiquitin-protein ligase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FAM13A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,FAM13A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC01133,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,LINC01133 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,APOBEC3B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,APOBEC3B Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
DISRUPTS,honokiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,honokiol Breast cancer metastatic,Female Breast Cancer
AFFECTS,reverse transcription polymerase chain reaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",reverse transcription polymerase chain reaction Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TSLP protein, human|TSLP",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TSLP protein, human|TSLP Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Secondary malignant neoplasm of spinal cord,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of spinal cord Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,bone sialoprotein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bone sialoprotein Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,Ephrin B Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ephrin B Receptors Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Obesity,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Other,Obesity Contralateral breast cancer,Female Breast Cancer
PREDISPOSES,ATXN3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,ATXN3 Breast cancer metastatic,Female Breast Cancer
AUGMENTS,PCB 118,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 118 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CERS6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CERS6 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ingredient,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ingredient Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PIM1 gene|PIM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIM1 gene|PIM1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cardamonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cardamonin Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"Oligonucleotides, Antisense",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Oligonucleotides, Antisense Breast cancer metastatic",Female Breast Cancer
AFFECTS,RAB1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,RAB1A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cyclin-Dependent Kinase Inhibitor 2A|CDK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cyclin-Dependent Kinase Inhibitor 2A|CDK4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Solvents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Solvents Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,DSCAM-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pancreatic carcinoma,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Pancreatic carcinoma Ductal Breast Carcinoma,Female Breast Cancer
PREDISPOSES,centromere protein F,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",centromere protein F Breast cancer metastatic,Female Breast Cancer
AFFECTS,paracrine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,paracrine Breast cancer metastatic,Female Breast Cancer
AFFECTS,Adrenergic Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Adrenergic Receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MIRN133B gene|MIR133B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN133B gene|MIR133B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCB 101,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCB 101 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Docosahexaenoate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Docosahexaenoate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Bleomycin|BLM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Bleomycin|BLM Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MDM1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Other,MDM1 Familial cancer of breast,Female Breast Cancer
PREDISPOSES,WISP1 gene|WISP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WISP1 gene|WISP1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Paracrine Communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Paracrine Communication Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cisplatin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cathepsins|CTSS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Cathepsins|CTSS Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LIMS1 gene|LIMS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIMS1 gene|LIMS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SORBS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SORBS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,erbB-2 Receptor|ECD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,erbB-2 Receptor|ECD Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SIX1 gene|SIX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIX1 gene|SIX1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hydrogel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Hydrogel Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SULF1 gene|SULF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULF1 gene|SULF1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Dopamine Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Dopamine Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,p65|RELA|SYT1|GORASP1|WNK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,p65|RELA|SYT1|GORASP1|WNK1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MAGI2-AS3 gene|MAGI2-AS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAGI2-AS3 gene|MAGI2-AS3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cell-Free DNA,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cell-Free DNA Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Annexin A1|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Annexin A1|ANXA1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,beta-site APP cleaving enzyme 1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Enzyme,"beta-site APP cleaving enzyme 1 Carcinoma, Ductal, Breast",Female Breast Cancer
PREDISPOSES,SOX5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Other,SOX5 Breast cancer metastatic,Female Breast Cancer
PREDISPOSES,OGDHL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,OGDHL Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Postmenopause,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Postmenopause Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,SP 1049C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,SP 1049C Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,systemic administration,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",systemic administration Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Chronic disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic disease Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Parabens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Parabens Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,talazoparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,talazoparib Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,insulin isophane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,insulin isophane Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,KDM6A gene|KDM6A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM6A gene|KDM6A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interferon Signaling Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Interferon Signaling Process Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fibroblast Growth Factor 2|FGF2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 2|FGF2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,UGT1A4 gene|UGT1A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UGT1A4 gene|UGT1A4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Alcohol intake above recommended sensible limits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Alcohol intake above recommended sensible limits Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ATOX1 gene|ATOX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATOX1 gene|ATOX1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"KISS1R protein, human|KISS1R",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","KISS1R protein, human|KISS1R Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,Infertility risk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Infertility risk Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,levothyroxine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,levothyroxine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,DNA Repair Gene,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,DNA Repair Gene Hereditary Breast and Ovarian Cancer Syndrome,Female Breast Cancer
CAUSES,DNA Modification Methylases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ceramide kinase,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,ceramide kinase Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,"Promoter Regions, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Promoter Regions, Genetic Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,GAS1 gene|GAS1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,GAS1 gene|GAS1 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,Primary Neoplasm,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Primary Neoplasm Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,cisplatin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,cisplatin Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,F2R gene|F2R,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,F2R gene|F2R Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,"Receptor, Notch4",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"Receptor, Notch4 Triple Negative Breast Neoplasms",Female Breast Cancer
AUGMENTS,LINC00668 gene|LINC00668,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00668 gene|LINC00668 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,chitosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chitosan Malignant neoplasm of breast,Female Breast Cancer
CAUSES,tumor protein D52|TPD52,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tumor protein D52|TPD52 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IGFBP7|SFPQ,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,IGFBP7|SFPQ estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,SH2B3 gene|SH2B3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SH2B3 gene|SH2B3 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,Carcinogens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,physiological aspects,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,physiological aspects Breast Carcinoma,Female Breast Cancer
AFFECTS,prothrombin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prothrombin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,cisplatin,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,cisplatin estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,MRTFA gene|MKL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MRTFA gene|MKL1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FDG-Positron Emission Tomography and Computed Tomography Scan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FDG-Positron Emission Tomography and Computed Tomography Scan Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,lead,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,lead Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SEPT7 gene|SEPT7,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SEPT7 gene|SEPT7 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","E2F1 protein, human|E2F1|UBE2L3 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Apolipoprotein E|APOE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein E|APOE Breast Carcinoma,Female Breast Cancer
AFFECTS,GATA3 gene|GATA3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,methylene chloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methylene chloride Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,AGO1 gene|AGO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AGO1 gene|AGO1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,tryptophan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,tryptophan Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antineoplastic Agents,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,CSK gene|CSK,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,CSK gene|CSK Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,"Receptors, Progesterone",Breast cancer stage III,0.0009990009990009,Female Breast Cancer,Hormone,"Receptors, Progesterone Breast cancer stage III",Female Breast Cancer
AFFECTS,Microinvasive tumor,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Microinvasive tumor Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,Estrogen Receptors,Breast cancer stage III,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer stage III,Female Breast Cancer
AFFECTS,Estrogen Antagonists,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,Estrogen Antagonists estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,OSW 1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,OSW 1 Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Saponin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Saponin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ATF4 gene|ATF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATF4 gene|ATF4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Genes, Essential",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Essential Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Late Relapse,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Late Relapse estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,PBX1 gene|PBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PBX1 gene|PBX1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,VLDLR gene|VLDLR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VLDLR gene|VLDLR Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,WNT6 gene|WNT6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT6 gene|WNT6 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,EXT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,EXT1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SIRT3 gene|SIRT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIRT3 gene|SIRT3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TGFB1 gene|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TGFB1 gene|TGFB1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZBTB1 gene|ZBTB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZBTB1 gene|ZBTB1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Cyclin B1|CCNB1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Cyclin B1|CCNB1 HER2-positive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Growth pattern,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Growth pattern Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Biological Markers,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Other,Biological Markers Recurrent Breast Carcinoma,Recurrent Breast Cancer
DISRUPTS,ELK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ELK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypoxia,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Hypoxia Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Ginkgo biloba extract,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Ginkgo biloba extract Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,CXCR2 gene|CXCR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR2 gene|CXCR2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fenamole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fenamole Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Rocky,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Rocky Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,IQGAP1 gene|IQGAP1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IQGAP1 gene|IQGAP1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,PSMG3-AS1 gene|PSMG3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSMG3-AS1 gene|PSMG3-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lactones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lactones Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sapphire,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sapphire Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Antioxidants,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Antioxidants Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,HER2/Neu Positive,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2/Neu Positive HER2-positive carcinoma of breast,Female Breast Cancer
AUGMENTS,FBXW5 gene|FBXW5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FBXW5 gene|FBXW5 Breast Carcinoma,Female Breast Cancer
AFFECTS,MIR451A wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR451A wt Allele Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinases Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,EPDR1 gene|EPDR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EPDR1 gene|EPDR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,bis(4-hydroxyphenyl)sulfone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,bis(4-hydroxyphenyl)sulfone Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SPINT1-AS1 gene|SPINT1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPINT1-AS1 gene|SPINT1-AS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXCR1 gene|CXCR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR1 gene|CXCR1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR26B gene|MIR26B,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR26B gene|MIR26B Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,TUFT1 gene|TUFT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TUFT1 gene|TUFT1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Alternative Splicing,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,S100P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,S100P Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,glycogen synthase kinase 3 beta,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,glycogen synthase kinase 3 beta Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Ingredient,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Ingredient Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ZG16B gene|ZG16B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZG16B gene|ZG16B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,triptolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,triptolide Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Photosensitizing Agents,Carcinoma breast stage IV,0.0,Female Breast Cancer,Chemical Viewed Functionally,Photosensitizing Agents Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Isolate - microorganism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Isolate - microorganism Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Potassium Channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Potassium Channel Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KMT5A gene|KMT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KMT5A gene|KMT5A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNHG7 gene|SNHG7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG7 gene|SNHG7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,resistin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,resistin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Treatment Status,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Treatment Status Breast Carcinoma,Female Breast Cancer
DISRUPTS,SETD2 gene|SETD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SETD2 gene|SETD2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"BMPR1B protein, human|BMPR1B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BMPR1B protein, human|BMPR1B Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,PKM gene|PKM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PKM gene|PKM Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Lymphangiogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Lymphangiogenesis Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Nucleic Acid Probes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nucleic Acid Probes Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,shikonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,shikonin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Suppressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Suppressor Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,berbamine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,berbamine Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Germ-Line Mutation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"Discoidin Domain-Containing Receptor 2, Human|DDR2",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,"Discoidin Domain-Containing Receptor 2, Human|DDR2 Breast Carcinoma",Female Breast Cancer
AUGMENTS,MEDAG gene|MEDAG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEDAG gene|MEDAG Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cell Cycle Control,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Cell Cycle Control Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MicroRNAs,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Inflammatory Breast Carcinoma,Female Breast Cancer
DISRUPTS,Protein Quaking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Quaking Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malaria,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Malaria Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,arginine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,STIP1 gene|STIP1|TFIP11|NECAB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STIP1 gene|STIP1|TFIP11|NECAB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of oropharynx,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of oropharynx Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,prolactin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Non-infiltrating lobular carcinoma,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Neoplastic Process,Non-infiltrating lobular carcinoma Recurrent Breast Carcinoma,Recurrent Breast Cancer
DISRUPTS,Stat3 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Collagen Type IV,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Collagen Type IV Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,TPX2 gene|TPX2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TPX2 gene|TPX2 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,IFNGR1 gene|IFNGR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IFNGR1 gene|IFNGR1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,proline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,proline Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,VEGFA gene|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGFA gene|VEGFA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Echogenic,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Echogenic Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,crocin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,crocin Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,Open Reading Frames,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Open Reading Frames Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR374B gene|MIR374B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR374B gene|MIR374B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AQP3 gene|AQP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AQP3 gene|AQP3 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Metric (substance),Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Substance,Metric (substance) Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,FGD5-AS1 gene|FGD5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGD5-AS1 gene|FGD5-AS1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SNHG15 gene|SNHG15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG15 gene|SNHG15 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,methylate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,methylate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ginsenoside Rh1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ginsenoside Rh1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNA 19B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 19B Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,cryptotanshinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cryptotanshinone Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,cyclin A2|CCNA2,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,cyclin A2|CCNA2 Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,alpha-hydroxyglutarate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,alpha-hydroxyglutarate Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ZNF213 gene|ZNF213,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZNF213 gene|ZNF213 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SRSF1 gene|SRSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRSF1 gene|SRSF1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,FAT3 gene|FAT3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FAT3 gene|FAT3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Low expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low expression Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MYC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,MYC Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Tumor Burden,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Tumor Burden Carcinoma breast stage IV,Female Breast Cancer
CAUSES,Transgenes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Transgenes Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,metformin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,metformin Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,IL6ST gene|IL6ST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL6ST gene|IL6ST Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Cytokinesis,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Biologically Active Substance,Cytokinesis Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,NME1 gene|NME1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Challenge:Type:Point in time:^Patient:Nominal,HER2-negative breast cancer,0.0,Female Breast Cancer,Other,Challenge:Type:Point in time:^Patient:Nominal HER2-negative breast cancer,Female Breast Cancer
AUGMENTS,CUL4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CUL4B Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,HOXB7 gene|HOXB7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXB7 gene|HOXB7 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"BAG Family Molecular Chaperone Regulator 3, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"BAG Family Molecular Chaperone Regulator 3, human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Dietary carbohydrate intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Dietary carbohydrate intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mouse Model,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Mouse Model Breast Carcinoma,Female Breast Cancer
AFFECTS,cinnamic aldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cinnamic aldehyde Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,FBXO15 gene|FBXO15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO15 gene|FBXO15 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,RNA Polymerase I|ERVW-4,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Polymerase I|ERVW-4 Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,FGD5-AS1 gene|FGD5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGD5-AS1 gene|FGD5-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TRAPPC10 gene|TRAPPC10,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TRAPPC10 gene|TRAPPC10 Breast Carcinoma,Female Breast Cancer
AUGMENTS,CT83 gene|CT83,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CT83 gene|CT83 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Thyroid microsomal antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thyroid microsomal antibodies Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,cytokine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,cytokine Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,PSMC2 gene|PSMC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSMC2 gene|PSMC2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Cell Adhesion Molecules,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Adhesion Molecules Malignant neoplasm of breast,Female Breast Cancer
CAUSES,FTO gene|FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FTO gene|FTO Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,4-aminohippuric acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,4-aminohippuric acid Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Increased risk,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Increased risk Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,PTPRT gene|PTPRT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPRT gene|PTPRT Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Serine-tRNA Ligase|TRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Serine-tRNA Ligase|TRNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Coal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Coal Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,PCYT1A wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PCYT1A wt Allele Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BRD4 gene|BRD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRD4 gene|BRD4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PDCD11 gene|PDCD11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PDCD11 gene|PDCD11 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Beta-glucuronidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Beta-glucuronidase Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ruyiping,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,ruyiping Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Multiparity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Multiparity Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Glucocorticoids,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,Glucocorticoids Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Genes,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,Genes Carcinoma of Male Breast,Male Breast Cancer
AFFECTS,MIR31 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR31 wt Allele Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,AEBP2 gene|AEBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AEBP2 gene|AEBP2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Breast Density,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Breast Density Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,erbB-2 Receptor|ERBB2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,erbB-2 Receptor|ERBB2 Inflammatory Breast Carcinoma,Female Breast Cancer
AUGMENTS,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,HOXA1 gene|HOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXA1 gene|HOXA1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Progranulins,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Progranulins Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,DPP8 gene|DPP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP8 gene|DPP8 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ACE2 gene|ACE2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ACE2 gene|ACE2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PCNT gene|PCNT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCNT gene|PCNT Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TIMM17A gene|TIMM17A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIMM17A gene|TIMM17A Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXCR5 gene|CXCR5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR5 gene|CXCR5 Breast Carcinoma,Female Breast Cancer
AFFECTS,DPP7 gene|DPP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP7 gene|DPP7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Phytochemical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemical Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR34A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MIR34A Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Neoadjuvant Therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,Neoadjuvant Therapy Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,PALB2 gene|PALB2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,PALB2 gene|PALB2 Carcinoma of Male Breast,Female Breast Cancer
AFFECTS,Lymphocyte antigen CD82|CD82,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Lymphocyte antigen CD82|CD82 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SMUG1 gene|SMUG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMUG1 gene|SMUG1 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,GABPA|NFE2L2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SEMA4C gene|SEMA4C,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SEMA4C gene|SEMA4C Breast Carcinoma,Female Breast Cancer
DISRUPTS,SEPTIN9 gene|SEPT9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEPTIN9 gene|SEPT9 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,UBQLN1 gene|UBQLN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBQLN1 gene|UBQLN1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cyclin-dependent kinase inhibitor 1B|IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cyclin-dependent kinase inhibitor 1B|IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,human papillomavirus,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,human papillomavirus Breast Carcinoma,Female Breast Cancer
AFFECTS,PITPNM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,PITPNM1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ADAR gene|ADAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAR gene|ADAR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,RBMS3 gene|RBMS3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RBMS3 gene|RBMS3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SOX10 gene|SOX10,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,SOX10 gene|SOX10 Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,Cell Growth,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Cell Growth Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,MAL2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Ribosomal Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Ribosomal Proteins Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Interventional procedure,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Interventional procedure Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,T-Cell Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,T-Cell Receptor Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Immunohistochemistry,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Immunohistochemistry Breast Carcinoma,Female Breast Cancer
DISRUPTS,CDK1 gene|CDK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK1 gene|CDK1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Indicators,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Breast Carcinoma,Female Breast Cancer
AFFECTS,ketamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ketamine Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ADAMTS9-AS1 gene|ADAMTS9-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAMTS9-AS1 gene|ADAMTS9-AS1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,NAA50 gene|NAA50,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAA50 gene|NAA50 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Analgesics, Opioid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Analgesics, Opioid Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Inflammatory Bowel Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Inflammatory Bowel Diseases Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,FBXL16 gene|FBXL16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXL16 gene|FBXL16 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Triglycerides,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Lipid,Triglycerides estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,"N-methylsulfonyl-12,12-dibromododec-11-enamide",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"N-methylsulfonyl-12,12-dibromododec-11-enamide Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,PVT1 gene|PVT1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PVT1 gene|PVT1 Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Dietary Polyphenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dietary Polyphenol Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,VIRMA gene|VIRMA,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Core needle biopsy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,Core needle biopsy malignant neoplasm of breast staging,Female Breast Cancer
AUGMENTS,HOTAIR gene|HOTAIR,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,MicroRNAs,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,CSTB wt Allele|CST6,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,CSTB wt Allele|CST6 Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,Molecular Target,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Molecular Target Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Thioredoxin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Thioredoxin 1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,LINC00174 gene|LINC00174,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00174 gene|LINC00174 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,quiescence,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,quiescence estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,chromosome loss,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,chromosome loss Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,BCLAF1 gene|BCLAF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCLAF1 gene|BCLAF1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,decitabine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,decitabine Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,NR2F1-AS1 gene|NR2F1-AS1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NR2F1-AS1 gene|NR2F1-AS1 Breast Carcinoma,Female Breast Cancer
AFFECTS,docetaxel,Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,Other,docetaxel Triple-Negative Breast Carcinoma,Female Breast Cancer
AFFECTS,GNG13 gene|GNG13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GNG13 gene|GNG13 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,False Positive,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,False Positive Inflammatory Breast Carcinoma,Female Breast Cancer
AFFECTS,IGLC2 gene|IGLC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IGLC2 gene|IGLC2 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Neoplasm Metastasis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,chemokine receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chemokine receptor Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Food Consumption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Food Consumption Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"herstatin protein, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,IRAK3 gene|IRAK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRAK3 gene|IRAK3 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC2A1 gene|SLC2A1 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,cytidylyl-3'-5'-guanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,cytidylyl-3'-5'-guanosine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MicroRNA 1246,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 1246 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,curcumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,curcumin Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Orosomucoid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Orosomucoid Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,WTAP gene|WTAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WTAP gene|WTAP Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Married (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Married (finding) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"NOS1 protein, human|NOS1|NANOS1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NOS1 protein, human|NOS1|NANOS1 Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,Androgen Receptor,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Androgen Receptor estrogen receptor-positive breast cancer,Female Breast Cancer
AFFECTS,ESR1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,ESR1 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Premature Menopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Premature Menopause Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CALCIUM/VITAMIN D,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Food,CALCIUM/VITAMIN D Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
PREDISPOSES,CGAS gene|CGAS,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,CGAS gene|CGAS Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Postmenopausal status NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Postmenopausal status NOS Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,Cellular Apoptosis Susceptibility Protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cellular Apoptosis Susceptibility Protein Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,carbohydrate analog,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,carbohydrate analog Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,TRIM72 gene|TRIM72,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM72 gene|TRIM72 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Fatty-acid synthase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,Fatty-acid synthase Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Fatty pancreas,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fatty pancreas Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MicroRNA 205-5p,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 205-5p Invasive carcinoma of breast,Female Breast Cancer
AUGMENTS,cholesterol,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Lipid,cholesterol estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,MIR451A wt Allele,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,MIR451A wt Allele Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,secretory protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",secretory protein Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Calcium Signaling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Calcium Signaling Malignant neoplasm of breast,Female Breast Cancer
CAUSES,DUSP8 gene|DUSP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DUSP8 gene|DUSP8 Malignant neoplasm of breast,Female Breast Cancer
COMPLICATES,Adrenal Gland Hyperfunction,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Adrenal Gland Hyperfunction estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,Sodium Butyrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Sodium Butyrate Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ethanol,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,ethanol Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Procedure findings:Finding:Point in time:^Patient:Narrative estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Body position,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body position Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,PSAT1 gene|PSAT1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,PSAT1 gene|PSAT1 Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,CCNE1 gene|CCNE1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,CCNE1 gene|CCNE1 Basal-Like Breast Carcinoma,Female Breast Cancer
AUGMENTS,dehydrodolichyl diphosphate synthase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,dehydrodolichyl diphosphate synthase Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Oxysterols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oxysterols Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,sinomenine hydrochloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,sinomenine hydrochloride Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SIN3A gene|SIN3A,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SIN3A gene|SIN3A Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Malignant neoplasm of breast,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Basal-Like Breast Carcinoma,Female Breast Cancer
PREDISPOSES,MicroRNAs,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Secondary malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,YTHDF3 gene|YTHDF3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YTHDF3 gene|YTHDF3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,"RNA, Long Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,>40 years,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Other,>40 years Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AUGMENTS,PNO1 gene|PNO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PNO1 gene|PNO1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,GSDME gene|GSDME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSDME gene|GSDME Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,TRANSCRIPTION FACTOR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,FERMT1 gene|FERMT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FERMT1 gene|FERMT1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Cell Cycle Checkpoints,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Cell Cycle Checkpoints Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,G-Protein-Coupled Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MIR449A gene|MIR449A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR449A gene|MIR449A Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Hypersensitivity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Hypersensitivity Breast Carcinoma,Female Breast Cancer
AFFECTS,Warburg Effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Warburg Effect Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,CDK18 gene|CDK18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK18 gene|CDK18 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Revival,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Revival Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genes,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Genes Breast Cancer, Familial",Female Breast Cancer
AUGMENTS,ILF3 gene|ILF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ILF3 gene|ILF3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ROS1 gene|ROS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ROS1 gene|ROS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,fluid flow,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,fluid flow Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CCNA2 gene|CCNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNA2 gene|CCNA2 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NSRP1 gene|NSRP1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,NSRP1 gene|NSRP1 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SOX13 gene|SOX13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOX13 gene|SOX13 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Segmental Mastectomy,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,Segmental Mastectomy Female Breast Carcinoma,Female Breast Cancer
AUGMENTS,Methylnitrosourea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Methylnitrosourea Malignant neoplasm of breast,Female Breast Cancer
CAUSES,MAFG-DT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAFG-DT gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,LINC00665 gene|LINC00665,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00665 gene|LINC00665 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,JAG1 gene|JAG1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,JAG1 gene|JAG1 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,PIEZO1 gene|PIEZO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIEZO1 gene|PIEZO1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,CHAC1 gene|CHAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHAC1 gene|CHAC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Retinoblastoma Protein|RB1,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Retinoblastoma Protein|RB1 Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Discoidin Domain Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Discoidin Domain Receptor 1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,inecalcitol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,inecalcitol Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SDC1 gene|SDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,specific immunity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,specific immunity Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,H19 gene|H19|HILS1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,CDH2 gene|CDH2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,CDH2 gene|CDH2 Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Diagnosis,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Other,Diagnosis Carcinoma of Male Breast,Male Breast Cancer
CAUSES,Molecular Target,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Molecular Target Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Candidate Disease Gene,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Candidate Disease Gene Breast Cancer, Familial",Female Breast Cancer
AFFECTS,"Membrane Potential, Mitochondrial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Membrane Potential, Mitochondrial Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,asparagine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,asparagine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SERPINB2 gene|SERPINB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SERPINB2 gene|SERPINB2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Leisure physical activity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Leisure physical activity Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,DST gene|DST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DST gene|DST Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ISYNA1 gene|ISYNA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ISYNA1 gene|ISYNA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"TLR2 protein, human|TLR2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TLR2 protein, human|TLR2 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,TFE3 gene|TFE3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TFE3 gene|TFE3 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"FRAP1 protein, human|MTOR",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Vitamin D Analog,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Food,Vitamin D Analog Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,ST8SIA6-AS1 gene|ST8SIA6-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ST8SIA6-AS1 gene|ST8SIA6-AS1 Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Primary Sj??gren's syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Primary Sj??gren's syndrome Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,margetuximab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,margetuximab Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"ERCC5 protein, human|ERCC5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ERCC5 protein, human|ERCC5 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,PROM1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,PROM1 Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,gamma-Glutamylcyclotransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,gamma-Glutamylcyclotransferase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SLC16A3 gene|SLC16A3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SLC16A3 gene|SLC16A3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,ELOVL5 gene|ELOVL5,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ELOVL5 gene|ELOVL5 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Transforming Growth Factor beta Receptors,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Receptors estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Adipokines,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Adipokines Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,PTPN18 gene|PTPN18,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PTPN18 gene|PTPN18 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ezogabine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ezogabine Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SPI1 gene|SPI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPI1 gene|SPI1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,SARS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SARS1 gene Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,VDR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,VDR Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,tumor growth,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,tumor growth Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"Radiosurgery, Stereotactic",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,"Radiosurgery, Stereotactic Triple Negative Breast Neoplasms",Female Breast Cancer
PREDISPOSES,SEMA3B-AS1 gene|SEMA3B-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEMA3B-AS1 gene|SEMA3B-AS1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Antibody-Drug Conjugates,HER2-negative breast cancer,0.0,Female Breast Cancer,Pharmacologic Substance,Antibody-Drug Conjugates HER2-negative breast cancer,Female Breast Cancer
PREDISPOSES,Phytochemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemicals Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Trichorhinophalangeal dysplasia type I Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Chemoimmunotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Chemoimmunotherapy Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,hla gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,hla gene Malignant neoplasm of breast,Female Breast Cancer
CAUSES,testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,testosterone Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Tandem Repeat Sequences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tandem Repeat Sequences Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SAA1 gene|SAA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SAA1 gene|SAA1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Wild Type,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Wild Type Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Offered,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Offered Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PRSS22 gene|PRSS22,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PRSS22 gene|PRSS22 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,glutamic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,glutamic acid Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Pesticides,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Other,Pesticides Malignant neoplasm of female breast,Female Breast Cancer
PREDISPOSES,copper,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,copper Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Thyroid dysfunction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thyroid dysfunction Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"PTK2 protein, human|PTK2",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTK2 protein, human|PTK2 Secondary malignant neoplasm of breast",Female Breast Cancer
AFFECTS,navitoclax,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,navitoclax estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Heterogeneous-Nuclear Ribonucleoprotein U,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Heterogeneous-Nuclear Ribonucleoprotein U Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,MIR217 gene|MIR217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR217 gene|MIR217 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,dihydrotanshinone I,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,dihydrotanshinone I Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,TP53 gene|TP53,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,inhibitors,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,inhibitors estrogen receptor-positive breast cancer,Female Breast Cancer
AUGMENTS,pertuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,pertuzumab Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Circulating MicroRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Circulating MicroRNA Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Emotional hypersensitivity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Emotional hypersensitivity Breast Carcinoma,Female Breast Cancer
AUGMENTS,USP46 gene|USP46,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,USP46 gene|USP46 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,BCAR4 gene|BCAR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAR4 gene|BCAR4 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Genetic Carriers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Carriers Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,chromium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,chromium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,TMEM9 gene|TMEM9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMEM9 gene|TMEM9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,USP10 gene|USP10,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,USP10 gene|USP10 Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,Neoplastic Cell Transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplastic Cell Transformation Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Hormone Receptor Positive,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,Hormone Receptor Positive Invasive carcinoma of breast,Female Breast Cancer
AFFECTS,Positive Regulation of Apoptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positive Regulation of Apoptosis Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,IFNK gene|IFNK,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,IFNK gene|IFNK Basal-Like Breast Carcinoma,Female Breast Cancer
AFFECTS,sulfoenolpyruvate,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,sulfoenolpyruvate Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Surviving free of recurrence of neoplastic disease,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Surviving free of recurrence of neoplastic disease contralateral breast cancer,Female Breast Cancer
PREDISPOSES,IGSF9 gene|IGSF9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGSF9 gene|IGSF9 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Liver carcinoma,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Liver carcinoma Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,icariin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,icariin Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,TP53 gene|TP53,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Pyruvate Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pyruvate Kinase Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dietary Intake,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Dietary Intake estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Performance,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Performance Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,omega-3 fatty acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,omega-3 fatty acids Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Pyrimidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Pyrimidine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Soluble Interleukin-6 Receptor Subunit Alpha, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"Soluble Interleukin-6 Receptor Subunit Alpha, Human Malignant neoplasm of breast",Female Breast Cancer
DISRUPTS,CMTM7 gene|CMTM7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CMTM7 gene|CMTM7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Genes, Duplicate",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Duplicate Malignant neoplasm of breast",Female Breast Cancer
CAUSES,Sphingolipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Sphingolipids Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,NAD+ kinase,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,NAD+ kinase Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,GDF2 gene|GDF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GDF2 gene|GDF2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ENPP1 gene|ENPP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ENPP1 gene|ENPP1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,ANXA1 gene|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANXA1 gene|ANXA1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Fibronectins,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Other,Fibronectins Inflammatory Breast Carcinoma,Female Breast Cancer
CAUSES,fructose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,fructose Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,GLIS3 gene|GLIS3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GLIS3 gene|GLIS3 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,ABCG1 gene|ABCG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCG1 gene|ABCG1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Mucin-1 Antigen,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Mucin-1 Antigen Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"estrogen receptor alpha, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","estrogen receptor alpha, human Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,DACH1 gene|DACH1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,DACH1 gene|DACH1 Carcinoma of Male Breast,Female Breast Cancer
PREDISPOSES,Skin tanning,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Skin tanning Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,"DKK3 protein, human|DKK3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DKK3 protein, human|DKK3 Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,DPT gene|DPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPT gene|DPT Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,MYC,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,MYC Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Experimental Result,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Experimental Result Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,Diagnostic assessment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Diagnostic assessment Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Puberty,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Other,Puberty estrogen receptor-positive breast cancer,Female Breast Cancer
PREDISPOSES,Oral health,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Oral health Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CLDN6 gene|CLDN6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CLDN6 gene|CLDN6 Breast Carcinoma,Female Breast Cancer
AFFECTS,TNF receptor-associated factor 6|TRAF6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TNF receptor-associated factor 6|TRAF6 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast",Female Breast Cancer
CAUSES,NORAD gene|NORAD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NORAD gene|NORAD Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,AKR1A1 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,AKR1A1 wt Allele Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,CXCL8 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ethanol,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Other,ethanol Female Breast Carcinoma,Female Breast Cancer
AUGMENTS,LONG INTERGENIC NONCODING RNA PINKY|PNKY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",LONG INTERGENIC NONCODING RNA PINKY|PNKY Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Acetyl-CoA Carboxylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Acetyl-CoA Carboxylase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Secretome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Secretome Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,histone deacetylase 2,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Other,histone deacetylase 2 Invasive carcinoma of breast,Female Breast Cancer
PREDISPOSES,Cancer Vaccines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Vaccines Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"interleukin-1, beta|IL1A|IL1B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,"interleukin-1, beta|IL1A|IL1B Malignant neoplasm of breast",Female Breast Cancer
AFFECTS,MIR223 gene|MIR223,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR223 gene|MIR223 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,abemaciclib,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,abemaciclib Carcinoma breast stage IV,Female Breast Cancer
AFFECTS,SPARCL1 gene|SPARCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPARCL1 gene|SPARCL1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SFRP2 gene|SFRP2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SFRP2 gene|SFRP2 Noninfiltrating Intraductal Carcinoma,Female Breast Cancer
AFFECTS,"YAP1 protein, human|YAP1",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","YAP1 protein, human|YAP1 Secondary malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,MAP kinase kinase kinase 7,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,MAP kinase kinase kinase 7 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,"SFRP1 protein, human|SFRP1",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SFRP1 protein, human|SFRP1 Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AFFECTS,Treatment Protocols,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Treatment Protocols Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Immunologic Factors,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,Immunologic Factors Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,cathepsin Z,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,cathepsin Z Early-Stage Breast Carcinoma,Female Breast Cancer
PREDISPOSES,Basis,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Basis Secondary malignant neoplasm of breast,Female Breast Cancer
AFFECTS,TPBG gene|TPBG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPBG gene|TPBG Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Estrogen Receptor Status - Clinical Trial Eligibility Criteria,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Status - Clinical Trial Eligibility Criteria Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Pathologic Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Pathologic Processes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DSCR9 gene|DSCR9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DSCR9 gene|DSCR9 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,"DDIT3 protein, human|DDIT3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DDIT3 protein, human|DDIT3 Malignant neoplasm of breast",Female Breast Cancer
AUGMENTS,nerve growth factor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,nerve growth factor Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Ultrasonography,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Other,Ultrasonography malignant neoplasm of breast staging,Female Breast Cancer
PREDISPOSES,Nicotinamide N-Methyltransferase,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,Nicotinamide N-Methyltransferase Carcinoma breast stage IV,Female Breast Cancer
AUGMENTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Biological Response Modifiers Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,garcinone E,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,garcinone E Carcinoma breast stage IV,Female Breast Cancer
DISRUPTS,GW 4869,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,GW 4869 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,imipramine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,imipramine Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,ARHGAP25 gene|ARHGAP25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP25 gene|ARHGAP25 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Abnormal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Abnormal Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,NLRP12 gene|NLRP12,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NLRP12 gene|NLRP12 Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,FBXW2 gene|FBXW2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXW2 gene|FBXW2 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"RTN4 protein, human|RTN4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","RTN4 protein, human|RTN4 Malignant neoplasm of breast",Female Breast Cancer
CAUSES,interleukin-8,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,interleukin-8 Secondary malignant neoplasm of breast,Female Breast Cancer
CAUSES,TAF8 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,TAF8 wt Allele Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,PEDS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PEDS1 gene Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,IL19 gene|IL19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL19 gene|IL19 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Lactates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Lactates Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,DNAJB6 gene|DNAJB6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DNAJB6 gene|DNAJB6 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,UBE3B gene|UBE3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE3B gene|UBE3B Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,ZNF703 gene|ZNF703,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF703 gene|ZNF703 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Extraction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extraction Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,metformin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,metformin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,Performance,Papillary carcinoma of the breast,0.0,Female Breast Cancer,Other,Performance Papillary carcinoma of the breast,Female Breast Cancer
AFFECTS,Terpenes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Terpenes Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,OTUB1 gene|OTUB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OTUB1 gene|OTUB1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,MAF1 gene|MAF1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,MAF1 gene|MAF1 HER2-positive carcinoma of breast,Female Breast Cancer
AFFECTS,magnoflorine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,magnoflorine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Squalene monooxygenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Squalene monooxygenase Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"plY protein, Streptococcus pneumoniae",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","plY protein, Streptococcus pneumoniae Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,Malignant neoplasm of thyroid,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of thyroid estrogen receptor-negative breast cancer,Female Breast Cancer
PREDISPOSES,KLF5 gene|KLF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF5 gene|KLF5 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,directive therapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Other,directive therapy Carcinoma breast stage IV,Female Breast Cancer
PREDISPOSES,interleukin-10,HER2-negative breast cancer,0.0,Female Breast Cancer,Other,interleukin-10 HER2-negative breast cancer,Female Breast Cancer
DISRUPTS,iridium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,iridium Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Fresh fruit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Fresh fruit Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Does ask questions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Does ask questions Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,zinc pyrithione,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",zinc pyrithione Triple Negative Breast Neoplasms,Female Breast Cancer
DISRUPTS,Transgenes,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,Transgenes Secondary malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SFRP2 gene|SFRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFRP2 gene|SFRP2 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,SOCS3 gene|SOCS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOCS3 gene|SOCS3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Post-mastectomy radiotherapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Post-mastectomy radiotherapy Breast Carcinoma,Female Breast Cancer
AFFECTS,Focal Adhesion Kinase 1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Focal Adhesion Kinase 1 Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,KDM2A gene|KDM2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM2A gene|KDM2A Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,oxaliplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,oxaliplatin Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,SIAE gene|SIAE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIAE gene|SIAE Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,secreted frizzled related protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",secreted frizzled related protein 1 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,LINC02086 gene|LINC02086,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC02086 gene|LINC02086 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SERPINA5 gene|SERPINA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SERPINA5 gene|SERPINA5 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Dried fruit intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Dried fruit intake Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Aptamer,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Other,Aptamer Breast Carcinoma,Female Breast Cancer
AFFECTS,GRAMD1B gene|GRAMD1B,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GRAMD1B gene|GRAMD1B Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,DACH1 gene|DACH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DACH1 gene|DACH1 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"PIK3CB protein, human|PIK3CB",Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Carcinoma breast stage IV",Female Breast Cancer
PREDISPOSES,GBP1 gene|GBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GBP1 gene|GBP1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,MBD4 gene|MBD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MBD4 gene|MBD4 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Vitamin supplementation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vitamin supplementation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,gene therapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,gene therapy Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,MUTYH Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MUTYH Gene Mutation Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Tobacco,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Tobacco Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Detected (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Detected (finding) Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Carcinogens,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Basal-Like Breast Carcinoma,Female Breast Cancer
CAUSES,Malignant neoplasm of thyroid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of thyroid Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,CHD4 gene|CHD4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CHD4 gene|CHD4 Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,SLC7A11 gene|SLC7A11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC7A11 gene|SLC7A11 Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Liposomes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Liposomes Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,"CREB3L4 protein, human|CREB3L4",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CREB3L4 protein, human|CREB3L4 Triple Negative Breast Neoplasms",Female Breast Cancer
DISRUPTS,beta catenin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,beta catenin Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,tomography,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Other,tomography Early-Stage Breast Carcinoma,Female Breast Cancer
DISRUPTS,NOTCH3 gene,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,NOTCH3 gene Carcinoma breast stage IV,Female Breast Cancer
CAUSES,ROS1 wt Allele|ROS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,ROS1 wt Allele|ROS1 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,EPYC gene|EPYC,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,EPYC gene|EPYC Breast Carcinoma,Female Breast Cancer
AFFECTS,Neoadjuvant Systemic Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Neoadjuvant Systemic Therapy Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Nuclear magnetic resonance normal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Nuclear magnetic resonance normal Malignant neoplasm of breast,Female Breast Cancer
CAUSES,EIF4E gene|EIF4E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EIF4E gene|EIF4E Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,Stat3 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,"DICER1 protein, human|DICER1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,reserpine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,reserpine Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,MGP gene|MGP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MGP gene|MGP Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Cytokeratin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Cytokeratin Triple Negative Breast Neoplasms,Female Breast Cancer
PREDISPOSES,VAMP7 gene|VAMP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VAMP7 gene|VAMP7 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,"Discharge, body substance",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Substance,"Discharge, body substance Noninfiltrating Intraductal Carcinoma",Female Breast Cancer
AUGMENTS,QSOX2 gene|QSOX2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,QSOX2 gene|QSOX2 Triple Negative Breast Neoplasms,Female Breast Cancer
AUGMENTS,NUP155 gene|NUP155,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NUP155 gene|NUP155 Breast Carcinoma,Female Breast Cancer
AFFECTS,scopolamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,scopolamine Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,ZNF410 gene|ZNF410,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF410 gene|ZNF410 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,"Culture Media, Conditioned",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Culture Media, Conditioned Malignant neoplasm of breast",Female Breast Cancer
CAUSES,CD8A wt Allele|CD8A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,CD8A wt Allele|CD8A Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Luteinizing Hormone-releasing Hormone Agonist,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Luteinizing Hormone-releasing Hormone Agonist Carcinoma of Male Breast,Female Breast Cancer
AFFECTS,Saturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Saturated fat Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Histone Deacetylase|HDAC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histone Deacetylase|HDAC9 Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Sugars,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sugars Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Scutellaria barbata extract,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Scutellaria barbata extract Triple Negative Breast Neoplasms,Female Breast Cancer
AFFECTS,Erianin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Other,Erianin Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,"CDK12 protein, human|CDK12",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDK12 protein, human|CDK12 HER2-positive carcinoma of breast",Female Breast Cancer
AUGMENTS,MIR190B gene|MIR190B,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,MIR190B gene|MIR190B estrogen receptor-positive breast cancer,Female Breast Cancer
DISRUPTS,Friend Leukemia Integration 1 Transcription Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Friend Leukemia Integration 1 Transcription Factor Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SCARNA4 gene|SCARNA4,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,SCARNA4 gene|SCARNA4 Early-Stage Breast Carcinoma,Female Breast Cancer
AUGMENTS,"RAI3 protein, human|GPRC5A",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","RAI3 protein, human|GPRC5A Triple Negative Breast Neoplasms",Female Breast Cancer
AFFECTS,"PLK1 protein, human|PLK1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PLK1 protein, human|PLK1 Malignant neoplasm of breast",Female Breast Cancer
PREDISPOSES,Total body fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Total body fat Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,JMJD1C gene|JMJD1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JMJD1C gene|JMJD1C Malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,PPP1R21 gene|PPP1R21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPP1R21 gene|PPP1R21 Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,BICD1 gene|BICD1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BICD1 gene|BICD1 Triple Negative Breast Neoplasms,Female Breast Cancer
CAUSES,Secretome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Secretome Malignant neoplasm of breast,Female Breast Cancer
AUGMENTS,SLC16A3 gene|SLC16A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC16A3 gene|SLC16A3 Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Hypertensive disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hypertensive disease Malignant neoplasm of breast,Female Breast Cancer
DISRUPTS,Triterpenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Triterpenes Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,ANXA9 gene|ANXA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANXA9 gene|ANXA9 Malignant neoplasm of breast,Female Breast Cancer
CAUSES,Mammary Neoplasms,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Other,Mammary Neoplasms Secondary malignant neoplasm of breast,Female Breast Cancer
PREDISPOSES,Histopathology finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Other,Histopathology finding Malignant neoplasm of breast,Female Breast Cancer
AFFECTS,Gene Mutation,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Gene Mutation Breast Cancer, Familial",Female Breast Cancer
PREDISPOSES,EMP2 gene|EMP2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EMP2 gene|EMP2 Triple Negative Breast Neoplasms,Female Breast Cancer
